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ABSTRACT
This thesis describes the total synthesis of the carbocyclic analogue of

hydantocidin and its 6,1-di-epi diastereoisomer. The essential feature of the carbocycli
analogue of hydantocidin was the spirocyclic structure, which consisted of a
functionalised cyclopentane ring attached via a spiro carbon to a hydantoin ring. This
structure was produced via a phosphine-catalysed cycloaddition reaction of an
appropriate alkyne or allene with an electron deficient alkene. Two regioisomers are
possible from this cycloaddition, regioisomers A and B.
Our retro-synthetic analysis revealed two possible pathways for the synthesis of
the spirocyclic ring system. In pathway A, the functionalised cyclopentane can be
produced first with functional groups set up for subsequent hydantoin ring formation,
while in pathway B, the hydantoin forms part of the electron deficient alkene, as a 5methylene hydantoin, in the cycloaddition reaction.
Chapter 2 describes our attempts at pathway A using the alkyne, ethyl 2butynoate, as the 3 carbon synthon and methyl 2-[(diphenylmethylene)amino]acrylate as
the electron deficient alkene. Only regioisomer A, 3-ethyl, 1-methyl 1[(diphenylmethylene)amino]-3-cylcopentene-l,3-dicarboxylate, was produced. The
hydantoin component was produced by conversion of this cycloadduct to a urea
derivative upon treatment with KCNO in HCI followed by base catalysed hydantoin
cyclisation. The study showed that protection of the nitrogens of the hydantoin was
necessary for further synthetic transformations.
Chapter 3 showed, in preparation for pathway B, that N, AT-diprotected 5methylene hydantoins could be prepared from amino acids cystine, 5-methyl cysteine
and serine. The latter was shown to be the most versatile in synthetic manipulation. The
phosphine-catalysed cycloaddition reaction of these 5-methylene hydantoins with the
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achiral alkyne, ethyl 2-butynoayte, and achiral allene, ethyl 2,3-butadienoate, discussed
in Chapter 4, also showed preference for formation of regioisomer A. Using Oppolzers
chiral camphorsultam as the chiral auxiliary on an A^-2-alkynoate derivative, optically
active cycloadducts of regioisomer A could be produced and readily separated by
column chromatography. In contrast the use of an Af-2-aikynoate derivative of an

oxazolidin-2-one resulted in reversal of regioselectivity, that is, preference for format
of regioisomer B. Furthermore, the use of (4S)-benzyl-2-oxazolidinone as the chiral N2-alkynoate oxazolidinone derivative gave diastereoselective products of regioisomer B.
To complete the total synthesis of carbocyclic hydantocidin and its 6,7-dipimer,
the cycloadduct ethyl l,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-7-ene-7carboxylate, regioisomer A of the phosphine-catalysed cycloaddition reaction,
underwent a series of synthetic transformations, as discussed in Chapter 5, including;
deconjugation of the double bond, ds-dihydroxylation of the double bond, protection of
the alcohols, reduction of the ester group to an alkyl alcohol and deprotection of the Nbenzyl and O-acetates.

HO^/-OH

HO—O
HN^V0
O H
carbocyclic hydantocidin

6,7-di-ep/-carbocyclic hydantocidin

COXc

(V-COXc
R-N

Xr°

/

Ft'
methylene hydantoin

regioisomer A

R1 R 2
regioisomer B

CHAPTER 1

http://www.rce.rutqers.edu/weeds/index-thumbnail.asp

W e e d n a m e : Dodder, Cuscuta spp., is a parasitic plant. This weed is
the yellow string like plant that wraps itself around the host plant. It is
yellow because it has no chlorophyll and thus it penetrates the host
plant with haustoria and derives its food from the host plant.

Chapter 1

1

C H A P T E R 1 - Introduction

1.1 IMPORTANCE AND DEVELOPMENT OF HERBICIDES
Herbicides are substances that kill plants or inhibit their normal growth. They

are often used in the agricultural industry as the easiest and most effective form of we
control.1 It has been reported that 75 % of known weed species are responsible for over

98 % of weed inflicted crop losses while these inflicted losses accounts for over 30 % o
potential total crop production.2 An advantage in using herbicides as a form of weed
control is that they are, in general, considered to be more environmentally sustainable

than the alternative practice of cultivation or tillage.3 The option of cultivation destr
soil structure, which leads to moisture loss and possibly erosion.
Herbicides have been around since the late 1800's. These early herbicides were
mainly inorganic and included the use of ash and salt derivatives such as solutions of

sulphuric acid, iron sulphate, copper nitrate and sodium arsenite. It was not until 1932,
with the development of derivatives of 2,4-dinitrophenols, a compound similar to plant
hormones, that the use of organic herbicides began.4 Now there are many commercially
available organic herbicides and their use is ubiquitous.
Consequently, over the many years of using these commercially available
herbicides, a growing population of herbicide resistant weeds has emerged. Figure 1.1
shows the chronological increase in unique cases of herbicide resistant weeds
worldwide. By the year 2000 the number of resistant biotypes had escalated to over 200.

Often farmers use the same herbicide year after year and thus natural selection has been
the predominant reason for this exponential trend in herbicide resistance.5(
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Figure 1.1 The chronological increase in unique cases of herbicide resistant weeds
worldwide.
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The problems associated with herbicide resistance has only now become

apparent as the turnover in weed growth and herbicide use is annual, unl

resistance in bacteria, which has a much smaller time frame. However, th

trend suggests that more and more different weed biotypes are becoming r
annually.

Currently in Australia, transgenic crops that are resistant to herbicide

developed as a form of weed control in addition to herbicides.3 The bene

approach is that it can actually reduce the overall amount of herbicides

Farmers often treat their land before plantation with herbicides in anti
competing weeds. With the design of transgenic crops, the herbicide can

in higher concentrations if necessary, only if weeds become the better c
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increase the safety of growing transgenic crops, the genes for herbicide resistance that
are incorporated into them are from non-plant sources such as bacteria. However,

despite the advantages of this research, consumers are still concerned with the safety
consuming transgenic crops.
At the moment, the agricultural industry is educating farmers to use different

herbicides or a combination of different herbicides every year to reduce the potential
natural selection for more herbicide-resistant weeds.5,6 However, despite the large
number of herbicides available on the market, surprisingly there are only about 15
known enzymatic targets which herbicides act upon.5'6'8'9 The number of weed biotypes
that are becoming resistant in each class of herbicide is increasing (Figure 1.2).

Figure 1.2 - T h e chronological increase in the n u m b e r of herbicide resistant weeds
for several herbicides in the world 7
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Hence, the limited number of mechanisms of herbicide attack and the growing concern
of herbicide resistance has resulted in a great demand for the development of new
herbicides with novel modes of action.

1.2 DISCOVERY OF HYDANTOCIDIN
Hydantocidin (1) is a naturally occurring spironucleoside that was first isolated
from the culture broth of Streptomyces hygroscopicus SANK 63584 by the Sankyo
Company in Japan.10 Later studies showed that it was present in other strains of
Streptomyces including, Tu-247411 and A1491.12 Structurally, it features a
spirohydantoin attached to D-ribofuranose at the anomeric position (Figure 1.3).
However biologically, it exhibited potent non-selective herbicidal activities against
annual weeds and perennial weeds10 with an efficacy similar to that of glyphosate. In
contrast, the phytotoxin showed low toxicity towards microorganisms, fungi, fish and
10

mice. In mice it had a L D 5 0 > lOOOmg/kg.

Figure 1.3 Various forms of Hydantocidin
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Further studies showed that hydantocidin was inactive in vitro studies and only
displayed phytotoxic activity in vivo studies. This led to the discovery that hydantocidin
acted as a proherbicide, being phosphorylated at the 5' position in vivo.13 In the
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phosphorylated form (2) it strongly binds to its target enzyme, adenylate succinate

synthetase (Adss).9'14,15 This is an enzyme involved in de novo purine synthesis in pla
that converts inosine monophosphate (IMP) to adenosine monophosphate (AMP)
(Scheme 1.1), an enzyme system that no current herbicide targets. It was also shown
that hydantocidin was a competitive inhibitor of IMP synthesis with a Kj of 22 nM,
which is a 1000 times stronger than its competitor. Adss is also site of action for
several antibiotics, including hadacidin and alanosine16 suggesting that derivatives
hydantocidin that inhibit this enzyme may also have use in therapeutic applications.

O
// Y
NH
synthase
H203PO-, 0 N^N^ ^ H203PO-, 0 N^V
l/ N
2. adenylosuccinate
\ /
lyase
V
HO OH HO OH
IMP AMP
Scheme 1.1 Adss converts I M P to A M P

NH 2
</ ]j "J
V N
\ /

A comparison of the structure of 2 with I M P and A M P showed that the
phosphorylated D-ribofuranose moiety was a common component to all three
compounds. Studies have shown this common component directed the compounds to

the active site of the synthetase enzyme, although recognition of these compounds by
the enzyme was primarily through their negatively charged phosphate groups.14 X-ray

crystallographic analysis of the Adss-inhibitor complex of phosphorylated hydantocid
2, established that 2 bound to the same active site and in the same way as AMP, the
natural feedback regulator of the enzyme [Figure 1.4].14'17 The X-ray analysis also
showed that the hydroxyl groups in the ribose ring were positioned to interact, via

hydrogen bonds, with several amino acid residues [Figure 1.4]. It also appeared that
favourable hydrogen bond interactions with the hydantoin ring and its restricted

6
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conformation at the spiro carbon enabled 2 to be held in the active site longer and hence
m a d e it a better competitor.14

Figure 1.4 - Interaction of (2) with the active site of Adss14
Dashed lines represent donor-acceptor interactions or coordination
bonds less than 3.2 A long. Ligands are drawn with bold lines.
(+) O indicates interaction with water molecules
Asn38

Thr129

Thr128
0 734 *;•-'
O609

Arg 303

Asp 114

Gly 127

Ser240

He 126

Arg 143*

Interactions involving
the a-phosphate

Interactions involving
the ribose and hydantoin

.10

The fermentation yield of hydantocidin from Streptomyces was low

and thus

there was a drive for the synthesis of optically active hydantocidin and its fourteen o
possible diastereoisomers around its four stereogenic centres. " However, these
studies showed that only the natural configuration of hydantocidin showed any
phytotoxic activity. Furthermore, deoxy derivatives of hydantocidin, that is compounds
without the hydroxyl groups, also revealed a dramatic decrease in activity, signifying
the importance of the hydrogen bonds to the hydroxyl groups.9'24'25 ^-acetyl derivatives
of hydantocidin were found to have no biological activity and therefore further
illustrated the importance of hydrogen bonding to the hydantoin ring.9 Herbicidal
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activity, however, w a s maintained w h e n the oxygen in the furan ring was replaced with
a carbon to form the carbocyclic analogue (3) 26

1.3 SYNTHETIC STUDIES ON HYDANTOCIDIN
M a n y of the synthetic strategies for hydantocidin18'20'23'27'28 and its analogues
have revolved around the use of sugar derivatives to generate the desired
stereochemistry of the hydroxyl groups in the furan ring. Using this strategy,
hexofuranose, hexopyranose and tetrofuranose analogues have been generated.
One problem associated with this strategy is that anomerization at the spiro carbon (C5)

can, and frequently does, occur during the synthesis. On the other hand, the syntheses of
carbocyclic analogues, which have a more stable cyclopentane ring, do not suffer from
this detriment.26'37 Other analogues of hydantocidin have involved modification of the
hydantoin ring38 and it has been shown that thiohydantocidins, where the C2 carbonyl is
replaced with a thiocarbonyl, can be produced22'39 and used without the loss of
herbicidal activity.
Commercially available hydantoin, itself, can be used directly in the synthesis of
hydantocidin18 (1) and its analogues,19'24'25 however, a diverse range of strategies are
available to synthesise the characteristic hydantoin component of hydantocidin. It can
be formed under acidic conditions from an amino acid using potassium cyanate
(KCNO) and hydrochloric acid (HCI). This proceeds via a urea intermediate, which
cyclises through an acid catalysed process, to form the hydantoin ring (Scheme 1.2)
Strong alkali bases can break open the hydantoin ring back to their acids. On the other

hand, the use of a non-alkali base in the presence of a urea and ester as starting materi
leads to hydantoin formation via nucleophilic attack of the deprotonated primary amine
group of the urea on the carbonyl of the ester (Scheme 1.3).30 Moreover, ureas with a
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vicinal alkyl alcohol can also be converted to their hydantoins by oxidation of the

alcohol, which simultaneously induces hydantoin formation (Scheme 1.4). In c

a reductive approach would begin with an a-azoamide (Scheme 1.5). This path

a two step process with the first step involving reduction of the azide func
amine. The second step involves addition of a carbon source, such as

carbonyldiimidazole, to complete the formation of the hydantoin ring. Altern

milder approach can be pursued by reaction of an a-azoamide with tributylph

An iminophosphorane intermediate is formed, which can then react with carbon
to form the hydantoin (Scheme 1.6).
O
COOH

COOH
NH.
NH
O
urea intermediate

KCNO/H+

\ *

NH 2

OH-

amino acid

H+ _ /SvlH
'
OH-

N'
O
hydantoin
H

Scheme 1.2 Synthesis of the hydantoin ring under acidic conditions40

41

0
COOMe

base

NH0

/

NH

'2

o

tf o

iri

methyl ester urea hydantoin
~30

Scheme 1.3 Synthesis of the hydantoin ring under basic conditions
0
OH
oxidation

M ^NH„0 *• ~

/^NH

H' o

alkyl alcohol urea hydantoin
23

Scheme 1.4 Synthesis of the hydantoin ring under oxidative conditions
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S c h e m e 1.5 Synthesis of the hydantoin ring under reductive conditions20
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Scheme 1.6 Synthesis of the hydantoin ring under neutral conditions
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Beginning with a ketone, synthesis of a spiro-hydantoin ring can proceed firstly
by the Strecker reaction or directly via the Bucherer-Berg reaction. Formation of the
hydantoin ring in the latter reaction is a one-pot reaction normally involving hydrogen
cyanide, ammonia and carbon dioxide.42 In practice though, the cyanide source
generally comes from potassium cyanide while the ammonia and carbon dioxide both
come from a m m o n i u m carbonate [Scheme 1.7].37'43"46 Studies have shown that the
mechanism for the synthesis of a hydantoin through the Bucherer-Bergs reaction
proceeds via formation of an a-aminonitrile carbamate intermediate that can cyclise to
form the hydantoin [Scheme 1.7] .4

O
CN
KCN

^O
ketone

NH4C03

NH
O
O

a-aminonitrile carbamate

N
H
O
hydantoin

S c h e m e 1.7 Hydantoin formation using the Bucherer-Berg reaction
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The optional Strecker reaction provides hydantoins in a two step process. It uses
potassium cyanide, as a source of cyanide, but uses ammonium chloride, as a source of
ammonia. Under these conditions, an a-aminonitrile is formed and can be isolated
[Scheme 1.8]. ' The hydantoin ring can subsequently be provided by adding a carbon
source such as ammonium carbonate in methanol water48 or pressurised carbon dioxide
in methanol. It can also be prepared using an appropriate cyanate such as
chlorosulphonyl isocyanide (C1S02NC0) (Scheme 1.8).26
NH4C03/MeOH
»-

KCN ^ \, C0275atm/MeOH

NH CI

<

ANH2

o7~^
CIS02NCO

ketone

a-aminonitrile

hydantoin

Scheme 1.8 Hydantoin formation using first the Strecker reaction

The difference between the Bucherer-Bergs and Strecker reactions can often be

manipulated to control stereoselectivity of the spiro-hydantoin ring formation.37'46 I
been shown that the products from the Bucherer-Berg reaction are thermodynamically
controlled while the formation of the a-aminonitriles are kinetically controlled.

1.4 AIMS OF THIS STUDY
In addition to its similar herbicide efficacy as hydantocidin (1), another
advantage of the carbocyclic analogue of hydantocidin (3) is that without the sugar
moiety it would not likely be readily metabolised in vivo and therefore would be more

effective over a longer period. By the same token, it may also have commercial value a
without an anomeric carbon, no epimerisation would take place and therefore its
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synthesis should be, in principle, simpler and therefore cheaper to produce. While

carbocyclic hydantocidin (3) has been tested as a herbicide,26 its analogues have no
Because the hydantoin component may act as a mimic for nucleosides, the carbocyclic

analogues may also exhibit activity in a variety of biological systems. Hence, the a

of this project were to develop a general and simple synthetic pathway to carbocycli
hydantocidin (3) and its analogues.

1.5 PREVIOUS SYNTHESES OF CARBOCYCLIC HYDANTOCIDIN
A previous synthesis of (±)-carbocyclic hydantocidin by Sano and Sugai began

with a norbornadiene (4). This compound was initially dihydroxylated and the result
diol protected as the acetonide 5 in an overall yield of 27 % [Scheme 1.9].

£.

55%

1. cat. Os0 4
TMNO
2. catp-TsOH
2,2-dimethoxypropane

7
77 % 61 %

"°

K

\y

03

HO—\
/—OH
V " ^
BnCI

then NaBH 4

5
27 %

8

W

°^X'0
/\
6
99 %

f-BuOK

9

Scheme 1.9 - Sano and Sugai's synthetic strategy for racemic key compound 9

Ozonolysis of 5 followed by a reductive work up gave a 99 % yield of the ring

opened symmetrical diol 6. One of the alcohols of 6 was protected as a benzyl ether
in 55 % yield, using benzyl chloride and potassium terf-butoxide, while the other
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alcohol w a s first converted to a mesylate, using methanesulfonyl chloride, then
converted to an iodide (8) using sodium iodide in acetone, in a yield of 77 % over the
two steps. Hydrogen iodide was eliminated using DBU, which gave an olefin that was
oxidatively cleaved to a ketone using sodium periodate in the presence of a catalytic
amount of osmium tetroxide. This afforded the key cyclopentenone 9 in a total yield of

61 %.
Using the Bucherer-Berg reaction, compound 9 could be directly converted to
the protected version of carbocyclic hydantocidin [Scheme 1.10]. However, the study
showed that this method gave exclusively the 5-e/?/-carbocyclic analogue of
hydantocidin 10 in a yield of 91 %.
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NH.
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S c h e m e 1.10 Sano and Sugai's synthetic strategy for carbocyclic hydantocidin
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The alternative Strecker synthesis, from 9, gave the aminonitriles 11 and 12 and

the cyanohydrin 13 in yields of 40 %, 15 % and 22 %, respectively. It is noted that in

this alternative approach, formation of the aminonitriles are kinetically controlled a
the study showed that the optimised temperature and stirring time to favour the
formation of the desired aminonitrile 11, was 90 °C and 24 h, respectively. Compound
11 was converted to hydantoin 14 using chlorosulphonyl isocyanide followed by acid

hydrolysis of the acetonide protecting groups in a total yield of 67 % for both steps.
Reductive debenzylation of compound 14 using hydrogen and palladium on carbon
gave (±)-carbocyclic hydantocidin (3) in a yield of 96 %.
The synthesis of the optically active version of carbocyclic hydantocidin, from
the same authors, began with the sugar derivative D-gulono-l,4-lactone 15 [Scheme

1.11]. The diols at C2 and C3 of the sugar were selectively protected in 85 % yield as
their acetonide, compound 16, using copper(II) sulphate in acetone in the presence of
concentrated sulphuric acid followed by treatment with acetic acid to hydrolyse small
amounts of the bis-acetonide of 15 that was also formed. Oxidative cleavage of the
unprotected diol of 16 was accomplished using sodium periodate. The resulting
hemiacetal was then protected as an isopropyl acetal 17 in 51 % yield over the two
steps, which was then converted to the cyclopentene derivative 18 in 51 % yield by
treatment with the lithium salt of dimethyl methylphosphonate, via an intramolecular
Horner-Wadsworth-Emmons reaction. Alkylation of 18 at C4 with a hydroxymethyl
group was achieved via a conjugate 1,4-addition of an organocopper derivative of
benzoxymethyl lithium. A single diastereoisomer of 9 was isolated in 99 % yield.
Compound 9 was treated in the same manner as described in Scheme 1.10 to obtain (+)carbocyclic hydantocidin in 21 % overall yield for the last three steps.
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S c h e m e 1.11 - Sano and Sugars synthetic strategy for
optically active key c o m p o u n d 9

1.6 OUR SYNTHETIC STRATEGY
Our structural analysis of carbocyclic hydantocidin (3) revealed that it consisted
of a polyfunctional cyclopentane ring, attached in a spiro fused manner to a hydantoin
ring system (Scheme 1.12). It was envisaged that the carbocyclic 5-membered ring
component could be divided into a three carbon synthon and a two carbon synthon and
therefore formation of the cyclopentane ring structure could be pursued through a [3 +
2] cycloaddition reaction. This method could be used to produce a cyclopentene amino

acid, as seen in pathway A, which consequently sets up the amino acid functionality for
hydantoin cyclisation. Alternatively, as seen in pathway B, the hydantoin component
can form part of the two carbon synthon as a 5-methylene hydantoin and therefore the
spirocyclic structure could be formed in one step. From either pathway, this facile

approach has the potential to be extended to [4 + 2] cycloaddition reactions to produce
6-membered ring analogues of 3.
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Scheme 1.12 O u r retrosynthetic analysis for carbocyclic hydantocidin

Cyclopentane framework
The phosphine-catalysed cycloaddition of ethyl buta-2,3-dienoate (19) or ethyl

2-butynoate (20) with an electron deficient alkene, which has been established as

useful method for producing highly functionalised cyclopentenes, was chosen as th

method to produce the carbocyclic framework of hydantocidin.497 In this method the
phosphine catalyst nucleophilically attacks the (3 carbon of 19 to directly form

resonance stabilised ylide 21 [Scheme 1.13],49'50'55 In the case of ethyl 2-butyno

the ylide 21c is formed initially, which upon proton transfer results in formatio

21. It is clear that from both three carbon synthons, 19 and 20, the same ylide 2
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produced. However, the advantage of using 20 is that it is commercially available while
compound 19 requires synthesis.58

= ^ °

R3P +

19

QPR 3

0

©PR,
-«

e

R3P +
20 0Et

OR

OEt

O

'<

0
PR,

O

I 3

»-

OEt

21b

H + transfer

—

0

OEt
21a

O
21c

OEt

Scheme 1.13 Phosphine reacts with 3 carbon synthons 19 and 20 to form ylide 21

Ylide 21 potentially, can then undergo a concerted cycloaddition or a stepwise
Michael-type reaction with an electron deficient alkene to eventually form a
cyclopentene ring. Two regioisomers are possible from this reaction depending on the

orientation of the ylide in relation to the substituted alkene [Scheme 1.14]. The ylid
may approach the alkene with its ester group facing away from the substituents on the
alkene, as seen in transition state A, and hence lead to synthesis of regioisomer A,

otherwise it can approach the alkene in the opposite sense, via transition state B, to

rise to regioisomer B [Scheme 1.14]. Clearly, the steric requirements of transition sta

A are much less than for transition state B and therefore formation of regioisomer A i
generally expected to be favoured.
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S c h e m e 1.14 T w o regioisomers are possible from the
phosphine catalysed [3 + 2] cycloaddition reaction
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The mechanism from either transition state to the cyclopentene ring is similar.
After the initial cyclisation, a zwitterionic cyclopentane intermediate, Al and Bl, is
formed. Proton transfer from these intermediates results in formation of intermediates
A2 and B2, respectively. These intermediates can then undergo a (3-elimination process
that consequently gives the cyclopentene products (regioisomers A or B) and
regenerates the phosphine catalyst.
Optically active cyclopentene derivatives have been prepared by using a chiral

phosphine catalyst54 or from the use of a chiral electron deficient alkene,53'56 which hav
been used to form optically active spiro heterocyclic derivatives.

Hydantoin formation
With careful consideration of the sensitivity of the functional groups, the
hydantoin ring system can be synthesised using any of the methods described earlier
(Section 1.3). Our proposed synthetic pathway utilising the phosphine catalysed [3 + 2]
cycloaddition is versatile in that synthesis of the hydantoin component can be prepared

before or after the cycloaddition reaction. However, its synthesis after the cycloadditi
reaction via pathway A [Scheme 1.15], would require careful set up of functional
groups for hydantoin ring closure. In this approach, we believed that the known dehydro
amino acid 2259 would be a suitable precursor for the cycloaddition reaction and

produce the functionality required for subsequent hydantoin ring formation as illustrate
in Scheme 1.3. The phosphine catalysed cycloaddition of this imine (22) with ethyl 2butynoate (20) has recently been established by our group and was found to give the
cyclopentene ring 23.56 Acid hydrolysis of the imine was expected to give the
hydrochloric salt 24. Conversion of the salt directly to its urea 25 using potassium
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cyanate in hydrochloric acid would set up the stage for base catalysed hydantoin ring

closure as described in Scheme 1.3 and therefore form the spirocyclic compound 26.

COOEt

COOMe

=(

Bu3P (0.1 eq)

Ph

N=<

COOEt

+

benzene
16 h

Ph
22

Ph
MeOOC

N

Ph

20

23
HCI

COOEt

COOEt
Base

O
MeOOC

N

H

A,NH

COOEt
KCNO/H+
MeOOC

25

26

NH2.HCI

24

Scheme 1.15 Synthetic strategy - Pathway A

Alternatively, hydantoin formation before the cycloaddition, pathway

B

[Scheme 1.16], would require synthesis of a 5-methylene hydantoin, which would the
subsequently react with the three carbon synthon, ethyl 2-butynoate (20), to form

key spirocyclic structure, 26. As formation of the hydantoin is the first step, mo

options are available for the synthesis of 5-methylene hydantoin. One possible syn

strategy utilises the Bucherer-Berg reaction (Scheme 1.16) on chloroacetaldehyde (
which gives the oc-chloro hydantoin 28. Basic conditions would deprotonate C5 and
subsequent P-elimination of chloride would give a 5-methylene hydantoin. Another

pathway for the synthesis of 5-methylene hydantoin could start from an appropriate

amino acid under acid conditions (Scheme 1.2). In this approach, it was expected t

elimination of a sulphur-containing amino acid (30), for example, starting from cy

or cysteine, or dehydration of a serine derivative (32) would give the 5-methylene
component (Scheme 1.16).
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S c h e m e 1.16 Synthetic strategy - Pathway B

Essentially, the same key cycloadduct, 26 is produced in both pathways A and
B. To reach our target carbocyclic hydantocidin (3), deconjugation of the double bond,
achievable with an appropriate base, was required. After deconjugation, cis
dihydroxylation of the double bond of 33, which can be catalysed by potassium osmate
and N-methyl morpholine oxide, would then give the necessary diol (34). Reduction of
the ester group in 34 was then expected to give the carbocyclic analogue of
hydantocidin (3) [Scheme 1.17]. Our attempts at both pathways A and B for
synthesising the key spiro cycloadduct 26 and its subsequent reactions leading to two
carbocyclic hydantocidin diastereoisomers are discussed in this thesis.
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S c h e m e 1.17 Synthetic strategy for carbocyclic hydantocidin
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W e e d name: Greenbriar, Smilax spp.. It is also called bull briar and
cat briar. It weaves itself together and forms an impenetrable shield.
There is no w a y of controlling this weed except by continued cutting,
even digging up the bulb has not been successful.

Chapter 2

22

CHAPTER 2 - Pathway A
Chapter 1 described our two approaches for making the spirocyclic ring system

of carbocyclic hydantocidin. This chapter describes our first attempts at preparing the
key spirocyclic ring structure of our target molecule by building up the cyclopentane
ring system first followed by formation of the hydantoin ring system, ie. pathway A.
In this strategy, it was envisaged that a protected a-methylene amino acid would
serve as a cycloaddition precursor for formation of a cyclopentene ring system, which,
after deprotection and subsequent reactions would also provide access to the hydantoin
ring via cyclisation of a urea.

2.1 SYNTHESIS OF A PROTECTED q-METHYLENE AMINO ACID
A candidate suitable for the phosphine-catalysed cycloaddition and subsequent
hydantoin cyclization was the known a-methylene amino acid derivative 22.59 The
synthetic pathway for this acrylate began with commercially available D, L-serine

methyl ester.hydrochloride [Scheme 2.1]. This was protected as the schiff base 35 in 85
% yield by a transimination reaction with benzophenone imine in DCM for 24 h.
Dehydration of the resultant product with 1,3-diisopropylcarbodiimide (DIPCD) and

copper chloride at RT for 20 h gave acrylate 22 in 80 %. The neutral conditions of this
reaction prevented cleavage of the ester and imine moieties. Work by Corey et al. has
shown that the dehydration occurs via a p-elimination process through an intermediate
isourea [Scheme 2.2].
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Scheme 2.1 - Synthesis of the acrylate 22
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Scheme 2.2 - Dehydration of 35 by ^-elimination

2.2 C Y C L O A D D I T I O N
The cycloaddition of acrylate 22 with 2 mol. equivalents of ethyl 2-butynoate

(20) catalysed by tributylphosphine in benzene at RT for 16 h proceeded smoot

% yield, producing cyclopentene 23 with selectivity for one regioisomer [Sche

This cycloaddition reaction was developed in our laboratories just prior to t

studies.56 The subsequent imine deprotection using 1M HCI at 0 °C for 20 min t

RT for 15 h provided the novel hydrochloric salt 24 in 95 % yield without este
hydrolysis.
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95%

MeOOC
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24

Scheme 2.3 - Synthesis of 23 and its subsequent hydrolysis

2.3 FORMATION OF THE UREA
Several methods were available to convert an amine to a urea. In the literature,
the more popular methods utilise K C N O in an acidic medium, either aqueous HCI or
acetic acid.61 In this acidic environment, potassium cyanate readily converts to the
reactive species, isocyanic acid (H-N=C=0) and it is the isocyanic acid that reacts with
nucleophilic primary amines to form ureas.
Another c o m m o n method, which has been used in the synthesis of symmetrical
and unsymmetrical ureas, involves the use of triphosgene [bis(trichloromethyl)carbonate].62'63 Triphosgene provides the carbonyl component between two free amines.
In this case, it is believed that urea formation proceeds via an isocyanate (R-N=C=0)
intermediate.
The feasibility and ease of each method was explored using amine 24 and 3,4dimethoxyphenylethylamine ( D M P E A ) as a model compound. The results of this study
are shown in Table 2.1.
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Table 2.1 - Formation of urea derivatives via three different methods
Amine

Conditions (Yield)

MeO

NH,

MeO

DMPEA

NH,

MeO
MeO

DMPEA

Product

HCI, K C N O (1 eq), RT, 17 h

MeO

(70 %)

MeO

1. triphosgene (0.37 eq), DIEA
(2.2 eq), 0 °C, D C M , 2 h
2. N H 3 (aq) (1 eq), DIEA (1 eq),
RT, D C M , 24 h
(75 %)*

H

Y
0

36

MeO
HN

MeO
MeO

>o

HN

MeO
37

COOEt

COOEt

acetic acid, K C N O (4 eq), RT, 25 h
MeOOC

NH2.HCI
24

(56 %)

sa

MeOOC

25

COOEt

N^NH2
H

COOEt

HCI, K C N O (4 eq), RT, 17 h
MeOOC

NH2.HCI
24

COOEt

MeOOC

NH2.HCI
24

(54%)

1. triphosgene (0.37 eq), DIEA
(2.2 eq), 0 °C, D C M , 2 h
2.NH3(aq)(leq),DIEA(leq),
RT, D C M , 24 h
(35%)*

sa

MeOOC

A

N^NH
25 H
COOEt

.X
MeOOC

38

XOOMe

N
Nv
H
EtOOC

D M P E A = Dimethoxyphenylethylamine
DIEA = Diisopropylethylamine
* Yield based upon the moles of amine used

In the model study using D M P E A , it was found that its urea derivative,

compound 36, could be synthesized in 70 % yield using 1 mol. equivalent of
HCI at RT for 17 h. However, when DMPEA was reacted with triphosgene and

diisopropylethylamine (DIEA) in DCM at 0 °C for 2 h followed by the additi

aqueous ammonia and 1 mol. equivalent of DIEA in DCM, a symmetrical urea 3
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formed in 75 %. Mass spectral, infrared and N M R data were able to confirm this
discovery.
The 13C NMR spectrum of the DMPE urea 36 was almost identical to its
symmetrical urea 37. However, ]H NMR spectroscopy could be used to distinguish
between these compounds. The symmetrical urea, 37, showed only one amino proton
peak that integrated for one proton while urea 36 showed two different amino proton

peaks integrating for one and two protons. Another distinguishing feature was observed
in the comparison of infrared data, which showed distinctive NH2 bands at 3449 cm"1
and 3328 cm" present in the urea 36 but was absent in the symmetrical urea 37. Both
compounds 36 and 37 did show the urea NH band at 3330 cm"1 and 3343 cm"1,
respectively.
Applying the procedure used for the synthesis of urea 36 using KCNO in HCI,
the urea derivative 25 could be synthesised in a reproducible yield of 54 % from the

hydrochloric salt 24. It was found that modifying the reaction to use acetic acid as th
solvent in replacement of HCI, slightly increased the yield of urea 25 (56%). However,

it should also be noted that in this method the product was difficult to purify, requi

tedious and careful chromatography. Under these conditions, it is possible that a biur
where the primary amine of the urea may further react with isocyanic acid, is formed
and thus may interfere with the purification process.
The advantage of using a HCI solution as the solvent was that urea 25
precipitated out of the aqueous solution as it was being formed, thus preventing any
further reactions. The product could easily be collected by filtration with no further

purification required. It was also found that increasing the molar equivalents of KCNO

as an attempt to improve the yield only resulted in an effective increase in the react
rate. The more hindered amine of compound 24, as compared to DMPEA, required one
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week for its urea derivative 25 to precipitate out of the reaction mixture when 1 mol.

equivalent of KCNO was used. However, when 4 mol. equivalents of KCNO were used
the reaction time was decreased to 17 h.
Attempts to form the urea derivative 25 using triphosgene, using the same
conditions as described earlier in our model study, also resulted in formation
symmetrical urea, 38. Once again !H NMR spectroscopy was used to distinguish
between the desired and symmetrical urea, 25 and 38 respectively. The *H NMR

spectrum of urea 25 [Figure 2.1] showed three amino protons while the symmetric
urea 38 [Figure 2.2] only showed one amino proton.

Figure 2.1 - ^ N M R spectrum (CDC1 3 ) of compound 25
COOEt
o
¥
MeOOC" 'N
H
25

NH2
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Figure 2.2 - XB. N M R spectrum (CDC1 3 ) of compounds 38
COOEt
0

. AH
MeOOC

N
H

N

Urea formation from primary amines via triphosgene generally requires a
tertiary amine base, so as not to partake in formation of a urea itself [Scheme 2.4].

Often the starting amine used is a hydrochloric salt (39) and 1 mol. equivalent of ba

consumed to neutralise the salt (step 1). Nucleophilic attack of the now free amine (
on the carbonyl group of triphosgene (0.37 mol. equivalent), produces 1/3 mol.
equivalent of intermediate 41 and anion 42 (step 2). Intermediate 41 is then
deprotonated by the tertiary base to displace another anion (42) and the reactive

isocyanate intermediate 43 results (step 3). Anion 42, from both steps 2 and 3, colla
to produce 2/3 mol. equivalents of phosgene (step 4). Phosgene can further react with
the remaining primary amine 40 to also form the isocyanate intermediate 43 (step 5).
The isocyanate intermediate could then be attacked with an appropriate amine
nucleophile (44) (step 6) or ammonia, to form the urea derivative 45. However, the
starting amine 40 potentially can act as the nucleophile, attacking the isocyanate
intermediate 43 and as a consequence, symmetrical ureas (R = R') are formed.
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Scheme 2.4 - Mechanism of the triphosgene reaction
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Majer and Randad were able to utilise this triphosgene reaction to produce
symmetrical and unsymmetrical ureas from valine methyl ester.hydrochloride.

62

They

found that formation of the isocyanate intermediate 43 (Step 3) was a rapid process
while the formation of the urea was a slower process (Step 6). This difference in

reaction rates allowed the selective formation of unsymmetrical ureas. It was also not
that anhydrous conditions were essential for the reaction to proceed, however
approximately 2-5 % of symmetrical urea products were still observed. In our studies,
unlike the conditions used by Majer and Randad, an aqueous ammonia solution was
used as the amino nucleophile with the rationale that the nucleophilicity of ammonia

would be greater than the nucleophilicity of water. It is possible that in our study w

attacks some of the intermediate isocyanate (43) resulting in formation of the free a

(40), after loss of CO2. The free amine (40) is then available to react with 43 to giv
symmetrical urea [Scheme 2.5]

NH3/H20
R—N—C—0 43

,0
//
^ R-N-0
OH

-C02

R-NI-L

2

40

0
II
•»

R-NH 2
40

+

R N—U—O
43

^

n

n

-N^°^N—R
H
H

syimmetrical urea

Scheme 2.5 Possible mechanism for formation of a symmetrical
urea from triphosgene and aqueous ammonia.

However, whether the urea dimers were formed before or after the addition of
aqueous ammonia was not certain. It was found that when 3 mol. equivalents of base
was used in the model study with the reaction of DMPEA, as an attempt increase the

rate of formation of the isocyanate intermediate (Step 3), the symmetrical urea 37 st
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persisted without formation of urea 36, but in lower yields (15 % ) and lower purity (a
light yellow solid was collected instead of a white crystalline solid).

2.4 HYDANTOIN CYCLISATION
The base catalysed hydantoin cyclisation of 25 proceeds via a nucleophilic
attack of the deprotonated primary amino group of the urea moiety upon the carbonyl of
the methyl ester [Scheme 2.6]. A methoxide anion is then mechanistically displaced in
the process.

COOEt
COOEt
0 OMe
NH2 +

MeOOC

Base

+ Base.H
25

COOEt

Scheme 2.6 - Base catalysed hydantoin cyclisation

Cyclisation of urea 25 was attempted with several bases including N a H ,
Li(TMS)2N and n-BuLi [Table 2.2]. It was found that Li(TMS)2N in THF provided the
best medium for the hydantoin ring formation giving the spirocyclic compound 26 in a
yield of 51 %. Using NaH or n-BuLi as base gave 26 in yields of 41 % and 37 %,

respectively. Molecular modelling studies revealed that the rigidity of the double bo
in 25 reduces the flexibility of the cyclopentene ring and thus increases the energy
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required for the cyclization to occur. This may explain the long reaction times requir
and also the moderate yields obtained.

Table 2.2 - Hydantoin cyclization of 38 using different bases to give 26

Conditions

Yield of 26

NaH, DMF, RT, 1 h

41%

Li(TMS)2N, THF, -78°C 1 h, RT, 17 h

51%

n-BuLi, THF, -78°C 1 h, RT, 30 h

37%

Spectral evidence was able to support the structure of 26. In particular, the mass
spectrum of 26, which showed a molecular ion at 225 (m/z M + 1, Cl+ve), revealed that

there was a reduction in mass, as compared to the starting urea 25, corresponding to a
loss of methanol. This was further supported by *H NMR spectroscopy that showed the
absence of a methyl ester resonance and the presence of two broad NH resonances, each

integrating for one proton, at 6.73 ppm and 9.00 pm. This suggested that a methyl este
had been displaced and the urea had cyclised to form the hydantoin. It was speculated

that the N3 proton, being flanked by two deshielding carbonyls, would be represented a
9.00 ppm. By default, it was assumed that the Nl proton appeared at 6.73 ppm..
Furthermore, the carbonyl of the urea of compound 38 occurred at 159.3 ppm in the C
NMR spectrum. After cyclisation this carbonyl became the C2 carbonyl of the
hydantoin ring of 26 and appeared at 156.6 ppm, typical of a hydantoin ring. Evidence
supporting these *H and 13C NMR assignments are discussed in Chapter 3.
It is also interesting to note that under basic conditions the displaced methoxide
may nucleophilically attack the carbonyl of the ethyl ester of 26 and hence form a

methyl ester. In each hydantoin cyclization reaction, transesterification was observe
approximately 10 %, as determined by integration of the lH NMR spectrum of 26.
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2.5 DECONJUGATION
It was anticipated that one of the acidic protons at C(9) of compound 26 could
be deprotonated with an appropriate base. Reprotonation was expected to occur

kinetically at the more electron rich position at C(7) resulting in deconjugation of
double bond [Scheme 2.7].
COOEt

COOEt

H+

26
Scheme 2.7 - Deconjugation of the double bond

Deconjugation of the double bond of 26 to form 46 was attempted with LDA.
However it was found that the acidic hydrogens of the hydantoin ring prevented
deprotonation of the proton at C(9) and thus the desired product was not observed.

when greater than 3 mol. equivalents of base were used, as an attempt to overcome th

problem, no product was formed. It was clear that the nitrogen groups in the hydant
ring needed to be protected. This option was not further pursued since the more

successful approach detailed in Chapters 3,. 4 and 5 was followed. In this approach
hydantoin ring was prepared first in its 7V,iV-diprotected form.
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W e e d name: Foxtails, Setaria spp.. There are many species of this
weed. The characteristic seed head that resembles a fox's tail easily
identifies them.
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C H A P T E R 3 - Pathway B: Methylene Hydantoins
In Chapter 2, the spirocyclic ring of carbocyclic hydantocidin was formed from
a phosphine-catalysed cycloaddition of ethyl butynoate 20 and the protected ccmethylene amino acid 22 with subsequent reactions leading to a base catalysed
hydantoin cyclisation. It was concluded that the hydantoin component of 26 needed to
be protected in order to perform any further reactions.
By taking the results of the previous study into consideration, we decided to take
the alternative synthetic pathway, pathway B, as described in Chapter 1, and synthesise
the hydantoin moiety of carbocyclic hydantocidin first followed by formation of the
cyclopentane ring. It was believed that a protected 5-methylene hydantoin could partake
in the phosphine-catalysed cycloaddition reaction and thus would provide a more
accessible pathway to the same target compound with fewer steps. The efficient
phosphine-catalysed cycloaddition reaction would still be utilised and formation of a
protected hydantoin ring would occur early in the synthesis.
The syntheses of several 5-methylene hydantoins using different precursors were
attempted and will be discussed in this chapter.

3.1 METHYLENE HYDANTOIN FROM CHLOROACETALDEHYDE
Several attempts to synthesise 5-methylene hydantoin were made using
chloroacetaldehyde as the key intermediate. According to the literature, it was
envisaged that l,l-diethoxy-2-chloroethane could be converted to
chloroacetaldehyde64,65 under acidic conditions and then utilising the Bucher Strecker
reaction, the hydantoin ring could be formed [Scheme 3.1].

Chapter 3

35
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/-\/H
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( NH 4) 2 C 0 3
KCN

*• HN

0

^—N

o

H

1,1-diethoxy-2-chloroethane chloroacetaldhyde 5-methylene hydantoin
Scheme 3.1 - Synthesis of 5-methylene hydantoin using chloroacetaldehyde

In our hands, our target compound could not be reached. It was found that in all

attempts to secure a final product, a viscous gel-like compound formed that coul
redissolved for NMR experiments. This suggested that unprotected 5-methylene-

hydantoin readily polymerises. It has been shown that 5-methylene hydantoin has
used as a precursor monomer unit in polymer chemistry to manufacture resins and
fibres. This study further supports the need to protect the hydantoin ring.

Careful selection of protecting groups for a protected 5-methylene hydantoin is

required with consideration of the subsequent reaction conditions it will be su

further in the synthesis. It is also important when selective removal of the pro
groups is required.
The advantage of using JV-Boc and Af-acetyl protecting groups is that they are

easily removed under acidic conditions. However, there ease of removal may limit

types of reactions performed on such compounds further in the synthesis. In cont
N-benzyl and /V-/?-methoxybenzyl (PMB) groups are more robust and are generally

cleaved using reductive and reductive or oxidative conditions, respectively. How

these aggressive conditions for their removal and their high stability may make
synthetic pathway more difficult.
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3.2 HYDANTOIN FORMATION
A practical method of synthesising hydantoins is via an amino acid. It has been
shown that heating a solution of an appropriate amino acid with KCNO in 10 % HCI for

3 h generates isocyanic acid. This acid adds across the amino acid functionality and
hydantoin ring is subsequently formed.40'41 Using this procedure the known cystine
hydantoin 42 was synthesised in 92 % yield (Lit. 91 %)40'67 as a white solid, which
a decomposition point of 305 °C (Lit. 305 °C67 and 310 °C 40). Serine hydantoin 32 and
5-(methylthio)methyl hydantoin 50, although both are commercially available, can be

synthesised from their respective amino acids using the same procedure in yields of 7
% and 75 %, respectively [Scheme 3.2]. Due to the different solubilities of the
hydantoins, the work up for each hydantoin reaction varied.

hUO, KCNO

S-S

—-

1 0 % HCI
reflux 3 h

47

HO

>-

COOH

H 9 0, K C N O
1 0 % HCI
reflux 3 h

NH2
31
COOH
CH3S
NH2
49

H20> K C N O

-CH3S

1 0 % HCI
reflux 3 h

Scheme 3.2 - Hydantoin formation using K C N O in refluxing H C I
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3.3 5-METHYLENE HYDANTOIN DERIVATIVES FROM CYSTINE
HYDANTOIN
A procedure established by Ravindanthan et al.67 found that sulphur elimination
of cystine hydantoin 48 could be eventuated with simultaneous nitrogen protection
using 6 mol. equivalents of benzyl bromide and 9 mol. equivalents of potassium
carbonate in DMF at 50 °C for 3 h [Scheme 3.3]. Using this procedure the known
67

dibenzylated methylene hydantoin 51 could be isolated in 8 3 % (Lit. 75 % )

O

O
HN

s-s

9 eq K 2 C0 3
6 eq BnBr
NH

»~

DMF, 50 °C, 3 h
O

O

48
Ph

S-S
52

Ph

Scheme 3.3 - Synthesis of dibenzyl methylene hydantoin 51

Mono-benzylated hydantoins were often seen in minute quantities in the H NMR

spectrum of the crude reaction mixture, as evident by broad NH peaks, suggesting t
reaction may not always go to completion.
The mechanism for formation of compound 51 begins with deprotonation of the
acidic protons with K2C03. These sites then undergo nucleophilic attack on benzyl
bromide leading to benzylation of the nitrogens. Benzyl bromide also attacks the

disulphide bond resulting in elimination of the sulphur, hence producing the methy

component and also producing diphenyl disulphide as a stable by product [Scheme 3.
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Scheme 3.4 - Mechanism for the formation of the 5-methylene hydantoin
51 from cystine hydantoin
As an attempt to produce other protected 5-methylene hydantoins from cystine
hydantoins, benzyl bromide was substituted with /?-methoxybenzyl bromide, p-

Methoxybenzyl bromide (54) was synthesized in 92 % yield (Lit. 100%)68 by stirrin

methoxy benzyl alcohol (53) in 45 % HBr, a known literature procedure [Scheme 3
45 % HBr
RT, 15 min
CH 3 0

53

(92%)

CH 3 0

54

Scheme 3.5 Synthesis of p-methoxybenzyl bromide
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The reaction of the freshly prepared /?-methoxybenzyl bromide 54 with cystine
hydantoin, under the same conditions as for the synthesis of 51, produced the disulphide
by product 57, a known compound in the literature,69 in 83 % yield. However, the
formation of the expected diprotected 5-methylene hydantoin 55 did not proceed as
efficiently with a yield of only 64 %. Its N M R spectra were similar to its related
analogue, compound 51. Surprisingly, this compound has not been reported previously
in the literature. It was noticed however, that the mono /V-/?-methoxybenzyl protected 5methylene hydantoin 56 was also observed in 15 % yield [Scheme 3.6]

N

OMe

</ "V-4. II

MeO^

u

XX

55 (64%)

IIN 1

' V^°

Q

HN
6

/

Q

y
-N
H

S-S

48

^

NH
N—<\
H
V
0

9eqK 2 C0 3

O

^ % J

56(15%)

6eq
CH

=°
DMF 50 °C 3 h

:

'

57 (83%)
^ O M e

M e O ^
,S'

OMe

HN
O

58(2%)

OMe
//

Scheme 3.6 - Reaction of cystine hydantoin with/;-methoxybenzyl bromide
The structure of compound 56 was elucidated by mass spectrometry, which
showed the molecular ion for the proposed structure. It was also noticed that this
compound eluted late by column chromatography suggesting a polar compound. The
free amine of 56 supports this observed property. In the ! H N M R spectrum of 56, only
one set of P M B signals were observed and the presence of a broad N H peak was seen at
8.12 ppm. It was deduced that the P M B protecting group was most likely at the N 3
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position. This nitrogen is flanked by two electron withdrawing carbonyls thus rendering

the proton in that position the most acidic proton of the two amides, Nl and N3. Thus, i
was expected that N3 would be deprotonated before Nl and therefore would be
alkylated first. Further studies, which will be discussed later in this section [Table
confirmed this prediction. In this case, the downfield appearance of the Nl proton can
be explained by the deshielding effects of both the double bond and C2 carbonyl.
It was interesting to note that compound 58 was isolated in small quantities
(2%). Its structure was inferred from its 'H NMR data. The *H NMR spectrum showed
two sets of PMB resonances and the presence of a broad NH singlet at 6.02 ppm. This
suggested that PMB substitution occurred at one of the nitrogens and at another

nucleophilic position. Using the same rationale as for the elucidation of the structure
56, it was suspected that the N-PMB group was at the N3 position. Further studies,
discussed in a later section, showed that N3 protons are deshielded by the flanking
carbonyls and generally appear at 8.39 ppm or more. The chemical environment of the
Nl proton, as seen in the system of compound 58, is deshielded by only one carbonyl
and therefore generally appears more upfield, in chemical shift, than its N(3)H
counterpart. The presence of an ABX system indicated that sulphur elimination did not
occur as expected and thus was still present. This suggested that the second PMB group
was on the sulphur as shown in the structure of 58.
Isolation of compound 58 suggested that protection of Nl is most likely the last
step in the mechanism for formation of 55. This may be due to both steric reasons and
the acidity of the proton of Nl compared with N3.
When benzyl bromide was replaced with acetic anhydride or di-tert-buty\
dicarbonate, no identifiable products were obtained. The success of the reaction of
benzyl bromide with cystine hydantoin was facilitated by the formation of a stable by
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product, dibenzyl disulphide. The formation of a diacetyl disulphide or di-tertbutoxycarbonyl disulphide by product is not expected to be as facile a reaction.
Compound 56 offered itself as a potential precursor for the subsequent
cycloaddition. However, it was believed that the free amine may interfere in the

cycloaddition reactions and therefore was protected. This was therefore protecte

an acetyl group, compound 59, or a Boc group, compound 60, under standard conditi

in high yield, 97 % and 93 %, respectively [Table 3.1]. The acetyl and Boc group

assist to better understand the cycloaddition reactions because of their differe
electronic properties and stereochemical requirements.

Table 3.1 - 5-Methylene hydantoin derivatives from compound 56

O

HN

,OMe

Conditions

y N\

R.
~N
O

O

,OMe
ISk

56
Reaction Conditions

Compound

R

Yield

A c 2 0 reflux, 15 h

59

acetyl

97%

Boc 2 0 (1.1 eq), C H 3 C N , D M A P (0.1 eq), R T , 7 h

60

Boc

93%

A summary of the characteristic 'H N M R chemical shifts of the known 5-

methylene hydantoin 51 and new 5-methylene hydantoins 55, 56, 59 and 60 synthesi

from cystine hydantoin is presented in Table 3.2. The table shows that the benzy
protons generally occur between 4.65 ppm and 4.77 ppm. The two olefinic protons
clearly separated in chemical shifts, one generally occurs between 4.68 ppm and

ppm while the other occurs between 5.32 ppm and 5.42 ppm. It was assumed that the

most downfield olefinic was the one cis to the deshielding C4 carbonyl. However,

R1 is substituted with an acetyl or Boc group, the carbonyls of these groups str
deshield both olefinic protons. This is evident by the observed downfield shift
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olefinic protons in compounds 59 and 60. This observation further supports our
hypothesis that the PMB group of the monoprotected 5-methylene hydantoin 56 and its
subsequent derivatives are in fact at the N3 position. An acetyl or Boc group at the

position would be too distant from the C5 position and therefore would not likely ha
such a dramatic influence on the chemical shifts of the olefinic protons.

Table 3.2 - Characteristic *H N M R chemical shifts (CDC1 3 ) of 5-methylene
hydantoins from cystine hydantoin
R1

O

"N
N
O

\ 2

R

Compound

R1

R2

Benzyl *H (ppm) a

Olefinic *H (ppm)

51

Bn

Bn

4.76b,4.77b

4.69c, 5.32c

55

PMB

PMB

4.68, 4.69

4.68, 5.37

56

H

PMB

4.65, (NH, 8.12)

4.91,5.42

59

acetyl

PMB

4.71, (acetyl, 2.63)

5.98, 6.47

60

Boc

PMB

4.65, (Boc, 1.58)

5.84, 5.98

a) only the C H 2 protons of the benzyl group are presented
b) c.f with 4.72 p p m for both benzyl C H 2 protons in reference'67
c) c.f with 4.63 p p m and 5.31 p p m as reported in reference67

3.4 5-METHYLENE HYDANTOINS FROM S-METHYL CYSTEINE
HYDANTOIN
Another option was to use S-methyl cysteine as a precursor. Using the monomer
version of cystine, it was anticipated that the subsequent acetyl or Boc protections
would proceed more smoothly and also the products would be easier to purify. It was
planned that the elimination of the S-methyl group to give the methylene component
could be accessed using benzyl bromide and K2C03 with S-benzyl-S-methyldisulphide
as the leaving group.
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The synthesis of 5-methyl cysteine hydantoin 50 from 5-methyl cysteine was
described earlier (Section 3.2). Protection of the hydantoin nitrogens
groups were performed under standard conditions as shown in Table 3.3.

shows that after work up, the !H NMR of the crude reaction mixture of e
showed only the diprotected species 61 and 63 in moderate yields of 52

respectively. The !H NMR data for these compounds indicated the presenc

acetyl or two Boc signals to confirm that both nitrogens were protected

Table 3.3 - Protection of S-methyl hydantoin
-SCH,
.SCH,
Conditions
*- R1 N

O

HN
-N

O

N.

H

O

50

Reaction
Conditions
Ac 2 0 (4 eq),
DMF, Et3N
(2.1 eq),
0°C to RT,

O

R1 •N

R2

O

Product M

Product M

Product N

R1 = acetyl
R 2 = acetyl
61

R 1 = acetyl,

R 1 = Boc
R 2 = Boc
63

R1 = Boc,
R2 = H
64

R 2 =H
62

,SCHL

O
N
H

Product N

Ratio of
M:N a before
column0

Ratio of
M:N b after
column0

Total
Yield

100:0

0:100

52

100:0

18:82

54d

(%)

3h
Boc20 (2.2
eq), DMF,
D M A P (0.2
eq), RT, 1 h
a)
b)
c)
d)

Ratio determined by integration of 1 H N M R spectrum of the isolated crude reaction mixture
Ratio determined from isolated yields
Column chromatography on silica gel
Combined yields of M and N

However, after column chromatography on silica gel the protecting groups at N3

were readily cleaved. In the *H NMR spectra of compounds 62 and 64, on
or Boc signal was seen with the presence of a NH peak at 9.12 ppm for
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p p m for 64. The low field chemical shifts of these N H resonances are typical of the
deshielded N(3)H proton. The loss of the protecting group at N3 may be due to the

acidity of the silica gel, resulting in the cleavage of groups at this labile position.
again the lability of the N(3) position can be rationalised by the delocalisation of
electrons on the nitrogen to the two flanking carbonyls, making this nitrogen a very
good leaving group.
Table 3.3 also showed that the acetyl group at N3 was the most labile with 100
% conversion to the mono-acetylated derivative 62 after its diprotected form 61 was
subjected to column chromatography. The Boc group at N3 was not as labile with only
82 % conversion to the mono-derivative 64 after column chromatography of 63 on silica
gel.
It is also interesting to note that the H5 proton of the hydantoin is also slightly

acidic and thus the C5 carbon is able to participate to nucleophilic addition reactions.
This was evident in the Boc protection of S-(methylthio)methyl hydantoin, where a triBoc derivative, compound 65, was isolated in 6 % yield [Figure 3.1]. This structure
was deduced from its *H NMR spectrum that showed three Boc signals while there was
still the presence of a S-methyl signal. Another distinguishing feature is the loss of
ABX coupling system, the CH2 signals now were part of an AB quartet. A similar acetyl
derivative was not observed.

CH,S

O

Figure 3.1 - Nucleophilicity of the C 5 position resulted in a tri-Boc derivative
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The next step was to eliminate the S-methyl functionality using benzyl bromide
and potassium carbonate in warm DMF overnight [Scheme 3.7]. Under these
conditions, it was discovered that the 5-methyl hydantoin compound 61 (R1 = R2 =

acetyl) required 2.2 mol. equivalents of benzyl bromide as the labile N3 acetyl gro

was displaced during the reaction and substituted with a benzyl group (66). The sec
equivalent of benzyl bromide was required to eliminate the S-methyl and hence form
5-methylene hydantoin, compound 67. This could only proceed in 14 %. *H NMR data
for this compound showed the typical olefinic protons and the presence of an acetyl
group and benzyl group, similar to the N3-PMB related 5-methylene hydantoin,
compound 59.

66 (45%)
SChL

BnBr (2.2 eq)
K2C03(2.2eq)

N

DMF, 45 -50 °C, O/N

N
61

67 (14%)

O

68 (27%)
Scheme 3.7 - S-methyl elimination of compound 61 using B n B r and K 2 C 0 3

The reaction also gave 45 % recovery of the S-methyl hydantoin compound 66
(R1 = acetyl, R2 = benzyl), which suggested that S-methyl elimination was a slow

process. However, the low yield of 67 in this reaction can be attributed to the com
benzylation reaction occurring at C5. This reaction pathway gave compound 68 in 27
yield.
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The structure of hydantoins 66 and 68 could be verified from ! H N M R analysis,
where compound 66 showed the typical chemical shifts of S-methyl hydantoin and also
the presence of an acetyl and benzyl group. A molecular ion for compound 66 was seen
in the mass spectrum to confirm the substitutions had taken place. Compound 67 also
showed similar resonances to compound 66, however the aromatic resonances
integrated for 10 protons suggesting that the molecule contained two benzyl groups.
Loss of an ABX system indicated that substitution of the second benzyl group most
likely occurred at the C5 carbon. To further confirm this structural assignment it was
found that the benzyl CH2 and SCH2 protons both appear as AB quartets, an effect from
being substituted at the chiral C5 position.
These results demonstrated once again, the acidity of the H5 proton and thus the

nucleophilicity of the resulting C5 anion. The equivalent reaction using Boc protectio
gave similar results as determined from analysis of the crude reaction mixture by H
NMR. These reactions also showed that a N3 acetyl or Boc group were readily cleaved
and therefore were not suitable as N3 protection groups for subsequent reactions.

3.5 5-METHYLENE HYDANTOINS FROM SERINE HYDANTOIN
An advantage of using serine hydantoin as the precursor to protected 5methylene hydantoins is that various N-protecting groups could be used, as the
methylene component could be synthesised by dehydration of the alcohol under mild
conditions. This is analogous to the synthesis of compound 22 described in Chapter 2,
where CuCl and DIPCD were used.
Serine hydantoin (32) was synthesised from serine in 75 % yield as described in
Section 3.2. Acetylation of 32 using acetic anhydride in warm DMF for 24 h showed the
formation of the diacetylated 5-metheylene hydantoin 69 from !H NMR analysis of the
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isolated crude reaction mixture (Table 3.5, later in this section) [Scheme 3.8].
However, after column chromatography only the mono-acetylated 5-methylene
hydantoin 70 was seen (34 %). The downfield shift of the broad NH singlet at 8.83 ppm
suggested that cleavage had occurred at the N3 position, once again demonstrating the

labile character for N3 acetyl groups. It also showed that iV-protection and dehydratio
of the alcohol could take place in a one-pot reaction.

o

HO

V

9

•

^NH DMF.A^O ^ N T y

o
0

Column

>, ^

\ ,

\-\ 45 oC, 24 h' o V Chr0mat°graphy OH
32

69

O

70 (34%)

Scheme 3.8 - Diacetyl 5-methylene hydantoin 69 can be synthesised from serine
hydantoin but is unstable to column chromatography

C o m p o u n d 70, in neat form, was found to be an unstable compound that readily
polymerised over time to give a clear film. In solution however, crystals of 70 were

to form. Crystallographic X-ray analysis showed a precise crystal lattice of 70 [Figu

3.2], and revealed that it was the Nl acetyl group that remained on the hydantoin ring
after column chromatography. This confirmed our earlier observations and hypothesis
for the acidity and thus displacement of N3 acetyl substitutions.
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(a)

(b)

Figure 3.2 - X-ray of compound 70 as a single unit (a) and in its crystal lattice (b

The di-Boc methylene hydantoin 71 could be synthesised in 32 % yield from

serine hydantoin (32) using 3.3 mol. equivalents of Boc anhydride, 0.1 mol. equivale
of DMAP in DMF at room temperature for 20 h [Scheme 3.9]. The !H NMR spectrum

of 71 was typical of 5-methylene hydantoins showing the presence of olefinic protons

It also showed the presence of two Boc signals. The chemical shifts for 71 are given

Table 3.5, later in this section. It was found that 71 was also unstable and viscous

were often seen. It is noteworthy that intermediate 72 was obtained in 5 % yield. In
*H NMR spectrum of 72, three Boc signals were seen with an ABX coupling system

and thus supported the proposed structure. However, the proposed structure indicated
that dehydration of the alcohol most likely proceeded via formation of a carbonate
intermediate that is eliminated to give the 5-methylene hydantoin.
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O
-O

N

O

o-

y~N

DMF, 3.3 eq Boc 2 0

0

*

0.1 eq. DMAP
RT20h

Y
71 (32%)

0

32

72 (5%)

Scheme 3.9 - Synthesis of di-Boc-5-methylene hydantoin 71 from serine hydantoin

These experiments suggested that 5-methylene hydantoins that are unprotected

at N3 are vulnerable to polymerisation and as a consequence, low yields were ob

Thus from these studies and earlier studies it was clear that the more stable p
group for the N3 position was a benzyl or PMB group.
Taking advantage of the fact that the proton at N3 was the most acidic, serine

hydantoin was selectively benzylated to 73 at this position in 64 % yield by tr

with 1 mol. equivalent of TiuOK and 1 mol. equivalent of benzyl chloride in DMS

1 h [Scheme 3.10]. The mono PMB analogue of hydantoin itself has been synthesise
in a similar manner with the use of P M B chloride

/

18

OH
•BuOK, D M S O

HN
O H
32

BnCI
RT, 1 h

(64%)

Scheme 3.10 - Selective N-benzylation of serine hydantoin
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Acetylation and simultaneous dehydration of compound 73 using 4 mol.

equivalents of acetic anhydride and 2 mol. equivalents of triethylamine in acetonitril

RT for 8 h gave 63 as the sole product in 91 % yield [Table 3.4]. Treatment of 73 with
2.1 mol. equivalents of Boc anhydride in the presence of a catalytic amount of DMAP
(0.2 mol. equivalent) in acetonitrile at room temperature for 15 h gave only the BOC

analogue 74 with a yield of 92 % [Table 3.4]. The characteristic chemical shifts of th
compounds are given in Table 3.5, later in this section.
It is interesting to note that in an earlier procedure Nl acetylated derivatives
were obtained using refluxing acetic anhydride, for example compound 69. This
pathway was not appropriate for the benzyl serine hydantoin 73 as the reaction often
yielded an O-acylated intermediate 75 [Figure 3.3] in 8 %. Its !H NMR data were
similar to compound 72 and showed the presence of two acetyl groups, a benzyl group
and an ABX coupling system. The efficiency and milder conditions using triethylamine
in acetonitrile suggested that dehydration of the O-acetyl intermediate via a base
catalysed reaction is a more facile process.

Table 3.4 - Protection of 3-N-benzyl serine hydantoin at N l and simultaneous
dehydration

^OH
Conditions

HN

O

N

<^X

y ISL

O

N.
O
73

Compound

R

Yield

A c 2 0 (4 eq), C H 3 C N , Et3N (2 eq), RT, 8 h

67

acetyl

91 %

Boc 2 0 (2.1 eq), C H 3 C N , D M A P (0.2 eq), RT, 15 h

74

Boc

92%

Conditions
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0
0
O

yN

X CH,
0

H3C

N
75

Figure 3.3 - A n 0-Acylated hydantoin intermediate

A summary of the *H N M R chemical shifts of the 5-methylene hydantoins

synthesised from serine hydantoin is presented in Table 3.5. The Table shows that t

acetyl carbonyl has a larger deshielding effect on the olefinic protons than the c

of the Boc group. In the acetyl derivatives 67, 69 and 70, the more deshielded olef

proton appears between 6.45 - 6.56 ppm while the more deshielded olefinic proton of

the Boc derivatives 71 and 74 were 6.05 ppm and 6.02 ppm, respectively. This findin

parallels the data of its PMB related analogues, compounds 59 and 60 described earl

in Table 3.2. The deshielding characteristic, displayed by the acetyl and Boc group

further confirm that the acetyl and Boc groups are on the Nl nitrogen. As a conseq

it also further confirms that benzylation was selective for the N3 nitrogen, as se
compounds 67 and 74.
Table 3.5 - Characteristic *H NMR chemical shifts of 5-methylene hydantoins
from serine hydantoin

O

•N
N
O

R2

Compound

Rl

R2

R ^ n d R ^ H (ppm)

Olefinic *H (ppm)

67

acetyl

Bn

2.62 (CH 3 ), 4.78 (Bn)

5.98, 6.45

69

acetyl

acetyl

2.66 (CH 3 ), 2.69 (CH 3 )

6.08, 6.56

70

acetyl

H

2.64 (CH 3 ), 8.83 (NH)

5.98,6.51

71

Boc

Boc

1.61 (Boc), 1.69 (Boc)

5.91,6.05

74

Boc

Bn

1.60 (Boc), 4.74 (Bn)

5.87, 6.02
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3.6 SUMMARY
These results show that N,iV-diprotected-5-methylene hydantoins can be
synthesised from an amino acid functionality. It also demonstrates that 5-methylene
hydantoins can be derived from hydantoins of cystine, S-methyl cysteine and serine.
However, manipulation of serine hydantoins was the most versatile. One advantage of
using serine hydantoin as a precursor to 5-methylene derivatives is that it can be
selectively JV(.?)-benzylated using stoichiometric amounts of reagents. Furthermore,
subsequent protection and dehydration can be achieved in a one pot reaction with high
efficiency. Unlike the reactions with S-(methylthio)methyl hydantoin, nucleophilic
addition to the C5 centre was not observed.
In all of the synthesised hydantoins it was found that N3 acetyl or Boc protected
compounds were not stable to column chromatography. Without protection in this
position for 5-methylene hydantoins, polymerisation readily occurs. It was found that
benzyl or PMB protection at N3 prevented this polymerisation and therefore 5methylene hydantoins protected with these groups at N3 generally gave higher yields.
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W e e d name: Oxalis, Oxalis spp.. The seed capsule goes under
tension as it dries and then explodes to throw the seed several feet.
It is a serious problem in nurseries and in newly seeded turf.
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C H A P T E R 4 - Pathway B: [3+2] Cycloadditions of
5-Methylene Hydantoins
In Chapter 2 we showed that the phosphine-catalysed [3+2] cycloaddition
reaction was an effective and efficient way of forming the spiro-cyclic system for
synthesis of carbocyclic hydantocidin. The scope of the phosphine-catalysed [3+2]

cycloaddition reaction with the various 5-methylene hydantoins described in Chapter

with the ylides formed from chiral and achiral butynes was investigated. The result
from this study are discussed in this Chapter.

4.1 [3+2] CYCLOADDITIONS USING ACHIRAL REACTANTS
Initially we re-examined the [3+2] cycloaddition of ethyl acrylate with the ylide

generated in situ from ethyl 2-butynoate and tributylphosphine, as first described
etal55 [Table 4.1].

Table 4.1 - Phosphine-catalysed reactions of ethyl 2-butynoate (20) with different
acrylates
COOEt
Bu3P (cat.)
COOEt
-COOEt
benzene, RT
COOR'
20
R COOR'
R
COOR'
regioisomer B
regioisomer A
acrylate

A

Acrylate

Compound
Number
Yield (%)a

Entry

1
2

Products
Ratiob A : B

R

R'

Regio A

Regio B

This
Study

L u et al.55

This
Study

L u et al.55

H

Et

76

77

85

85

89: 11

89: 11

Me

Me

78

79

83

46c

82: 18

72 : 28c

a)

b) Ratio determined from the ratio of the olefinic resonances of regioisomers A and B in the H
N M R spectrum of the isolated crude reaction mixture.
c) Methyl 2-butynoate was used as the alkyne.
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The yields and ratio of regioisomers (76 and 77) that w e achieved [Table 4.1]
were comparable to that of Lu's group (85 % yield, ratio of regioisomers A:B (76:77)
was 89: ll).55 When the reaction was modified by replacing ethyl acrylate with methyl

methacrylate, the reaction yielded regioisomers A (78) and B (79) in a total yield of 83
% with a ratio of 82:18 (A:B).
This phosphine-catalysed [3+2] cycloaddition reaction was also modified to
utilise the various 5-methylene hydantoins prepared from the previous Chapter. The
tributylphoshine-catalysed [3+2] cycloaddition reactions of the hydantoins 51, 55, 60,
67 and 74 with ethyl 2-butyonate (20) was able to provide the key spirocyclic

framework needed for the synthesis of carbocyclic hydantocidin [Table 4.2]. In general,
the cycloadducts were prepared from a benzene solution of the 5-methylene hydantoin
with 2 mol. equivalents of the butyne 20 and tributylphosphine as the catalyst (10 mol.
%) for 15 h at room temperature (RT). In one instance, freshly prepared ethyl 2,3CO

butadienoate

19, an allene, was used in replacement of the 2-butyne (20) and

triphenylphosphine was used as the catalyst. Whether the alkyne or allene is used, it h
been hypothesised that both lead to the same ylide intermediate 21, although the
phosphine component is different, as discussed in Chapter 1 [Scheme 1.13].
It was found that the [3+2] cycloaddition reactions did not readily occur with the
mono-protected 5-methylene hydantoins, where R1 or R2 = H, or when R1 = R2 = acetyl
or when R1 = R2 = Boc. It was suspected that the acetyl and Boc group at N3 were

displaced in situ resulting in the mono-protected hydantoin. It is possible that the ac
of the amide proton of hydantoins, where R1 or R2 = H, may interfere with formation of
the polarised ylide 21, the essential intermediate for the cycloaddition reaction.
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O n the other hand, the [3+2] cycloaddition reactions with 5-methylene

hydantoins where R2 = Bn or PMB proved to be a more successful pathway. The resul
of this study are shown in Table 4.2.

Table 4.2 - Phosphine-catalysed reactions of the three carbon synthons ethyl 2butynoate (20) or ethyl 2,3-butadienoate (19) with different 5-methylene
hydantoins.
COOEt
1

,o RPR3 9 —- R\ v r, x
o

vy°

O

21

regioisomer B

regioisomer A

R 1 =Bn
R 2 =Bn
1
R =PMB R 2 =PMB
R1=Boc R 2 =PMB
R1=acetyl R 2 =Bn
R1=Boc R 2 =Bn

Hydantoin
Entry

80
82
84
86
88

Three
Carbon
Synthon

R 1 =Bn
R2=Bn
1
R =PMB R 2 =PMB
R1=Boc R2=Bn
R1=acetyl R2=Bn
R1=Boc R 2 =PMB

Phosphine
catalyst

81
83
85
87
89

Yield3
(%)

Ph.P

82

80:20

20

Bu 3 P

81

PMB

20

Bu3P

Boc

Bn

20

acetyl

Bn

Boc

PMB

2

R

R

Bn

Bn

19

Bn

Bn

PMB

R1=Bn R2=Bn
R 1 =PMB R 2 =PMB
R1=Boc R2=Bn
R1=acetyl R2=Bn
R1=Boc R 2 =PMB

Products
Ratio"
A:B

1

\R2

R2

5-methylene hydantoins

51
55
60
67
74

O +

OEt

'©"

V
R2

R1

,—,

Olefinic *H
(PPm)

B
6.60

7.17

>98 : <2

6.60

N/A

86

83: 17

6.61

6.86

Bu 3 P

57

78:22

6.60

7.20

20

Bu 3 P

43

80:20

6.69

7.10

20

Bu3P

32

6.67

N/A

>98 : <2

a) Total yield of both regioisomers after purification by column chromatography.
b) Ratio determined by the ratio of the olefinic resonances of regioisomers A and B in the H N M R
spectrum of the isolated crude reaction mixture.

The yields for each [3+2] cycloaddition reaction varied and may parallel the

stability of the hydantoin protecting groups used. The N(l)-acyl and N(l)-Boc pr
hydantoins, 60, 67 and 74 provided lower yields of the cycloadducts [Table 4.2,

4, 5 and 6] while the more stable N(l), N(3)-di-PMB and N(l), N(3)-dibenzyl prot

hydantoins, 51 and 55, gave the better yields of the cycloaddition products [Tab
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entries 1, 2 and 3]. These yields refer to the combined yields of regioisomers A and B.
The regioisomers of the cycloadducts of the N(l), N(3)-di-PMB and N(l), N(3)-

dibenzyl protected hydantoins [Table 4.2, entries 1, 2 and 3], could be fully separat
and characterised while the cycloadducts of the N(l)-acyl and N(l)-Boc protected

hydantoins [Table 4.2, entries 4, 5 and 6] could not be fully separated and hence only
the major regioisomer (regioisomer A in each case), was fully characterised.
The ratio of the regioisomers A and B that were formed in these reactions was
determined by integration of the olefinic proton resonances for A (typically between
6.60 ppm and 6.69 ppm) and B (typically between 6.86 ppm and 7.20 ppm) in the 'H
NMR spectrum of the isolated crude reaction mixture [Table 4.2]. The olefinic protons

generally appeared as a triplet or a doublet of doublets with couplings between 1.2 Hz
and 2.4 Hz. Justification for these !H NMR assignments will be discussed later.
The cycloadducts were characterised by mass spectrometry and NMR including
2D NMR and will be discussed with reference to the numbering system and generic
regioisomer names, A and B, as shown in Figure 4.1.

COOEt

v

R

8

'/

9 \

/

6

8
9

(

1

j^-COOEt

V X^o
/

3X

R*

regioisomer A

regioisomer B

Figure 4.1 - T h e numbering system used to characterise the cycloadducts of
regioisomer A and regioisomer B

In general, the benzyl protons appeared between 4.0 - 5.5 ppm. lK N M R data

showed that the N(l) benzyl protons, being in close vicinity to the stereogenic cent

(C5), were diastereotopic and thus generally appeared as an AB quartet with coupling
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ranging between 15.0 H z to 16.5 Hz, while the N(3) benzyl protons, being further away

and having less influence from the stereogenic centre, appeared as a singlet. B
correlating these proton assignments with the 13C NMR resonances from HSQC
experiments, the benzyl carbons at N(l) and N(3) were determined to be between

and 44 ppm. In general, the N(l) benzyl carbon appeared downfield from its N(3)
benzyl counterpart. HMBC experiments also assisted in these assignments, which

showed two and three bond proton to carbon correlations. These experiments indi

that the N(3) benzyl protons correlated to the two carbonyl carbons on the hyda

One correlation was seen with a carbonyl that generally occurred between 153-15

and the other was a correlation with a carbonyl that generally occurred between

ppm. The N(l) benzyl protons, however, correlated to only the carbonyl peak tha
occurred between 153-155 ppm and also the spiro-centre C5 (65-75 ppm). It was

therefore deduced that the chemical shift of the C(2)0 carbonyl was 153-155 ppm
the chemical shift of the C(4)0 carbonyl was 173-176 ppm [Figure 4.2]. These

assignments appeared to generalise the hydantoin component of all the cycloaddu
70 72

and also matched the assignments of characterised hydantoins in the literature.
Examples of these assignments can be seen in Figures 4.4, 4.5, 4.6 and 4.7 for
NMR, 13C NMR, HSQC and HMBC experiments on compound 80.

^A

C5 appears between

,.

P P

65 an d 75 ppm _ ^^ &«&%T™
o 77

" ^

8

C2 appears between "?^jf^JS* '
153-155 ppm

between 42 - 44 ppm

Figure 4.2 - General characteristic carbon assignments for hydantoin cycloaddu
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The regioisomers of each [3+2] cycloaddition reaction could be identified using
*H NMR and 13C NMR experiments in conjunction with DEPT, COSY, HSQC, HMBC
and NOESY experiments. The assignments for compounds 80 and 81 will be discussed
in detail and will generalise the assignments for the other cycloadducts.
It was clear that the difference between the regioisomers was the position of the

ester and double bond. Regioisomer A had these functionalities at the C7 position w
regioisomer B had these groups at the C6 position. The influence of the stereogenic
centre (C5) upon the chemical shifts of substitutions at C6 and C9 also played an
important role in distinguishing the two regioisomers.
For compound 80, the !H NMR spectrum showed the protons attached to C6 and
C9 occurred at 2.45 ppm (m, 1H), 2.54 ppm (m, 1H), 3.01 ppm (ddd, 1H), and 3.05 ppm
(ddd, 1H) [Figure 4.4]. HSQC data showed that the pair of protons at 2.45 ppm and

3.01 ppm correlated to the same carbon at 43.7 ppm and the pair of protons at 2.54 p
and 3.05 ppm correlated to the same carbon at 41.1 ppm [see Figure 4.5 for the I3C
NMR spectrum and Figure 4.6 for the HSQC spectrum]. Because of their similar

chemical shifts it was suspected that protons 2.45 ppm and 2.54 ppm (Hb) were on the

same face of the cyclopentene ring, while protons 3.01 ppm and 3.05 ppm (Ha) were on
the opposite face. Due to the chemical shifts of protons 3.01 ppm and 3.05 ppm (Ha)

being more downfield, it was suspected that they may be deshielded by the C4 carbony
and thus may be facing the same side as the carbonyl groups. This is illustrated in
Figure 4.3a and 4.3b.
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Figure 4.3a - Molecular model (Spartan, A M I ) of regioisomer A, compound 80

Figure 4.3b - Characteristic proton assignments for compound 80, regioisomer A
(<—> indicate observed cross-peaks)

Olefinic proton appears at 6.60 ppm

C(6) and C(9) H b protons at
2.45 ppm and 2.54 ppm

C(6) and C(9) Ha
protons at 3.01 ppm
and 3.05 ppm are
deshielded by the
C(4)0 carbonyl

Hb<->N(1)
benzyl C H 2 in
NOESY

C(6) and C(9) Ha
protons have a
H M B C correlation
with C(4)0

N(1) benzyl protons
appear as an A B quartet

N(3) benzyl protons
appear as a singlet

H M B C spectra revealed that the protons at 3.01 ppm and 3.05 p p m (Ha) had a

three bond coupling to the C4 carbonyl (175.1 ppm) while the protons at 2.45 pp

2.54 ppm (Hb) had no such correlation [Figure 4.7]. Since proton to carbon thre

correlations depend on the dihedral angle between the coupled proton and carbon

60
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information suggested that the latter protons (C(6)Hb and C(9)Hb) have a dihedral

angle with C4 of approximately 90°, while the former protons (C(6)Ha an

have a dihedral angle of approximately 0° or 180°. In this case the dih

approximately 0°, indicating that the Ha protons are on the same face o

cyclopentane ring as the C4 carbonyl [Figure 4.3b], verifying our earlie

Our findings were further confirmed from NOESY experiments, where NOESY

peaks were seen between the N(l) benzyl protons (4.40 ppm) and the prot
ppm and 2.54 ppm (Hb) [Figure 4.8].

Figure 4.4 - X H N M R (CDC13) spectrum of 80
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Figure 4.5 -13 C N M R (CDC13) spectrum of 80
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Figure 4.6 - H S Q C (CDCI3) spectrum of 80
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Figure 4.7 - H M B C (CDC13) spectrum of 80
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In contrast, the protons attached to C 8 and C 9 , for regioisomer B, appeared at
1.90 ppm (m, 1H) and between 2.40-2.68 ppm (m, 3H) [Figure 4.10]. HSQC
experiments showed that the protons at 2.40 ppm and 2.59 ppm (C(8)HaHb) were on
the same carbon at 31.0 ppm while the protons at 1.90 ppm and 2.45 ppm (C(9)HaHb)
were correlated to the same carbon at 33.3 ppm [see Figure 4.11 for the 13C NMR
spectrum and Figure 4.12 for the HSQC spectrum]. The significant difference in

chemical shifts of the protons connected to the carbon at 33.3 ppm implies that this CH
is in close vicinity to a chiral environment such as seen at C5, which is consistent
the chemical environment of the C9 protons. On the other hand, the CH2 protons at C8,
being more distant from C5, would not experience this difference in chemical

environment as strongly and are expected to be closer in terms of chemical shifts, thus
supporting the observed chemical shifts of 2.40 and 2.59 ppm for these protons. HMBC
spectrum [Figure 4.13], which correlated only the C(9)Ha proton at 2.45 ppm to the
carbon at C(4)0, indicated that this proton was three bonds away from C(4)0. No
correlation between C(8)Ha and C(4)0 was observed consistent with their separation by
four bonds. This finding strongly supported the structure of regioisomer B and further
supported the previous assignments. These assignments are shown in Figure 4.9b with
its structure illustrated in Figure 4.9a.
One distinguishing feature, which identified regioisomer B, was the difference

in splitting patterns of the methylene protons of the ethyl ester in the *H NMR spect
in comparison to regioisomer A. In regioisomer B the ester group is closer to the
stereogenic centre (C5) and thus the diastereotopic effect has a larger influence on
chemical shifts. This can be clearly seen in the ]H NMR spectrum of compound 81
[Figure 4.10], which showed that each proton of the OCH2 of the ethyl ester appeared
as doublet of quartets at 3.69 ppm and 3.87 ppm. In contrast, when the ester
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functionality was in the C 7 position, as in regioisomer A, the O C H 2 group appeared at
4.15 ppm as a doublet of quartets, integrating for two protons [Figure 4.4].

Figure 4.9a - Molecular model (Spartan A M I ) of regioisomer B, compound 81

Figure 4.9b - Characteristic proton assignments for compound 81, regioisomer B

Olefinic proton appears at 7.17 ppm
C(8)HaHb protons at
2.40 p p m and 2.59 ppm

C(9)Hb proton
at 1.90 p p m

O C H a H b protons of
ester each appear as
doublet of quartets
C(9)Ha at 2.45
ppm is deshielded
by carbonyl C(4)0

C(9)Ha has a H M B C
correlation with C(4)0
N(1) benzyl protons
appear as an A B quartet

N(3) benzyl protons
appear as a singlet
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Figure 4.10 - *H N M R (CDC13) spectrum of 81

0 ppm

Figure 4.11 - 13 C N M R (CDCI3) spectrum of 81
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Figure 4.12 - H S Q C (CDC13) spectrum of 81
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Once the regioisomers had been distinguished, it was discovered that the
chemical shift of the olefinic protons of regioisomer A generally occurred between
6.60-6.69 ppm while the olefinic protons of regioisomer B, in comparison, generally
occurred downfield between 6.86-7.20 ppm. It has been reasoned by Du et al. that the
olefinic proton of type B regioisomers appear more downfield, in comparison to type A
regioisomers, was a result of the deshielding effect on the double bond by a proximal
carbonyl group at the spirocentre. In our studies this effect may come from the C4
carbonyl, which has had a similar effect on the protons on C6 and C9 as described
earlier [Figures 4.3 and 4.9].
Inspection of Table 4.2 indicated that the regioselectivity for the cycloaddition
reaction is approximately 80:20 in favour of regioisomer A. This occurred in all cases
except for one. The reaction of compound 51 with ethyl 2-butynoate (20) in the
presence of a catalytic amount of tributylphosphine (Table 4.2, entry 2) gave only
regioisomer A in 81% yield. However, for the same reaction with an allene (ethyl 2,3butadienoate, 19) as the three carbon synthon and triphenylphosphine as the catalyst, a
reduction in regioselectivity was observed (Table 4.2, entry 1). It should be noted that
the use of tributylphosphine for the [3+2] cycloaddition reaction using this allene
resulted in an incomplete reaction and gave low yields of the expected cycloadducts.
In a recent independent study by Du et al.,51 it was found that the same reaction
using compound 51 with ethyl 2-butynoate (20) and tributylphoshine as the catalyst, a
94 % yield of the expected cycloadducts 80 and 81 was obtained with high
regioselectivity for regioisomer A (80) (>97:3, ratio of regioisomer A:B). The parallel
reaction using ethyl 2,3-butadienoate (19) and triphenylphosphine gave a 96 % yield of
the cycloadducts (80 and 81) but with lower regioselectivity (65:35 ratio of regioisomer
A:B). These results are similar to those obtained from our study. However, it should be
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noted that in our study the reaction m e d i u m was benzene, while in the study by D u et
al.51 the reaction medium was toluene.
en

The study by D u et al.

also showed that the regioselectivity of the [3+2]

cycloaddition could be enhanced by using a tert-butyl ester in replacement of the ethyl

ester in the ylide (21). In this instance, refluxing benzene was required for the react
to proceed. In Chapter 1, it was explained that the mechanism for the formation of
regioisomer B proceeded through a transition state that positioned the ester group, of
ylide, near the a-carbon of the electron deficient alkene [Scheme 1.14]. It was
rationalised that the steric bulk of the terr-butyl ester may make this pathway highly

unfavourable and therefore there is an improved selectivity for regioisomer A. In futur
work, the steric bulk of the alkyne will be considered if increased regioselectivity is
required.
Theoretically, the cycloadducts A and B are acrylates that potentially can
undergo further cycloaddition as shown in Scheme 4.1.

EtOOC
COOEt
ethyl 2-butynoate (20)
Bu 3 P
benzene, RT

COOEt

ethyl 2-butynoate (20)

R1

COOEt

^N

Bu3P
benzene, RT
90 - (7 % ) , R1 = Boc, R 2 = Bn
91 - (6 % ) , R1 = Bn, R 2 = Bn

Scheme 4.1 - Cycloadducts are acrylates that can potentially undergo further
cycloaddition as evident from isolation of compounds 90 and 91
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Our investigations found this to be true based on the isolation of compounds 90
and 91 in yields of 7 % and 6 % from their respective cycloaddition reactions (Table
4.2, entries 2 and 4 respectively). Crystallographic X-ray analysis of compound 91,

Figure 4.14, revealed that it was regioisomer B that underwent the further cycloadditio
reaction. Hence, this may explain the apparent high regioselectivity for compound 80

(regioisomer A) in the cycloaddition of 51 with ethyl 2-butynoate (20) [Table 4.2, ent

2]. It is noted that in the related reaction using the allene, [Table 4.2, entry 1], the
double cycloadduct (91) was not found. No further cycloadditions with regioisomer A
cycloadducts were ever isolated. Thus the ratios of regioisomers A and B in Table 4.2

are most likely incorrect, as the amount of regioisomer B is underestimated since it do
not take into account that some of this regioisomer (6-7%) has undergone further
cycloaddition with ylide 21.

Figure 4.14 - X-ray crystallography analysis of c o m p o u n d 91
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It is interesting to note that the X-ray analysis showed the C6a' ester, the C3a'

hydrogen and the C4 amino group are all syn as illustrated in Figure 4.14. Similar to the
initial [3+2] cycloaddition with the 5-methylene hydantoin, there are two possible
transition states that the three carbon synthon can approach the alkene in the second
cycloaddition, transition states C and D as seen in Scheme 4.2. Transition state D is

unlikely due to the both the steric hinderance and the electrostatic repulsion between t
electronegative C4 carbonyl on the ylide and ester group of 81. While transition state C
orientates the ester of the ylide away from the C4 carbonyl and therefore is more

favourable. In transition state C, it is more likely that the ylide approaches the a-fac
that is, from the C4 carbonyl side, of the cyclopentene ring, as the Nl benzyl group
sterically blocks the approach from the [3-face of the cyclopentene ring. As a
consequence, the addition places the C6a' ester, C3a' hydrogen and the C4 amino group
in an all syn relative configuration as observed in the X-ray of compound 91 [Figure
4.14].

S c h e m e 4.2 - T w o possible transition states for the second [3+2] cycloaddition
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4.2 [3+2] CYCLOADDITIONS WITH CHIRAL 2-BUTYNES
After studying the [3+2] cycloaddition reaction with the protected hydantoins,
we then turned our attention to attempt diastereoselective [3+2] cycloadditions using
chiral auxiliaries on the alkyne. To synthesise such precursors we used a procedure used
by Fonquerna et al.73 to produce 2-butynoyl derivatives of oxazolidin-2-ones and 2butynoyl derivatives of Oppolzers74"77 camphor sultam from 2-butynoic acid [Scheme
4.4]. The one-pot method, originally developed by Evans78 involved forming the lithium
salt of the 2-oxazolidinone (92y or 92z) or camphorsultam (92x) using n-butyl lithium
at -78 °C in THF. This salt was then added to an in situ generated 2-butynoyl pivaloyl
anhydride, prepared from the reaction of pivaloyl chloride, 2-butynoic acid and
triethylamine mixture in THF, to give the corresponding 2-butynoyl (93) and/or
pivaloyl (94) derivatives.
,0

o

//
<

OH
2-butynoic acid

H-Xc
92

f-BuCOCI, EtoN, THF
-78 °C, 15 min
0 °C, 45 min

rhButi, T H F
-78 °C, 15 min

X

2-butynoyl pivaloyl anhydride
-78 °C to RT
Li-Xc
10h
lithium salt
n

jX
\
Xc

//

<

93

Xc

Xc

•X?\J

94

"<jy

Bn

S c h e m e 4.3 - O n e pot m e t h o d for synthesising
2-butynes (93) with various auxiliaries
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In this study, the (lS)-camphor sultam (92x) and (450-4-benzyl-2-oxazolidinone
[92y] were used as the chiral auxiliaries, while 2-oxazolidinone [92z] was used as an
achiral auxiliary. The use of the achiral auxiliary will become clearer later in this

section. In general, the formation of the 2-butynoyl derivatives (93) dominated over t
competing formation of the pivaloyl derivatives (94) [Table 4.3] with the chiral 2oxazolidinone (92y) giving the best yield (90 %) of its 2-butynoyl derivative (93y)
(Table 4.3, entry 2).

Table 4.3 - Results of the synthesis of the 2-butynes (93) with various chiral
auxiliaries
Entry

Auxiliary

Yield of 93 (%)

Yield of 94 (%)

1

X

60

28

2

y

90

3

3

z

28

14

The [3+2] cycloaddition reactions using 1 mol. equivalent of the 2-butyne
derivatives (93) and 5-methylene hydantoins, 51, 55 and 74 were performed in benzene
at RT with tributylphoshine (10 mol. %) as the catalyst. These results are summarised
Table 4.4.
Table 4.4 shows that the yields from these reactions were moderate, with the
camphor sultam derivative 95x being formed in the higher yield of 74 % and the 2oxazolidinone 7Y-PMB protected hydantoins (97y and 98y) derivative produced in the

lowest total yield of 32 %. One reason for the lower yields is that the chiral 2-butyne
(93) were not stable to the reaction conditions used. Evidence of this was seen in the
recovery of (45)-4-benzyl-2-oxazolidinone (92y) in 20 % and 17 % [Table 4.4, entry 2
and 4 respectively], suggesting cleavage of the 2-butyne (93y) in situ, and hence
reducing its availability for the intended [3+2] cycloaddition reaction.
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Table 4.4 - [3+2] Cycloaddition of 5-methylene hydantoins with the 2-butynoyl
derivatives (93x-z)

o
R1
N'

Bu3P

>=0 +

=x

-N.
O

R2

5-methylene hydantoin

93

benzene, RT

X

c

regioisomer A

regioisomer B

o

o

Xc= /.
•N

o=s—
II
o x

regioisomer A
95x R1=Bn
R2=Bn
1
95y R =Bn
R2=Bn
1
95z R =Bn
R2=Bn
1
97y R =PMB R 2 =PMB
99y R1=Boc R2=Bn

51 R1=Bn R2=Bn
55 R 1 =PMB R 2 =PMB
74 R1=Boc R2=Bn

regioisomer B
96x R1=Bn
R2=Bn
1
96y R =Bn
R2=Bn
1
96z R =Bn
R2=Bn
1
98y R =PMB R 2 =PMB
100y R1=Boc R2=Bn

Products

R1

R'

2-Butyne
Auxiliary
(93)

Bn

Bn

x

Bn

Bn

54c%

Boc

Bn

43%

PMB

PMB

32d%

Bn

Bn

42%

Entry

O

Bn

5-methylene hydantoin

Hydantoin

-N

O

Ratio of
Regioisomersb
[A]:[B] (de)

Optical Rotation
25x

of [B] (fab*3)

Yield3

74%

100 (0%) : 0
11(0%):
89 (>98%)
5 (0%):
95 (>98%)
18 (0%):
82 (>98%)

+4.7 (c 2.6, C H C 1 3 )

20:80

N/A

N/A
+12(cl.6,CHCl3)

+3.6 (c 2.2, C H C 1 3 )

a) Total yield of both regioisomers after purification by column chromatography.
b) Ratio determined by the ratio of the olefinic resonances of regioisomers A and B in the *H N M R
spectrum of the isolated crude reaction mixture. Diastereomeric excess (de) was determined by
the olefinic resonances of the diastereoisomers in the 'H N M R spectrum of the purified
regioisomers.
c) 4-Benzyl-2-oxazolidinone was recovered in 20 %.
d) 4-Benzyl-2-oxazolidinone was recovered in 17 %.

Once again, the characteristic chemical shifts of the olefinic protons were used
to distinguish between the two possible regioisomers. It was observed that when the
camphor sultam (93x) was used, only regioisomer A (95x), as a pair of diastereoisomers
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in a ratio of 1:1, was isolated [Table 4.2, entry 1]. The diastereoisomers (5J?)-95x
([a] D

-10 (c 1.7, CHC1 3 )) and (5S)-95x ([a] D

22

-25 (c 1.7, CHC1 3 )) were readily

separated by column chromatography and were obtained as colourless crystals. By
using X-ray crystallography the absolute configuration at the spirocentre for each
diastereoisomer could be determined [Figure 4.15]. Given that the camphor sultam used
had the (S) configuration at the CI position, it was discovered that (SR)-95x had the

(5R) configuration while (5S)-95x had the (55) configuration. Due to the steric bulk of
the camphor sultam, it is unlikely that its regioisomer B could have formed and hence
this may explain the complete selectivity for regioisomer A.

Figure 4.15 - X-ray crystallographic analysis of compounds (5S)-95x and (5R)-95x
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In contrast, the [3+2] cycloaddition reactions using the 2-oxazolidinone
auxiliaries 93y and 93z [Table 4.4, entries 2-5] yielded regioisomer B as the major
product. This was based on the major products having olefinic proton resonances appear
in the lU NMR spectrum between 7.02-7.20 ppm, a characteristic of B regioisomers,
and the minor isomers having these protons appear between 6.40-6.69 ppm, a
characteristic of A regioisomers, as established in Section 4.1.
To further confirm that indeed regioisomer B was the major product, the 4benzyl-2-oxazolidinone moiety of compound 96y was cleaved and converted to its
Oft

methyl ester derivative 101

([OC]D

- 2.6 (c 1.75, CHC1 3 )) using samarium(III) triflate in

refluxing methanol for 12 h [Scheme 4.4]. Compound 101 was obtained in 97 % yield
and gave spectral data, in particular 'H NMR spectra (Figure 4.16), comparable to the
analogous ethyl ester cycloadduct 81 (Figure 4.10).

r - ^

/ ft O M e

Sm(lll)(OTf)3
^

N

X^

.-Hv/^
96y w /
/

I.
O

[a]D25+12(c1.6,CHCI3)

methanol, A, 12 h
97%
101

XyX°
r
y
-N

\\

//

[a]D26 - 2.6 (c 1.75, CHCI3)

Scheme 4.4 - Conversion of 96y to 101 using samarium(III) triflate in methanol
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Figure 4.16 - Mi N M R (CDC13) spectra of compound 101
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Another potential method to exchange the 2-oxazolidinone for a methyl ester

was through the use of potassium carbonate in methanol at RT for 1 h [S
Although this pathway gave the expected methyl ester derivative 101 in

%), it also gave the oxazolidinone ring opened, amino alcohol compound,
major product (35 % ) [Scheme 4.5].

N
0

K2C03, MeOH

101 (9%)

RT, 1 h

Scheme 4.5 - Conversion of 96y to 101 and 102
using potassium carbonate in methanol
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The structure of compound 102 was confirmed by various spectral data
including 2D NMR experiments. Mass spectra showed a molecular ion at 510 [m/z, M +
1, Cl+ve], which matched our proposed structure. The C NMR spectrum of compound
102 showed one less carbonyl signal at 152.4 ppm as compared to its precursor 96y.
HMBC experiments showed that the N(3) benzyl protons, that appeared as a singlet in
the *H NMR spectrum, correlated with the carbonyls 156.6 ppm and 175.7 ppm that

belonged to the hydantoin ring. This suggested that the hydantoin ring remained int
and supported the hypothesis that the loss of the carbonyl signal was that of the
oxazolidinone. The !H NMR spectrum indicated the presence of a NH peak at 6.42
ppm, which appeared as a doublet [Figure 4.17]. The COSY data correlated this

doublet with a NCH proton (m) at 4.07 ppm, consistent with the proposed structure of
compound 102.

Figure 4.17 - XH N M R spectrum of compound 102
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In the latter procedure, the basic conditions convert methanol to the methoxide
anion, which in turn nucleophilically attacks the carbonyl carbon, forming the methyl
ester and as a consequence mechanistically displaces the 2-oxazolidinone [Scheme 4.6].

MeOH + Base *• MeO

S c h e m e 4.6 - M e c h a n i s m for the conversion of 96y
to its methyl ester derivative 101

However, the methoxide anion can also attack the carbonyl of the 2oxazolidinone and thus ring open the 2-oxazoldinone functionality, to form a methyl
carbonate derivative [Scheme 4.7]. A second methoxide anion can then attack the
carbonyl of this carbonate derivative and thus form dimethyl carbonate. After aqueous
work up the amino alcohol 102 is formed.
The advantage with using samarium(ITI) triflate is that samarium has an affinity

for oxygen and therefore it is likely that it coordinates to the oxazolidinone carbonyl

and the proximal amide carbonyl [Figure 4.18]. In this position in can direct the attac

of methanol to the more reactive amide carbonyl, therefore the selectivity and high yie
of the esterification is observed.
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+

1
MeO

OMe

X^
Scheme 4.7 - Mechanism for the formation of the amino alcohol 102 from 96y

X ^
Figure 4.18 - Samarium(III) triflate co-ordinates to carbonyls and
thus directs the nucleophilic attack of methanol.
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F r o m our previous findings, of the phosphine-catalysed [3+2] cycloaddition
reactions of 5-methylene hydantoins with 20, the corresponding cycloadditions using
the chiral 2-butyne 93y were not expected to give regioisomer B as the major product,

due to the steric bulk of the chiral auxiliary [Chapter 1, Scheme 1.14]. It was initially

speculated that favourable interactions, such as n stacking of the benzyl substituents of
the 5-methylene hydantoin with the benzyl group on the 2-oxazolidinone of 93y may
allow pathway to transition state B instead. However, the [3+2] cycloaddition of the 3(2-butynoyl)-l,3-oxazolidin-2-one (93z) that is, without the benzyl group on the 2oxazolidinone, with the 5-methylene hydantoin 51 [Table 4.4, entry 5] gave the
analogous cycloadducts 95z and 96z in similar ratios, with regioisomer B (96z) as the
major product. This suggests that the 2-oxazolidinone functionality plays an essential

role for the reversed regioselectivity and its effect is probably of an electronic nature
On closer examination, it was discovered that the oxazolidinone had a large
influence on the electronics of the in situ generated ylide. Semi-empirical calculations
using Spartan (AMI, PC Spartan Pro) showed that the electron density of the HOMO
orbitals at the a and y carbons were significantly larger in the 2-oxazolidinone derived

ylide of 93z than in the ester derived ylide 21, which had most of its electron density o

the ester group [Figure 4.19]. The larger electron density at the y position of the ylide
93z would increase its ability to attack the P-carbon of the electron deficient 5methylene hydantoin and hence give rise to the formation of regioisomer B.
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Figure 4.19 - H O M O orbitals of the ylide 21 and ylide of 93z as calculated using
Spartan ( A M I )

O

©PBu,

P

O

©PBu,

EtO
21
Note: In the modelling picture from Spartan, the phosphine (P) is illustrated without the
butyl groups for simplicity.

It is also interesting to note that, regioisomer A of the [3+2] cycloadducts
containing the chiral (4Sy4-benzyl-2-oxazolidinone auxiliary, compounds 95y, 97y and
99y, were isolated as a 1:1 mixture of diastereoisomers, similar to the results of the
related camphor sultam derivatives (5R)-95x and (55)-95x. It was suspected that the
position of the chiral auxiliary in the transition state leading to regioisomer A was
distant from the developing stereogenic carbon (C5) to have any influence on the

diastereoselectivity during the [3+2] cycloaddition. In contrast, the chiral auxiliary,
seen in transition state B for the formation of regioisomer B (Chapter 1, Scheme 1.14),
is positioned closer to the stereogenic carbon (C5) and therefore allows for a

diastereoselective [3+2] cycloaddition. It was found that the [3+2] cycloadditions usi

the (4S)-4-benzyl-2-oxazolidinone as the chiral auxiliary gave optically active produc
of regioisomer B. The optical rotations of these compounds are presented in Table 4.4.
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4.3 STEREOCHEMISTRY OF REGIOISOMER B
T o determine the absolute configuration at the spirocentre of the chiral versions
of regioisomer B, we aimed to convert regioisomer B to the known amino diacid 107
[Scheme 4.8], which had been previously been synthesised by our group.56
Deprotection, followed by acid hydrolysis of the hydantoin is expected to give the
amino diacid. It was envisaged that the ;V-PMB amide protecting groups, under
1 8 f\9.

oxidative conditions, ' m a y be easier to remove than the A/-benzyl amide protecting
group, thus compound 98y was chosen for the conversion.

^-COOH

Acid ^

C~%^ C O O H

hydrolysis H2N
107

COOH

98y
Scheme 4.8 - Synthetic analysis for the synthesis of amino diacid 107 from 98y

Using samarium(ITI) triflate in refluxing methanol for 12 h, compound 98y
could readily be converted to its methyl ester analogue 103 ([a]D - 5.5 (c 2.7, CHC13)
in 70 % yield [Scheme 4.9]. Subsequent treatment of 103 with eerie ammonium
nitrate18,68 (CAN) in acetonitrile/water gave the expected A^-dideprotected hydantoin
derivative 104 ([a]D24 - 33 (c 0.45, CHC13)) in 26 % yield. The reaction, unexpectedly,
also gave mono-deprotected benzylic oxidation products, the amides 105 in 11 % and
106 in 62 % yield. The former compound formed single crystals from which its relative
structure could unequivocally be determined by X-ray crystallographical structural
analysis [Figure 4.20]. The X-ray further confirmed the regiochemical outcome of the
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[3+2] cycloaddition reaction using the chiral oxazolidinone. It also confirmed that the
N(3)-PMB protecting group had been oxidised to the amide.

COOMe
Sm(OTf) 3 , M e O H

PIMB-

reflux, 12 h

PMB
103 (70%)
25

O

[a]D - 5.5 (c 2.7, CHCI3)

PMB
98y

[oc]D25 +3.6 (c 2.2, CHCI 3 )

Ce(NH4 ) 2 (N0 3 )
CH 3 CN/H 2 0
RT, 45 min

COOMe
COOMe

MeO

O
106(62%)
[a] D 23 -3.8 (c 2.2, CHCI 3 )

104 (26 %)
105(11 %)
[X-ray]

[a]D24 -32.5 (c 0.45, CHCI3)

1 0 % HCI
100°C, 30 min
microwave

COOH
H2N

COOH

107 (100%)
H20)

[a]D23-12(c0.10,

Scheme 4.9 - Synthetic pathway for the amino diacid 107
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Figure 4.20 - X-ray crystallographic analysis of c o m p o u n d 105

The mechanism for the oxidative removal of a P M B group begins with an initial
single electron transfer [SET], followed by loss of a proton and a further SET to give
the intermediate 108 [Scheme 4.10]. Hydrolysis of this intermediate then gives pmethoxybenzaldehyde and the free amine. Why the N3 PMB group is preferentially

cleaved is not clear since the initial intermediate formed after the first SET is a be

radical and it is expected that the Nl nitrogen would provide more stabilisation for an

a-benzyl radical than the N3 nitrogen as is discussed in the next chapter, Section 5.4.
Although both PMB protecting groups were expected to cleave to form 104, it is clear
that further oxidation at the benzylic positions had occurred resulting in loss of two
electrons and two hydrogens and therefore forming the amides, compounds 105 and
106, which can not be cleaved in the reaction [Scheme 4.10].
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OMe

SET

OMe

OMe

H20

CAN
-H +
-2e-

;N
PMB protected
nitrogen

108

H+
2e-

^^/OMe

I
/NH
free amine

+
0
P-methoxybenzaldehyde

S c h e m e 4.10 - M e c h a n i s m for the oxidative removal of a P M B group

Microwave assisted acid hydrolysis of compound 106 using 10 % HCI at 100 °C
for 30 min quantitatively gave the desired amino diacid 107 ([a]D - 12 (c 0.10, H20)).
Compound 107 gave spectral data that matched the spectral data reported for this
compound.56 However, its optical rotation, although closely matched in magnitude to
that of the reported (15)-enantiomer ([oc]D23 +11 (c 0.4, H20), ee 88 %),56 had the
opposite sign therefore indicating that compound 107 had the (IR) configuration. The
higher absolute value of the rotation implied that the enantiomeric excess was greater
than 88 %.
Stereoselectivity in the formation of regioisomer B, using the (4S)-4-benzyl-2oxazolidinone as the chiral auxiliary, was most likely due to favourable steric
orientation in the transition state of the (45)-benzyl-2-oxazolidinone that minimises
interaction with the protecting groups on the hydantoin. Based upon our chemical
correlation studies [Scheme 4.9], it is likely that all the cycloadducts in this study
produced from the butyne (93y) possess the (5R) stereochemistry and that the opposite

Chapter 4

86

configuration at the spirocentre m a y be achieved if one started with the (4/?)-3-(2butynoyl)-4-benzyloxazolidin-2-one.

4.4 FURTHER [3+2] CYCLOADDITIONS WITH (4S)-3-(2-BUTYNOYL)-4BENZYL-2-OXAZOLIDINONE (93y)
To see if the reversal in regioselectivity could be applied to other electron
deficient alkenes other than hydantoins, we performed the phosphine-catalysed [3+2]

cycloaddition reaction of 2-butyne 93y with methyl acrylate. This acrylate, as discussed
earlier in this chapter [Table 4.1], generally gives regioisomer A as the major product
when reacted with the ylide derived from achiral ethyl 2-butynoate (20). However,
when the chiral 2-butyne 93y was treated with 1 mol. equivalent of methyl acrylate and
a catalytic amount of tributylphosphine, a mixture of the expected regioisomers A and B
(109) could only be obtained in 9 % yield [Scheme 4.11].
o

o

COOMe

^lxn

/T\

N

methyl acrylate
O

93y

Bu3P(0.1 eq)
Benzene RT
15 h
0

MeOOC-

I
110 (37%

O
N. ,0
\

MeOOC
H
MeOOC
109A

H O

/

/-V

sj

0

109B

o%:

Scheme 4.11 - Reaction of 2-butyne 93y with 1 mol. equivalent of methyl acrylate
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Other products recovered from the reaction included 9 % of unreacted 2-butyne
(93y), 29 % of 4-benzyl-2-oxazolidinone (92y), 3 % of the bis-oxazolidinone (111) and
37 % of the ester (110). This once again demonstrated that the chiral 2-butyne 93y was
not stable to the reaction conditions due to cleavage of the chiral auxiliary.
The liberated 4-benzyl-2-oxazolidinone 92y can undergo Michael addition with
methyl acrylate or the chiral 2-butyne (93y) to give compounds 110 and 111,

respectively. The spectral data of these new compounds, in particular mass spectral dat
that showed the parent molecular ion for each compound, matched their proposed
structures and thus verified our hypothesis.
It was clear that the low yield of the desired product was a consequence of the
competing reactions forming the by products 110 and 111. Thus, in an attempt to
increase the yield of the desired products compounds 109A and 109B, 2 mol.

equivalents of the chiral 2-butyne were used. Under these conditions, a total yield of
% of regioisomers A and B, (109) respectively, was obtained [Scheme 4.12].
HPLC was able to separate the two regioisomers and also showed that the ratio
of these regioisomers was 55:45 in favour of regioisomer A [Figure 4.21]. It was also

able to separate the diastereoisomers of regioisomer B. Therefore by integration of th
HPLC trace the ratio of the diastereoisomers of regioisomer B was determined to be
18:82 [Figure 4.21]. Further derivatives of the diastereoisomers, which will be
23

discussed later, showed that the major isomer was the (li?) isomer (LR)-109B ([a] D

+

77 (c 0.5, CHC13)) and the minor isomer was the (IS) isomer (15)-109B ([a]D23 + 14 (c
0.8, CHC13)). On the other hand, the diastereoisomers of 109A could not be separated
by normal HPLC and thus were not fully characterised. Further derivatives of 109A
showed that the ratio of the diastereoisomers of 109A were essentially in equal
proportions.

o

o
/

MeOOC

Bn

methyl acrylate

93y 2 mol equivalent

Bu3P (0.1 eq)
Benzene RT
15 h

+
MeOOC

MeOOC

H

H

°0

Regioisomer B

Regioisomer A
109 A

109B

Total yield 39 % (Ratio A:B is 55:45)

Diastereoisomers
separable by H P L C

Diastereoisomers
inseparable by H P L C

Bn

X

\

N. .0
COOMe

COOMe

(1fl)-109B
23
[a] D +77 (c 0.5, CHCIg).

(1S)-109B
[a]D +14(c0.8, CHCI3).

H

23

Ratio (1fl)-109B:(1S)-109B is 82:18

S c h e m e 4.12 - Reaction of 2 mol. equivalent of 2-butyne 93y with methyl acrylate
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Fig 4.21 - H P L C trace (using Waters Prep N o v a P a k 6 p,m 60 A Silica column, 25 x
1 0 0 m m , eluting with 12 % ethyl acetate/petroleum spirit at 20 m L / m i n ) from the
reaction of 2 mol. equivalent of 2-butyne 93y with methyl acrylate

(Iff )-109A and (IS )-109A \

(+)-(lfl)-109B •
J—'

1)

(+)-(15)-109B

c

I

X>
<

Retention Time (min)

V

Regioisomer B

Y

Regioisomer A

T o determine the optical purity of compounds (1U)-109B and (1S)-109B and
also to determine the ratio of the diastereoisomers of 109A, we converted them to their
dimethyl ester cyclopentene derivative 112A, (1#)-112B and (1S)-112B using
samarium(ni) triflate in refluxing methanol for 12 h. The results of these reactions are
summarised in Table 4.5. The Table shows moderate to low yields of the dimethyl ester

cyclopentene derivatives. This is most likely related to their volatility and thus diffi
in handling. Therefore the recovery of the cleaved 4-benzyl-2-oxazolidinone (92y) is
perhaps a better indication of the efficiency of the reaction.
By comparing the signs of the optical rotations of compounds (1£)-112B and its
enantiomer (15)-112B to the known literature value for these compounds ([a]D -56.5
for the S isomer),79 it was determined that compound (1R)-U2 ([a]D + 55 (c 0.2,
CHC13)) had the li? configuration while compound (1S)-112 ([afo - 56 (c 0.15,
CHC13)) had the IS configuration.
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Table 4.5 - Results of the conversion of the benzyl oxazolidinone cyclopenti
derivatives (109) to its dimethyl ester cyclopentene derivative (112) using
samarium(III) triflate in refluxing methanol for 12 h.
Products
Starting material
Yield of 92y

Yield, Rotation and ee of
dimethyl ester cyclopentene

Bn

COOMe

0

/—\

/f~0

x

xX °
MeOOC

H
109A

Ratio of diastereoisomers
46:54
Bn

XX
M

COOMe

Bn
(1/7)-109B

,x H
/ X/X°

Vb x

HN
\

0
/

Bn
81 %
0

x
HN
\

Ratio of enantiomers
(ee 8%)

xJy~-COOMe
H

0
/

Bn
610%

x
HN
\

MeOOC H
112A61 %

COOMe

(1fl)-112B 2 0 %
[a] D 23 +55 (c 0.2, CHCI 3 )
(ee >98 % )

x\~COOMe
H

COOMe
(1S)-112B 3 7 %
0

/

[a]D23-56(c0.15, CHCI 3 )
(ee > 98 % )

Bn'
78%

Taking
advantage
of the volatility of the dimethyl ester cyclopentene
°v
o
H

COOMe

derivatives,
these compounds were subjected to chiral gas chromatographic (GC)
(1S)-109B

analysis. It was found that the ratio of the enantiomers of compound 112A (regioisomer
A) was 46:54 [Figure 4.22]. The optical purity of each of the B regioisomers,
enantiomers (1R)-112B and (1S)-112B, was quantified using chiral GC [Figures 4.24
and 4.25]. It was found that each had an enantiomeric excess greater than 98 %. A
spiked sample containing both (l/f)-112B and (1S)-112B needed to be run on the chiral
GC to confirm their relative retention times [Figure 4.23]. However the GC traces of
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the individual samples of compounds (15)-112B and (LR)-112B are shown in Figures
4.24 and 4.25.

Figure 4.22 - G C trace* of compound
112A showing ratio of diastereoisomers

D C M peak

ratio

Figure 4.23 - G C trace* showing
relative retention times of
(-)-(S)-112B and (+)-(fl)-112B

integration (46:54)

D C M Peak

1

(+)-(/?)-! 12B

(-)-(S)-112B

c

c

Retention Time (min)

Retention Time (min)

Figure 4.24 - G C trace* of a
sample of (-)-(S)-112B

Figure 4.25 - G C trace* of a
sample of (+)-(R)-U2B

D C M Peak

DCM Peak

(+)-(R)-l 12B

(-)-(S)-112B
c

C

(+)-(fl)-112B

(-)-(S)-112B

U
Retention Time (min)

Retention Time (min)

* Chiral G C was performed on a Varian 3700 Gas chromatograph using a G a m m a Dex fused silica
capillary column (30 M x 0.25 m m x 0.25 p m ) from Supelco at 130 °C (isothermal) at a flow rate of
lml/min.
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4.5 SUMMARY
In summary, the phosphine-catalysed [3+2] cycloaddition reactions using ethyl
2-butynoate (20) and 5-methylene hydantoins has been shown to be an efficient reaction
that gives predominantly regioisomer A. Increased selectivity for regioisomer A can be
achieved by using a large auxiliary on the 2-butyne such as a ferr-butyl ester group, as
en

seen in the study by D u et al., or the use of a camphor sultam as seen in this study.
Using a chiral camphor sultam as the auxiliary, diastereoisomers are produced that can
easily be separated by column chromatography.
Selectivity for regioisomer B can be induced by using a 2-oxazolidinone
auxiliary. Optically active versions can be obtained by using the (4S)-benzyl-2oxazolidinone auxiliary, which generally gives selectivity for one diastereoisomer.
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W e e d name: Jimsonweed, Datura stramonium (DATST). It is a
potent hallucinogen but it is also very toxic and several people have
become seriously ill or have died from the seeds.
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Chapter 5 - Completion of the Synthesis
F r o m the previous chapter, it was realised that the P M B and benzyl protected
cycloadducts were provided in the highest yields. However the difficulty of removing
the PMB group by oxidative cleavage, with formation of amides, steered us away from
further reactions with this protecting group. As a result, in this chapter we only
concentrate on the dibenzyl protected compound 80 and its enantiomerically pure
analogues (5S)-95x and (5R)-95x.
With compound 80 at hand, several synthetic transformations can take us to
carbocyclic hydantocidin. These included; deconjugation of the double bond, cisdihydroxylation of the double bond, reduction of the CI ester to an alcohol and
deprotection of the hydantoin nitrogen groups [Scheme 5.1]. A study of the feasibility
and diastereoselectivities of these reactions, with the aim of synthesising carbocyclic
hydantocidin, was explored and will be discussed in this chapter.

COOEt

COOEt
deconjugation

H O C O O E t
dihydroxylation

H0

/

\

- rn ^cXX
o
deprotection

S c h e m e 5.1 Synthetic transformations of 80 required
for the total synthesis of carbocyclic hydantocidin
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Before further discussion can take place, it needs to be mentioned that although
most of the diagrams of compounds in this chapter are drawn with an absolute

configuration, it should be noted that this is only to aid in distinguishing the relat
configurations of isomers. For most compounds, racemic mixtures were obtained. In the
case where pure enantiomers are involved, the absolute configuration is shown and an
optical rotation is given.

5.1 DECONJUGATION REACTIONS
In Chapter 2, we attempted to deconjugate the double bond of the unprotected
hydantoin 26 using LDA, but to no avail. Here we describe our attempts to deconjugate
the double bond with a iV,iV'-diprotected hydantoin.
Although deconjugation of the double bond of compound 80 was attempted with
several bases including lithium diisopropylamine (LDA) and lithium bistrimethylsilyl
amide Li(TMS)2N, the most effective procedure for deconjugation was achieved by
stirring a solution of cycloadduct 80 in THF with potassium bistrimethylsilylamide
(K(TMS)2N) at -78 °C under an argon atmosphere for 10 min [Scheme 5.2]. After
quenching with acetic acid, the diastereoisomers 113 and 114 could be separated by

careful chromatography in quantitative yield. By integration of the olefinic protons i
the *H NMR spectrum of the isolated crude reaction mixture, the ratio of the
diastereoisomers 113:114 was found to be 3:2. A variety of NMR experiments,
including *H NMR, 13C NMR, HSQC, HMBC and NOESY, were used to distinguish
the two diastereoisomers.
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ratio of 113:114 is 3:2
Scheme 5.2 - Deconjugation of 80 using K ( T M S ) 2 N under argon

In the *H NMR spectrum of diastereoisomer 113 [Figure 5.2], two new olefinic
resonances were observed at 5.26 ppm and 6.10 ppm, which indicated that the double

bond had migrated and was no longer attached to a substituted carbon, that is, C7. Ea

olefinic resonance appeared as a doublet of doublets suggesting coupling to each oth
and long range coupling, most likely to the C7 proton. The 13C NMR spectrum [Figure
5.3] along with HSQC spectra verified that these new olefinic proton resonances
belonged to olefinic protons attached to carbons at 130.3 ppm and 136.9 ppm,
respectively [Figure 5.4]. HSQC spectra were able to establish that the C(6) carbon
33.9 ppm had its methylene protons at 2.52 ppm (Ha) and 2.39 ppm (Hb). It also
showed that the carbon at 49.7 ppm was the C7 carbon and that it correlated to the
proton at 3.79 ppm (C(7)Ha).
The ABX coupling system between the protons C(7)Ha and C(6)HaHb allowed

elucidation of the relative positions of these protons [Figure 5.1]. It was found th

C(6)Ha proton (2.52 ppm) appeared as a doublet of doublets and had J values of 9.0 Hz

and 14.4 Hz while the C(6)Hb proton (2.39 ppm), also appeared as a doublet of doublet
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and had J values of 6.0 H z and 14.4 Hz. The large J value of 14.4 H z showed the
geminal coupling constant between C(6)Ha and C(6)Hb while the smaller J values of

6.0 Hz and 9.0 Hz were the vicinal coupling constants to the neighbouring C(7)H pro
(3.79 ppm).80 The C(7)H proton also showed corresponding J values of 6.0 Hz and 9.0

Hz. The larger J value of 9.0 Hz between the protons at C(6)Ha (2.52 ppm) and C(7)Ha

(3.79 ppm) suggest that these protons have a cis relationship while the smaller J v

of 6.0 Hz suggest that C(6)Hb (2.39 ppm) was trans to the proton at C(7)Ha.80 Thus by

deduction, it was concluded that the C(6)Hb proton (2.39 ppm) was on the same side a
the ester.80 This analysis is illustrated in Figure 5.1.

Figure 5.1 - Characteristic NMR assignments for compound 113
C(6)Hb proton <-->
C(7)CO carbon in H M B C

OEt

C(7)Ha at 3.79 ppm,
J = 6.0 Hz; 9.0 Hz
C(6)Haat2.52ppm,
J=9.0Hz; 14.4 Hz

C(6)Hb at 2.39 ppm,
J=6.0Hz;14.4Hz

C(6)Ha proton <-->
C(4)Q carbon in H M B C

Olefinic protons appear at
5.26 ppm and 6.10 ppm
A B X system
C(6)Hb proton <--> N(1)CH 2
protons in N O E S Y
note:

^C(6)Ha-C(6)Hb=14-4Hz(9eminal)
^C(6)Ha.C(7)Ha = 9-0Hz(C/SViCinal)
^C(6)Hb-C(7)Ha = 6-0HZ(^nSV'lCinal)

double headed arrow indicates H M B C correlation

H M B C experiments on compound 113, revealed that both protons at C 6 had

correlations with the carbonyl resonances of the ethyl ester (172.3 ppm) and C4 (1
ppm) [Figure 5.5]. However, on closer examination it was found that the proton at

ppm (C(6)Ha) had a more intense correlation with the C4 carbonyl at 174.3 ppm, whi

the proton at 2.39 ppm (C(6)Hb) had a more intense correlation with the carbonyl o
ester at 172.3 ppm. As HMBC data show correlations of protons to carbons with
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dihedral angles closer to 0° or 180° more intensely, it suggested that the proton at 2.52
ppm (C(6)Ha) was syn to the C4 carbonyl of the hydantoin and that the proton at 2.39
ppm (C(6)Hb) was syn to the ester. This supports our !H NMR analysis and provides
evidence for the relative stereochemistry of compound 113.
To further confirm the relative stereochemistry of compound 113, NOESY
experiments were performed [Figure 5.6]. These showed that the protons at 2.39 ppm
(C(6)Hb), which has just been established as being syn to the ester, showed a cross
to the N(1)CH2 benzyl protons at 4.50 ppm. This indicated that the ester, the proton
2.39 ppm (C(6)Hb) and the N(l) benzyl group were all facing the same side thus
verifying the structure of compound 113.

Figure 5.2 - *!! N M R (CDC1 3 ) spectrum of compound 113
COOEt

0

ppm
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Figure 5.3 - 13 C N M R (CDC13) spectrum of compound 113
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Figure 5.5 - Partial H M B C (CDC13) spectrum for compound 113
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C o m p o u n d 114, also showed the presence of two new olefinic resonances in the
'H NMR spectrum (5.38 ppm and 6.25 ppm), similar to its diastereoisomer [Figure
5.8]. Its 13C NMR [Figure 5.9] and HSQC spectra showed that these olefinic proton
resonances belonged to hydrogens attached to carbons resonating at 129.9 ppm and
138.2 ppm, respectively [Figure 5.10]. HSQC experiments confirmed that the two
proton resonances at 1.98 ppm (C(6)Hb) and 2.64 ppm (C(6)Ha) were attached to the
same carbon, C6 (34.5 ppm), while the carbon at 50.2 ppm was attached to the C(7)Hb
proton at 3.53 ppm.
The ABX coupling system analysis, as described before for compound 113, was
used to determine the relative configuration of compound 114 [Figure 5.7]. It was
found that C(6)HaHb protons had a geminal coupling constant of 14.7 Hz and that the
vicinal coupling constants to C(7)Hb were 6.3 Hz and 8.4 Hz for protons 2.64 ppm
(C(6)Ha) and 1.98 ppm (C(6)Hb), respectively. The values of these coupling constants
suggested that the proton C(6)Hb (1.98 ppm) was cis to the neighbouring C(7)Hb
proton (3.53 ppm). As a consequence, it also suggested that the highly deshielded
proton C(6)Ha (2.64 ppm) had a trans relationship with the C(7)Hb proton and
therefore was syn to the ester. Figure 5.7 illustrates these findings.
Again, HMBC experiments were able to verify the relative orientation of the

hydantoin ring with respect to the ester [Figure 5.11]. It showed that the proton at 2
ppm (C(6)Ha) had intense correlations with the carbonyls at 171.2 ppm and 173.7 ppm,

belonging to the ester and C(4) carbonyl of the hydantoin, respectively. This suggest
that the ester, C(6)Ha proton and C(4)0 carbonyl were in close proximity in space,
consistent with the structure of compound 114.
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Figure 5.7 - Characteristic N M R assignments for compound 114

C(7)Hb at 3.53 ppm,
J =6.3 Hz; 8.4 Hz

EtO
C(6)Ha proton <-->
C(4)0 &C(7)CO
carbons in H M B C

C(6)Hbat1.98ppm,
J =8.4 Hz; 14.7 Hz

C(6)Ha at 2.64 ppm,
J=6.3Hz; 14.7 Hz
Olefinic protons appear at
5.38 ppm and 6.25 ppm

A B X system
5
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J

C(6)Hb - C(7)Hb = 8 " 4 H Z (C'S V ' C ' nal )
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double headed arrow indicates H M B C correlation

Figure 5.8 - *H N M R (CDC1 3 ) spectrum of compound 114
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13
Figure 5.9 -1J
C N M R (CDC13) spectrum of compound 114
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Figure 5.11 - Partial H M B C (CDC1 3 ) spectrum for compound 114
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After the structure of each diastereoisomer was established and its N M R data

assigned, it was noticed that a characteristic difference between the diastereoisomer

was the significant difference in chemical shifts of the protons connected to C6. The

differences in chemical shifts can be explained by the deshielding effect of the prox
carbonyl groups of the ester and C4 of the hydantoin [Figures 5.1 and 5.7]. In
compound 114, the C(6)Ha proton is flanked by these two carbonyls and thus its
chemical shift is more downfield (2.64 ppm) than its geminal partner, the C(6)Hb
proton (1.98 ppm), which does not experience any deshielding effect. Conversely, the

C6 protons in diastereoisomer 113 are closer in chemical shifts as they both experien

deshielding effects, although more so by the C4 carbonyl of the hydantoin. It was not
that in compound 113, C(6)Ha (2.52 ppm) is deshielded by the C4 carbonyl of the
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hydantoin while C(6)Hb (2.39 p p m ) is deshielded by the carbonyl of the ester. These
distinguishing features were used to identify the diastereoisomers of any subsequent
related compounds.
Our early attempts at the deconjugation of 80 with base used a nitrogen
atmosphere instead of argon. However, the lower density of nitrogen failed to
completely exclude oxygen from the reaction mixture since the ketone 115 and the 7hydroxy substituted compound 116 were obtained in yields of 42 % and 37 %,
respectively [Scheme 5.3].

COOEt
1. K(TMS)2N, N 2
-78 °C, THF, 10 min

115 (42%)

»-

2. acetic acid
quantitative

116 (37%)
Scheme 5.3 - Deconjugation of 80 using K ( T M S ) 2 N under nitrogen

Evidence for the structure of 115 arose from the 13C NMR spectrum that showed
a carbonyl resonance at 202.6 ppm, suggesting the presence of a cyclopentenone
carbonyl group.81 The typical hydantoin carbonyls at 155.2 ppm and 171.4 ppm were
still present. Further evidence came from the lU NMR spectrum, which lacked the

resonances of the ethyl ester but showed olefinic resonances more downfield than usua
at 6.33 ppm and 6.90 ppm, as compared with the olefinic resonances of compounds 113
and 114. The downfield shift comes from the deshielding effect of the C7 carbonyl.
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In the ] H N M R spectrum of the C 7 hydroxylated compound 116, the ethyl ester
resonances and two new olefinic resonances at 5.56 ppm and 6.10 ppm were seen,
suggesting that the double bond had deconjugated. It was also noticed that the
diastereotopic C(6)H2 protons were each doublets, which indicated that they were only
coupled to each other. Therefore it was deduced that the C7 position was substituted
with another functional group apart from the ester. Mass spectrum analysis of 116
showed a M + 1 ion at m/z 421 (CI +ve), 16 mass units more than the mass of the
• starting material 80, which suggested that the C7 substitution was an alcohol, thus
supporting the structure of 116. Further support came from the 13C NMR spectrum that
showed the C7 carbon as a quaternary carbon at 95.1 ppm. Its appearance at a low field
verified that it was connected to a hydroxyl group. It was of interest to note that 116
was formed as a single diastereoisomer, however, no attempts were made to determine
its configuration.
It was proposed that the presence of molecular oxygen, which has been used in
other studies to hydroxylate the cc-carbon of a lactone,82 allowed the formation of the
products 115 and 116. However, the mechanism for the formation of these products in
our studies was not clear. We speculated that the mechanism may begin with a single
electron transfer (SET) from 117A to an oxygen molecule [Scheme 5.4]. Combination
of the resulting C7 radical (117B) with the superoxide radical gives the peroxide-anion

118. The anion of 118 can nucleophilically attack the ethyl ester, which mechanisticall
displaces ethanol and carbon dioxide and therefore gives the observed ketone 115, as
shown in Scheme 5.4. Alternatively, the peroxide anion can be protonated and then be
reduced to the alcohol 116. Macias et aln have used triethyl phosphite to perform this
type of reduction. In our studies though, the peroxide intermediate was not expected to
be stable, however, sources for its reduction to the alcohol were not certain.
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Q/COOEt

. .COOEt
Single
Electron
Transfer

Scheme 5.4 - Proposed mechanism for the formation of ketone 115 and alcohol 116

The deconjugation reaction was also applied to the camphor sultam containing
chiral cycloadducts (5S)-95x and (5/c)-95x, under an argon atmosphere. It was found
that when (5S)-95x was subjected to these deconjugation conditions only one
deconjugated diastereoisomer was formed [Scheme 5.5]. The !H NMR analysis of the
isolated crude reaction mixture showed, by integration of the olefinic protons of the
starting material and product, that deconjugation took place with 90 % conversion.
Column chromatography failed to completely separate the starting material (55)-95x
from the product (5R, 7S)-119 and therefore the absolute configuration of {5R, 7S)-119
and its optical rotation could not be determined directly. However, further synthetic
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transformations including dihydroxylation and acetonide protection, which will be
discussed in the next section, were able to show that (5R, 7S)-119 had an absolute
configuration of 5R and 75.

1.K(TMS)2N, Ar
-78 °C, THF, 10 min
2. acetic acid

(5R, 7S)-119 (90%)

(5S)-95x

+ 10%(5S)-95x

1. K(TMS)2N, Ar
-78 °C, THF, 10 min

(5S, 7fl)-120 major

3

2. acetic acid

(5R)-95x

(5S, 7S)-121 minor
Total yield was 94 %
ratio of 120:121 is 3:2

Scheme 5.5 - Deconjugation of chiral cycloadducts (55)-95x and (5R)-95x
On the other hand, when (5R)-95x was deconjugated using the same conditions,

two diastereoisomers were formed in a total isolated yield of 94 % in a ratio of 3:2 a
determined by 'H NMR integration of the isolated crude reaction mixture [Scheme 5.5].

It was interesting to note that the isolated crude reaction mixture showed no signs o

starting material and thus the less than quantitative yield is probably due to loss of
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compound during work up and purification. T h e two diastereoisomers could not be fully
separated by column chromatography and therefore their optical rotations could not
accurately be determined. However, using the rationale already established earlier to
distinguish between the two racemic deconjugated diastereoisomers 113 and 114, the
absolute configuration of the major (120) and minor (121) diastereoisomers could be
determined, given the absolute configuration at C5 [Figure 5.12 and Figure 5.13].

Starting with (5/f)-95x, the absolute configuration of both its deconjugated products 120
and 121 at C5 would be S, as a result of the change in the priority order of the
substituents.
The *H NMR spectrum of the minor product 121 [Scheme 5.5] showed a large
difference in chemical shifts of the C(6)H2 protons, with one at 1.82 ppm (C(6)Hb) and
the other at 2.86 ppm (C(6)Ha). This large difference suggested that the proton at 2.86
ppm is most likely deshielded by two carbonyls, one from the substituent carbonyl at C7
and the other from C4 in the hydantoin. This would signify that the C4 carbonyl and C7
camphor sultam substitution were syn to each other and therefore would give structure
121, where C7 had the S configuration [Figure 5.12].

Figure 5.12 - Typical chemical shifts for Isomer (5S, 7S)-121
CS
C(7)Hbat4.19ppm

C(6)Ha is strongly
deshielded by 2
carbonyls

C(6)Hbat1.82ppm,
J =7.5 Hz; 14.7 Hz

C(6)Ha at 2.86 ppm,
J =6.6 Hz; 14.7 H z
Olefinic protons appear at
5.34 ppm and 6.16 ppm
CS = Camphor Sultam group

A B X system
^c(6)Ha.c(6)Hb = -'4.7Hz(geminal)
^c(6)Hb-c(7)Hb = 7.5. H z (cis vicinal)
J,C(6)Ha - C(7)Hb= 6.6 H z {trans vicinal)

note:
double headed arrow indicates deshielding effect

Chapter 5

109

The A B X coupling system between C(6)H 2 and C(7)H further confirmed this

structural assignment. It showed that the more deshielded proton at 2.86 ppm (C(6)Ha)
had a trans vicinal coupling of 6.6 Hz to C(7)Hb while the less deshielded proton
C(6)Hb (1.82 ppm) had a cis vicinal coupling of 7.5 Hz to C(7)H, consistent with the
structure of (55, 75)-121 [Figure 5.12].
In comparison, the 'H NMR spectrum of the major (120) product showed a
smaller difference in chemical shifts of the C(6)H2 protons, one at 2.07 ppm (C(6)Hb)

and the other at 2.76 ppm (C(6)Ha). As proved earlier in this section, the C(4) carbo
has the most influential deshielding effect thus the proton at 2.76 ppm (C(6)Ha) was

assigned as being on the same side as the C(4) carbonyl [Figure 5.13]. This proton al

had the larger vicinal coupling constant of 9.3 Hz with the C(7)Ha proton at 4.38 ppm
suggesting a cis relationship between these protons. By default, this suggested that
C(6)Ha (2.76 ppm) was trans to the camphor sultam auxiliary, therefore placing the
camphor sultam on the opposite side of the C4 carbonyl. Given that C5 had the S
configuration, it would mean that C7 of the major product [(55, 7/?)-120] had the R
configuration. A summary of this analysis can be seen in Figure 5.13.

Figure 5.13 - Typical chemical shifts for Isomer (55,7fl)-120
C(7)Ha at 4.38 ppm

C(6)Hb is deshielded
by the ester carbonyl

C(6)Ha at 2.76 ppm,
J = 9 . 3 H z ; 14.7 Hz
C(6)Hb at 2.07 ppm,
J=5.4Hz;14.7Hz

Olefinic protons appear at
5.34 p p m and 6.14 p p m

C(6)Ha is deshielded
by the C 4 carbonyl

A B X system
Jc(6)Ha-C(6)Hb=14-7HZ(geminal)

CS = Camphor Sultam group

^C(6)Ha-C(7)Ha=9-3Hz(C/SVicinal)

= 5.4 Hz {trans vicinal)

-/C(6)Hb - C(7)Ha

note:
double headed arrow indicates deshielding effect
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5.2 DIHYDROXYLATION REACTIONS ~
The most common method used to oxidise a double bond to a cis diol is through
the use of a catalytic amount of osmium tetroxide and a co-oxidant in an aqueous
medium with a miscible organic solvent. In our experiments, dihydroxylation was
achieved by dissolving the starting alkene in an acetone/water mixture (4:1) and then
adding 0.1 mol. equivalents of potassium osmate as the catalyst and 4 mol. equivalents
of iV-methyl morpholine oxide as the co-oxidant. All reactions were performed at RT,
however the reaction times varied for each compound and the results of this study are
shown in Table 5.1.
For the ease of handling, the prevention of side products in subsequent reactions
and for clarity in NMR studies when endeavouring to determine the stereochemical
outcome of the dihydroxylations, most of the diol products were protected as their

acetonides or their acetates [Table 5.2]. Acetonide protection was generally achieved b
stirring the diol in a dichloromethane/dimethoxypropane (1:1) mixture with a catalytic
amount (0.1 mol. equivalent) of /?ara-toluenesulphonic acid (p-TsOH) at RT for 8 h.

Alternatively, the protection of alcohols as their acetates was accomplished by stirrin

the alcohol in a mixture of acetonitrile, pyridine and acetic anhydride at RT for 10 h.
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Table 5.1 - Dihydroxylations of various alkenes using 0.1 mol. equivalents of
potassium osmate and 4 mol. equivalents of iV-methyl morpholine oxide in
acetone/water (4:1)
R8

R 7A

)8 /
R9

(a

Ft7B

6>

cryco
Starting Alkene
Entry
Substitution3

No.

Reaction
Time

7

1

R : COOEt
A7'8

5SR [80]

2

R7 : COOEt
A8'9

5RS,
ISR
[113]

3

R7 : COOEt
A8'9

5RS,
IRS
[114]

4

R 7 : CO(CS) c
A8'9

5R, IS
[119]d

5

R7 : C H 2 O H
A8'9

7

6

R : CH2OH
A 8,9

5RS,
SRS
[156]

5RS,
SSR
[142]

15 h

5d

3d

3d

5d

3d

Diol Product
Substitution15

R/A = COOEt
R7B = OH
R8 = OH
R/A = COOEt
R7B = OH
R8 = OH
R7A = COOEt
R8 = OH
R9 = OH
R7A = COOEt
R8 = OH
R9 = OH

No.
5SR, IRS, 8SR,
[122]

43

5SR, ISR, SRS
[123]

43

SRS, ISR, SSR,
9RS [126]

74

SRS, IRS, SRS,
9SR [111]

60

R7A = CO(CS)c
5R, IS, 85, 9R
R8 = OH
[128]e
9
R = OH
7A
R = CH 2 OH
SRS, 6SR, IRS,
R8 = OH
SSR [131]g
9
R = OH
R/A = CH 2 OH
SRS, 6RS, ISR,
R8 = OH
SSR [132]g
9
R = OH

21h

SRS, 6RS, ISR,
SRS, [133]' and
5RS, 6RS, ISR,
SRS [134]1

63j

R7A = CH 2 OH
R8 = OH
R9 = OH

A7'8 indicates C 7 - C 8 double bond, A8'9 indicates C 8 - C 9 double bond
Only non-hydrogen subtituents indicated
C S represents the camphor sultam group
90 % pure starting material as obtained from the deconjugation reaction of 55 -95x
[a] D 2 b -8.7 (cl.3,CHCl 3 )
46 % was recovered starting material 119
Dihydroxylation resulted in change in order of priority groups thus R9, R 8 and R 7 are on
carbons C6, C 7 and C8, respectively
h) 16 % was recovered starting material 149
i) Compounds that could not be separated by column chromatography
j) Total yield of reaction
a)
b)
c)
d)
e)
f)
g)

Yield

37f

28 h
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Table 5.2 - Acetonide and acetate protection of various title diols from Table 5.1
Starting Diol
Entry
Substitution3

No.

Protection
Type

Protected Product
Substitution2

No.

Yield
(%)

R

7A

1

= COOEt
R = OH
R8 = O H

55/?, IRS,
8SR,
[122]

2

R7A = COOEt
R7B = O H
R8 = O H

55i?, ISR,
SRS [123]

3

R7A = COOEt
R8 = O H
R9 = O H

SRS, ISR,
SSR,9RS
[126]

4

R7A = CO(CS)b
R8 = O H
R9 = O H

SR, 75,
85, 9R
[128]

7B

5

R7A = CH 2 OH
R8 = O H
R9 = O H

5RS, 6RS,
ISR, SRS,
[133]'
and SRS,
6RS, ISR,
SRS
[134]'

6

R7A = CH 2 OH
R8 = O H
R9 = O H

5RS, 6RS,
ISR, SRS,
[133]'
and SRS,
6RS, ISR,
SRS
[134]'

7

R7A = CH 2 OH
R 8 & R9 =
acetonide

5RS, 6RS,
ISR, SRS
[135]'

8

R7A = CH 2 OH
R 8 & R9 =
acetonide

SRS, 6RS,
ISR, SRS,
[136]e

a)
b)
c)
d)
e)

R

7A

acetonide

= COOEt
R7B, R8 =
acetonide

[124]

80

acetonide

R7A = COOEt
R7B, R8 =
acetonide

[125]

86

acetonide

R7A = COOEt
R8, R9 =
acetonide

[129]

94

acetonide

R7A = COOMe'
R8, R9 =
acetonide

[130]d

53

R
acetonide

7A

= CH 2 OH
R8,R9 =
acetonide

R7A = CH 2 OH
R8,R9 =
acetonide

5RS,
6RS,
ISR,
SRS,
[135]'
5RS,
6RS,
ISR,
SRS
[136]'

31

46

acetate

R7A = CH 2 OAc
R8 = OAc
R9 = OAc

[139],
[140]

91

acetate

R7A = CH 2 OAc
R8 & R9 =
acetonide

[137]

95

acetate

R/A = CH 2 OAc
R 8 & R9 =
acetonide

[138]

99

Only non-hydrogen substituents indicated
C S represents the camphor sultam group
Methyl ester is formed during acetonide protection, theexplanation for this is £iven in the text
[a] D 23 + 35 (c 0.4, C H C 1 3 )
Dihydroxylation resulted in change in order of priority groups thus R9, R8 andR7 are on
carbons C 6 , C 7 and C 8 , respectively
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Although diastereoselectivity was poor, it was found that m-dihydroxylation of

the conjugated compound 80 gave the best yield. It gave a 1:1 mixture o

and 123 in a total yield of 86 %, which was readily separated by column
chromatography [Table 5.1, entry 1] [Scheme 5.6]. These diols could be

their acetonides 124 and 125 in good yield, 80 % and 86 %, respectively

entries 1 and 2]. Using our discovery that the chemical shifts of the p

C(6)HaHb are greatly influenced by the relative positions of the C4 car
hydantoin and the carbonyl of the ethyl ester, as described in Chapter

Section 5.1, we were able to determine the relative configuration and h

between the two diastereoisomers of the acetonides 124 and 125 by !H NMR

y
HO
Bn

OH
'^COOEt

^ N ^''-^°
-N^
Bn

cat. K20s04.2H20
NMO (2 eq.)
80

acetone/H20 (4:1)
RT, 15 h

O

2,2-dimethoxypropane
DCM, cat. p-TsOH
RT,8h

122 (43 %)

Bn

O
) T-COOEt

^ N ' "y>°
O

h~N,
'Bn
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Scheme 5.6 - Dihydroxylation of conjugated compound 80
followed by acetonide protection

The C6 protons of the acetonides 124 and 125 were easily distinguished from

the C9 protons, as the C6 protons now each appeared as doublets. In on

found that the C6 protons were at 2.28 ppm and 2.67 ppm and each had a
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constant of 15.0 H z . This relatively large difference in chemical shift suggests that one
proton was deshielded by both the C4 carbonyl and the carbonyl of the ethyl ester,
indicating that the ethyl ester and C4 carbonyl were on the same side of the
cyclopentane ring and thus this isomer was assigned as compound 125 [Figure 5.14].

C(6)Hb at 2.55 ppm
is deshielded by
carbonyl of ester
OEt

C(6)Hb at 2.28 ppm

C(6)Ha at 2.63 ppm
is deshielded by C 4
carbonyl
124

OEt

C(6)Ha at 2.67 ppm is
strongly deshielded
by 2 carbonyls
125

note:
double headed arrow indicates deshielding effect
Figure 5.14 - Distinguishing features of acetonides 124 and 125

To further support our prediction, it was found that the chemical shifts of the C6
protons of the other isomer (124), seen at 2.55 ppm and 2.63 ppm and each apparently
appearing as doublets (15.9 Hz), were much closer together. In fact, they were
considered so close that they were classed as an AB quartet with a / value of 15.9 Hz
and Av of 24 Hz. It would suggest that each proton on the C6 carbon experienced a
similar deshielding chemical environment, indicating that the C4 carbonyl and ethyl
ester were on the opposite sides of the cyclopentane ring, therefore supporting the
structure of compound 124 (Figure 5.14).
It was also found that dihydroxylation of the conjugated compound 80 occurred

in a shorter reaction time, in 15 h compared to 3 - 5 d for the deconjugated analogues.

Chapter 5

115

This is contrary to what is expected since an electron deficient alkene should normally
react slower. It was hypothesised however, that the double bond between C7 and C8,
being distant from the sterically demanding spiro-C5 substitution, allows osmium to
more readily coordinate to the double bond. As a consequence, the dihydroxylated
compounds are produced more quickly. However, by the same token, this less hindered
orientation of the double bond in conjunction with the relative flatness of the
cyclopentene ring allows osmium to approach on either side of the double bond and
thus explains why no 7i-facial diasstereoselectivity is observed.
In contrast, Table 5.1 shows that the cw-dihydroxylation of the deconjugated
compounds 113, 114 and 119, each selectivity gave a single diastereoisomer, the diols
126,127 and 128 in yields of 74 %, 60 % and 37 %, respectively (Table 5.1, entries 2,
and 4) [Scheme 5.7].
COOEt
COOEt
cat. K20s04.2H20
N M O (2 eq.)
>
acetone/H20(4:1)
RT, 5d
126 (74 %)

°113

HO

COOEt

COOEt
cat. K20s04.2H20
N M O (2 eq.)
»
acetone/H20(4:1)
RT, 3d

HO"

Nr '"f°
Jr-N
D

127(60%)

cat. K20s04.2H20
N M O (2 eq.)
a

acetone/H20(4:1)
RT, 3d

O

119

~ 128(37%)

Scheme 5.7 - Dihydroxylation of compounds 113,114 and 119
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Fortunately, 127 was isolated as a crystalline compound and therefore X-ray

crystallographic analysis was able to unequivocally reveal its structure [Figure 5.15]
The ORTEP representation of 127 showed that ds-dihydroxylation had occurred syn to
the C7 ester group.

Figure 5.15 - X-ray of c o m p o u n d 127

HO.

COOEt
fa i

'~^0

O n the other hand, the structure of compounds 126 and 128 were elucidated

from NMR data of their respective acetonide protected derivatives, compounds 129 and
130 (Table 5.2, entries 3 and 4). The lH NMR spectrum of compound 129 revealed a
doublet at 4.44 ppm which was coupled, with a coupling constant of 5.1 Hz, to a
doublet of doublets at 4.97 ppm [Figure 5.16]. This coupling pattern suggested they
belonged to the protons at C(9)H and C(8)H respectively. HMBC experiments showed a
cross peak between the proton at 4.44 ppm (C(9)H) and the C4 carbonyl of the
hydantoin that suggested that this proton and carbonyl were on the same side of the
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cyclopentane ring. Therefore it was deduced that the acetonide functionality was facing

the opposing side of the cyclopentane ring to the C4 carbonyl and therefore was sy

the N(l) benzyl group and ester. X-ray crystallographical analysis of a derivative
(compound 150, Figure 5.20) where the hydantoin was reduced at C4, which is
discussed in Section 5.3, was able to verify this assignment.

Figure 5.16 - *H N M R (CDC1 3 ) of compound 129
COOEt
0-<9

Ni '"f
N

"

y- 129

X
>—v

00

u
0 ppm

Although the deconjugated, camphor sultam containing, cycloadduct 119 was
only 90 % pure, with 10 % contamination by its conjugated form 95x, only the cisdihydroxylated product of the deconjugated cycloadduct was isolated. The bulky
camphor sultam, in the conjugated form, may sterically hinder the coordination of
osmium to the double bond and therefore prevent its dihydroxylation.
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It was found that when the optically active diol 128 ([a] D 26 -8.7 (c 1.3, CHC1 3 ))
was protected as the acetonide using a catalytic amount of /?TsOH in dichloromethane
and 2,2-dimethoxypropane, unexpected cleavage of the camphor sultam resulted with
formation of a methyl ester, to give compound 130 [Scheme 5.8]. Camphor sultams, in
general, can be cleaved under acid conditions and it is known that the mechanism of

acetonide protection results in methanol being liberated. Therefore we hypothesised th
pTsOH was able to catalyse the cleavage of the camphor sultam by methanol.

COOMe
2,2-dimethoxypropane
DCM, p-TsOH
RT, 8h

[oc]D26 -8.7 (c 1.3, CHCI3)

130 (53 %)
[a]D + 35 (C0.4, CHCI3)
23

S c h e m e 5.8 - Acetonide protection of diol 128 resulted in methyl esterification

This surprising result, however, allowed determination of the absolute
configuration of the optically active methyl ester 130 ([a]D2 + 35 (c 0.4, CHCI3)).
Apart from the difference in the resonances of the ethyl ester groups, the *H NMR of
129 showed identical resonances to compound 130, in which the relative
stereochemistry had already been established (Figure 5.17 compared with Figure 5.16).
This suggested that dihydroxylation unexpectedly occurred on the more sterically
crowded side, that is, on the same face of the cyclopentene ring as the camphor sultam
and N(l) benzyl group. Given that the configuration at C5 and C7 were R and S,
respectively, this would indicate that the configurations of C8 and C9 would be S and R,
respectively.
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Figure 5.17 - *H N M R (CDC13) of compound (5R, IS, 85, 9R)-13Q
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It appeared that this facial selectivity in the dihydroxylation reactions may be
induced by the carbonyl group attached to C7. One possibility is that

coordinate to the carbonyl of the C7 substitution and hence direct the

was found that when the carbonyl of the C7 substitution was reduced to

selectivity was significantly reduced, as was evident in the dihydroxy

compounds 142 and 156 [Scheme 5.9] (the preparation of compounds 142 a

discussed later in Section 5.3, Table 5.6, Scheme 5.19 for 142 and Sch
156).

The dihydroxylation of alcohol 156 gave isomer triols 131 and 132 in a

yield of 49 %, triol 131 was isolated in 21 % while triol 132 was isol

[Table 5.1, entry 5, Scheme 5.9]. The relative orientation of the subs

the isomers of the dihydroxylation (triol 131) must be analogous to th
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the substitutions of compound 127 [Figure 5.15], that is, the diol, C 4 carbonyl and the
ester/alcohol are on the same face of the cyclopentane ring. Therefore, by comparing
and correlating the resonances of the *H NMR spectrum of 127 to the !H NMR
spectrum of one of the two triol isomers, 131 and 132, the data belonging to triol 131
could be determined [Table 5.3].

HO,

.-—OH
cat. K20s04.2H20
N M O (2 eq.)

Bn.
*N

O

"T
/

O}r-H Bn
156

>

acetone/H20 (4:1)
RT, 5d

HO"
Bn.

N

HO^

^-QH

,—OH

iT
N,
~Bn
132 (28%)

131 (21 %)

cat. K20s04.2H20
N M O (2 eq.)

O

+

Bn

acetone/H20 (4:1)
RT, 3d

142

133

134

63 %, Inseparable mixture, ratio* 133:134 is 1:2
(* determined by 1 H N M R integration of their triacetates
derivatives! 39 and 140 as discussed in text)

S c h e m e 5.9 - Dihydroxylation of alcohols 142 and 156 results in triols

The ! H N M R spectrum of diol 127 showed the N 3 benzyl protons as a singlet at
4.74 ppm while the Nl benzyl protons, each appearing as doublets (J = 16.2 Hz), were
at 4.61 and 4.69 ppm. The spectral data of one of the triol isomers displayed similar
characteristics, showing a singlet for the N3 benzyl protons at 4.71 ppm and doublets
for each of the Nl benzyl protons at 4.53 ppm and 4.67 ppm, with a matching coupling
constant of 16.2 Hz. From these correlations, it was reasonable to assign this set of
spectral data to triol 131. In contrast, the lU NMR spectrum of the other triol isomer
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(132) showed the N 3 benzyl protons as a singlet at 4.64 p p m and the N l benzyl protons,
each appearing as doublets (J = 16.5 Hz), at 4.71 and 4.98 ppm. A summary of this
analysis is seen in Table 5.3.

Table 5.3 - The relative configuration of the triols 131 and 132 was determined by
comparing the benzyl splitting patterns of these triols with the benzyl splitting
patterns of the structurally proven diol 127
HO,
HO

COOEt

O

HO,

,—OH

HO L\

HO

,.—OH

H0J\

oyco (xXX) xxx)
U

127
Compound

*H N M
O R131Chemical Shift (ppm) O 132
N(l)CH2Ph

N(3)CH2Ph

127

4.61, 4.69 (J= 16.2 Hz)

4.74

131

4.53, 4.67 (J= 16.2 Hz)

4.71

132

4.71, 4.98 (J =16.5 Hz)

4.64

Dihydroxylation of compound 142 was expected to give two triols, one of which
would have the same relative stereochemistry as carbocyclic hydantocidin due to the
fact that the structure of the starting alkene had the hydroxylmethyl group and N l in a
cis relationship. The reaction gave a mixture of triols 133 and 134 in 63 % yield, which
were not readily separable by column chromatography [Table 5.1, entry 6]. The triols

were protected as their triacetates 139 and 140 in 91 % yield [Table 5.2, entry 6,
Scheme 5.10], however these could not be completely separated. Integration of the N 3
benzyl protons of these two isomers in the !H NMR spectrum, at 4.69 ppm and 4.71
ppm of the isolated crude reaction mixture revealed the ratio of isomers was 2:1.
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Protection of the triols 133 and 134 as their acetonide derivatives 135 and 136,

proceeded in a total yield of 77 %, with acetonide protection only forming between the
C6 and C7 carbons of the cis diols [Scheme 5.10].

HO.^^y-OH yx°\/^~0H

OAc
Ac 2 0, pyridine
acetonitrile
RT, 10 h
135 (31 %)
minor

2,2-dimethoxypropane

137 (95 % )

DCM, p-TsOH
RT, 8h

y°
Ac20, pyridine
acetonitrile *-

OAc

O
Bn

RT, 10 h
134
136(46%)
major

Inseparable triol mixture

138(99%)

Ac 2 0, pyridine
acetonitrile
RT, 10 h

AcO

OAc

AcO

AcO

OAc

AcO

/XN^
X
Bn
139

140
Total yield 9 1 %
Inseparable triacetate mixture
Ratio 139:140 is 2:1

Scheme 5.10 Dihydroxylation and subsequent protection of the inseparable
mixture of compounds 133 and 134

The acetonides 135 and 136 were readily separated by column chromatography and
were obtained in yields of 31 % and 46 %, respectively (Table 5.2, entry 5, Scheme
5.10). The primary alcohol in these compounds was then protected as its acetate

derivative to give 137 and 138, respectively, in high yields (Table 5.2, entries 7 a
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Scheme 5.10). The isolated yields of 135 and 136 would suggest that the ratio of these

derivatives was 3:2, which is different to the ratios of the isomers determined for th

related triacetate derivatives (139:140, 2:1), although both were synthesised from the
same precursor diol mixture of 133 and 134. The difference may be due to loss of
compounds during work up, purification and isolation. Therefore the outcome of the
dihydroxylation reaction of compound 142 could not be quantified, although it is clear
that formation of one isomer is slightly preferred.
A comparison of the characteristic benzyl resonances of 135 and 136 with those
of the previously structure proven compound 129 was used to determine the relative
stereochemistry of 135 and 136 [Table 5.4]. For compound 129, the ester, acetonide
and Nl benzyl group are on the same face of the cyclopentane ring. The 'H NMR
spectrum of this compound (Figure 5.16) showed each of the Nl benzyl protons as
doublets (/ = 15.6 Hz) at 4.66 ppm and 4.96 ppm, while the N3 benzyl protons appeared
as a singlet at 4.66 ppm. The !H NMR spectrum of the major acetonide isomer (136),

shown in Scheme 5.10, showed a similar benzyl splitting pattern. It showed that each of
the Nl benzyl protons appeared as doublets (J = 16.2 Hz) at 4.66 ppm and 4.98 ppm
and showed that the N3 benzyl protons was a singlet at 4.67 ppm. Therefore it was
deduced that the syn isomer was the major product of the dihydroxylation reaction. By
default, the minor product (135) was the and isomer, where the alkyl alcohol and Nl

benzyl group are positioned on the opposite side of the cyclopentane ring to the diols

this orientation however, a diastereotopic effect is experienced by both sets of benzy
protons of the acetonide derivative 135, since each benzyl proton now appeared as a
doublet. The Nl benzyl protons appeared at 4.43 ppm and 4.73 ppm coupled by 16.5
Hz, while the N3 benzyl protons appeared at 4.67 ppm and 4.76 ppm coupled by 14.7
Hz. A summary of the above analysis can be seen in Table 5.4. Table 5.4 also shows
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that the subsequent acetate derivatives still retained the similar characteristic splitting

pattern for the benzyl protons, further justifying our rationalisation for distingu
the two isomers.
Table 5.4 - The relative configuration of the acetonides 135 and 136 was
determined by comparing the benzyl splitting patterns of these acetonides with the
benzyl splitting patterns of the structurally proven acetonide 129

129

136 R = H
138 R = Ac

135 R = H
137 R = Ac

*H N M R Chemical Shift (ppm)
Compound
N(l)CH2Ph

N(3)CH2Ph

129

4.66, 4.96 (7 =15.6 Hz)

4.66 (s)

136

4.66, 4.98 (7 = 16.2 Hz)

4.67 (s)

138

4.66,5.03(7= 16.2 Hz)

4.68 (s)

135

4.43,4.73 (7= 16.5 Hz)

4.67, 4.76 (7 =14.7 Hz)

137

4.43, 4.78 (7= 16.2 Hz)

4.72 (ABq, 7 = 14.7 Hz)

In summary, dihydroxylations of conjugated cyclopentenes occurred readily
with no diastereoselectivity. In contrast, dihydroxylations of deconjugated
cyclopentenes take much longer, and generally prefer to hydroxylate syn to the C7
substitution. The sterically crowded side of the C7 substituent may explain the

significantly longer reaction times required. For the purpose of synthesising car
hydantocidin, cis dihydroxylation needs to occur and to the C7 substituent and Nl
benzyl group. Work by Mio et a/.,18 in their endeavours to synthesise the natural

of hydantocidin, also have shown that dihydroxylation is preferred on the side wi

C7 substitution [Scheme 5.11].18 In their study, Nl was unprotected and the C7 alco
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w a s protected as a benzyl ether. However, they could selectively induce dihydroxylation
to the opposite face by introducing a bulky benzyloxycarbonyl (Cbz) group to Nl,
although this method was compromised by a lower yield (48 % with 50 % starting
material) and longer reaction time (5 d). The Cbz group may also block osmium
coordinating to Nl and therefore reduce the preference for formation of the syn product.
In our studies however, a bulky camphor sultam that had a cis relationship with the
bulky Nl benzyl group (compound 119) did not induce dihydroxylation to the opposite
face, the syn dihydroxylated product 128 still persisted. Therefore our studies have
shown that forces other than steric factors may be in effect. It has also shown that the
carbonyl substituent at C7 also plays a role in the formation of the syn product.

~OBn

Os04, NMO
O

O ^ \
HN "•f
O

Acetone/H20
(1:1)

24 h
58%

10%

OsO,, N M O
Acetone/H20
(1:1)
5d

x^x

48%
(50 % recovered
starting material)
18
Scheme 5.11 - Mio et al. have shown that a bulky group at Nl
such as a C b z group, can direct the dihydroxylation

The unexpected c/s-dihydroxylation that predominantly occurs on the more

sterically demanding face of a cyclopentene ring, i.e. syn to the two allylic substituents,

have been reported in the literature.83'85 While steric effects, for the most part, has been
used to explain the outcome of dihydroxylations, the explanation given to this anomaly,
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as observed in this study, has been considered to be of an electronic nature and has been
termed the Cieplak effect.83,86'87 It has been shown in other studies that in a sterically
unbiased environment, TC-facial stereoselective dihydroxylation occurs on the side with
the more powerful electron withdrawing group.88'89 This explanation arises from the
consideration of the stabilisation energy from the alignment of the bonding (o) orbitals
of the allyl substituents and the developing antibonding orbitals (o*) in the transition
state of the osmylation reaction [Figure 5.18].

Figure 5.18 - T w o possible transition states are possible in the dihydroxylation of a
cyclopentene ring system

OS
"\\
0

0

A
FILLED

a

VACANT a'

Transition state B - vacant a*
is stabilised by a Oc-c bond
(Not favoured by Cieplak)

Transition state A - vacant a *
is stabilised by a OC-H bond
(Favoured by Cieplak)

In our studies, o s m i u m can either approach the double bond syn to the allyl C 7

substituent (transition state A) or anti to the allyl C7 substituent (transition state B).
transition state A the developing a* interacts with the filled rjC7-H bond while in
transition state B it interacts with the filled GC7-c bond. Cieplak's hypothesis suggests
that transition state A is favoured as the

GC7-H

bond is considered to be a better electron

donor than oC7-c bond and hence is able to stabilise the developing vacant a*.87
Furthermore, the electron withdrawing character of the carbonyl group of the C7
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substituent, as seen in transition state B further reduces the ability of the crC-c bond to
stabilise the developing vacant a*. The theory satisfactorily explains the higher syn
selectivity of the dihydroxylation of the C7 ester/amide substituted compounds 113,114
and 119 (Table 5.1, entries 2, 3 and 4) compared to the lower syn selectivity of their
alcohol counterparts 142 and 156 (Table 5.1, entries 5 and 6).

5.3 REDUCTION REACTIONS
The pathway to carbocyclic hydantocidin required that the ethyl ester and

camphor sultam substituents of their respective cycloadducts be converted to their alk

alcohols. In order to fulfil this requirement we undertook a study on the practicality
reducing these moieties with different reducing agents including; lithium borohydride
(LiBH4),90"93 sodium borohydride (NaBH4),94"96 diisobutyl aluminiumhydride
(DIBAL)90'97'98 and borane methylsulphide (BMS).99"102 In general, LiBH4 reductions
were performed at RT in a diethyl ether solution with 1 mol. equivalent of MeOH. For
NaBH4 reductions, the starting materials were usually dissolved in THF at 0 °C before a
solution of NaBH4 in H20 was added. After 10 mins the reaction would then be allowed
to continue stirring at RT. DIBAL reductions were performed at -78 °C in THF for 1 h
and then allowed to warm to RT. All carboxylic acid derivatives were reduced using
BMS in THF at 0 °C for 10 mins and then at RT for 6 h. Completion of each reaction
was determined by thin layer chromatography (TLC). The results of these studies are
presented in Table 5.5 and Table 5.6.
In each reduction, evidence for the expected alcohol was seen by lH NMR
analysis which showed loss of the resonances of the ethyl ester or camphor sultam but
showed the presence of hydroxymethyl (CH2OH) resonances. In the 'H NMR spectra,
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the C H 2 O H resonances typically appeared between 3.40 p p m and 4.00 p p m while in the
13

C NMR spectra, loss of an ester/amide carbonyl peak, as observed in the starting

material, coincided with the appearance of a CH2OH carbon resonance that typically
appeared between 60.0 and 66.0 ppm. Mass spectral evidence was also in agreement
with the expected alcohol.

Table 5.5 - Reductions of the conjugated cycloadducts
,R7
reducing
agent

Entry

Compound

Reducing Agent

Yield (%)

1

80 R7 = COOEt

DIBAL

15

2

(5S)-95xR7 = CO(CS)a

DIBAL

32

3

(5S)-95x R7 = CO(CS)a

LiBH4

32

a) C S represents the camphor sultam group

Table 5.6 - Reductions of the deconjugated cycloadducts where R 7 and N l are in a
cis configuration
D77
>R
— /
// A

a

reducing
agent

f

XX)

0

~OH

~7\

•CO
V12

0

Entry

Compound

Reducing Agent

Yield (%)

1

113 R7 = COOEt

NaBH4

5

2

113 R7 = COOEt

DIBAL

10

3

119 R7 = CO(CS)a

NaBH4

24

4

119 R7 = CO(CS)a

LiBH4

26

5

154 R7 = C O O H

BMS

95

a) C S represents the camphor sultam group
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Table 5.5 shows our model reduction studies on conjugated systems 80 and
(5S»)-95x. Reduction of the ethyl ester of 80 using DIBAL gave the lower yield (15 %)
of the alcohol 141, while the reductions of the camphor sultam derivative (5S)-95x,
using either DIBAL or LiBH4, gave the better yields of 141 (32 % in both cases). This

can be rationalised by the fact that the camphor sultam group is a better leaving group
than the ethoxy group of the ethyl ester.
In pursuit of synthesising carbocyclic hydantocidin and in light of some of the
results of the previous dihydroxylation studies, we focused our attention on the
1 1

reduction of the R

group on the deconjugated compounds where R and N l had a cis

relationship [Table 5.6]. As described previously, dihydroxylations with the ethyl est
or camphor sultam still intact could only lead to epimers of carbocyclic hydantocidin
[Scheme 5.7].
The results from Table 5.6 parallel the results of Table 5.5. Ethyl ester 113 was
more difficult to reduce to the alcohol 142 than its related camphor sultam derivative
119. The ethyl ester 113 could be reduced in 5 % yield using NaBH4 and 10 % yield
using DIBAL while the camphor sultam amide 119 could be reduced to the alcohol 142
in 24 % yield using NaBH4 and in 26 % yield using LiBH4. In both cases the yields
were consistently lower than their conjugated counterparts as seen in Table 5.5.
In all cases, the yields of the reduction reactions using the common hydride
reducing agents DIBAL, NaBH4 and LiBH4 were not satisfactory. It was speculated that
these non-selective reducing agents also reduced the hydantoin ring, which can

potentially open the ring and therefore give a variety of products that were difficult
isolate and characterise. There have been many reports which show that the C4 carbonyl
, . ,

TVTOAT

103-105 xTotm 106,107

of the hydantoin is vulnerable to reducing agents such as D I B A L ,

iNacn 4 ,

and LiBH4.70'108"in These reductions generally lead to formation of 4-hydroxy-2-
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imidazolidinones (Figure 5.19). Other studies have shown that further reductions of the
carbonyls on the hydantoin results in 143112'113 and 145113 and also 144114'115 and 146.113
More aggressive reducing conditions can lead to ring opening and hence formation of
N-methylethylenediamines 147.

R5

R 5'

R5

N

0

\

~143 R3

V

4-hydroxy-2-imidazolidinones

R5 R5'
R1

R5

N" >
N
o •

N ^
^—N
X

\
3

„ « R3
145

R

144

R5 R5'

R 5 R5R1

-N

u_N
146

X

HN^
R3

147

R3

Figure 5.19 - Studies have shown that the hydantoin
ring can be reduced to different products

On closer examination, it was discovered that our studies also experienced
hydantoin reduction at C4, although we did not pursue to isolate or characterise such
compounds from the reactions shown in Table 5.6. In most cases the C NMR
spectrum of the crude isolated reaction mixture showed loss of carbonyl signals
between 170 ppm and 178 ppm as compared to its starting material. The signals
belonging to the carbonyl of the ester/ camphor sultam amide fall into this range and
therefore this loss suggested that they have been reduced to their alcohols. However,
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established in Chapter 4 Section 4.1, this range is also typical for the chemical shift of
the C4 carbonyl of the hydantoin.
In one occasion the 13C NMR spectrum of an isolated mixture after column
chromatography of the DIBAL reduction (Table 5.6, entry 2) showed carbonyl signals
between 170 ppm and 178 ppm. However, the presence of the ethyl ester in the ]H
NMR spectrum and doubling of the 13C NMR resonances was observed. The presence

of the ethyl ester resonances suggested that this mixture still had the ethyl ester i
and therefore reduction of the C4 carbonyl had most likely taken place. The observed
pairing of resonances in the 3C NMR spectrum suggested that this reduction had
resulted in a mixture of epimers at C4.
A good example of this type of reduction occurring at C4 and the formation of
epimers at C4 was seen in the reduction of compound 114 with a LiBH4/MeOH mixture
in diethyl ether at RT for 1 h [Scheme 5.12].

1:1 mixture of iseparable epimers at C(4)
148A+148B (56%)

Scheme 5.12 - Reduction of the ethyl ester of 114 with L i B H 4 also reduces the C 4
carbonyl of the hydantoin resulting in a mixture of inseparable epimers

The reaction exclusively gave 148, where both the ester and C4 carbonyl were reduced,
in 56 % yield as a mixture of inseparable epimers at C4 (148A and 148B). Suggestive
evidence for this compound arose from the 13C NMR spectrum, which lacked the

resonances of the carbonyl of the ethyl ester and the C4 carbonyl, signifying that b
had been reduced. Once again, the 13C NMR resonances appeared in pairs and therefore
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suggested a mixture of epimers, integration of the *H N M R spectrum showed that the
epimers were essentially in equal proportions.
Further evidence for C4 reduction was seen in the LiBHU reduction of the
acetonide protected cycloadduct 129. This reaction not only gave compound 149, where
both the ethyl ester and C4 carbonyl were reduced, in 17 % yield but it also gave
compound 150, where only the C4 carbonyl was reduced, in 71 % yield [Scheme 5.13].
Both products were isolated as single diastereoisomers.

LiBH,
M e O H (1 mol. eq.)
diethyl ether, RT, 1 h

129

150 (71 %)

Scheme 5.13 - Reduction of 129 using LiBH4 results in 149 and 150

A study of the reductions of 3-substituted hydantoins to 4-hydroxy-2imidazolidinones and vicinal diamines by Cortes and Kohn70 demonstrated that there
were key features that are distinctive to C4 reduced hydantoins (ie, 4-hydroxy-2-

imidazolidinones). One such characteristic is the loss of water from the molecular io

the mass spectrum. All the C4 reduced hydantoins in our studies were in agreement with
this feature.
Another characteristic described by Cortes and Kohn70 was that the reduction of

the carbonyl at C4 introduces a chiral centre and therefore the benzylic protons at N3

become diastereotopic. This was also clear in our studies for all C4 reduced hydantoi
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where the N 3 benzylic protons that were singlets before the reduction, n o w each

appeared as doublets. Cortes and Kohn70 also demonstrated that the introduction of the
hydroxy group at C4 led to an appearance of a diagnostic C4 hydroxy signal between
78.0 ppm and 87.5 ppm. In addition to this agreement, our studies showed, using HSQC
experiments on compound 150, that the diagnostic C4 carbinol signal (84.8 ppm for
150) correlated to the C(4)H singlet (4.51 ppm for 150) in the lU NMR spectrum,
providing further evidence for the reduction of the C4 carbonyl.
Fortunately, compound 150 was isolated as rhombic crystals that were suitable
for X-ray crystallographic analysis. The ORTEP plot of 150 (shown in the enantiomeric
form) unequivocally showed the C4 hydroxyl carbon [Figure 5.20], confirming our
NMR analysis and structural assignment.

Figure 5.20 - X-ray of c o m p o u n d 150 (shown in the enantiomeric form)
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The X-ray also revealed that the ester, N l benzyl group and the acetonide were all in a
syn relationship further supporting our previous predictions of the outcome of the
dihydroxylation reactions described in Scheme 5.7 for compound 126.
It is interesting to note that the reduction reaction of the acetonide protected
cycloadduct 129 resulted in preferential reduction of the C4 carbonyl [Scheme 5.13].
This can be explained by considering the steric crowding of the ester group by the syn-

acetonide ring, which therefore reduced the esters susceptibility to reduction. Moreove
both products of the reduction reaction gave single diastereoisomers of 149 and 150
[Scheme 5.13], unlike the reduction of the deconjugated compound 114, which gave
epimers at C4 [Scheme 5.12].
X-ray crystallographic analysis of 150 [Figure 5.20] revealed that the hydroxy
group was pointing in the same direction as the C9 carbon on the hydantoin ring. It was
assumed that the related ester reduced compound 149 would share the same orientation.
The C4 carbonyl, as seen in the acetonide protected cycloadduct 129, is clearly
unhindered and therefore it is unlikely that the observed stereoselectivity of its
reduction was a result of steric control.
It has been postulated by Cortes and Kohn70 that the C4 hydroxyl group of 4hydroxy-2-imidazolidinones may epimerise and thus give the most thermodynamically
more stable 4-hydroxy-2-imidazolidinones.70 It was also suggested that the pathway for
the epimerisation may proceed via a ring opening-ring closure mechanism involving the
N3-C4 bond. We also, independently, considered this mechanism as an explanation for
our observed stereochemical outcome of compounds 149 and 150. Our interpretation of
the mechanism is shown in Scheme 5.14.
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Scheme 5.14 - Proposed mechanism for the epimerisation of the
C 4 hydroxyl group of 4-hydroxy-2-imidazolidinones

Further evidence for this epimerization theory could be found in the reduction of
compound 125 using LiBH4 in the conditions as described earlier [Scheme 5.15]. The
isolated crude reaction mixture showed pairing of carbon resonances in the C NMR
spectrum, which suggested that C4 epimers had formed. However, after purification by
column chromatography only one isomer of 151 was isolated in 80 % yield. Compound
151 had only one set of signals in the 13C NMR spectrum and showed all the

characteristics of a C4 reduced hydantoin as described earlier. No attempts were made
to determine the relative configuration of the C4 hydroxyl group. This experiment

suggested that epimerisation may be catalysed by the slight acidity of the silica use
the purification process.

125

151

Scheme 5.15 - Reduction of 125 using LiBftt gave the
diol 151 as a single diastereoisomer

(80%)
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O n the other hand, it was also noted that reduction of the analogous compound
124 with LiBH4 gave compounds 152 and 153 in yields of 34 % and 56 % respectively

[Scheme 5.16]. Preferential reduction of the ester without reduction of the C4 carbonyl,
as seen in 152, was most likely due to the steric interference by the acetonide group,
which made the C4 carbonyl less accessible to hydride reduction, since the acetonide
and the C4 carbonyl group were on the same side of the cyclopentane ring.

COOEt

152 (34%)

LiBH.
M e O H (1 mol. eq.)
diethyl ether, RT, 1 h

O
OH

124

-„ ^OH
s*

XX)

1:1 mixture of iseparable epimers at C(4)
153A + 153B (56%)
Scheme 5.16 - Reduction of 124 using LiBH4
gave c o m p o u n d s 152 and 153A + 153B

Compound 153 was isolated as a 1:1 mixture of C4 epimers (153A + 153B). Based on
the epimerisation theory, it would suggest that those 4-hydroxy-2-imidazolidinone
derivatives that showed epimers, even after column chromatography, such as 148 and
153, did not have a thermodynamically favoured diastereoisomer.
The combined results of the reduction of compounds 114,124,125 and 129 also

suggested that the relative position of the ester to the C4 carbonyl had an effect on t
outcome of the reduced products. It was found that where the ester and C4 carbonyl
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were on the same side of the cyclopentane ring, reduction of both functionalities was
imminent, as seen in compounds 114 and 125 (Scheme 5.12 and Scheme 5.15). In these
circumstances, lithium may coordinate to both functionalities and therefore
simultaneously increase their susceptibility to reduction.
The study clearly indicated that a more selective reducing agent was required.
One such agent was borane methyl sulphide (BMS),99"102 which is known to selectively
reduce carboxylic acids over ketones. The mechanism for reduction of acids using BMS

involves formation of a borate ester as an intermediate [Scheme 5.17]. In this position
the reagent can direct a hydride to the carbonyl of the newly formed ester thus
selectively reducing the carbonyl via an intermediate aldehyde, to a primary alcohol.

Me

O V^-Me
COOK

V„?,'_B

y~m

JL^JSXX XX„
Scheme 5.17 - Mechanism for selective reduction of carboxylic acids by BMS
To explore this avenue, the ethyl ester cycloadduct 113 was converted to its

carboxylic acid derivative 154. Initial attempts to perform this conversion used lithi
hydroxide (LiOH) in THF/H20 (3:1) at RT for 24 h. However, the basic conditions
deprotonated the C9 proton that consequently led to epimerisation of the C7 carbon.
The deconjugated acids 154 and 155 were isolated in yields of 48 % and 20 %,
respectively (Scheme 5.18).
A better method to hydrolyse the ethyl ester to its acid involved stirring the
cycloadduct 113 in acetonitrile and 10 % HCI (1:1) at 90 °C for 15 h. This gave the

desired acid, 154, in quantitative yield with no epimerisation. Subsequent reduction o
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the acid with B M S in T H F at 0 °C for 6 h selectively gave alcohol 142 in 95 % (Table
5.6, entry 5) [Scheme 5.19].
COOH

COOEt
154 (48%)
LiOH
COOH

^C "''f <^\

HF/H20( 3:1)

y
O

X^

RT, 24 h

113
O
155 (20%)

Scheme 5.18 - Hydrolysis of 113 under basic conditions

COOEt
X^O

Bn

CH 3 CN
10% HCI

Bn

y

90°C,15h \ /

Bn

o
113

OH

COOH
BMS
THF

*^sxfo

0°C,6h

)r^ Bn
O
154 (>99%)

\— N
O

Bn

142 (95%)

Scheme 5.19 - Acid hydrolysis of 113 with subsequent reduction using B M S

To examine the generality of the acid hydrolysis, the same sequence of reacti
was performed on the diastereoisomer of 113, compound 114 [Scheme 5.20]. The

results of this experiment also showed that acid hydrolysis, of 114 to give 1
quantitative and did not lead to any epimerisation.
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^
/^OH

COOEt
COOH
CH3CN
h \
Bn.^ o 10%HC> Bn. X 0 ^ Bn ^,
\ I 90 0C,15h N f ~^XTt \ 1
//

u

O

Bn

0

O

Bn

114 155 (>99%) 156 (92%)

Scheme 5.20 - Acid hydrolysis of 114 with subsequent reduction using BMS
It had been shown earlier in this study, that when using LiBH4 as the reducing agent,

and that when the C4 hydantoin carbonyl was in a cis relationship with the ethyl est
such as seen in compound 114, both functionalities were susceptible to reduction.
However, as seen in the reduction of compound 155 [Scheme 5.20], reduction of the
acid functional group with the BMS reagent was selective and occurred in 92 % yield
which meant that because of the formation of the borate ester reduction to the C4
carbonyl did not occur.

5.4 DEPROTECTION REACTIONS
To reach our synthetic target of carbocyclic hydantocidin (3), deprotection of the

N-benzyl groups was required. It is known that the deprotection of N-benzylamides ar
difficult using hydrogenolysis.116"118 However, the more successful methods for
deprotection of TV-benzylamides include reagents such as sodium (Na) in liquid
ammonia,119"123 tert-butyllithium with oxygen (?-BuLi/02) (or M0OPH),124 potassium
tert-butoxide with oxygen (f-BuOK/02),125 aqueous hydrobromic acid (HBr),126 N197

chlorosuccinamide (NCS) or A^-bromosuccinamide (NBS).
Our early attempts in deprotection of compound 152 using aqueous HBr (45 %)
only resulted in deprotection of the acetonides [Scheme 5.21]. When aqueous HBr was
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substituted with H B r in acetic acid (48 % ) , bromination of the primary alcohol,
compound 158, was observed [Scheme 5.21].

O

HO

O

OH

48 % HBr (aq)
100 °C, 3h
quantitative

157

152

HO

OH

45 % HBr in acetic acid
80 °C, 3 h
quantitative

158

Scheme 5.21 - Deprotection of 152 using aqueous H B r and H B r in acetic acid

The Na or Li in liquid ammonia deprotection method of TV-benzyl groups
involves a Birch-type reduction. Addition of an electron to the benzene ring gives a
radical anion that eliminates the amino group as an TV-centred anion and a benzyl
radical. The latter is further reduced and protonated to give toluene [Scheme 5.22].
To attempt this method of deprotection, compound 138 (synthesis for 138 is
shown in section 5.2, Scheme 5.10) was dissolved in THF and treated with Na in
ammonia at -78 °C for 30 min [Scheme 5.23]. The reaction gave the C4 reduced
compound 149 in 28 % yield and the C4 reduced, mono deprotected compound 159 in
33 % yield. In both cases, the acetate group was cleaved. Compound 149 from this

reaction was identical in all spectral data to the compound synthesised from 129 using
LiBH4 as the reducing agent (Section 5.4, Scheme 5.13).
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eQ

"N

,

~N

*-

NO

N a + or Li+

L

/V-benzyl

<T)
0

radical anion

H+

NH

"N0

I
deprotected
amine

/V-centred anion

benzyl radical

,0

H3C

0H2C
H+

0

toluene

Scheme 5.22 - Mechanism for debenzylation by Birch reduction

1.Na/NH3THF

149 (28%)

-78 °C, 30 min
2. NH4CI

138

°159 (33%)

Scheme 5.23 - Attempted debenzylation of 138 using Birch conditions

It is noteworthy that" compound 149 was, once again, isolated as a single

diastereoisomer, although the reduction of the C4 carbonyl has the potential t
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epimers. Moreover, reduction from L i B H 4 is a result of hydride attack and reduction
under Birch conditions is via a radical-anion mechanism. From two very different

pathways the same single isomer was isolated. This finding, in conjunction with the fa
that the C4 carbonyl is sterically unhindered, further supported our hypothesis that
epimerisation at the C4 carbon resulted in the more thermodynamically stable epimer.
Compound 159 was also isolated as a single diastereoisomer. Its mass spectra
showed a loss of water from the molecular ion, which was typical evidence that
indicated that the C4 carbonyl had been reduced to its alcohol. It was deduced that a
single benzyl group had been deprotected as the aromatic signals in the *H NMR
spectrum only integrated for 5 protons and there was also an appearance of a broad NH
peak at 6.47 ppm. As the C4 carbonyl had been reduced, the difference in the N(l) and
N(3) protons could not easily be distinguished by H NMR, as they both were
deshielded by the one same carbonyl. By comparing the benzylic resonances of the
other product of the reaction, compound 149, with compound 159, the deprotected
nitrogen was determined.
In compound 149, the Nl benzyl protons appeared as doublets at 4.56 ppm and
4.85 ppm (J = 16.2 Hz), while the N3 benzyl protons that also appeared as doublets,
were seen at 4.15 ppm and 4.73 ppm (J = 15.3 Hz). For compound 159, the TV-benzyl
protons appeared as doublets at 4.56 ppm and 4.72 ppm and were coupled by a 7 value
of 16.2 Hz. This is in good agreement with Nl benzyl protons of compound 149, thus

supporting the structure assigned for 159, that is, TV-benzyl deprotection occurred at

As described in Chapter 3, N3 can form the more stable TV-centred anion and this can be
used to explain the selectivity for the benzyl cleavage at the N3 position.
The mechanism for the TV-benzylamide deprotection reaction using Birch
conditions [Scheme 5.22], involves an anion intermediate at the N3 nitrogen. This
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would be protonated during the aqueous work up but not during the reaction since
ammonia is too weak an acid. However, this anion intermediate would make

deprotection of the second Nl benzyl group even more difficult. By the same token, the
N3-anion intermediate would also be expected to protect the C4 carbonyl from further
reduction. Therefore it was hypothesised that the reduction of the C4 carbonyl in
compound 159 may have occurred upon quenching the reaction mixture with ammonia
chloride or methanol. On the other hand, if the reduction of the C4 carbonyl was to
occur first in the reaction as evident in the formation of compound 149, then it was

expected that the resulting anion on the oxygen of the C4 carbon would prevent further
benzyl reduction and therefore debenzylation.
A second deprotection reaction was attempted using f-BuOH (as a protic source
in the reaction) in liquid ammonia at -78 °C for 30 min on compound 136. In this
instance, methanol was used to quench the reaction [Scheme 5.24].

1.Li/NH 3 THF
f-butanol
-78 °C, 30 min
2. M e O H

136

O
160 (30%)

Scheme 5.24 - Attempted debenzylation of 136 using
Birch conditions using f-butanol as the protic source

The reaction gave the mono deprotected Birch product 160 in 30 % yield. The typical
loss of water from the molecular ion, once again, suggested reduction of the C4

carbonyl, which was further supported by the absence of the C4 carbonyl, typically a
172.0 ppm, and the appearance of the C4 alcohol at 81.8 ppm in the 13C NMR spectrum.

Compound 160 is described as the Birch reduction product as it was clear that reduct
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of the benzene ring had also taken place. This was evident by the absence of aromatic
resonances, which coincided with the presence of olefinic resonances at 5.70 ppm. The

protic source, terf-butanol, may have quenched the radical-anion intermediate before the
benzyl group could leave, leading to Birch reduction of the aromatic ring and thus
giving rise to the 1,4-cyclohexadiene species. The neighbouring diastereotopic N(1)CH2
protons of the cyclohexadiene each appeared as doublets, suggesting that the CI carbon
of the cyclohexadiene was not connected to a proton and therefore supported the
position of the double bonds in the structure of 160 [Scheme 5.24]. As the reaction was

similar to the reduction of 138, described previously [Scheme 5.23], it was believed tha
deprotection occurred at N3. Although not isolated, it was believed that a
dicyclohexadiene, C4 reduced compound, similar to compound 149, was another
product of the reaction. Once again it was speculated that the C4 reduction most likely
occurred upon quenching of the reaction mixture.
In both Birch reduction circumstances it was clear that the C4 carbonyl was
vulnerable to reduction. Therefore the removal of the benzyl group was approached
using a different, non reductive method. We then turned our attention to deprotection

via NBS. In this method, a radical initiator is required to form the bromine radical tha
abstracts a hydrogen atom from the benzylic position, which in turn starts the
propagation cascade [Scheme 5.25]. The benzylic position is brominated in the process.
An aqueous work up hydrolyses the brominated benzyl group, via a SN2 process, which
eliminates the amine and forms benzaldehyde.
As a trial reaction of the NBS deprotection method, we attempted to deprotect
the TV-benzyl groups of the tri-acetate mixture of compounds 139 and 140, which had
been established by !H NMR to be in favour of the protected 6,7-diepimer of

carbocyclic hydantocidin (139) in a ratio of 2:1 (Section 5.2). The mixture was heated i
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boiling chlorobenzene for 10 h with 3 mol. equivalents of N B S and a catalytic amount
of AEBN (Scheme 5.26).

.0
N-Br

AIBN

V

O
NBS

+ Br*

O

H
*N

HBr

x^
<°
Br,

N-Br

O

.0
Br H

H20

Br?

"N

+

Br"

x^x
H20

'NH
Deprotected
Amine

H

x^
Benzaldehyde

Scheme 5.25 - Deprotection of TV-benzyl groups using N B S

NH
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OAc

1.NBS(3eq.)
AIBN (cat.)
PhCI
reflux, 10 h

162 (20%)
16 % unreacted 139 and 140

2. H20

1.NBS(3eq.)
AIBN (cat.)
PhCI
reflux, 10 h
* 2. H 2 0

140
2:1 mixture (139:140)
as determined by
integration of the1 H
N M R spectrum

162 (10%)

161 (22%)

AcO
AcO

AcO,

OAc

OAc

AcO

164 (15%)

S c h e m e 5.26 Debenzylation of the triol mixture using the
N B S deprotection m e t h o d in refluxing chlorobenzene

After the addition of water, this reaction [Scheme 5.26] gave the mono-TV-benzyldeprotected compounds 161 and 162 in yields of 39 % and 20 %, respectively. However
16 % of the starting material remained unreacted. The reaction was monitored by mass
spectrometry (CI +ve), which showed molecular ions m/z 523 [M + 1] (139 and 140)
and m/z 433 [M + 1] (161 and 162). This method of monitoring revealed that even at
longer reaction times the fully debenzylated compounds 163 and 164 were not seen and
that the unreacted starting materials 139 and 140 remained. It is likely that the high
temperature of the reaction lead to decomposition of the NBS and therefore did not
permit further debenzylation.
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In a separate experiment, compounds 139 and 140 was initially treated with 3
mol. equivalents of NBS and AIBN for 10 h, as seen in Scheme 5.26, and then, without

purification, the crude reaction mixture was retreated with another 3 mol. equivalents
NBS and AIBN for another 10 h. By performing the second sequential retreatment,
followed by hydrolysis by water, no unreacted starting materials (139 and 140) were
observed in the mass spectrum, however, the fully debenzylated compounds 163 and
164 (Cl+ve, m/z 343 [M + 1]) and the mono-TV-benzyl-deprotected compounds 161 and
162 were seen. Surprisingly, the latter four compounds 161-164 were readily separable
by column chromatography and were isolated in yields of 22 %, 10 %, 28 % and 15 %,
respectively [Scheme 5.26].
An overall more direct and efficient method for the debenzylation involved
heating the mixture of 139 and 140 in a sealed tube at 125 °C for 14 h with 3 mol.
equivalents of NBS and a catalytic amount of AIBN [Scheme 5.27]. This modification
gave compounds 161 and 162 in yields of 25 % and 11 %, respectively, while the fully
debenzylated compounds 163 and 164 were isolated in yields of 31 % and 15 %,
respectively.
It is interesting to note that the ratio of the protected 6,7-diepimers of

carbocyclic hydantocidin, 161 and 163, are essentially in a ratio of 2:1 to the protec

carbocyclic hydantocidin compounds, 162 and 164, respectively. This ratio is similar t
the ratio of the isomers (139 to 140) before the reaction suggesting that bromination
subsequent debenzylation is indiscriminate of the steric crowding at C5 for these
compounds.
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AcO

OAc

AcO

XX
139

OAc

AcO

OAc

AcO

AcO

AcO

AcO

OAc

MM" "f

1.NBS(3eq.)
AIBN (cat.)
PhCI
125 °C
sealed tube,
14h
2. H 2 0

161

(25%)

163 (31 %)

AcO

OAc

2:1 mixture (139:140)
as determined by
integration of the1 H
N M R spectrum
S c h e m e 5.27 Debenzylation of the triol mixture using the
N B S deprotection m e t h o d in a sealed tube

Unlike the TV-benzyl deprotection under Birch conditions, there is preferential
deprotection of the benzyl groups at Nl, rather than N3, using the NBS deprotection
method, based on the isolation of compounds 161 and 162. Evidence of Nl deprotection
was seen in the JH NMR spectrum. For compound 161, the benzylic protons appeared
as a singlet at 4.63 ppm, which is typical of an N3 benzyl group, while a broad NH
proton was seen at 6.20 ppm, which falls into the chemical shift range for the Nl
proton. A proton in the deshielded N3 position was expected to have a resonance at a
lower field. Compound 162 showed the benzylic proton resonances as doublets and
showed a broad NH peak at 6.78 ppm. This was at a comparatively higher chemical
shift than the N(1)H resonance of compound 161, however this was a lower chemical
shift when compared to the NH resonances of its fully debenzylated derivative 164,
which will be discussed later. These comparisons are presented in Table 5.7.
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Table 5.7 - A comparison of N l and N 3 protons of the products from the
debenzylation reaction using the N B S method
AcO.

AcO,

-OAc

AcO-

AcO

HNTY
\

0

OAc

r\f°

HNi

3/

0^X

161 R = Bn
163 R = H

162 R = Bn
164 R = H
l

H Chemical Shift (ppm)

Compound
N(1)H

N(3)H

161

6.20

N/A

163

5.87

7.89

162

6.78

N/A

164

7.24

8.73

Scheme 5.25 showed that a benzyl radical is generated from the N B S

deprotection method. Preferential Nl deprotection might be due to the extra resonance

stabilisation of the benzyl radical by the Nl nitrogen in this position [Scheme 5.28].

The N3 lone pairs are less available for resonance stabilisation due to delocalisatio
resonance into two flanking carbonyl groups.
R

R'

The N3 lone pairs are less
available for resonance
stabilisation due to delocalisation
onto two carbonyl groups

Scheme 5.28 N l can stabilise the benzyl radical
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Indisputable evidence for compound 163 was from its X-ray crystallographic
analysis that showed both nitrogens were unprotected and that it was the relative

diepimer of carbocyclic hydantocidin at positions C6 and C7 [Figure 5.21]. In further
support of this analysis, the :H NMR of spectrum also showed the presence of two NH
resonances, one at 5.87 (Nl) ppm and the other at 7.89 ppm (N3). By default,

compound 164 was given the structure of acetylated carbocyclic hydantocidin. This wa
verified from analysis of its ]H NMR spectrum, which showed NH resonances at 7.24
ppm and 8.73 ppm. The chemical shift at 8.73 ppm was assigned to the more deshielded

N(3)H proton. Therefore the N(1)H proton was assigned the chemical shift at 7.24 ppm,
which substantiates our assignment for N(1)H at 6.78 ppm for compound 162 [Table
5.7]

Figure 5.21 - X-ray of compound 163
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It was noticed that this mild and neutral form of deprotection, using N B S , did

not cleave the acetates, evident by the presence of three CH3CO signals in the lH NMR
for compounds 161, 162, 163 and 164. It was also anticipated that the isolated mono
benzyl products 161 and 162 could be retreated in a sealed tube with the same NBS
conditions for further deprotection to their respective debenzylated compounds 163
164.
Cleavage of the acetates in high yield for both compounds 163 and 164 was
achieved by refluxing each compound in 10 % HCI and THF for 4 h followed by
evaporation of all the volatile components [Scheme 5.27]. From the hydrolysis of
compound 164 was isolated 3 (95 %) (mp 150 °C, lit.26'37 158 - 160 °C), which had
Of\ "^7

spectral properties almost identical to those reported in the literature,

while from

compound 163 gave the first authentic sample of (±)-6,7-di-e/?i'-carbocylic hydanto
165 (99 %). A comparison of the data from the *H NMR spectrum of these compounds
are shown in Table 5.8 and Table 5.9.

AcO

OAc
10% HCI, THF

AcO

•

»

reflux, 4 h

165 (99%)

163

AcO,

OAc
1 0 % HOI, THF

AcO'"

»

HO"

reflux, 4 h

3 (95%)
Scheme 5.29 - Deacetylation of 163 and 164 using acid hydrolysis
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Table 5.8 *H N M R data of 3 ( C D 3 O D ) and 164 (CDC1 3 ) from this study and *H
N M R data of 3 ( C D 3 O D ) reported by Sano and Sugai.26 37

164
X

l

H N M R Chemical
Shift of 3 (ppm)
(from this study)

*H N M R Chemical
Shift of 164 (ppm)
(from this study)
1.76
(dd,7=8.4, 14.4 Hz)

Assignment

H N M R Chemical
Shift of 3 (ppm)
(from Sano and Sugai)

C(9)HAHB

1.62
(dd, 7 = 7.6, 12.9 Hz)

1.62
(dd,7=7.5, 13.2 Hz,)

C(9)HAHB

2.29
(dd, 7 = 9.2, 12.9 Hz)

2.63
2.29
(dd,7 = 9.3, 13.2 Hz) (dd,7= 10.2, 14.4 Hz)

C(8)H

2.34 - 2.44 (m)

2.33 - 2.42 (m)

2.86 - 2.93 (m)

4.14
3.55
(dd, 7 = 5.1, 10.8 Hz) (dd, 7 =5.7, 11.4 Hz)
4.22
3.61
(dd,7=5.4, 10.8 Hz) (dd, 7 =5.4, 11.4 Hz)

C(10)H2

3.58
(ABq, 7=5.2, 10.8 Hz)

C(7)H

3.87
(dd, 7 =3.2, 6.0 Hz)

3.88
(dd, 7 = 3.3, 6.3 Hz)

5.22
(dd, 7 =5.4, 8.4 Hz)

C(6)H

3.96
(d, 7 =6.0 Hz)

3.98
(d, 7 =6.3 Hz)

5.32
(d, 7 =5.4 Hz)

In Table 5.8, it was clear that the spectral data obtained for compound 3 from
this study closely matched those reported in the literature for carbocyclic
hydantocidin.26'37 Although, Sano and Sugai reported the hydroxymethyl protons

(C(10)H2) of 3 as an AB quartet, our study revealed that the C(10)H2 methylene
formed part of an ABX system with the proton at C(8)H, both in our sample of

Chapter 5

153

acetylated precursor, 164 (Table 5.8). In further support of this finding compound 165

and its acetylated precursor 163 also showed the C(10)H2 protons were part of an AB
system [Table 5.9].

Table 5.9 *H NMR data of 163 (CDC13) and 165 (CD3OD) from this study

AcONi^OAc

HO

v /^OH
X~^\y-\

AcO

0

HN^V

>-N
163 165

Assignment

*H N M R Chemical
Shift of [163] (ppm)
(from this study)

*H N M R Chemical
Shift of [165] (ppm)
(from this study)

C(9)HAHB

1.89
(dd,7=13.8, 17.7 Hz)

1.74
(dd, 7=9.6, 13.8 Hz,

C(9)HAHB

2.60
(dd, 7 =9.0 Hz, 17.7 Hz)

2.32
(dd, 7 = 9.6, 13.8 Hz)

C(8)H

2.68 - 2.66 (m)

2.10-2.18 (m)

C(10)H 2

4.03
(dd,7=5.7, 11.1 Hz)
4.17
(dd, 7=8.1, 11.1 Hz)

3.58
(dd, 7=6.0, 10.8 Hz)
3.76
(dd, 7 = 7.8, 10.8 Hz)

C(7)H

5.64 (t, 7 =3.6 Hz)

4.14
(t, 7 =3.3 Hz)

C(6)H

5.14 (d, 7 =3.6 Hz)

4.04
(d, 7 = 3.3 Hz)

The configuration of the 6,7-diepimer, compound 165, was established by the X-

ray analysis of its acetylated precursor, 163 [Figure 5.21]. The !H NMR spectrum of
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165 was able to further support the observed configuration of the diols. It showed that
the chemical shifts of the protons on C6 and C7 of 165 (4.04 ppm and 4.14 ppm,
respectively) were further downfield than the chemical shifts of the protons on C6 and
C7 in compound 3 (3.98 ppm and 3.88 ppm, respectively). This suggested that these
protons in compound 165 were syn to the C4 carbonyl and consequently was deshielded
by it, consistent with the structure of 165.
As deduced from its structure, the C6 proton, in general, was assigned to the
most downfield doublet, while the C7 proton was assigned to the most downfield
doublet of doublet that had a matching coupling constant with the doublet of C(6)H.
This system was clear in the JH NMR spectrum of 3 and 164. In compound 3 the C6
and C7 protons appeared at 3.98 ppm and 3.88 ppm, respectively, with a large cis

coupling of 6.3 Hz. The doublet of doublet at C7 showed a smaller trans coupling to the

C8 proton, consistent with the structure of 3. However, it is interesting to note that
system was not so clear with compound 165 that showed the C6 and C7 protons at 4.04
ppm and 4.14 ppm, respectively, coupled by a 7 value of 3.3 Hz. The C7 proton
appeared as a triplet (7 = 3.3 Hz), which implied that it coupled to C(8)H and C(6)H
with the same coupling constant. This coupling pattern for the C7 proton also emerged
in the acetylated compound 163, which showed a coupling constant of 3.6 Hz between
the three protons (Table 5.9). Examination of the X-ray of 163 [Figure 5.21] showed

that the syn relationship of the bulky groups resulted in puckering of the cyclopentane
ring. This puckering, placed the C7 proton into a pseudo-equatorial position while the
C6 and C8 protons appear in a pseudo-axial position. In this conformation the dihedral
angles between each vicinal pair of protons was similar and hence C(7)H is seen as a
triplet.
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5.5 SUMMARY
The studies described in this chapter have established a procedure for the
deconjugation of the double bond of several [3+2] cycloadducts that were prepared
according to Chapter 4. The dihydroxylation reactions of the deconjugated compounds
gave cw-diols with unexpected stereochemistry while reductive reactions demonstrated
the vulnerability of the C4 carbonyl to reduction. However, this study also established a
method for selective reduction of a carboxylic acid functional group in the presence of
the C4 carbonyl group. It also revealed a method for mild deprotection of TV-benzyl
groups from amides.
Although compounds 165 and 3 were obtained as racemic products, it was
envisaged that the optically active versions could be synthesised using compounds 119,
120 or 121 where the camphor sultam was used as the chiral auxiliary. The camphor
sultam amide can directly be converted to the acid under aqueous acidic conditions;
otherwise it can readily be converted to its methyl ester equivalent using samarium
triflate and methanol (Chapter 4). Hydrolysis of this ester moiety to its acid using
refluxing HCI, as seen in this Chapter (Section 5.3), is expected to give an optically
active acid derivative. The subsequent reactions as described in this chapter would
eventually give carbocyclic hydantoin and/or its diepimer in an optically active form.
The studies in this Chapter have also shown many unexpected reactions and unexpected
stereochemical outcomes. By manipulating these reactions and stereochemical
outcomes, many potential analogues of carbocyclic hydantocidin can be generated in
future studies.
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http://www.rce.rutqers.edu/weeds/index-thumbnail.asp

Weed name: Pigweed, Amaranthus spp.. There are many species
and they are weed pests in several cropping systems. Smooth
pigweed was the first triazine resistant plant uncovered.
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CHAPTER 6 - Conclusion
The phosphine-catalysed cycloaddition reaction has been shown to be an
effective and efficient reaction for providing the carbon framework of carbocyclic
hydantocidin and its analogues. Of the two pathways proposed for the formation of the
common spirocyclic structure 11, it was found that pathway B was the most efficient.
Although it was found that the phosphine-catalysed cycloaddition in pathway A
proceeded in high yield giving exclusively regioisomer A, its subsequent reactions gave
the desired products in moderate yields. It was found that urea formation, with
consideration of its ease of synthesis, was best achieved using KCNO in HCI, which
proceeded in 54 %, while the following base catalysed hydantoin formation was best
achieved using Li(TMS)2N in a yield of 51 %. However, our studies have shown that
hydantoin protection was necessary in order to further manipulate the spiro-cyclic
structure.
In contrast, hydantoin formation from an amino acid using KCNO under acid
conditions, as seen in the alternative pathway B, was the most efficient procedure for
preparing this heterocycle. Although this study showed that there were several methods
available for the synthesis of 5-methylene hydantoins, it was discovered that starting
with serine hydantoin was the most versatile approach. Various protecting groups for
the hydantoin nitrogens were investigated. Our studies showed that TV-protection of
serine hydantoin with an acetyl or Boc group resulted in simultaneous dehydration,
while 7V-PMB and TV-benzyl protection at N3 gave the most stable derivatives. Without
these protecting groups at N3, the hydantoins were susceptible to polymerisation.
This finding aided in revealing the distinctive properties of the nitrogens of the
hydantoin ring both chemically and in NMR studies. It was found that substitutions at

the N3 position are generally more labile than substitutions on Nl. This was rationalised
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by the lower electron density at the N 3 position as a result of delocalisation of the
electrons to the two flanking carbonyls. By the same token, the two flanking carbonyls
result in significant deshielding, in the NMR spectra, of any carbon or proton attached
to N3. Furthermore, it was found that the 13C NMR chemical shift of the C2 carbonyl,
which is flanked by two electron donating nitrogens, generally appeared more upfield,
between 150-160 ppm. In contrast, the C4 carbonyl appeared between 170-175 ppm.
Elucidation of these typical properties of the hydantoin ring was essential for
understanding and determination of the outcome of subsequent reactions of the
hydantoin derivatives.
The cycloaddition reactions of 5-methylene hydantoins, using pathway B, gave
predominantly regioisomer A when ethyl 2-butynoate was used and it was found that
when a chiral camphor sultam was used as a chiral auxiliary on the alkyne, two
diastereoisomers of regioisomer A in equal proportions were obtained. These
diastereoisomers were readily separated by column chromatography. However, when an
oxazolidinone was used as an auxiliary, formation of regioisomer B was the
predominant outcome. This occurred in high diastereoselectivity when the chiral 4benzyloxazolidinone auxiliary was used. The reversal of regioselectivity was attributed
to the electronics of the oxazolidinone system.
NMR studies, in particular HMBC analysis, provided a useful tool in
determining the relative stereochemistry around the spiro-centre of the cycloaddition

products. The characteristic deshielding affect of the carbonyls, such as the C4 carbonyl

and the carbonyl of the ester, and the characteristic splitting patterns of the substitue
proximal to the spiro-carbon including the Nl and N3 benzyl protons, were features that
played an important role in structural analysis for many of the derivatives. This was
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particularly useful in determining the regioselectivity of the cycloaddition reactions and
the stereoselectivity of the deconjugation reactions.
In attempting to complete the synthesis towards carbocyclic hydantocidin it was
found that dihydroxylation generally occurred syn to the carbonyl substituent at

the spiro-cyclic structure. Without the carbonyl substituent at C7 syn selectivit
significantly reduced. It was also found that the C4 carbonyl was vulnerable to

reduction reactions, making selective reduction of the C7 ester group exceedingly

difficult. However, selective reduction of its carboxylic acid was accomplished u
BMS.
Deprotection of the 7V-PMB groups of a cycloadduct using eerie ammonium

nitrate was difficult, surprisingly resulting in the formation of amides. Deprote
TV-benzyl groups, on the other hand, was best accomplished by NBS bromination of
benzyl groups, followed by aqueous hydrolysis.
This study was able to show that the [3+2] phosphine-catalysed cycloaddition

reaction could be used for the synthesis of (±)-carbocyclic hydantocidin. It also

the first synthesis of an authentic sample of (±)-6,7-di-e/?/-carbocyclic hydanto

which was unequivocally proven by X-ray crystallographic analysis of its triaceta

derivative 163. The study has also set the ground work for future studies of opti

active derivatives of carbocyclic hydantocidin, and its analogues, by using a chi
camphor sultam as a chiral auxiliary. The future work may also be extended to six

membered ring carbocyclic hydantocidin analogues via [4+2] cycloaddition reaction
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W e e d name: Pineapple weed, Matricaria matricariodes (MATMT).
W h e n crushed the leaves have the distinct fragrance of pineapple. It
is a winter annual and is difficult to control.
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Chapter 7 - Experimental
7.1 GENERAL PROCEDURES
All reagents used were of commercial grade and, unless specified, used as

received. THF and diethyl ether were distilled over Na/benzophenone before use while
CH2CI2 and chlorobenzene were distilled over CaH2 before use. Anhydrous methanol

and anhydrous benzene were purchased from Aldrich in sure sealed bottles and used as
supplied. Microwave assisted reactions were performed using a Milestone Microwave
Laboratory Systems, Microwave Solvent Extraction Lab Station connected to a Lab
Terminal 800 Controller operating at a maximum of 1000 watts. Flash chromatography
was performed using Merck Silica gel 60 (230-400 mesh). Semi preparative
chromatography and analytical thin layer chromatography (TLC) was carried out on
Merck silica gel 60 F254 plates. Melting points (mp) were determined using a
Gallenkamp melting point apparatus and are uncorrected. Optical Rotations were

measured at the specified temperature with a Jasco DIP-370 polarimeter at the sodium

D line (concentration in g/100 mL). Infra Red (IR) spectra were recorded on a Nicole
Avatar 360 FTIR spectrometer. HPLC was performed using a Waters Prep Nova Pak 6
urn 60 A Silica column (25 x 100mm) with a Waters pump set at a flow rate of 20
mL/min and a Waters 486 Tunable Absorbance Detector set at a wavelength of 254 nm.
Eluting solvents were degassed before use. Chiral GC was performed on a Varian 3700
Gas chromatograph using a Gamma Dex™ fused silica capillary column (30 M x 0.25

mm x 0.25 um) from Supelco at 130 °C (isothermal) at a flow rate of lml/min. Nuclear
Magnetic Resonance (NMR) spectra were recorded, as specified, either on a Varian
Unity 300 MHz, Varian Mercury 300 MHz, Varian Unity 400 MHz or Varian Inova 500
MHz Fourier Transform NMR spectrometer. NMR data are reported as chemical shifts
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(8) in parts per million and are referenced to the internal standard, tetramethylsilane

TMS (which is given a value of 0.00 ppm) for ]H NMR or referenced to the
solvent signal for

13

C NMR. The multiplicity, the integrated intensity a

assignment of each resonance are described in the parentheses. Low reso

spectra (LRMS) were generated on either a Shimadzu QP-5000 mass spectro

chemical ionisation (CI) using the direct insertion technique with an e

energy of 70eV or on a VG Quattro Triple Quadrupole mass spectrometer u

electrospray (ES). Mass spectra are described in terms of the charge to

and the percentage of the peak in comparison to the base peak. High res
spectra (HRMS) were generated using a VG Autospec spectrometer or on a

spectrometer using either polyethylene or polypropylene glycol as the i
Many of the N-Boc derivatives did not show a molecular ion in their CI

In those cases, a HRMS of the parent ion was not possible. X-ray crysta

was obtained from the Department of Chemistry, University of Western Au

7.2 E X P E R I M E N T A L F O R C H A P T E R 2

Methyl 2-[(diphenylmethylene)amino]acrylate [22]
COOMe Compound 35 (10.0 g, 35.3 mmol) was dissolved in dry CH2C12 (50

Ph
/
22

Ph

mL)

under

a

N2

atmosphere

at

RT

and

then

1,3-

diisopropylcarbodiimide (8.91 g, 70.6 mmol) was added followed by

the addition of CuCl (1.17 g, 11.8 mmol). After 20 h the reaction was f

pad of celite, and the celite was washed with CH2C12. The filtrate was w

water (2 x 100 mL) and brine (100 mL), dried (MgS04) and concentrated i

give a crude yellow oil. Purification by column chromatography on sili
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EtOAc/Pet. Sp.) gave the title compound 22 as a yellow oil (7.49 g, 80 % ) with spectral

properties identical to that reported in the literature.59'128 XH NMR (CDC13, 300

3.66 (s, 3H, OCH3). 4.83 (s, 1H, =CH), 5.56 (s, 1H, =CH), 7.18-7.72 (m, 10H, ArCH).

[lit.59'128 XH NMR (CDC13, 300 MHz) 8 3.7 (s, 3H). 4.8 (s, 1H), 5.5 (s, 1H), 7.5 (
m)]. 13C NMR (CDC13, 75 MHz) 8 52.3 (OCH3). 110.3 (=CH2), 128.3 (ArCH), 128.4
(ArCH), 128.7 (ArCH), 129.2 (ArCH), 129.7 (ArCH), 131.3 (ArCH), 136.3 (ArC),
138.9 (ArC), 147.0 (=C), 164.8 (C=N), 171.0 (C=0).

3-Ethyl 1-methyl l-[(diphenylmethylene)amino]-3-cylcopentene-l,3-dicarboxylat
[23]
COOEt ^°
23

a S0Uit

i°n °f

trie acr

ylate 22 (5.46 g, 20.6 mmol) in dry

_/

I—\

benzene (50 m L ) , under a N 2 atmosphere at R T was added

y) Ph
J^x / ethyl 2-butynoate (4.62 g, 41.2 mmol) followed by dropwise
Ph
addition of tributylphosphine (0.525 g, 2.06 mmol). The

reaction mixture was stirred for 16 h and then concentrated in vacuo to give a

brown residue that was purified by column chromatography (20 % EtO Ac/Pet. Sp.

title compound 23 was isolated as a yellow oil (7.38 g, 95 %). Its spectral da

identical to that reported in the literature.56 *H NMR (CDC13, 300 MHz) 8 1.29 (
7.2 Hz, 3H, OCH3), 3.04 - 3.16 (m, 2H, CH2), 3.20 - 3.24 (m, 1H,
3H, OCH3), 3.28 - 3.40 (m, 1H,

CHAMB),

CHAHB),

3.30 (s,

4.19 (q, J= 7.2 Hz, 2H, OCH2), 6.67 (m, 1H,

=CH), 7.16 - 7.56 (m, 10H, ArCH). [lit.56 *H NMR (CDC13, 300 MHz) 8 1.28 (t, 3H),

3.03-3.15 (m, 2H), 3.18 - 3.28 (m, 1H), 3.30 (s, 3H, OCH3), 3.32-3.38 (m, 1H), 4
2H), 6.65 (m, 1H), 7.11-7.58 (m, 10H)].

13

C NMR (CDCI3, 75 MHz) 8 14.5 (CH3),

46.8 (CH2), 48.5 (CH2), 52.0 (OCH2), 60.5 (OCH3), 72.8 (Cspiro), 128.1-130.6 (ArCH),

162
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134.0 (ArC), 137.1 (ArC), 140.1 (=CH), 140.6 (=C), 164.7 (C=N), 168.5 (COOEt),
174.5 (COOMe). LRMS CI: m/z 378 (M + 1).

3-Ethyl 1-methyl l-aminocyclopent-3-ene-l,3-dicarboxylate.hydrochloride salt
COOEt To a solution of compound 23 (2.4 g, 6.37 mmol) in diethyl
24
ether at 0 °C was slowly added 1 M HCI (8.28 mL, 8.28
MeOOC

N H HCI m 11101 )-

After stirrm

g

for 2 0 m i n tne t w o

Phase

reaction

mixture was allowed to warm to RT and stirring was continued for 15 h. The aq

phase was separated, washed with diethyl ether and the water was removed under

reduced pressure to give a white solid. Recrystallization from boiling diethy

the title compound 24 as white crystals (1.51 g, 95 %), mp 202 - 204 °C (dec).
NMR (D20, 300 MHz) 8 1.11 (t, / = 7.2 Hz, 3H, CH3). 2.74-2.85 (m, 2H, CH2),
3.20 (m, 2H, CH2), 3.70 (3H, s, OCH3), 4.07 (q, J = 7.2 Hz, 2H, OCH2), 6.64 (m, 1H,
=CH). 13C NMR (CD3OD, 75 MHz) 8 14.5 (CH3), 43.1 (CH2), 44.6 (CH2), 54.4 (OCH3),

61.9 (OCH2), 64.2 (Cspiro), 134.2 (=C), 139.7 (=CH), 164.7 (COOEt), 172.1

(COOMe). LRMS: (CI +ve) m/z 214 (M+l). HRMS: (CI +ve) Calcd. for C10H16NO4
(MH+) 214.1079, Found 214.1080.

3-Ethyl 1-methyl l-ureidocyclopent-3-ene-l,3-clicarboxylate [25]
COOEt Procedure A: Compound 24 (400 mg, 1.61 mmol) was
dissolved in 1M HCI (3 mL) and stirred at 0 °C. KCNO (521
0
M e O O C - N ^ N H 2 mg, 6.44 mmol) was then added in several portions and the
25 " reaction warmed to RT. After 17 h a white precipitate

formed, which was collected by filtration giving the title compound 25 as a w
(221 mg, 54 %).
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Procedure B: Compound 24 (1.8 g, 7.21 mmol) was dissolved in acetic acid (56 m L )

and KCNO (2.34 g, 28.8 mmol) was added. The reaction mixture was stirred at RT f

25 h and was then neutralised with NaHC03 and extracted into ethyl acetate (2 x

mL). The combined organic extracts were dried (MgS04) and concentrated in vacuo

give a crude yellow oil. Column chromatography (50 % EtOAc/Pet. Sp.) gave the t
compound 25 as a white solid (1.04 g, 56 %).

Data for [25]: mp 142 - 146 °C. *H NMR (300 MHz, CDC13) 8 1.29 (t, J = 7.2 Hz, 3
CH3), 2.82 - 2.95 (m, 2H, 2 x CHAHB), 3.19 - 3.32 (m, 2H, 2 x CHAHB), 3.75 (s, 3H,

OCH3), 4.19 (q, / = 7.2 Hz, 2H, OCH2), 5.28 (br s, 2H, NH2), 6.69 (m, 1H, =CH), 6.90
(br s, 1H, NH). 13C NMR (75 MHz, CDC13) 8 14.1 (CH3), 43.3 (CH2), 44.7 (CH2), 52.8
(OCH2), 60.4 (OCH3), 64.0 (Cspiro), 133.1 (=C), 140.2 (=CH), 159.3 (NHCONH2), 164.4
(COOEt), 175.3 (COOMe). LRMS: (CI +ve) m/z 257 (M+l). HRMS: (CI +ve) Calcd.
for C11H17N2O5 (MH+) 257.1137, Found 257.1142.

Ethyl 2,4-dioxo-l,3-diazaspiro[4.4]non-7-ene-7-carboxylate [26]
COOEt Procedure A: To a dry flask containing NaH in 60 % oil dispersion
(26 mg) was added dry petroleum spirit (5 mL). The suspension

HN' ^°
"N

was stirred for 2 min and the etroleum s irit was s rin ed out

P

P

y §

-

This process was repeated 3 times before a solution of the urea 25

H

O'
26

(100 mg, 0.391 mmol) in dry D M F (2 m L ) was added dropwise.

The reaction mixture was stirred at RT for 1 h and was then diluted with ethy

(20 mL) and then poured into a solution of NH4C1 (20 mL) at 0 °C. The resulting

mixture was extracted with ethyl acetate (2 x 20 mL). The combined organic ex

was washed with brine, dried (MgS04) and concentrated in vacuo. Semi-preparati
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thin layer chromatography (50 % EtOAc/Pet. Sp.) gave the title compound 26 as a foam
(36mg,41%).

Procedure B: To a solution of the urea 25 (100 mg, 0.391 mmol) in dry THF (1 ml
-78 °C under a N2 atmosphere, was added a 1 M solution of lithium

bis(trimethylsilyl)amide in THF (0.391 mL). After 1 hr, the reaction was warme
and stirring was continued for 17 h. The reaction was then quenched with NH4C1

and then extracted with ethyl acetate (2 x 10 mL). The combined organic extrac
then washed with water, brine, dried (MgS04) and concentrated in vacuo. Semi-

preparative thin layer chromatography (50 % EtOAc/Pet. Sp.) gave the title com
26 as a foam (45 mg, 51 %).

Procedure C: To a solution of the urea 25 (300 mg, 1.17 mmol) in dry THF (5 mL

78 °C under a N2 atmosphere, was added a 1.6 M solution of rc-butyllithium in h

(0.121 mL). The reaction was allowed to warm to RT and stirred for 30 h. It wa

diluted with ethyl acetate (50 mL) and then washed with water (50 mL) and brin
mL). The organic extract was dried (MgS04) and concentrated in vacuo to give a
residue that was purified by column chromatography (50 % EtOAc/Pet. Sp.). The
compound 26 was obtained as a foam (143 mg, 37 %).

Data for [26]: *H NMR (300 MHz, CDC13) 8 1.30 (t, J = 7.2 Hz, 3H, CH3), 2.77 (m,
1H, CHAHB), 2.85 (m, 1H, CHAHB), 3.21 (m, 1H, CHAHB), 3.27 (m, 1H, CHAHB), 6.69

(m, 1H, =CH), 6.73 (br s, 1H, NH), 9.00 (br s, 1H, NH).

13

C NMR (75 MHz, CDC13) 8

14.2 (CH3), 43.2 (CH2), 44.8 (CH2), 60.8 (OCH2), 67.8 (Cspiro), 133.6 (=C), 138.8
(=CH), 156.6 (C(2)=0), 163.7 (COOEt), 177.1 (C(4)=0). LRMS: (CI +ve) m/z 225
(M+l). HRMS: (CI +ve) Calcd. for Ci0Hi2N2O4 (MH+) 225.0875, Found 225.0870.
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Methyl 2-[(diphenylmethylene)amino]-3-hydroxypropanoate [35]
To a solution of a racemic mixture of serine methyl ester

HO COOMe
\ /

ph

hydrochloride (20.0 g, 129 mmol) in dry CH2C12 (300 mL), under

N \ a N2 atmosphere, at RT was added dropwise benzophenone imine

Ph
35

(23.3 g, 129 mmol). After 24 h the precipitated NH4C1 was

filtered and washed with CH2C12. The filtrate was concentrated in vacuo to give

yellow oil which was then taken up in diethyl ether (200 mL) and washed with w

(200 mL) followed by brine (200mL). The organic extract was dried (MgS04) and t

solvent was removed in vacuo to give the title compound 35 as white crystals (
85 %), mp 80-84 °C (lit.129 87-89 °C) *H NMR (CDC13, 300 MHz) 8 3.13 (br m, 1H,

OH), 3.75 (s, 3H, OCH3), 3.93 (m, 2H, CHjOH), 4.25 (t, J = 5.1 Hz, 1H, CH), 7.16-7.
(m, 10H, ArCH). 13C NMR (CDC13, 75MHz) 8 52.8 (OCH3). 60.0 (CH), 67.7
(CH2OH), 126.0 (ArCH), 126.9 (ArCH), 128.0 (ArCH), 128.2 (ArCH), 128.4 (ArCH),
128.6 (ArCH), 128.9 (ArCH), 129.1 (ArCH), 129.2 (ArCH), 143.2 (ON), 172.9 (OO).

2-(3,4-Dimethoxyphenyl)ethyIurea [36]
The title compound 36 was prepared following
H
N
NH
XX 2 the same procedure as for compound 25 procedure A, using the following starting
36

materials: 3,4-dimethoxyphenylethylamine (1.0

g, 5.92 mmol), 1M HCI (10 mL), KCNO (481 mg, 5.92 mmol). The title compound 36
was isolated as a white solid (750 mg, 70 %), mp 150 - 153 °C. IR (Nujol film)

3330, 2923, 1460, 1377 cm'1. *H NMR (400 MHz, CDC13) 8 2.75 (t, / = 6.8 Hz, 2H,
CH2CH2NH), 3.41 (dt, J = 6.4, 6.8 Hz, 2H, CH.CH^NH), 3.86 (s, 3H, OCH3), 3.87 (s,
3H, OCH3), 4.12 (br s, 2H, NH2), 4.43 (br s, 1H, NH), 6.72 - 6.80 (m, 3H, ArCH). 13C

166
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N M R (100 M H z , CDC13) 35.7 (CH 2 NH), 41.9 (BnCH2), 55.9 (OCH3), 55.9 (OCH3),

111.5 (ArCH), 112.1 (ArCH), 120.7 (ArC(2)H), 131.5 (ArC), 147.7 (ArCOCH3), 14

ArCOCH3), 158.3 (OO). LRMS: (CI +ve) m/z 225 (M+l). HRMS: (CI +ve) Calcd. f
C11H17N2O3 (MH+) 225.1239, Found 225.1234.

l,3-Bis[2-(3,4-dimethoxyphenyI)ethyl]urea[37]
Q\AQ

The

title compound

37

was

prepared following the same
OMe
procedure as for compound 38
37 using the following starting

materials: 3,4-dimethoxyphenylethylamine (1.0 g, 5.92 mmol), CH2C12 (10 mL

triphosgene (558 mg, 2.19 mmol), diisopropylethylamine (2.27 mL, 13.0 mmol

aqueous NH3 solution (0.357 mL, 5.92 mmol) and diisopropylethylamine (1

5.92 mmol) The title compound 37 was isolated as a white solid (1.72 g

- 144 °C. (lit.130 mp 143 -144 °C). IR (Nujol film) 3342, 2923, 1460, 137
NMR (400 MHz, CDC13) 8 2.80 (t, J = 6.8 Hz, 2H, CBbCH2NH), 3.46 (dt, J =

12.8 Hz, CH.CIfcNH), 3.92 (s, 6H, 2 x OCH3), 4.28 (t, / = 5.6 Hz, 1H, NH), 6.7
6.86 (m, 3H, ArCH).

13

C NMR (100 MHz, CDC13) 35.9 (CH2NH), 41.8 (BnCH2), 55.9

(OCH3), 55.9 (OCH3), 111.4 (ArCH), 112.0 (ArCH), 120.7 (ArC(2)H), 131,6 (ArC),
147.7 (ArCOCH3), 149.0 ArCOCH3), 157.9 (OO). LRMS: (CI +ve) m/z 389 (M+l).
HRMS: (CI +ve) Calcd. for C21H29N205 (MH+) 389.2076, Found 389.2074.
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l,3-Bis[3-ethoxycarbonyl-l-methoxycarbonyl-cyclopent-3-ene]urea[38]
COOEt To a solution of 24 (170 mg, 0.68 mmol) in
Q

CH 2 C1 2 at 0 °C was added a solution of

AH
MeOOC

38

EtOOC

N
H
mL

'

N

x

^COOMe

triphosgene (75 mg, 0.25 mmol) in CH 2 C1 2 (10
mL) followed by diisopropylethylamine (0.261

L5

° mrao1)'

After

2 h, a 28 % aqueous NH3

solution (0.041 mL, 0.68 mmol) and diisopropylethylamine (0.131 mL, 0.

were added and the reaction was stirred for 24 h at RT. The reaction w

with CH2C12 and washed with water. The organic extract was dried (MgS04)

concentrated in vacuo to give the title compound 38 as a white solid (

NMR (300 MHz, CDC13) 8 1.27 (t, J = 7.2 Hz, 3H, OCH^Hj), 2.80 - 2.92 (m, 2
CHAHB),

3.06 - 3.27 (m, 2H, 2 x

CHAHB),

3.74 (s, 3H, OCH3), 4.19 (q, J = 7.2

OCH2CH3), 5.52 (br s, 1H, NH), 6.69 (m, 1H, =CH).

13

C NMR (75 MHz, CDC13)

14.1 (CH3), 43.3 (CH2), 44.7 (CH2), 52.8 (OCH3), 60.5 (OCH2), 64.0 (Cspiro), 133.1
(=CH), 140.3 (=CH), 159.1 (NHOONH), 164.4 (COOMe), 175.0 (COOEt).

7.3 EXPERIMENTAL FOR CHAPTER 3

5-Hydroxylmethylhydantoin (Serine hydantoin) [32]
OH To a warm solution of serine (3.0 g, 28.6 mmol) in water (9 mL) was
added KCNO (3.47 g, 42.9 mmol) followed by 10 % HCI (18 mL). The

HN X X ^0
\—*l

n

reaction mixture was then heated at reflux for 3 h, after which water

H
32

was removed in vacuo leaving behind a white residue. Methanol (50

mL) was added and the mixture was boiled with stirring. While still ho

white solid was quickly filtered and the filtrate was cooled on ice. O

168
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like crystals of serine hydantoin 32 were formed and were collected by filtration (2.8 g,

75 %), mp 190 - 194 °C (dec.) (lit.131 186-187 °C). *H NMR (300 MHz, DMSO
(ddd, J = 3.0, 4.5, 11.4 Hz, 1H, CH2), 3.61 (ddd, J = 3.3, 5.4, 11.4 Hz,
(dd, J = 3.0, 3.3 Hz, 1H, OH), 5.08 (dd, J = 4.5, 5.4 Hz, 1H, CH), 7.78
10.51 (br s, 1H, NH).

13

C NMR (75 MHz, DMSO) 8 60.0 (CH2), 60.4 (CH), 158.0

(OO), 174.7 (OO). LRMS: (CI +ve) m/z 131 (M+l). HRMS: (EI +ve) Calcd. for
C4H7N203 (MH+) 131.0457, Found 131.0467.

Bis(2,4-dioxoimidazolidin-5-ylmethyl) Disulfide (Cystine hydantoin) [48]
To a suspension of cystine (10.0 g, 41.7 mmol)
O
JJ in boiling water (45 mL) was added KCNO

NH

s-s

/ (7.43 g, 91.7 mmol). Once the mixture went into
O

48

solution a reflux condenser was attached to the

flask and 10 % HCI (120 mL) was slowly added. After heating at reflux fo

white precipitate was seen, the reaction was then cooled to RT and the w

collected by filtration to yield cystine hydantoin 48 (11.1 g, 92 %), mp

[Lit. 305 °C (dec)67 and 310 °C (dec)40]. JH NMR (300 MHz, DMSO) 8 2.48 (m, 1H
OH), 3.00 (dd, / = 3.9, 14.1 Hz, 1H, CHAHB), 3.14 (dd, J = 3.9, 14.1 Hz, 1H,
CHAHB)4.33 (dd, J = 3.9, 6.9 Hz, 1H, CH), 8.05 (br s, 1H, NH), 10.77 (br s, 1H, NH).
13

C NMR (75 MHz, DMSO) 8 40.8 (CH2), 57.1 (CH), 157.3 (OO), 174.4 (OO).

LRMS (CI +ve) m/z 291 (M+l).
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5-[(Methylthio)methyl]imidazolidine-2,4-dione[50]
SCH

To a vi orousl

S

y stirring suspension of S-methyl cysteine (1.00 g, 7.40

X 3
mmol) in warm H20 (5 mL) was added KCNO (899 mg, 11.1 mmol)

HN^^0
\

/

in several portions. Once the reaction formed a clear solution, 10 %

X~H

0
HCI was added. A reflux condensor was attached to the flask and the
50
reaction mixture was heated at reflux for 30 min. It was then cooled to RT a
extracted with ethyl acetate (3 x 50 mL). The organic extracts were combined

(MgS04) and concentrated in vacuo to give the title compound 50 as a white p
(877 mg, 74 %), mp 104 -106 °C. XH NMR (300 MHz, CDC13) 8 2.19 (s, 3H, CH3),
2.74 (dd, J = 8.7, 14.1 Hz, 1H, CHAHB), 3.06 (dd, J = 3.3, 14.1 Hz, 1H, CHAHB), 4.28

(ddd, /= 0.9, 3.3, 8.7 Hz, 1H, CH), 6.10 (br s, 1H, NH), 8.29 (br s, 1H, NH).

(75 MHz, CDC13) 8 16.1 (CH2), 36.2 (SCH3), 57.9 (CH), 156.6 (C(2)0), 172.7 (C(4)0)
LRMS: (CI +ve) m/z 161 (M + 1). HRMS: (CI +ve) Calcd. for C5H8N202S (M+)
160.0306, Found 160.0315.

l,3-Dibenzyl-5-methylenehydantoin[51]
To a solution of cystine hydantoin 48 (250 mg,
O , 0.86 mmol) in dry DMF (5 mL) under a N2
atmosphere at 40 °C was added anhydrous
K2C03 (1.07 g, 7.75 mmol). This resulted in a

green solution. Benzyl bromide (884 mg, 5.17 mmol) was then slowly added, w

turned the green reaction solution into a creamy mixture with a white solid
suspension. The reaction mixture was allowed to stir at 40 - 50 °C for 3 h
cooled before the white suspension was removed by filtration. The filtrate

with water (50 mL) and then extracted with petroleum ether (5 x 30 mL). The
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extract was dried (MgS0 4 ) and solvent removed in vacuo to give a yellow residue,

which was purified by column chromatography (20 % EtOAc/Pet. Sp.) to give the t

compound 51 as a white solid (416 mg, 83 %), mp 86 - 88 °C [lit.67 84 - 85 °C] *H
NMR (300 MHz, CDC13) 8 4.69 (d, J = 2.1 Hz, 1H,

=CHAHB),

4.76 (s, 2H, BnCHAHB),

4.77 (s, 2H, BnCHAHB), 5.32 (d, J = 2.1 Hz, 1H,

=CHAHB),

7.22 - 7.45 (ni, 10H,

ArCH) [lit.67 *H NMR (90 MHz, CDC13) 8 4.63 (d, J = 2 Hz, 1H,
4H, 2 x BnCH2), 5.31 (d, J = 2 Hz, 1H,

=CHAHB),

4.72 (s,

=CHAHB),

7.27 (m, 10H, ArCH)].

13

C NMR

(75 MHz, CDC13) 8 42.5 (BnCH2), 44.1 (BnCH2), 95.5 (=CH2), 127.2 (ArCH), 127.8
(ArCH), 127.9 (ArCH), 128.6 (ArCH), 128.6 (ArCH), 128.8 (ArCH), 134.9 (=C), 135.5
(ArC), 135.7 (ArC), 154.1 (OO), 162.0 (OO). LRMS: (CI +ve) m/z 293 (M+l).
HRMS: (CI +ve) Calcd. For Ci8H17N202 293.1290, found 293.1278.

l,3-Bis(4-methoxybenzyl)-5-methylenehydantoin[55],3-(4-MethoxybenzyI)-5methyleneimidazolidine-2,4-dione [56], Di-^-methoxybenzyl disulphide) [57] and
(3-(4-Methoxybenzyl)-5-[(4-methoxybenzylthio)methyl]imidazolidine-2,4-dione)
[58]

To p-methoxybenzyl alcohol (53) (1.8 g, 13 mmol) was added 45 % HBr in acetic ac

(2 mL). The yellow solution was allowed to stir at ambient temperature for 15 mi

before it was then diluted with water and extracted with diethyl ether. The die
extract was then washed with dilute NaHC03, dried with MgSO, and the solvent

removed in vacuo to yield p-methoxybenzyl bromide (54) as a faint yellow oil (2

%), which was used without further purification. The same procedure used for the

synthesis of 51 was applied using the following starting materials; cystine hyd
(500 mg, 1.72 mmol), DMF (lOmL), K2C03 (2.14g, 15.5 mmol) and/,-methoxybenzyl

bromide (54) (2.07 g, 10.3 mmol). The resultant yellow residue was chromatograph

ill
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on silica gel (20 % EtOAc/Pet. Sp. to 40 % EtOAc/Pet. Sp.) to give 55 as a colourless

oil (780 mg, 64 %), 56 as a white solid (124 mg, 15 %), 57 as a white so
%) and 58 as a yellow oil (13 mg, 2 %).

Data for [55]: XH NMR (300 MHz, CDC13) 8 3.78 (s, 6H, 2x OCH3), 4.68 (s, 2H,
BnCH2), 4.69 (s, 2H, BnCH2),
,OMe 4.68 (d, J = 2.1 Hz, 1H, =CHAHB),
5.37 (d, 7=2.1 Hz, 1H, =CHAHB),

MeO
55

6.85, 6.86, 7.17, 7.38 (each d, J =

9.0 Hz, 8H, ArCH).

13

C NMR (75 MHz, CDC13) 8 42.0 (BnCH2), 43.6 (BnCH2), 55.2

(2x OCH3), 95.3 (=CH2) 113.9 (ArCH), 114.2 (ArCH), 127.1 (ArC), 128.0 (ArC), 1
(ArCH), 130.2 (ArCH), 135.6 (=C), 154.2 (OO), 159.2 (ArC), 159.3 (ArC), 162.1

(OO). LRMS: (CI +ve) m/z 353 (M+l) (80 %), 121 (PMB) (100 %). HRMS: (CI +
Calcd. for C20H2iN2O4 353.1501, found 353.1489.

Data for [56]: white solid, mp 132 -134 °C. *H NMR (300 MHz, CDC13) 8 3.
OCH3), 4.65 (s, 2H, BnCH2), 4.91 (d, J = 2.4 Hz, 1H,
-O ^ OMe =CHAHB),5.42(d,7=2.4Hz,

1H,=CHAHB),6.84,7.35

(each d, J = 2.4 Hz, 4H, ArCH), 8.12 (br s, 1H, NH).
13
56

C NMR (75 MHz, CDC13) 8 41.6 (BnCH2), 55.2

(OCH3), 96.6 (=CH), 113.9 (ArCH), 128.2 (ArC), 130.0 (ArCH), 134.1 (=C), 154.8
(OO), 159.3 (ArC), 162.7 (OO). LRMS (CI +ve) m/z 233 (M+l). HRMS (CI +ve)
Calcd. for C12Hi3N203 233.0926, Found 233.0906.

Data for [57]: white solid, mp 98 - 100 °C [lit.69 mp 98 - 100 °C]. *H NM
CDC13) 8 3.61 (s, 4H, 2 x SCH2),
3.81 (s, 6H, 2 x OCH3), 6.88 (d, 7 =

MeO'

OMe

8.4 Hz, 4H, ArCH), 7.19 (d, J = 8.4
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Hz, 4H, ArCH) [lit.69 lH N M R (300 M H z , CDC13) 8 3.72 (s, 4H, SCH 2 ), 3.82 (s, 6H, 2
x OCH3), 6.8 - 7.4 (8H, Aromatic)].

13

C NMR (75 MHz, CDC13) 8 43.1 (SCH2), 55.

(OCH3), 114.2 (ArCH), 129.7 (ArC), 130.9 (ArCH), 159.34 (ArC).

Data for [58]: *H NMR (300 MHz, CDC13) 8 2.45 (dd, J = 9.3, 14.1 Hz, 1H,
2.84 (dd, J = 3.3, 14.1 Hz, 1H, CHAHB), 3.76 (s, 3H,

OCH3), 3.78 (s, 3H, OCH3), 3.84 (s, 2H, BnCH2),

OMe

OMe

4.38 (ddd, J = 1.2, 3.3, 9.3 Hz, 1H, CH), 4.55 (s, 2H,
BnCH 2 ), 6.02 (br s, 1H, NH), 6.82, 6.85, 7.21, 7.30

58

(each d, J = 8.7 Hz, 8H, ArCH).

13

C NMR (75 MHz,

CDC13) 8 39.3 (CH2), 41.8 (BnCH2), 42.6 (BnCH2), 55.2 (OCH3), 55.3 (OCH3), 56.4

(CH), 113.9 (ArCH), 114.1 (ArCH), 127.9 (ArC), 128.3 (ArCH), 130.5 (ArCH), 15
(OO), 159.1 (ArC), 159.1 (ArC), 171.8 (OO). LRMS: (CI +ve) m/z 233 (M - (SPMB)). HRMS: (CI +ve) Calcd. for C12Hi3N203 233.0926, Found 233.0902.

l-Acetyl-3-(4-methoxybenzyl)-5-methylenehydantoin [59]
Compound 56 (30 mg, 0.129 mmol) was dissolved
-OMe -n acetjc anhydride (3 mL) and the solution was
heated at reflux for 15 h. Acetic anhydride was
59
removed in vacuo to give an orange residue,

which was purified by semi-preparative plate chromatography (20 % EtOAc

yield the title compound 59 as a colourless oil (34 mg, 97 %). *H NMR (
CDC13) 8 2.63 (s, 3H, CH3), 3.79 (s, 3H, OCH3), 4.71 (s, 2H, BnCH2), 5.98 (d,
Hz, 1H,

=CHAHB),

4H, ArCH).

6.47 (d, J = 0.9 Hz, 1H,

=CHAHB),

6.83, 7.38 (each d, J = 8

13

C NMR (75 MHz, CDC13) 8 26.4 (CH3), 42.3 (BnCH2), 55.3 (OCH3),

107.9 (=CH), 114.0 (ArCH), 126.9 (ArC), 130.3 (ArCH), 131.8 (ArCH), 152.1 (OO)
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159.4 (ArC), 160.6 ( O O ) , 169.0 ( O O ) . L R M S : (CI +ve) m/z 275 (M+l) (70 % ) , 121

(PMB) (100 %). HRMS: (ES +ve) Calcd. for C14H14N204 274.0953, Found 274.09

l-te^-Butoxycarbonyl-3-(4-methoxybenzyl)-5-methylenehydantoin[60]
To a solution of compound 56 (40 mg,

OMe
0.17 mmol) in acetonitrile (2 mL) was
added Boc anhydride (41 mg, 0.19
mmol), and a crystal of DMAP. The
reaction mixture was stirred for 7 h, and then the solvent was removed

remaining residue was by purified by semi-preparative plate chromatogr

EtOAc/Pet. Sp.) to give the title compound 60 as a colourless oil (52 m
NMR (300 MHz, CDC13) 8 1.58 (s, 9H, tert-Bu), 3.IS (2, 3H, OCH3), 4.65 (s,

BnCH2), 5.84 (d, J= 1.2 Hz, 1H, =CH2), 5.98 (d, J= 1.2 Hz, 1H, =CH2), 6.8, 7.5
d, J = 8.4 Hz, 4H, ArCH).

13

C NMR (75 MHz, CDC13) 8 27.9 (CH3, tert-Bu), 42.

(BnCH2), 55.2 (OCH3), 85.2 (OC(CH3)3), 105.0 (=CH2), 113.9 (ArCH), 127.1 (ArC),
130.2 (ArCH), 131.9 (=C), 147.6 (OO), 149.9 (OO), 159.3 (ArC), 160.5 (OO).

LRMS: (CI +ve) m/z 332 (M+), 277 (M - C4H8 + 1), 233 (M - C5H802 + 1). HR
(CI +ve) Calcd. for Ci2Hi3N203 233.0926, Found 233.0909.

l,3-Diacetyl-5-[(methylthio)methyl]imidazolidine-2,4-dione [61]
SCH

To a solution of cysteine hydantoin 50 (100 mg, 0.625 mmol)

O
in D M F (1 mL) at 0 °C, under a N 2 atmosphere, was added

O

N

acetic anhydride (255 mg, 2.50 mmol). Triethylamine (132 mg,

N,
O

1.31 mmol) was then added dropwise and the reaction w

61

O

allowed to warm to RT. Stirring of the mixture was co
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for 3 h before it was then diluted with diethyl ether (10 m L ) and then washed with

water, saturated NaHC03 and then water again. The organic extract was then d
(MgS04) and concentrated to yield the title compound 61 as a colourless oil
%). XH NMR (300 MHz, CDC13) 8 2.10 (s, 3H, SCH3), 2.62 (s, 3H, CH3), 2.63 (s, 3H,
CH3), 3.13 (dd, J = 2.4, 14.7 Hz, 1H, CHAHB), 3.49 (dd, J = 4.2, 14.7 Hz, 1H, CHAHB),

4.81 (dd, J = 2.4, 4.2 Hz, 1H, C(5)H). 13C NMR (75 MHz, CDC13) 8 17.4 (SCH3), 25.3
(COCH3), 26.6 (COCH3), 33.8 (CH2), 58.6 (CH), 150.3 (C(2)=0), 167.3 (COCH3),
167.9 (COCH3), 169.4 (C(4)=0). LRMS: (CI +ve) m/z 203 (100 %) (M - Ac + 1), 245
(46 %) (M + 1).
l-Acetyl-5-[(methylthio)methyl]imidazoIidine-2,4-dione[62]
SCH Compound 61 (80 mg, 0.328 mmol) was chromatographed on
3
O
r^
flash silica (20 % EtOAc/Pet. Sp.) to yield the title compound 62
O
*N
as the only product (65 mg, 98 % ) . *H N M R (300 M H z , CDC13)
N
H
8 2.11 (s, 3H, SCH 3 ), 2.59 (s, 3H, CH 3 ), 3.11 (dd, J = 2.1, 14.4
°'
62
Hz, 1H, C H A H B ) , 3.48 (dd, J = 4.5, 14.4 Hz, 1H, C H A H B ) , 4.83 (dd, J = 2.1, 4.5 Hz, 1H,

CH), 9.19 (br s, 1H, NH). 13C NMR (75 MHz, CDC13) 8 17.26 (SCH3), 24.9 (COCH3),
33.4 (CH2), 60.5 (CH), 153.5 (C(2)=0), 169.5 (COCH3), 170.6 (C(4)=0). LRMS: (CI
+ve) m/z 203 (M + 1). HRMS: (CI +ve) Calcd. for C7HuN203S (MH+) 203.0490,
Found 203.0498.
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Di-tert-butyl-4-[(methylthio)methyl]-2,5-dioxoimidazolidine-l,3-dicarboxylate[63],
tert-Butyl-5-[(methylthio)methyl]-2,4-dioxoimidazolidine-l-carboxylate[64]and

Tri-tert-butyl-4-[(methylthio)methyl]-2,5-dioxoimidazolidine-l,3,4-tricarboxyl
[65]

To a solution of cysteine hydantoin 50 (210 mg, 1.31 mmol) in DMF (5 mL) under

atmosphere was added di-terf-butyl dicarbonate (630 mg, 2.89 mmol) and DMAP (3

mg, 0.27 mmol). The reaction was stirred at RT for 18 h and then diluted with e
acetate (20 mL) and washed with water followed by 10 % aqueous NaHC03. The

organic extract was dried (MgS04) and concentrated in vacuo to give a yellow o
which was purified by column chromatography (20 % EtOAc/Pet. Sp. to 40 %

EtO Ac/Pet. Sp.) to give 63 (47 mg, 10 %), 64 (142 mg, 44 %) and 65 (36 mg, 6 %
oils.

Data for [63]: *H NMR (300 MHz, CDC13) 8 1.50 (s, 9H, f-butyl), 1.55 (s, 9H, f-b

O

/SCH 3

2.17 (s, 3H, SCH 3 ), 2.90 (dd, J = 11.4, 14.7
Hz, 1H, CHAHB), 3.14 (dd, 7 = 4.2, 14.7 Hz,

O
1H, CHAHB), 4.54 (dd, J = 4.2, 11.4 Hz, 1H,

O

C(5)H).

63

13

C NMR (75 MHz, CDC13) 8 17.3

O
(SCH3), 27.7 (OC(CH3)3) 27.9 (OC(CH3)3),

34.4 (CH 2 ), 59.6 (CH), 85.2 (OC(CH 3 ) 3 ), 86.7 (OC(CH3)3), 147.5 (COOC(CH 3 ) 3 ), 148.4
(COOC(CH3)3), 166.5 (C(2)=0). LRMS: (CI +ve) m/z 303 (11 %) (M - C4H8 +1), 261
(100 %) (M - C5H802 + 1), 205 (17 %) (M - C5H802 - C4H8 + 1), 161 (31 %) (M - 2 x
[C 5 H 8 0 2 ] + 1).
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Data for [64]:X H N M R (300 M H z , CDC13) 8 1.57 (s, 9H, r-butyl), 2.15 (s, 3H, SCH 3 ),
3.13 (dd, J = 2.4, 14.7 Hz, 1H, C H A H B ) , 3.36 (dd, J =
SCH

O

3 4.8, 14.7 Hz, 1H,

O

r

CHAHB),

4.68 (dd, J = 2.4, 4.8 Hz,

\^0 1H, CHX), 8.39 (br s, 1H, NH).

13

C NMR (75 MHz,

CDC13N) 8 17.4 (SCH3), 28.0 (CH3), 34.1 (CH2), 61.4
o H
64(CH), 84.8 (OC), 147.4 (OO), 151.1 (OO), 170.0

(OO). LRMS: (CI +ve) m/z 260 (5 %) (M + 1), 205 (68 %) (M - C 4 H 8 +1), 161 (100
%)(M-C5H802+1).
Data for [65]: *H NMR (300 MHz, CDC13) 8 1.43 (s, 9H, t-butyl), 1.51 (s,
1.61 (s, 9H, f-butyl), 2.08 (s, 3H, SCH3),
CH3S
CH2).

3.41 (ABq, J = 14.7 Hz, Av = 18.9 Hz, 2H,

13

C NMR (75 MHz, CDC13) 8 17.2

(SCH3), 27.7 (CH3), 27.8 (CH3), 28.0 (CH3),
36.1 (CH2), 59.6 (C5), 83.9 (OC), 84.0 (OC),
84.7 (OC), 147.9 (OO), 148.1 (OO), 152.5

(OO), 163.7 (OO), 168.0 (OO). LRMS: (CI +ve) m/z 361 (8 %) (M - C5H802 +
305 (92 %) (M - C5H802- C4H8+ 1), 261 (100 %) (M - 2 x (C5H802) + 1).

l-Acetyl-3-benzyl-5-[(methylthio)methyl]imidazolidine-2,4-dione [66] and (1-

Acetyl-3-benzyl-5-methylenehydantoin) [67] and (l-Acetyl-3,5-dibenzyl-5
[(methylthio)methyl]imidazolidine-2,4-dione)[68]

To a solution of diacetyl S-methyl hydantoin 61 (181 mg, 0.74 mmol) in

mL) under a N2 atmosphere at 40 °C was added anhydrous K2C03 (153 mg, 1.1

Benzyl bromide (126 mg, 0.74 mmol) was then slowly added and the mixtur
allowed to stir at 40 °C for 3 h. After this time, the resultant white
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removed by filtration. The filtrate was diluted with water (10 mL) and then extracted

into diethyl ether (3 x 10 mL). The organic extract was combined, dried

solvent removed in vacuo to give a yellow residue, which was purified b
chromatography (20 % EtOAc/Pet. Sp. to 40 % EtOAc/Pet. Sp.) to give 66
%), the 5-methylene hydantoin 67 (26 mg, 14 %) and 68 (78 mg, 27 %) as

Data for [66]: !H NMR (300 MHz, CDC13) 8 1.91 (s, 3H, SCH3), 2.59 (s, 3H, C
3.08 (dd, J = 2.1, 14.7 Hz, 1H, CHAHB), 3.48 (dd, J =

O

'3

4.5, 14.7 Hz, 1H,

CHAHB),

4.74 (s, 2H, BnCH 2 ), 4.76

N' ^=>0 r-r^^ (dd' 7 = 2.1, 4.5 Hz, 1H, CH), 7.32 - 7.43 (m, 5H,
ArCH).
66

13

C N M R (75 M H z , CDC13) 8 17.1 (SCH3),

25.0 (COCH3), 33.6 (CH2), 42.9 (BnCH2), 59.1 (CH),

128.3 (ArCH), 128.6 (ArCH), 128.7 (ArCH), 134.7 (ArC), 153.9 (C(4)=0), 169.2

(OOCH3), 169.9 (C(2)=0). LRMS: (CI +ve) m/z 293 (M +1). HRMS: (CI +ve) Cal
for Ci4Hi7N203S (MH+) 293.0960, Found 293.0970.

Data for [67]: *H NMR (300 MHz, CDC13) 8 2.62 (s, 3H, CH3), 4.78 (s, BnCH
(d, J = 0.9 Hz, 1H, =CHAHB), 6.45 (d, 7 = 0.9 Hz, 1H,
=CHAHB),

7.30 - 7.65 (m, 5H, ArCH).

13

C NMR (75

MHz, CDC13) 8 26.4 (CH3), 42.8 (bzCH2), 108.0
67

(=CH2), 128.3 (ArCH), 128.6 (ArCH), 128.7 (ArCH),

131.8 (=C), 134.7 (ArCH), 152.1 (OO), 160.6 (OO), 168.9 (OO). LRMS: (CI +v

m/z 245 (M+l). HRMS: (CI +ve) Calcd. for Ci3Hl3N203 245.0926, Found 245.09
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Data for [68]: *H N M R (300 M H z , CDC13) 8 1.95 (s, 3H, SCH 3 ), 2.51 (s, 3H, CH 3 ),
3.10 (d, J = 14.1 Hz, 1H, C(5)CHAHBBn), 3.15 (d, 7 =
13.5 Hz, 1H, SCHAHB), 3.58 (d, 7 = 13.5 Hz, 1H,

3.74 (d, 7 = 14.1 Hz, 1H, C(5)CHAHBBn),

SCHAHB),

4.51 (s, 2H, BnCH2), 6.85 - 7.36 (m, 10H, ArCH).
13

C NMR (75 MHz, CDC13) 8 16.9 (SCH3), 26.1

(COCH3), 38.6 (SCH2), 39.5 (BnCH2), 42.6 (BnCH2),
68
72.1 (C), 128.0 (ArCH), 128.3 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.6 (ArCH
129.1 (ArCH), 133.6 (ArC), 134.4 (ArC), 153.2 (C(4)=0), 170.5 (OOCH3), 170.5

(C(2)=0). LRMS: (CI +ve) m/z 383 (M+l). HRMS: (CI +ve) Calcd. for C2iH23N20
(MH+) 383.1429, Found 383.1423.

l-Acetyl-3-benzyl-5-methylenehydantoin [67]
0 To a solution of benzyl serine hydantoin 73 (200 mg,
O yX^^ 0.91 mmol) in anhydrous acetonitrile (5 mL) was added

N

N.
^^-X^Jy acetic
anhydride (371 mg, 3.64 mmol) and triethylamine

O

67

(184 mg, 1.82 mmol). The reaction mixture was allowed

to stir at ambient temperature for 8 h. After this time, the acetonitr

vacuo and the residue was partitioned between diethyl ether and water.

extract was washed with saturated NH4C1 and then saturated NaCl. It was
(MgS04) and the solvent removed in vacuo to give the title compound 67

oil (202 mg, 91 %), which gave spectral data identical to its preparat

61.
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l,3-Diacetyl-5-methyleneimidazolidine-2,4-dione [69]
To a solution of serine hydantoin 32 (200 mg, 1.54 mmol) in

0
DMF (3 mL) at 45 °C was added acetic anhydride (784 mg,
\ / 7.69 mmol). Stirring was continued for 24 h and the product

N
X
n -y
^
I
was extracted into diethyl ether (30 mL) and then washed with
water (2 x 30 mL). The organic extract was dried (MgS04) and

concentrated in vacuo to give the title compound 69 as a yellow oil (10
NMR (300 MHz, CDC13) 8 2.66 (s, 3H, CH3), 2.69 (s, 3H, CH3), 6.08 (d, 7
1H,

=CHAHB),

6.56 (d, 7 = 1.2 Hz,

=CHASB).

13

C NMR (75 MHz, CDC13) 8 26.3

(CH3), 26.7 (CH3), 108.2 (=C), 109.6 (=CH2), 130.2 (C(4)=0), 167.3 (2 x OO), 168
(C(2)=0).

1 -Acetyl-5-methyleneimidazolidine-2,4-dione [70]
O Compound 69 (102 mg, 0.52 mmol) was ehroniatographed on
:0 flash silica (30 % EtOAc/Pet. Sp.) to give a clear gel of the title

N

N compound 70 (80 mg, 99 %), which was pure by NMR. Crystals

O-

H

of 70 formed in deuterated chloroform and were analysed by X-

ray crystallography. XH NMR (300 MHz, CDC13) 8 2.64 (s, 3H, CH3), 5.98 (
=CHAHB),

6.51 (s, 1H,

=CHAHB),

8.83 (br s, 1H, NH).

13

C NMR (75 MHz, CDC13) 8

26.3 (CH3), 108.2 (=C), 109.6 (=CH2), 130.2 (C(4)=0), 167.3 (OO), 168.3 (C(2)=
LRMS: (CI +ve) m/z 155 (M + 1). HRMS: (EI +ve) Calcd. for C6H6N203 (M+)
154.0378, Found 154.0388.
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Di-tert-butyl-4-methylene-2,5-dioxoimidazolidine-l,3-dicarboxylate [71] and (Di-

ter/-butyl-4-[(tert-butoxycarbonyloxy)methyl]-2,5-dioxoimidazolidine-l
dicarboxylate) [72]

To a solution of serine hydantoin 32 (190 mg, 1.46 mmol) in DMF (3 mL)

Boc anhydride (1.05 g, 4.82 mmol) and DMAP (16 mg, 0.146 mmol). The reac

stirred at ambient temperature for 20 h and was then quenched with wat

with diethyl ether. The combined diethyl ether extract was dried (MgS04

solvent removed in vacuo to give a yellow oil which was purified by co

chromatography (20 % EtO Ac/Pet. Sp.) to yield 71 as a foam (146 mg, 32
an oil (30 mg, 5 %).

Data for [71]: *H NMR (300 MHz, CDC13) 8 1.61 (s, 3H, CH3), 1.69(s, 3H,
(s, 1H, =CH), 6.08 (s, 1H, =CH).
O

13

C NMR

(75 MHz, CDC13) 8 27.7 (CH3), 27.8(CH3),

o

•O^N
N 0-

I 86-° (C)' 86J (c)' 106-5 (=CH)' 130-7
O

(=CH), 145.0 (OO), 145.8 (OO), 147.61
O
71
(C(2)=0), 157.4 (C(4)=0). LRMS: (CI +ve)
m/z 313 (1 %) (M+l), 213 (40 % ) (M - C 5 H 8 0 2 +1), 157 (M - (C 5 H 8 0 2 ) - (C4H8 + 1),
113 (10 %) (M - 2(C5H802 + 1).

Data for [72]: *H NMR (300 MHz, CDC13) 8 1.46 (s, 3H, CH3), 1.57 (s, 3H

O

(s, 3H, CH 3 ), 4.41 (dd, 7 = 2.1, 11.4 Hz, 1H,
CHAHB), 4.51 (dd, 7 = 2.1, 3.0 Hz, 1H, CH),
4.85 (dd, 7 = 3.0, 11.4 Hz, 1H, CHAHB).

LRMS: (CI +ve) m/z 215 (10 %) (M -

N.

O

(C5H802) - (C4H8) +1), 219 (100 %) (M -

72

O
(C5H802) - 2(C4H8) + 1), 175 (81 %) (M -
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2(C 5 H 8 0 2 ) - (C 4 H 8 ) + 1), 131 (18 % ) (M - 3(C 5 H 8 0 2 ) + 1).

3-Benzyl-5-hydroxylmethylhydantoin [73]
Serine hydantoin 32 (1.0 g, 7.7 mmol) was dissolved in
anhydrous DMSO (7 mL) under a N2 atmosphere and
potassium tert-butoxide (861 mg, 7.7 mmol) followed by
benzyl chloride (969 mg, 7.7 mmol) were then added. The

reaction mixture was allowed to stir at ambient temperature for 1 h before it

into cold water and then extracted with ethyl acetate (3 x 100 mL). The organ
was dried (MgS04) and the solvent evaporated to give a white solid. The white

was recrystallised from hot ethyl acetate to yield the title compound 73 (1.08

a white solid, mp 142 - 144 °C. *H NMR (300 MHz, CDC13) 8 2.05 (t, 5.1 Hz, 1H,
OH), 3.82 - 3.95 (m, 2H, CH2), 4.16 (ddd, 7 = 1.5, 3.9, 5.4 Hz, 1H, CH), 4.61

14.7 Hz, 1H, N(3)CHAHBBn), 4.68 (d, 7 = 14.7 Hz, 1H, N(3)CHAHBBn), 5.84 (br s, 1H
NH), 7.26 - 7.38 (m, 5H, ArCH). 13C NMR (75 MHz, DMSO) 8 41.0 (BnCH2), 59.3
(CH2), 59.9 (CH), 126.9 (ArCH), 127.1 (ArCH), 128.3 (ArCH), 136.3 (ArC), 157.0
(OO), 172.8 (OO). LRMS: (CI +ve) m/z 221 (M+l). HRMS: (CI +ve) m/z Calc. For
C11H13N2O3 221.0926, found 221.0923.

l-te^-Butoxycarbonyl-3-benzyl-5-methylenehydantoin[74]
To a solution of benzyl serine hydantoin [73]
II (440 mg, 2 mmol) in anhydrous acetonitrile
-O N y p |] (15 mL) (the reaction mixture was often

O to ease dissolution), was
slightly warmed
74
added Boc anhydride (915 mg, 4.2 mmol) and D M A P (45 mg, 0.4 mmol). The reaction
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mixture was stirred at ambient temperature for 15 h before the solvent was then

removed in vacuo and the remaining residue partitioned between ethyl acetate and
water. The organic extract was dried (MgS04), solvent removed in vacuo and the

remaining residue was purified by column chromatography (20 % EtOAc/Pet. Sp.) to
give the title compound 74 as a colourless oil (550 mg, 92 %). *H NMR (300 MHz,
CDC13) 8 1.60 (s, 9H, f-butyl), 4.74 (s, 2H, BnCHAHB), 5.87 (d, 7 = 1.2 Hz, 1H,
=CHAHB), 6.02 (d, 7 = 1.2 Hz, 1H, =CHAHB), 7.26 - 7.44 (m, 5H). 13C NMR (75 MHz,

CDC13) 8 27.7 (CH3, f-butyl), 42.3 (BnCH2), 84.8 (OC(CH3)3), 104.8 (=CH2), 127.7
(ArCH), 128.2 (ArCH), 128.4 (ArCH), 131.6 (=C), 134.6 (ArC), 147.3 (OO), 149.6
(OO), 160.2 (OO). LRMS: (CI +ve) m/z 247 (M - (C4H8) +1) (100 %), 203 (M (C5H802) + 1) (55 %). HRMS: (CI +ve) Calcd. for C11H11N2O2 203.0821, Found
203.0807.

l-Acetyl-3-benzyl-5-acetyloxymethylhydantoin [75] and l-AcetyI-3-benzyl-5methylenehydantoin [67]

Benzyl serine hydantoin 73 (60 mg, 0.273 mmol) was dissolved in acetic anhydrid

mL) and the solution was heated at reflux for 15 h. Acetic anhydride was removed
vacuo to give an orange residue, which was purified by semi-preparative plate
chromatography (30 % EtOAc/Pet. Sp.) to yield compound 67 (54 mg, 82 %) (which

gave identical spectral data from its preparation from compound 61) and compoun
as a light yellow oil (7 mg, 8 %).
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Data for compound [75]: J H N M R (300 M H z , CDC13) 8 1.71 (s, 3H, CH 3 ), 2.58 (s, 3H,
Q

CH3), 4.41 (dd, 7 = 2.1, 11.7 Hz, 1H, CHAHB), 4.65

(4 7 = 14.1, 1H, BnCHAH B ), 4.70 (dd, 7= 2.1, 2.4 Hz,
1H, CH), 4.79 (d, 7= 14.1, 1H, BUCHAHB), 4.81 (dd,

N
0

r°f\

J = 2.4, 11.7 Hz, 1H, CHAHB), 7.27 - 7.43 (m, 5H,

ArCH). 13 C N M R (75 M H z , CDC13) 8 20.1 (CH3),

75
24.9 (CH3), 42.8 (BnCH2), 58.1 (OCH2), 60.3 (CH), 128.2 (ArCH) 128.6 (ArCH),
(ArCH), 134.8 (ArC), 153.2 (OO), 168.2 (OO), 168.8 (OO), 169.6 (OO). LRMS:

(CI +ve) m/z 305 (M+l)' HRMS: (CI +ve) Calcd. for Ci5H17N205 305.1137, Fou
305.1120.

7.4 E X P E R I M E N T A L F O R C H A P T E R 4

Diethyl cyc!opent-3-ene-l,3-dicarboxylate [76]

,COOEt Ethyl acrylate (185mg, 1.85 mmol) and ethyl 2-butynoate (414 mg,
3.7 mmol) were reacted using the same conditions as for the
y^ \ preparation of 80 using procedure A. Purification by column
76 chromatography (20 % EtOAc/Pet. Sp.) gave a mixture of the title

compound 76 and its regioisomer 77 as colourless oils (330 mg, 85 %) T

major isomer, compound 76 to the minor isomer, compound 77 as determin
integration of the olefinic protons (6.69 ppm for 76 and 6.99 ppm for

reaction product was 89:11. Compound 77 was not fully separated for sp

With the same reaction, the same yield and the same ratio of regioisom

reported by Lu et al."9 i.e. 85 %, 89:ll.49 Data for [76]: *H NMR (300 M

1.28 (t, 7 = 7.2 Hz, 3H, CH3), 1.30 (t, 7 = 7.2 Hz, 3H, CH3), 2.80 - 2.
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CH 2 ), 3.23 (m, 1H, CH), 4.16 (q, 7 = 7.2 Hz, 2H, OCH 2 ), 4.20 (q, 7 = 7.2 Hz, 2H,

OCH2), 6.69 (t, 7= 2.4 Hz, 1H, =CH). [lit. 49 *H NMR (300 MHz, CDC13) 8 1.25 - 1.

(m, 6H), 2.80 - 2.91 (m, 4H), 3.23 (td, 7 = 7.3, 9.2 Hz, 1H, CH), 4.13 - 1.
6.69 (t, 7 = 2.5 Hz, 1H)]. 13C NMR (75 MHz, CDC13) 8 14.1 (CH3), 14.1 (CH3), 34.9
(CH2), 36.4 (CH2), 41.4 (CH), 60.0 (OCH2), 60.5 (OCH2), 134.6 (=C), 140.7 (=CH),
164.1 (C(3)00), 174.6 (C(1)C=0). LRMS: (CI +ve) m/z 213 (M+l). HRMS: (CI
+ve) Calcd. for CnHi704 (MH+) 213.1126, Found 213.1120.

3-Ethyl 1-methyl l-methylcyclopent-3-ene-l,3-dicarboxylate [78]
COOEt Methyl methacrylate (214 mg, 2.14 mmol) and ethyl 2-butynoate
/ \ (479 mg, 4.27 mmol) were reacted using the same conditions as for
H C COOMe

tne

preparation °f 80 using procedure A. Purification by column

O

78
chromatography (20 % EtOAc/Pet. Sp.) gave a mixture of the title
compound 78 and its regioisomer 79 as colourless oils (377 mg, 83 %). The

major isomer, compound 78 to the minor isomer, compound 79 as determined by
integration of the olefinic protons (6.64 ppm for 76 and 6.89 ppm for 77)

reaction product was 82:18. Compound 77 was not fully separated for spectra

Data for [78]: *H NMR (300 MHz, CDC13) 8 1.29 (t, 7 = 7.2 Hz, 3H, CH3), 2.3
(m, 1H, CHAHB), 2.47 - 2.54 (m, 1H, CHAHB), 3.05 - 3.10 (m, 1H, CHAHB), 3.11 -

3.17 (m, 1H,

CHAHB),

3.71 (OCH3), 4.19 (q, 7= 7.2 Hz, 2H, OCH2), 6.64 (t, 7= 2.

1H, =CH). 13C NMR (75 MHz, CDC13) 8 14.4 (OCH2CH3), 26.0 (CCH3), 43.2 (CH2),
44.7 (CH2), 48.2 (Cspiro), 52.2 (OCH3), 61.3 (OCH2), 134.1 (=C), 140.3 (=CH), 164.6
(OOOEf), 177.5 (OOOMe). LRMS: (CI +ve) m/z 213 (M +1). HRMS: (EI +ve)
Calcd. for CnHi604 (M+) 212.1048, Found 212.1041.
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Ethyl l,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-7-ene-7-carboxylate [80],

Ethyl l,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-6-ene-6-carboxylate [81] and
Diethyl l,3-dibenzyl-2,5-dioxo-2,,3,,3a',6,-tetrahydro-6a,H-spiro[imidazolidine4,l'-pentalene]-4',6a'-dicarboxylate[91]
Procedure A: To a solution of compound 51 (134 mg, 0.46 mmol) in dry benzene (1
mL) under a N2 atmosphere, was added ethyl 2-butynoate (103 mg, 0.92 mmol)

followed by tributylphosphine (9 mg, 0.046 mmol). The reaction mixture was allowe

to stir at ambient temperature for 15 h and was then concentrated and then parti

between diethyl ether and water. The organic extract was dried (MgS04), concentra
and purified by column chromatography (30 % EtOAc/Pet. Sp.) to give compound 80
a colourless oil (150 mg, 81 %) and compound 91 as a white solid (14 mg, 6 %).
Procedure B: Compound 51 (400 mg, 1.37 mmol) was dissolved in benzene (5 mL)

and then ethyl 2,3-butadienoate (307 mg, 2.74 mmol), followed by triphenylphosphi
(36 mg, 0.137 mmol), were then added to the solution. The reaction mixture was

allowed to stir at ambient temperature for 24 h before it was concentrated and t

partitioned between diethyl ether and water. The organic extract was dried (MgS04

concentrated in vacuo and then purified by column chromatography (30 % EtOAc/Pet

Sp.) to give 51 (50 mg, 13 %) and 2 regioisomers, 80 (361 mg, 65 %) and 81 (94 mg
%) as oils. Spectral data for 80 and 81 were comparable to those reported in the

literature.57 (Note: Literature spectral data was reported on the mixture of 80 a
Data for [80]: *H NMR (300 MHz, CDC13) 8 1.25 (t, 7 = 7.2 Hz, 3H, CH3), 2.45 (m,
COOEt

1H

'

C(A)HAMB),

8

2.54 (m, 1H,

3.01

C(B)HAMB),

V
(ddd,

O ^X 3-05

(ddd

'

J = 2l1

'

2-7

'

C(B)HAHB), 4.15 (dq, J = 1.5, 7.2 Hz, 2H,

7 = 2.1, 2.7, 17.4 Hz, 1H,

19 2 Hz

-

'

1H

'

C(A)HAHB),
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OCH 2 ), 4.38 (d, 7 = 15.3 Hz, 1H, N(l)CHAHBBn), 4.47 (d, 7 = 15.3 Hz, 1H,
N(l)CHAHBBn), 4.73 (s, 2H, N(3)CH2Bn), 6.60 (dt, 7 = 1.5, 2.7 Hz, 1H, =CH),
7.43 (m, 10H, ArCH). 13C NMR (75 MHz, CDC13) 8 14.1 (CH3), 41.1 (CH2), 42.4
(BnCH2), 42.7 (BnCH2), 43.7 (CH2), 60.5 (OCH2), 69.5 (Cspiro), 128.0 (ArCH), 127.9

(ArCH), 128.1 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.7 (ArCH), 133.9 (=C), 13
(ArC), 137.4 (ArC), 138.7 (=CH), 155.2 (OO), 163.2 (COO), 175.1 (OO). LRMS:
(CI +ve) m/z 405 (M+l). HRMS: (CI +ve) Calcd. for C24H25N204 (MH+) 405.1814,
Found 405.1800.

Data for [81]: *H NMR (300 MHz, CDC13) 8 0.97 (t, 7 = 7.2 Hz, 3H, CH3), 1
8

7

C(9)HAHB), 2.40 (m, 1H, C(8)HAHB), 2.45 (m,

COOEt 1H> C(9)HAHB), 2.59 (m, 1H,

C(8)HAHB),

3.69

^ |1 (dq, 7 = 10.8, 7.2 Hz, 1H, OCHAHB), 3.87 (dq, 7
O ~^^X

=

10.8, 7.2 Hz, 1H, OCHAHB), 4.28 (d, J= 15.9

81
Hz, 1H, N(l)CHAHBBn), 4.50 (d, 7 = 15.9 Hz,

1H, N(l)CHAHBBn), 4.74 (s, 2H, N(3)CH2Bn), 7.17 (t, 7 = 2.4 Hz, 1H, =CH), 7.
7.52 (m, 10H, ArCH). 13C NMR (75 MHz, CDC13) 8 13.8 (CH3), 31.0 (CH2) 33.3
(CH2), 42.8 (BnCH2), 44.0 (BnCH2), 60.6 (OCH2), 74.8 (Cspiro), 127.6 (ArCH), 127.7

(ArCH), 128.1 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.7 (ArCH), 132.8 (=C), 13
(ArC), 137.1 (ArC), 152.0 (=CH), 156.1 (OO), 161.8 (COO), 174.6 (OO). LRMS:
(CI +ve) m/z 405 (M+l). HRMS: (CI +ve) Calcd. for C24H25N204 (MH+) 405.1814,
Found 405.1802.
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Data for [91]: white solid (6 % ) , m p 118 - 120 °C. *H N M R (300 M H z , CDC13) 8 0.92
(t, 7.2 Hz, 3H, CH3), 1.28 (t, 7.2 Hz, 3H, CH3),
1.56-1.76 (m, 1H,
1H,

C(2')HAHB),

1.69-1.76 (m,

1.93-2.08 (m, 1H, C(3')HAMB),
COOEt
4
Na ''1=0 fX^X
2.19-2.31 (m, 1H, C(2')HAHB), 2.64 (dd, 7 = 2.7,

C(3')HAHB),

y^

20.7 Hz, 1H, C(6')HAHB), 3.78 (q, 7 = 7.2 Hz,

91
2H, OCH 2 ), 3.99 (d, 7 =

16.8 Hz, 1H,

N(l)CHAHBBn), 4.11 (dt, 7 = 2.4, 20.7 Hz, C(6')HAHB), A.U-A.22 (m, 2H, OCH 2 ),

4.25-4.29 (m, 1H, C(3'a)H), 4.68 (d, 7 = 14.4 Hz, 1H, N(3)CHAHBBn), 4.86

14.4 Hz, 1H, N(3)CHAHBBn), 5.08 (d, 7 = 16.8 Hz, 1H, N(l)CHAHBBn), 6.54 (
=CH), 7.20 - 7.52 (m, 5H, ArCH).

13

C NMR (75 MHz, CDC13) 8 13.9 (CH3), 14.3

(CH3), 29.9 (C(3')H2), 35.1 (C(2')H2), 39.8 (C(6')H2), 43.0 (N(l)CH2Bn), 44.8

(N(3)CH2Bn), 51.7 (C(3'a)H), 60.4 (OCH2), 61.7 (OCH2), 68.1 (C(6'a)), 74.0 (

126.0 (ArCH), 127.3 (ArCH), 127.7 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.8

(ArCH), 135.9 (ArC), 137.4 (ArC), 138.2 (=CH), 138.4 (=C), 156.2 (C(2)=0), 1

(OO), 172.0 (OO), 172.9 (C(2)=0). LRMS: (CI +ve) m/z 517 (M+l). HRMS: (EI
+ve) Calcd. for C3oH32N206 (M+) 516.2260, Found 516.2235.

Ethyl l,3-bis(4-methxybenzyl)-2,4-dioxo-l,3-diazaspiro[4.4]non-7-ene-7carboxylate [82] and Ethyl l,3-bis(4-methoxybenzyl)-2,4-dioxo-l,3diazaspiro[4.4]non-6-ene-6-carboxylate [83]

Compound 55 (200 mg, 0.57 mmol) and ethyl 2-butynoate (128 mg, 1.14 m

reacted using the same conditions as for the synthesis of compound 80
A. Purification by column chromatography (30 % EtOAc/Pet. Sp. to 40 %
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Sp.) gave a pair of regioisomers, each were colourless oils; Major isomer, compound 82
(180 mg, 68 %) and minor isomer, compound 83 (39 mg, 18 %).
Data for [82]: JH NMR (300 MHz, CDC13) 8 1.24 (t, 7 = 7.2 Hz, 3H, CH3),
,COOEt 2H, CH2), 3.02 (m, 2H, CH2), 3.77
(s, 3H, OCH 3 ), 3.79 (s, 3H, OCH 3 ),

OMe

4.14 (dq, 7 = 1.8, 7.2 Hz, 2H,
OCH2), 4.32 (d, 7 = 15.6 Hz,

MeO

N(l)CHAHBBn), 4.39 (d, 7 = 15.6
Hz, 1H, N(l)CHAHBBn), 4.65 (s, 2H, N(3)CH2), 6.61 (t, 7 = 2.4 Hz, 1H, =CH), 6.80,
13/
6.88, 7.16, 7.36 (each d, 7 = 8.4 Hz, ArCH). 13
C N M R (75 M H z , CDC13) 8 14.1 (CH3),

41.1 (CH2), 42.2 (CH2), 42.4 (CH2), 43.1 (CH2), 55.1 (OCH3), 55.2 (OCH3), 60.6

(OCH2), 69.4 (Cspiro), H3.8 (ArCH), 114.0 (ArCH), 128.3 (ArC), 129.2 (ArC), 129.4

(ArCH), 130.0 (ArCH), 133.9 (=C), 138.8 (=CH), 155.2 (OO), 159.1 (ArC), 159.2

(ArC), 163.3 (OO), 175.2 (OO). LRMS: (CI +ve) m/z 357 (M+l). HRMS: (CI +ve
Calcd. for C26H29N206 (MH+) 465.2025, Found 465.1986.

Data for [83]: *H NMR (300 MHz, CDC13) 8 0.92 (t, 7 = 7.2 Hz, 3H, CH3),
1H, C ( 9 ) H A H B ) , 2.05

^ COOEt
^ 3H,
O ^ ^ .OMe

C(9)HAHB

- 2.29 (m,

and C(8)H2), 3.78

(s, 3H, OCH3), 3.80 (s, 3H,

MeO

OCH3), 3.91 (d, 7 = 16.8 Hz, 1H,

N(l)CHAHBBn), 4.19 (dq, 7 = 2.4, 7.2 Hz, 2H, OCH 2 ), 4.61 (d, 7 = 14.1 Hz, 1H,
N(3)CHAHBBn) 4.78 (d, 7 = 14.1 Hz, 1H, N(3)CHAHBBn), 5.01 (d, 7 = 16.8

N(l)CHAHBBn), 6.86 (t, 7 = 2.4 Hz, 1H, =CH), 6.83, 6.87, 7.13, 7.43 (ea
Hz, 8H, ArCH).

13

C NMR (75 MHz, CDC13) 8 14.3 (CH3), 35.2 (CH2), 39.7 (CH2),

42.4 (CH2), 44.2 (CH2), 55.2 (OCH3), 55.3 (OCH3), 60.5 (OCH2), 68.2 (Cspiro), 113.9
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(ArCH), 114.0 (ArCH), 127.5 (ArC), 128.4 (ArC), 129.6 (ArCH), 130.4 (ArCH), 138.4
(=CH), 138.6 (=C), 156.4 (OO), 158.9 (ArC), 159.3 (ArC), 164.0 (OO), 173.2 (OO).
LRMS: (CI +ve) m/z 357 (M+l). HRMS: (CI +ve) Calcd. for C26H29N206 (MH+)
465.2025, Found 465.1968.

Ethyl l-butoxycarbonyl-3-benzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-7-ene-7-

carboxylate [84] and Diethyl l-te^-butoxycarbonyl-3-benzyl-2,5-dioxo-2,,3,,3a
tetrahydro-6a,H-spiro[imidazolidine-4,l'-pentalene]-4,,6a'-dicarboxylate[90]

Compound 74 (400 mg, 1.33 mmol) and ethyl 2-butynoate (20) (299 mg, 2.66 mmo

were reacted using the same conditions as for the preparation of 80 using pro

Purification by column chromatography (30 % EtOAc/Pet. Sp.) gave a mixture of

and its regioisomer 85 as colourless oils (312 mg, 57 %) The ratio of the maj
compound 84 to the minor isomer, compound 85 as determined by integration of

olefinic protons (6.60 ppm for 84 and 7.20 ppm for 85) in the *H NMR spectrum

crude reaction product was 78:22. Compound 85 could not be fully separated fo

spectral analysis. A double cyclised product, compound 90 was also isolated a
(49 mg, 7 %).

Data for [84]: *H NMR (300 MHz, CDC13) 8 1.19 (t, 7 = 7.2 Hz, 3H, CH3), 1.42 (
COOEt '-butyl), 2.98 (m, 2H, CH2), 3.04 (m, 2H, CH2),
O /" ~\ 4.04 (q, 7 = 7.2 Hz, 2H, OCH2), 4.60 (s, 2H,

.0^\N' N^° yX^ BnCH2), 6.60 (t, 7 = 2.1 Hz, 1H, =CH), 7.227.41 (m, 5H, ArCH).

13

C NMR

(75 MHz,

O
Oft

CDC1 3 ) 8 14.6 (CH 3 ), 28.3 (te/t-butyl, CH 3 ), 42.6
(CH2), 43.0 (CH2), 44.2 (CH2), 60.8 (OCH2), 67.7 (Cspiro), 84.9 (CBoc), 128.4 (ArC),
128.9 (ArCH), 128.9 (ArCH), 134.2 (=C), 135.3 (ArCH), 139.1 (=CH), 148.0 (OO),
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151.7, ( O O ) , 163.6 (COO), 174.5 ( O O ) . L R M S : (CI +ve) m/z 315 (M - C 5 H 8 0 2 + 1).

HRMS: (CI +ve) Calcd. for Ci7Hi9N205 (M - C5H802 + 1) 315.1345, Found 315.

Data for [90]: lH NMR (300 MHz, CDC13) 8 0.95 (t, 7.2 Hz, 3H, CH3), 1.2
3H, CH3), 1.55 (s, 9H, f-butyl), 1.66-1.76 (m,
1H,

C(2')HAHB),

2.36-2.48 (m, 1H,

C(3')HAHB), 2.46 (dd, 7 = 2.4, 19.2 Hz, 1H,

0 Na '1=0 y^X

C(6')HAHB),

O

2.49-2.60 (m, 1H,

C(3')HAMB),

2.55-2.66 (m, 1H, C(2')HAHB), 3.79 (dq, 7 =
90
10.5, 7.2 Hz, 1H, C(6'a)COOCHAHB), 3.84 (dd,

1.8, 19.2 Hz, C(6')HAHB), 3.90 (dq, 7 = 10.5, 7.2 Hz, 1H, C^COOCHAHB), 4.17
(dq, 7 = 4.2, 7.2 Hz, 1H, C(4')COOCHAHB), 4.21 (dq, 7 = 4.2, 7.2 Hz, 1H,
C(4')COOCHAHB),

4.32 (apparent t, 7 = 7.5 Hz, 1H, C(3'a)H), 4.71 (ABq, 7 =

Av = 35.7 Hz, 2H, N(3)CH2Bn), 6.47 (apparent t, 7 = 2.4 Hz, 1H, =CH), 7.
5H, ArCH).

13

C NMR (75 MHz, CDC13) 8 13.8 (CH3), 14.3 (CH3), 28.0 (terf-butyl

CH3), 31.2 (C(2')H2), 37.7 (C(3')H2), 39.6 (C(6') H2), 42.9 (BnCH2), 53.7 (C

60.3 (OCH2), 61.5 (OCH2), 69.7 (C(6'a)), 73.9 (Cspiro), 84.8 (OC), 127.9 (ArCH),

(ArCH), 128.7 (ArCH), 135.2 (ArC), 137.3 (=CH), 139.4 (=C), 148.8 (OO(Boc))

151.7 (C(2)=0), 164.0 (C=0), 171.7 (OO), 172.3 (C(4)=0). LRMS: (CI +ve) m/
(M - C4H9 + H +1) (12 %), 427 (M - C5H902 + H +1) (100 %). HRMS: (CI +ve)
Calcd. for C23H27N206 (M - C5H902 + H +1) 427.1869, Found 427.1860.

Ethyl l-acetyl-3-benzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-7-ene-7-carbo

Compound 67 (200 mg, 0.82 mmol) and ethyl 2-butynoate (183 mg, 1.64 mm

reacted using the same conditions as for the preparation of 80 using p

Purification by column chromatography (30 % EtOAc/Pet. Sp.) gave a mix
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title compound 86 and its regioisomer as a faint yellow oil (125 mg, 43 % ) . The ratio of
the major isomer, compound 86 to the minor isomer, compound 87, as determined by
integration of the olefinic protons (6.69 ppm for 86 and 7.10 ppm for 87) in the ! H
N M R spectrum of the crude reaction product was 80:20. Compound 87 could not be
fully separated for spectral analysis.
Data for [86]: *H N M R (300 M H z , CDC1 3 ) 8 1.23 (t, 7 = 7.2 Hz, 3H, CH 3 ), 2.49 (s, 3H,
COOEt

Acyl CH3)

'

O

31

°

(m

'

4H

'

/^\

H O^'
N^° sX^X
'3

2x CH2)

' 4-18 (q-7 = 7-2

Hz

> 2 H > OCFI2), 4.68 (s, 2H, BnCH 2 ), 6.69 (t, 7 =

21 Hz

N

NMR

'

1H

'

=CH)

' 7'28 ~ 7'41

(m

(75 M H z , CDC1 3 ) 8 14.2 (CH3), 25.9

(AcylCH3), 41.5 (CH2), 42.8 (CH2), 42.8 (CH2),
60.5 (OCH 2 ), 67.7 (Cspir0), 128.2 (ArCH), 128.4 (ArCH), 128.7 (ArCH), 133.6 (=C),
134.8 (ArC), 138.7 (=CH), 152.9 (C=0), 163.4 (C=0), 168.6 (COO), 174.5 (C=0).
L R M S : (CI +ve) m/z 357 (M+l). H R M S : (CI +ve) Calcd. for Ci 9 H 2 iN 2 0 5 (MH + )
357.1450, Found 357.1388.

(45)-3-(2-Butynoyl)-4-benzyloxazolidin-2-one [93y] and (4S)-3-(2,2Dimethylpropanoyl)-4-benzyloxazolidin-2-one [94y]
To a solution of 2-butynoic acid (300 mg, 3.57 mmol) in redistilled T H F (20 mL) at -78
°C under a N 2 atmosphere was added dropwise trimethylacetyl chloride (471 mg, 3.93
mmol) followed by triethylamine (397 mg, 3.93 mmol). The mixture was stirred at this
temperature for 15 min and it was then warmed to 0 °C for 45 min and then recooled to
-78 °C. In a second flask, n-butyllithium (2.45 m L of 1.6 M n-butyllithium in hexane,
3.93 mmol) was added dropwise to a solution of (-)-(45)-benzyl-2-oxazolidinone (632
mg, 3.57 mmol) in redistilled T H F (10 m L ) at -78 °C under a N 2 atmosphere and was

'
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allowed to stir for 15 min. After this time the contents of the second flask was
transferred to the first flask via a cannula with both flasks remaining at

completion of the transfer, the reaction mixture was slowly warmed up to roo

temperature and stirring was continued for 10 h. Potassium bisulphate (20 m

was then added and the mixture extracted with ethyl acetate. The combined o

extracts were washed with water, brine, dried (MgS04) and the solvent was re
vacuo. The remaining residue was purified by column chromatography (10 %

EtOAc/Pet. Sp. to 30 % EtOAc/Pet. Sp.) to give 93y as a crystalline solid (7
%) and 94y as a crystalline solid (30 mg, 3 %).

Data for mp [93y]: mp 78 - 80 °C (lit.73 88 %, mp 78 - 80 °C). XH NMR (300 MHz,
0

O CDC13) 8 2.12 (s, 3H, CH3), 2.79 (dd, 7 = 9.3, 13.5 Hz, 1H,

— // l
^ N
O B I I C H A H B ) > 3 . 3 1 (dd,7=3.3, 13.5 Hz, 1H, finCH^), 4.17
6 ^ (m, 2H, OCH2), 4.66 (m, 1H, CH), 7.20 - 7.36 (m, 5H,
\=/

g3y

ArCH) [lit.73 *H NMR (200 MHz, CDC13) 8 2.11 (s, 3H),

2.74 - 2.86 (dd, 7 = 9.5, 13.5 Hz, 1H), 3.25 - 3.33 (dd, 7 = 3.3, 13.5 Hz, 1

4.19 (m, 2H), 4.60 - 4.74 (m, 1H), 7.19 - 7.34 (m, 5H)]. 13C NMR (75 MHz, CDC
4.7 (CH3), 37.7 (BnCH2), 55.1 (CH), 65.9 (OCH2), 72.8 (C), 94.8 (C), 127.3 (ArCH),
128.9 (ArCH), 129.3 (ArCH), 134.8 (ArC), 150.5 (OO), 151.9 (OO). LRMS: (CI

+ve) m/z 244 (M + 1). HRMS: (EI +ve) Calcd. for Ci4H,3N03 (M+) 243.0895, Foun
243.0896.

Data for [94y]: white solid, mp 82 - 85 °C. JH NMR (300 MHz, CDC13) 8 1.40 (s
Q

3 x CH3), 2.77 (dd, 7 = 9.9, 13.5 Hz, 1H, BnCHAHB), 3.22 (dd,

A J\ J= 3.3, 13.5 Hz, 1H, BnCHAHB), 4.11 - 4.22 (m, 2H, OCH2),
N
O
\ / 4.66 - 4.74 (m, 1H, NCH), 7.18 - 7.36 (m, 5H, ArCH). 13C
94

NMR (75 MHz, CDC13) 8 26.4 (CH3), 37.9 (BnCH2), 41.7 (C),
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57.4 (CH), 66.1 (OCH 2 ), 127.1 (ArCH), 128.7 (ArCH), 129.3 (ArCH), 135.4 (ArC),
152.13 (C(3)=0), 178.3 (OO). LRMS: (ES +ve) m/z 262 (M+l). HRMS: (CI +ve)
Calcd. for C15H19N03 (MH+) 262.1443, Found 262.1445.

(IS, 5R, 7fl)-4-But-2-ynoyl-10,10-dimethyl-3,3-dioxo-3-thio-4-

azatricyclo[5.2.1.0ls]decane [93x] and (15,5R, 7/?)-4-(2,2-Dimethylpropanoyl
10,10-dimethyl-3,3-dioxo-3-thio-4-azatricyclo[5.2.1.01'5]decane[94x]

2-Butynoic acid (100 mg, 1.2 mmol) and (-)-camphor sultam (258 mg, 1.2 mmo

reacted using the same conditions as for the synthesis of compound 93y. Pur

column chromatography (10 % EtO Ac/Pet. Sp. to 30 % EtO Ac/Pet. Sp.) gave 93
crystalline solid (213 mg, 60 %) and 94x as a white solid (100 mg, 28 %).
Data for [93x]: mp 170 -172 °C (lit.73 mp 170 -172 0C)}lL NMR (300 MHz, CDC13)
0.98 (s, 3H, CH3), 1.18 (s, 3H, CH3), 1.25 - 1.44 (m,
4H), 1.89 - 2.19 (m, 3H), 2.08 (s, 3H, CH3), 3.47

U

/ (ABq, 7 = 13.8 Hz, Av = 24 Hz, 2H, S02CH2), 3.87
(dd, 7 = 4.8, 7.8 Hz, 1H, NCH). [lit.73 *H NMR (200

MHz, CDC13) 8 0.98 (s, 3H), 1.18 (s, 3H), 1.23 - 1.60 (m, 4H), 1.88 - 2
2.08 (s, 3H), 3.37 (d, 7 = 14.0 Hz, 1H), 3.46 - 3.52 (d, 7 = 13.8 Hz, 1H), 3.82 (dd, 7 = 4.8, 7.9 Hz, 1H)]. 13C NMR (75 MHz, CDC13) 8 4.3 (CH3), 19.9 (CH3), 20.9
(CH3), 26.4 (CH2), 32.8 (CH2), 38.3 (CH2), 44.7 (CH), 47.8 (C), 48.3 (C), 53.0
(S02CH2), 64.9 (NCH), 72.7 (C), 92.3 (C), 150.0 (OO). LRMS: (CI +ve) m/z 282
(M+l). HRMS: (ES +ve) Calcd. for Ci4H,9N03S (M+) 281.1086, Found 281.1090.
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Data for [94x]: white solid (28 % ) , m p 124 - 126 °C.X H N M R (300 M H z , CDC13) 8
0.95 (s, 3H, CH3) 1.15 (s, 3H, CH3), 1.25 - 1.49 (m, 3H),
1.34 (s, 9H, 3 x CH3), 1.79 - 2.05 (m, 4H), 3.45 (ABq, 7
= 13.5 Hz, Av = 15.6 Hz, 2H, S02CH2), 4.01 (dd, J = 4.8,

94x SOj'
7.8 Hz, 1H, NCH).

13

C NMR (75 MHz, CDC13) 8 19.8

(CH3), 20.4 (CH3), 26.6 (CH2), 27.2 (3 x CH3), 32.6 (CH2), 38.8 (CH2), 42.3 (C),
(CH), 47.7 (C), 48.0 (C), 53.7 (S02CH2), 67.1 (NCH), 179.4 (OO). LRMS: (ES

m/z 300 (M+l). HRMS: (CI +ve) Calcd. for C15H26NO3S (MH+) 300.1633, Fou
300.1635.

3-(2-Butynoyl)-l,3-oxazoIidin-2-one [93z] and 3-(2,2-Dimethylpropanoy
oxazolidin-2-one [94z]

2-Butynoic acid (400 mg, 4.76 mmol) and 2-oxazolidinone (518 mg, 4.76

reacted using the same conditions as for the synthesis of compound 93

column chromatography (10 % EtOAc/Pet. Sp. 30 % EtOAc/Pet. Sp.) gave 9

crystalline solid (204 mg, 28 %) and 94z as a yellow oil (116 mg, 14 %

Data for [93z]: mp 84 - 86 °C (lit.132 85 - 86 °C). lH NMR (300 MHz, CDC1
(s, 3H, CH3), 4.03 (t, 7 = 7.5 Hz, 2H, OCH2), 4.44 (t, 7 = 7.5

O o
//
93z

fl

Hz, 2H, NCH 2 ). (lit.132J H N M R (400 MHz, CDC13) 8 2.10

\ / (s, 3H), 4.03 (t, 7 = 7.8 Hz, 2H), 4.44 (t, 7 = 7.7 Hz, 2H)).

13

C NMR (75 MHz, CDC13) 8 4.0 (CH3), 41.9 (NCH2), 61.7 (OCH2), 72.0 (C), 94.1

150.1 (OO), 151.6 (OO). LRMS: (CI +ve) m/z 154 (M + 1). HRMS: (EI +ve)
for C7H7N03 (M+) 153.0426, Found 153.0434.
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Data for [94z]:X H N M R (300 M H z , CDC1 3 ) 8 1.36 (s, 9H, 3 x C H 3 ) , 4.05 (t, 7 = 7.5 Hz,
Q Q

2H, OCH2), 4.43 (t, 7 = 7.5 Hz, 2H, NCH2). 13C NMR (75 MHz,

y.x
N

94z

^

0
'

CDC1 3 ) 8 25.8 (CH 3 ), 40.8 (C), 44.8 (NCH 2 ), 61.8 (0CH 2 ), 151.9
(C=0), 177.7 ( O O ) . L R M S : (CI +ve) m/z 272 (M +1).

(5/e)-l,3-Dibenzyl-7-[(lS,5/?,7/J)-(-10,10-dimethyl-3,3-dioxo-3-thio-4-azatricyclo[5.2.1.01,5]decane-4-carbonyl]-l,3-diaza-spiro[4.4]non-7-ene-2,4-dione[(-)5fl-95x] and (5S)-l,3-Dibenzyl-7-[(lS, 5R, 7/?)-10,10-dimethyl-3,3-dioxo-3-thio-4aza-tricyclo[5.2.1.01,5]decane-4-carbonyl]-l,3-diaza-spiro[4.4]non-7-ene-2,4-dione
[(-)-5S-95x]
Compound 51 (1.56 g, 5.34 mmol), and compound 93x (1.50 g, 5.34 mmol were reacted
using the same conditions as for the preparation of 80 using procedure A. Purification
by column chromatography (30 % EtOAc/Pet. Sp. to 40 % EtOAc/Pet. Sp.) gave the
title compound [(-)-5/?-95x] as needle like crystals (1.14 g, 37 % ) and its
diastereoisomer [(-)-5S-95x] as rhombic crystals (1.14 g, 37 %).

Data for [(-)-5/?-95x] mp 149 -151 °C. [oc]D23 -10° (c 1.7, CHC13). Note: CS denot
chemical shift belonging to camphor sultam
component. *H NMR (300 MHz, CDC13) 8
[(-)-5A?-95x]
O
1.01 (s, 3H, CH3), 1.23 (s, 3H, CH3), 1.331.47 (m, 3H, C(c.s)H), 1.87-2.10 (m, 4H,
C(c.s)H), 2.50-2.57 (m, 1H,
2.72-2.78 (m, 1H,
(m, 1H,

C(A)HAHB),

3.40-3.46 (m, 1H,

C(B)HAHB),

C(A)HAHB),

C(B)HAHB),

2.98-3.04

3.52 (ABq, 7= 13.5 Hz, Av = 39.0

Hz, 2H, S02CH2), 4.09 (dd, 7 = 4.2, 7.2 Hz, 1H, NCH), 4.19 (d, 7 = 15.3 Hz, 1H,
N(l)CHAH B Bn), 4.71 (ABq, 7 = 14.4 Hz, A v = 20.1 Hz, 2H, N(3)CH 2 Bn), 4.80 (d, 7 =
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15.3 Hz, 1H, N(l)CHAHBBn), 6.64 (t, 7 = 1.2 Hz, 1H, =CH), 1.22-1 Al (m, 10H,
ArCH).

13

C NMR (75 MHz, CDC13) 8 20.0 (CH3), 21.4 (CH3), 26.5 (C(C.S)H2), 33.3

(C(C.s)H2), 38.4 (C(C.s)H2), 42.3 (N(3)CH2Bn), 43.1 (CH2), 43.2 (CH2), 43.5

(N(l)CH2Bn), 45.3 (C(C.S)H), 47.8 (C(C.S)), 48.3 (C(CS)), 53.8 (S02CH2), 65.7 (NCH
68.2 (Cspiro), 127.5 (ArCH), 127.8 (ArCH), 128.3 (ArCH), 128.4 (ArCH), 128.5

(ArCH), 128.6 (ArCH), 134.7 (=C), 136.0 ((ArC), 137.8 (ArC), 140.1 (=CH), 15

(C(2)=0), 164.7 (OO), 175.4 (C(4)=0). LRMS: (ES +ve) m/z SI A (M+l). HRMS
+ve) Calcd. for C32H36N305S (MH+) 574.2376, Found 574.2374.

Data for [(-)-5S-95x]: mp 179 - 180 °C, [cc]D22 -25° (c 1.7, CHC13). Note:
chemical shift belonging to camphor sultam
component.
[(-)-5S-95x] *H NMR (300 MHz, CDC13) 8
1.01 (s, 3H, CH3), 1.24 (s, 3H, CH3), 1.34 1.47 (m, 3H, C(c.s)H), 1.87 - 2.14 (m, 4H,
C(c.s)H), 2.32 - 2.40 (m, 1H,

C(A)HAHB),

2.96 - 3.04 (m, 1H, C(B)HAHB), 3.04 - 3.11
(m, 1H, C(A)HAHB), 3.14 - 3.21 (m, 1H,
C(B)HAMB),

3.47 (ABq, 7 = 13.8 Hz, Av = 30.3 Hz, 2H, S02CH2), 4.05 (dd, 7

Hz, 1H, NCH), 4.15 (d, 7 = 15.6 Hz, 1H, N(l)CHAHBBn), 4.72 (s, 2H, N(3)CH

4.80 (d, 7 = 15.6 Hz, 1H, N(l)CHAHBBn), 6.43 (dd, 7 = 1.8, 2.7 Hz, 1H, =
7.44 (m, 10H, ArCH).

13

C NMR (75 MHz, CDCI3) 8 19.9 (CH3), 21.2 (CH3), 26.4

(C(C.s)H2), 33.1 (C(C.s)H2), 38.4 (C(C.s)H2), 41.7 (CH2), 42.7 (CH2), 43.4 (N(3)

43.6 (N(l)CH2Bn), 45.1 (C(C.s)H), 47.7 (C(C.s)), 48.1 (C(C.s)), 53.4 (S02CH2),
(NCH), 69.5 (Cspiro), 127.6 (ArCH), 127.7 (ArCH), 128.1 (ArCH), 128.2 (ArCH),

(ArCH), 128.5 (ArCH), 134.2 (=C), 135.9 (OO), 137.1 (OO), 138.8 (=CH), 155.2
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(C(2)=0), 164.4 ( O O ) , 174.6 ( O O ) . L R M S : (ES +ve) m/z 574 (M+l). H R M S : (CI
+ve) Calcd. for C32H36N305S (MH+) 574.2376, Found 574.2374.

(+)-(5/?)-l,3-Dibenzyl-6-[(45)-4-benzyl-2-oxo-oxazolidine-3-carbonyl]
l,3-diazaspiro[4.4]non-6-ene [96y]
Bn Compound 51 (431 mg, 1.48 mmol) and compound 93y
N | (719 mg, 2.96 mmol) were reacted using the same

\—O
conditions as for the preparation of 80 using procedure
A. Purification by column chromatography (30 %
EtOAc/Pet. Sp. to 40 % EtOAc/Pet. Sp.) gave 4-benzyl2-oxazolidinone (106 mg, 20 %) as a solid and the title compound 96y

oil (429 mg, 54 %). Regioisomer 95y was detected in the !H NMR spectru

crude reaction mixture as a 1:1 mixture of diastereoisomers (6.42 -6.

protons). The ratio of the major isomer, compound 96y to minor isomer,

as determined by integration of the olefinic protons in the *H NMR sp

crude reaction mixture was 89:11. Data for [96y]: [a]D25 + 12° (c 1.55, CH
OX denotes chemical shifts belonging to the oxazolidinone component.

MHz, CDC13) 8 1.89 (ddd, 7= 5.7, 8.7, 14.1, 1H, CH2), 2.28 (ddd, 7= 4.

1H, CH2), 2.49 - 2.74 (m, 2H, CH2), 2.55 (dd, 7 = 10.2, 13.5 Hz, 1H, BnCH2), 3

7= 2.7, 13.5 Hz, 1H, BnCH2), 4.11 (m, 2H, OCH2), 4.27 (d, 7= 15.3 Hz, BnCH2(N

4.37 (m, 1H, CH), 4.71 (d, 7 = 15.3 Hz, BnCH2(Nl)), 4.80 (s, 2H, BnCH2(N3)
(m, 1H, =CH), 7.11-7.51 (m, 15H, ArCH).

13

C NMR (75 MHz, CDC13) 8 31.7 (CH

31.9 (CH2), 37.4 (Bnox, CH2), 42.9 (BnCH2), 43.8 (BnCH2), 56.9 (CH), 66.5 (OCH
76.7 (Cspiro), 127.2 (ArCH), 127.4 (ArCH), 127.5 (ArCH), 128.3 (ArCH), 128.3

(ArCH), 128.3 (ArCH), 128.4 (ArCH), 128.8 (ArCH), 129.2 (ArCH), 131.4 (=C),
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(ArC), 136.3 (ArC), 137.3 (ArC), 151.8 (=CH), 152.4 ( O O ) , 156.2 ( O O ) , 162.5

(OO), 174.5 (OO). LRMS: (ES +ve) 536.2 (M+l). HRMS: (CI +ve) Calcd. fo
C32H30N3O5 (MH+) 536.2185, Found 536.2145.

l,3-Dibenzyl-6-(2-oxo-oxazolidine-3-carbonyl)-l,3-diaza-spiro[4.4]nondione [96z]
Compound 51 (96 mg, 0.33 mmol), and
X\. h—O

N'

"xx?
0

Y°

compound 93z (101 mg, 0.66 mmol were

7

oo

/
.
reacted using the same conditions as for the
(
-N
"~^\ J] preparation of 80 using procedure A.

Purification by column chromatography (30 %
EtOAc/Pet. Sp. to 40 % EtOAc/Pet. Sp.) gave the title compound 96z as a white solid

(62 mg, 42 %). Regioisomer 95z was detected in the lH NMR spectrum of t

reaction mixture as a 1:1 mixture of diastereoisomers (6.42 - 6.43 ppm
protons). The ratio of the major isomer, compound 96y to minor isomer,

as determined by integration of the olefinic protons in the *H NMR spe

crude reaction mixture was 80:20. Data for [96z]: mp 159 -161 °C *H NMR
MHz, CDC13) 8 2.03 (ddd, 7 = 7.5, 8.1, 14.4 Hz, 1H,
13.5 Hz, 1H,

CHAHB),

2.60 - 2.81 (m, 2H, 2 x

CHAHB),

CHAHB),

2.25 (ddd 7 =

3.57 - 3.71 (m. 2H, NC

4.23 (dd, 7 = 7.2, 8.7 Hz, 2H, OCH2), 4.46 (ABq, 7 = 15.6 Hz, Av = 90 Hz, 2H,
N(3)CH2Bn), 4.76 (s, 2H, N(l)CH2Bn), 7.09 (t, 7 = 2.4 Hz, 1H, =CH), 7.21 8H, ArCH), 7.44 - 7.47 (m, 2H, ArCH).

13

C NMR (75 MHz, CDC13) 8 31.2 (CH2), 31

(CH2), 42.8 (NCH2), 43.1 (NCH2), 43.3 (NCH2), 61.8 (OCH2), 76.3 (Cspiro), 127.1

(ArCH), 127.5 (ArCH), 128.1 (ArCH), 128.2 (ArCH), 128.4 (ArCH), 128.7 (ArCH)

131.2 (=C), 136.1 ((ArC), 137.1 (ArC), 152.1 (C(2)=0), 152.5 (=CH), 156.3 (O
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162.4 ( O O ) , 174.5 (C(4)=0). L R M S : (CI +ve) m/z 446 (M+l). H R M S : (CI +ve)
Calcd. for C25H23N305 (M+) 445.1637, Found 445.1627

(+)-(5/J)-l,3-Bis(4-methoxybenzyl)-6-[(4S)-4-benzyl-2-oxo-l,3-oxazolid
carbonyl]-2,4-dioxo-l,3-diazaspiro[4.4]non-6-ene[98y]
Bn Compound 55 (200 mg, 0.57 mmol) and compound
N
PMB^M/*\xP QO^

j

93y (276 mg, 1.14 mmol) were reacted using the same
conditions as for the preparation of 80 using procedure
A. Purification by column chromatography (30 %

EtOAc/Pet. Sp. to 40 % EtOAc/Pet. Sp.) gave 4-

benzyl-2-oxazolidinone (34 mg, 17 %) as a solid and the title compoun

colourless oil (110 mg, 32 %). Regioisomer 97y was detected in the 'H

of the crude reaction mixture as a 1:1 mixture of diastereoisomers (6

olefinic protons). The ratio of the major isomer, compound 97y to mino

compound 98y, as determined by integration of the olefinic protons in

spectrum of the crude reaction mixture was 82:18. Data for [98y]: [cc]D2

CHC13). Note: OX denotes chemical shifts belonging to the oxazolidinone
*H NMR (300 MHz, CDC13) 8 1.93 (ddd, 7 = 6.3, 9.0, 15.3 Hz, 1H, CH2),

4.5, 9.0, 13.5 Hz, 1H, CH2), 2.45 (dd, 7 = 10.5, 13.5 Hz, 1H, Bn0XCH2), 2.54 -

2H, CH2), 3.05 (dd, 7 = 3.0, 13.5 Hz, 1H, Bn0XCH2), 3.74 (s, 3H, OCH3), 3.77 (s,

OCH3), 4.11 (m, 2H, OCH2), 4.30 (d, 7 = 151.6 Hz, 1H, BnCH2), 4.36 (m, 1H, C0XH)
4.55 (d, 7 = 151.6 Hz, 1H, BnCH2), 4.73 (s, 2H, BnCH2), 7.04 (t, 7 = 2.4 Hz,

6.79, 6.83, 7.13, 7.43 (each d, 7 = 8.7 Hz, 8H, ArCH), 7.22 - 7.38 (m, 5H,

NMR (75 MHz, CDC13) 8 31.5 (CH2), 31.9 (CH2), 37.3 (BnCH2), 42.3 (BnCH2), 43.
(BnCH2), 55.2 (OCH3), 55.2 (OCH3), 57.0 (CH), 66.4 (OCH2), 76.5 (Cspiro), 113.7
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(ArCH), 113.7 (ArCH), 127.2 (ArC), 128.4 (ArC), 128.8 (ArCH), 129.2 (ArCH), 129.3

(ArCH), 129.9 (ArCH), 129.9 (ArCH), 131.5 (=C), 135.2 (ArC), 151.8 (=CH), 15

(OO), 156.2 (OO), 158.8 (ArC), 158.9 (ArC), 162.3 (=0), 174.6 (OO). LRMS: (

+ve) m/z 596 (M+l) (44 %), 121 (PMB) (100 %). HRMS: (CI +ve) Calcd. fo
C34H34N307 (MH+) 596.2397, Found 596.2363

(+)-(5/?)3-Benzyl-l-butoxycarbonyl-6-[(4S)-4-benzyl-2-oxo-oxazolidinecarbonyl]-2,4-dioxo-l,3-diazaspiro[4.4]non-6-ene[100y]
Bn Compound 74 (300 mg, 0.993 mmol) and
,N j compound 93y (241 mg, 0.993 mmol) were

\—O
QQ'

reacted using the same conditions as for the

preparation of 80 using procedure A.
O NBn
1n n

Purification by column chromatography (30 %

EtOAc/Pet. Sp. to 40 % EtOAc/Pet. Sp.) gave the title compound lOOy as

oil (234 mg, 43 %). Regioisomer 99y was detected in the *H NMR spectru

crude reaction mixture as a 1:1 mixture of diastereoisomers (6.58 - 6.

protons). The ratio of the major isomer, compound lOOy to minor isomer

99y, as determined by integration of the olefinic protons of in the *H

the crude reaction mixture was 95:5. Data for [100y]: [a]D23 + 4.7 ° (c 2.

OX denotes chemical shifts belonging to the oxazolidinone component. *

MHz, CDC13) 8 1.49 (s, 9H, /-butyl), 2.34 - 2.52 (m, 2H, CH2), 2.81 - 2.9

CH2), 2.69 (dd, 7 = 9.6, 13.2 Hz, 1H, Bn0XCH2), 3.20 (dd, 7 = 3.0, 13.2 Hz, 1H

BnoxCH2), 4.13 (m, 2H, OCH2), 4.45 (m, 1H, CH), 4.76 (s, 2H, BnCH2), 7.16 (t, 7
Hz, 1H, =CH), 7.10 - 7.47 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 27.8 (f

butyl, CH3) 32.2 (CH2), 32.3 (CH2), 37.2 (CH2), 42.8 (CH2), 56.9 (OCH2), 66.2 (C
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76.2 (CSpiro), 84.2 (CBoc), 127.1 (ArCH), 127.6 (ArCH), 128.3 (ArCH), 128.5 (ArCH),
128.7 (ArCH), 129.2 (ArCH), 131.3 (=C), 134.9 (ArC), 135.1 (ArCH), 147.7 ( O O ) ,
151.4 (=CH), 152.1 ( O O ) , 152.2 ( O O ) , 162.2 ( O O ) , 172.7 ( O O ) . L R M S : (CI +ve)
m/z 446 (M - C 5 H 8 0 2 +1). H R M S : (CI +ve) Calcd. for C 2 5 H 2 4 N 3 0 5 (M - C 5 H 8 0 2 +1)
446.1716, Found 446.1700.

Methyl (-)-(5/?)-l,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-6-ene[101]
To a solution of compound 96y (50 mg, 0.093
COOMe

mmol) in anhydrous methanol (5 mL) was added

°<x^x
samarium(ITI)triflate (56 mg, 0.093 mmol). The
reaction was heated at reflux for 12 h. After this
time the reaction was diluted with ethyl acetate (50
mL) and then washed with brine followed by saturated sodium bicarbonate (2 x 20 mL)
and then brine again. The organic extract was dried (MgS04), filtered and the solvent
was removed in vacuo to yield a yellow oil. Column chromatography (40 % EtOAc/
Pet. Sp.) gave the product as a clear oil (35 mg, 97 % ) . [a]D26 - 2.6° (c 1.75, CHC13). *H
N M R (300 M H z , CDC13) 8 1.92 - 2.03 (m, 1H, CH 2 ), 2.36 - 2.65 (m, 3H, CH 2 ), 3.21
(s, 3H, OCH 3 ), 4.30 (d, 7 = 15.6 Hz, 1H, BnCH 2 ), 4.48 (d, 7 = 15.6 Hz, 1H, BnCH 2 ),
4.75 (s, 2H, BnCH 2 ), 7.10 (t, 7 = 2.4 Hz, 4.20 -7.51 (m, 10H, ArCH). 13 C N M R (75
MHz, CDC13) 8 31.2 (CH2), 33.3 (CH2), 42.9 (BnCH2), 44.0 (BnCH2), 51.4 (OCH3),
74.7 (Cspiro), 127.6 (ArC), 127.6 (ArC), 128.0 (ArCH), 128.3 (ArCH), 128.4(ArCH),
128.8 (ArCH, 132.3 (=C), 136.1 (ArC), 137.0 (ArC), 152.1 (=CH), 155.9 ( O O ) , 162.0
( O O ) , 174.3 ( O O ) . L R M S : (ES +ve) 391 (M+l). H R M S : (CI +ve) Calcd. for
C 2 3 H 2 3 N 2 0 4 (MH + ) 391.1657, Found 391.1625.
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AT-(l-benzyl-2-hydroxyethyl)-l,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-6-ene6-carboxamide [102]
Compound 96y (336 mg, 0.628 mmol)
was dissolved in dry methanol and
potassium carbonate (95 mg, 0.691 mmol)
was added. The reaction was allowed to
stir for 1 h at RT and the reaction turned
X^yy 102 orange. Methanol was removed in vacuo
and the remaining orange residue taken up in ethyl acetate and washed

then a solution of brine. The organic extract was dried (MgS04), filter

was removed in vacuo to give a yellow oil. Purification by chromatogra

EtOAc/Pet. Sp. to 60 % EtOAc/Pet. Sp.) gave compound 101 as a clear oi
%), 4-benzyl-2-oxazolidinone (51 mg, 46 %) and the title compound 102

foam (112 mg, 35 %). 2H NMR (300 MHz, CD3OD) 8 2.17 (ddd, 7 = 4.2, 7.8,
1H, CHAHB), 2.41 (ddd, 7 = 6.9, 7.8, 14.1 Hz, 1H, CHAHB), 2.64 - 2.70 (m, 2H, CH2),

2.82 (dd, 7 = 9.3, 13.8 Hz, 1H, BnCHAHB), 3.03 (dd, 7 = 5.4, 13.8 Hz, 1H, B
3.54 (m, 1H, CH), 3.78 (dd, 7= 2.7, 12.0 Hz, 1H, OCHAHB), 4.00 (dd, 7= 7.5, 12.0 Hz,

1H,

OCHAHB),

N(DCHAHBBII),

ArCH).

4.27 (d, 7 = 16.2 Hz, 1H, N(l)CHAHBBn), 4.63 (d, 7 = 16.2 Hz,
4.72 (s, 2H, N(3)CH2Bn), 7.08 (m, 1H, =CH), 7.00 - 7.41 (m,

13

C NMR (75 MHz, CD3OD) 8 32.6 (CH2), 33.8 (CH2), 37.0 (BnCH2), 43.7

(NCH2Bn), 44.7 (NCH2Bn), 53.0 (CH), 64.1 (OCH2), 74.4 (Cspiro), 128.5 (ArCH), 12

(ArCH), 128.7 (ArCH), 129.2 (ArCH), 129.3 (ArCH), 129.4 (ArCH), 130.0 (ArCH)

130.0 (ArCH), 132.2 (ArC), 136.1 (ArC), 137.4 (ArC), 138.5 (=C), 155.0 (=CH),

(C(2)=0), 162.5 (NOO), 176.3 (C(4)=0). LRMS: (ES +ve) m/z 510 (M+l). HRMS:
(CI +ve) Calcd. for C31H32N304 (MH+) 510.2393, Found 510.2363.

Chapter 7

203

(5/?)-Methyll,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-6-ene-6-carboxylate
[103]
Compound 98y (50 mg, 0.084 mmol)
was treated in the same manner as
compound 96y in the synthesis of

MeO
compound 101. Purification by

column chromatography (30 % EtOAc/Pet. Sp to 40 % EtOAc/Pet. Sp) gave th

compound 103 as a clear oil (26 mg, 70 %). [a]D25 - 5.5 ° (c 2.7, CHC13). *H

MHz, CDC13) 8 1.88 - 2.02 (m, 1H, CH2), 2.36 - 2.63 (m, 3H, CH2), 3.23 (

OCH3), 3.74 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 4.20 (d, 7= 15.3 Hz, 1H, BnCH2), 4.

(d, 7 = 15.3 Hz, 1H, BnCH2), 4.66 (s, 2H, BnCH2), 7.09 (t, 7 = 2.4 Hz, 1H, =CH)
6.84, 7.12, 7.41 (each d, 7 = 8.7 Hz, 8H, ArCH).

13

C NMR (75 MHz, CDC13) 8

(CH2), 33.2 (CH2), 42.2 (BnCH2), 43.3 (BnCH2), 51.3 (OCH3), 55.1 (2x OCH3), 74.5

(Cspiro), H3.6 (ArCH), 113.7 (ArCH), 128.4 (ArC), 129.0 (ArC), 129.3 (ArCH), 130.
(ArCH), 132.3 (=C), 151.9 (=CH), 155.8 (OO), 158.9 (ArC), 158.9 (ArC), 162.0
(OO), 174.3 (OO). LRMS: (ES +ve) m/z 451 (M+l) (60 %), 121 (PMB) (100 %).
HRMS: (CI +ve) Calcd. for C25H26N206 (M+) 450.1791, Found 350.1792.

Methyl (5/c)-2,4-dioxo-l,3-diazaspiro[4.4]non-6-ene-6-carboxylate [104],

(5/?)-3-[4-methoxyphenylcarbonyl]-2,4-dioxo-l,3-diazaspiro[4.4]non-6-en

carboxylate [105] and Methyl (5/f)-l-[4-methoxyphenylcarbonyl]-2,4-diox
diazaspiro[4.4]non-6-ene-6-carboxylate [106]

To a solution of the compound 103 (100 mg, 0.22 mmol) in acetonitrile (

added a solution of eerie ammonium nitrate (5 mL, 3.33 mmol). The reacti

stirred at ambient temperature for 45 min before it was then diluted wi
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(25 mL). The organic extract was washed with brine, dried (MgS04), filtered and the

solvent was removed in vacuo to yield a yellow residue. The residue was

semi-preparative plates (50 % EtOAc/Pet. Sp) to yield p-methoxybenzalde

50 %) and compound 104 (12 mg, 26 %), compound 105 (8 mg, 11 %) and comp
106 (47 mg, 62 %) as oils.

Data for [104]: [oc]D24 - 32.5° (c 0.45, CHC13). *H NMR (300 MHz, CDC13) 8 2.
2.24 (m, 1H, CH2), 2.62 - 2.73 (m, 3H, CH2), 3.73 (s, 3H,
COOMe QCH3), 6.28 (br s, 1H, NH), 7.14 (t, 7= 2.1 Hz, 1H, =CH), 8.57
(br s, 1H, NH).

13

C NMR (75 MHz, CDC13) 8 30.8 (CH2), 35.8

(CH2), 52.1 (OCH3), 77.2 (Cspiro), 133.5 (=C), 150.8 (=CH),

156.2 (OO), 162.6 (OO), 175.5 (OO). LRMS: (CI +ve) m/z 211 (M+l). HRMS: (EI
+ve) Calcd. for Ci5Hi9N03 (M+) 210.0641, Found 210.0646.

Data for [105]: (11 %). *H NMR (300 MHz, CDC13) 8 2.16 - 2.17 (m, 1H, CH2)
2.79 (m, 3H, CH2), 3.81 (s, 3H, OCH3), 3.89 (s, 3H,
OCH3), 6.34 (br s, 1H, NH), 6.97, 8.03 (each d, 7 =

OMe
9.0 Hz, 4H, ArCH), 7.16 (t, 7 = 2.1 Hz, 1H, =CH).
LRMS: (ES +ve) m/z 345 (M+l). HRMS: (CI +ve)
105 Calcd. for Ci7Hi7N206 (MH+) 345.1086, Found
345.1080.

Data for [106]: [a]D23 - 3.8° (c 2.2, CHC13). *H NMR (300 MHz, CDC13) 8 2.59 (m, 3H, CH2), 3.04 - 3.16 (m, 1H, CH2), 3.73
COOMe (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 6.89, 7.60

O
(each d, 7 = 9.0 Hz, 4, ArCH), 2.27 (t, 7 = 2.4

MeO

Hz, 1H, =CH), 8.96 (br s, 1H, NH). 13 C N M R

106

(75 MHz, CDC13) 8 32.4 (CH2), 34.6 (CH2),
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52.0 (OCH 3 ), 55.4 (OCH 3 ), 77.1 (Cspiro), 113.2 (ArCH), 126.2 (=C), 130.3 (ArC), 131.2
(ArCH), 152.7 (OO), 153.7 (=CH), 162.9 (ArC), 163.0 (OO), 167.6 (OO), 174.0
(OO). LRMS: (ES +ve) m/z 345 (M+l). HRMS: (CI +ve) Calcd. for Ci7H17N206
(MH+) 345.1086, Found 345.1089.

(l/J)-Amino-2-cyclopentene-l,2-dicarboxyllic acid (hydrochloride salt) [107
A solution of compound 106 (30 mg, 0.087 mmol) in 10 %
C 3^-COOH HC1 (10 mL) was

neated at 10

° °c for 30

mins with

stirring

HCI.NHg COOH in a sealed Teflon vessel in a microwave reactor. After this
107
time the reaction vessel was allowed to cool down and was
then diluted with water (50 mL) and washed with ethyl acetate (2 x 50 mL).

aqueous portion was rotary evaporated to dryness to yield the title compoun

light brown powder. [a]D23 - 12° (c 0.10, H20) [lit.56 (15), [a]D22 +11° (c 0.4, H20

NMR (300 MHz, D20) 8 2.10 - 2.19 (m, 1H, CH2), 2.39 - 2.48 (m, 1H, CH2), 2.55

2.68 (m, 2H, CH2), 7.21 (br s, 1H, =CH) [as Free Base - 6.71 (br s, 1H, =CH)
l

H NMR reported as free base, XH NMR (300 MHz, D20) 8 2.09 - 2.18 (m, 1H), 2.

2.48 (m, 1H), 2.57 - 2.68 (m, 2H), 6.82 (br s, 1H, H-3)].
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Methyl 3-[(4S)-4-methyl-2-oxo-l,3-oxazolidin-3-yl]carbonylcyclopent-3-ene-lcarboxylate [109A], (+)-Methyl (7fl)-2-[(4S)-4-benzyl-2-oxo-l,3-oxazolidine-3carbonyl]cyclopent-2-ene-l-carboxylate [(+)-(l#)-109B], (+)-Methyl (15)-2-[(4S)-4benzyl-2-oxo-l,3-oxazolidine-3-carbonyl]cyclopent-2-ene-l-carboxylate[(+)-15109B], Methyl 3-[(4S)-4-benzyl-2-oxo-l,3-oxazolidin-3-yl]propanoate [110] and
(4S)-4-benzyl-3-[3-methyl-3-[(4S)-4'-benzyl-2,-oxo-oxazolyl]-l-oxoprop-2enyl]oxazolidin-2-one [111]
Procedure A: Methyl acrylate (58 mg, 0.675 mmol) and compound 93y (327 mg, 1.35
mmol) were reacted using the same conditions as for

Bn
^1

the preparation of 80 using procedure A. Purification

j, Q by column chromatography (30 % EtO Ac/Pet. Sp) gave
compound 93y (81 mg, 25 % of starting 93y),
iwionnr
compound 110 (13 mg, 7 %) and 111 (17 mg, 6 %) as
oils and a mixture of diastereoisomers of both regioisomers 109A and 109B as
colourless oils which hardened in the fridge (87 mg, 39 %). Separation of the
regioisomers was achieved by normal phase HPLC (12 % EtO Ac/Pet. Sp. at 20
mL/min). The ratio of regioisomer 109 to regioisomer 109B was 55:45, as determined
by HPLC peak integration. Regioisomer 109A appeared at 31 mins as a pair of

diastereoisomers with a ratio of 46:54, as determined by chiral GC of its derivativ

compound 112A. The diastereoisomers of 109A could not be separated and therefore it

spectral data was not obtained. Diastereoisomers of 109B, [(+)-lS-109B] and [(+)-(l
109B] were separated by normal phase HPLC and had retention times of 24 mins and

27 mins, respectively. The ratio of the [(+)-15-109B] isomer to the [(+)-(lR)-l09B]
isomer was 18:82, as determined by integration of the peaks on the HPLC trace.

Chapter 7

207

Procedure B: Methyl acrylate (116 mg, 1.35 mmol) and 93y (327 mg, 1.35 mmol) were

reacted using the same conditions as for the preparation of 80 using proc
Purification by column chromatography (30 % EtOAc/Pet. Sp) gave compound
mg, 9 % of starting 93y), diastereoisomers of both regioisomers 109A and

colourless oils which hardened in the fridge (38 mg, 9 %), dimer of the c
111 as an oil (17 mg, 3 %), compound 110 (133mg, 37 %) and 4-benzyl-2oxazolidinone as a white solid (70 mg, 29 %).

Data for [(+)-(l/c)-109B]: [a]D23 + 77° (c 0.5, CHC13). Note: OX denotes chemi
Bn shifts belonging to the oxazolidinone component. *H NMR
/ \ (300 MHz, CDC13) 8 2.16 - 2.28 (m, 1H, CH2), 2.29 - 2.41

(m, 1H, CH2), 2.53 - 2.74 (m, 2H, CH2), 2.85 (dd, 7 = 9.9, 13
O
COOMe
R z m B n C H 2 ) 3 41 (dd j= 33 13 5 H z 1 H BnCH 2 ), 3.70
(s, 3H, OCH3), 4.08 - 4.15 (m,lH, CH), 4.17 (dd, 7 = 3.3, 9.3

Hz, 1H, OCH2), 4.23 (dd, 7 = 6.6, 9.3 Hz, 1H, OCH2), 4.67 (ddt, 7 = 3.3, 6.6, 9.9 Hz
1H, C0XH), 6.65 (m, 1H, =CH), 7.22 - 7.37 (m, 5H, ArCH). 13C NMR (75 MHz,

CDC13) 8 27.3 (CH2), 32.8 (CH2), 37.6 (CH2), 51.0 (CH), 52.1 (OCH3), 56.3 (CH), 66

(OCH2), 127.2 (ArCH), 128.8 (ArCH), 129.4 (ArCH), 135.2 (=C), 135.5 (ArC), 144.3
(=CH), 152.8 (OO), 165.9 (OO), 173.8 (OO). LRMS: (CI +ve) m/z 330 (M+l).
HRMS: (CI +ve) Calcd. for C18H20NO5 (MH+) 330.1341, Found 330.1330.

Data for [(+)-lS-109B]: [a]D23 + 14° (c 0.8, CHC13). Note: OX denotes chemica
belonging to the oxazolidinone component. *H NMR (300
\ MHz, CDC13) 8 2.19 - 2.30 (m, 1H, CH2), 2.32 - 2.45 (m, 1H,

< j] CH2), 2.52 - 2.72 (m, 2H, CH2), 2.72 (dd, 7 = 10.2, 13.5
H

%

°

O

COOMe
[(+HS-109B] ^

1H> B nCH 2 ),
OCH^^ 4

3.44 (dd, 7 = 3.3, 13.5 Hz, 1H, BnCH 2 ), 3.70 (s,
^ (ddJ=5A g4 Hz m 0CH2) 424 (dd j
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= 8.4, 9.0 Hz, 1H, OCH 2 ), 4.27 (m, 1H, CH), 4.80 (dddd, 7 = 3.3, 5.4, 9.0, 10.2 Hz, 1H,
C0XH), 6.65 (dd, 7 = 2.1, 2.4 Hz, 1H, =CH), 7.21 - 7.36 (m, 5H, ArCH). 13C NMR (75
MHz, CDC13) 8 27.3 (CH2), 32.8 (CH2), 38.0 (CH2), 51.0 (CH), 52.1 (OCH3), 55.3
(CH), 66.6 (OCH2), 127.2 (ArCH), 128.8 (ArCH), 129.2 (ArCH), 135.2 (=C), 135.9
(ArC), 144.0 (=CH), 152.9 (OO), 166.0 (OO), 173.8 (OO). LRMS: (CI +ve) m/z

330 (M+l). HRMS: (CI +ve) Calcd. for C18H20NO5 (MH+) 330.1341, Found 330.1330

Data for [110]: *H NMR (300 MHz, CDC13) 8 2.55 - 2.77 (m, 2H, CH2), 2.58, (h
MeOOC-^ O 1H, CFUHeBn), 3.20 (dd, 7 = 3.9, 13.5 Hz, 1H, CHAHeBn),
^N O 3'44 (ddd' J = 6'3' 7'5' 13'5 Hz' 1H' NC2AHB)> 3.71 (s, 3H,

ft ^ / OCH3), 3.72 - 3.79 (hidden, 1H,

NCHAHB),

3.98 - 4.13 (m,

\=/ 2H, OCH2), 4.04 - 4.09 (m, 1H, NCH), 7.18 - 7.39 (m, 5H,
110 „
ArCH). 13 C N M R (75 M H z , CDC13) 8 32.6 (CH2), 37.9
(CH2), 38.3 (CH2), 51.9 (OCH3), 56.6 (CH), 66.8 (OCH2), 127.0 (ArCH), 128.1
(ArCH), 128.9 (ArCH), 135.2 (ArC), 157.7 (NOO), 171.9 (OOOMe). LRMS: (CI
+ve) m/z 264 (M+l). HRMS: (CI +ve) Calcd. for Ci4Hi7N04 (M+) 263.1157, Found
263.1143.
Data for [111]: *H NMR (300 MHz, CDC13) 8 2.76 (dd, 7 = 10.2, 13.5 Hz, 1H,
BnCHAHB), 2.83 (dd, 7 = 10.2, 13.5 Hz, 1H,
^ // \ BnCHAHB), 2.87 (s, CH3), 3.39 (dd, 7 = 3.3, 13.5 Hz,
O ~ / \
,0 1H, BnCHAHe), 3.48 (dd, 7 = 3.3, 13.5 Hz, 1H,

-\
v

,
I-

\x\

\ ( °t \

o

n

BHCHAHB),

4.16- 4.26 (m, 4H, 2 x OCH 2 ), 4.50 (dddd,

\ // \ J= 3.3, 6.9, 10.2, 13.5 Hz, 1H, NCH), 4.80 (dddd, 7 =
3.3, 6.9, 10.2, 13.5 Hz, 1H, NCH), 7.03 (s, 1H, =CH),
111
7.24 - 7.38 (m, 10H, ArCH). 13C NMR (75 MHz,
CDC13) 8 16.9 (CH3), 36.4 (BnCH2), 38.3 (BnCH2), 55.5 (CH), 57.7 (CH), 65.4
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(OCH 2 ), 66.0 (OCH 2 ), 77.2 (=C), 101.1 (=CH), 127.2 (ArCH), 127.3 (ArCH), 128.8
(ArCH), 129.0 (ArCH), 129.4 (ArCH), 129.5 (ArCH), 134.8 (ArC), 135.4 (ArC),

(OO), 154.6 (OO), 164.5 (OO). LRMS: (CI +ve) m/z 421 (M+l). HRMS: (EI +ve
Calcd. for C24H24N205 (M+) 420.1685, Found 420.1671.

Dimethyl (-)-(lS)-cyclopent-2-ene-l,2-dicarboxylate[(-)-(lS)-112B]
Compound [(+)-(lS)-109B] (19 mg, 0.058 mmol) was
UMe

treated in the same manner as compound 96y in the

MeOOC H synthesis of compound 101. Purification on semi
[(-)-(1 S)-112B1
preparative TLC plates (30 % EtOAc/Pet. Sp) gave the title

compound [(-)-(15)-112B] as an oil (4 mg, 37 %) and 4-benzyl-2-oxazol

78 %). Data for [(-)-(15)-112B]: [a]D23 - 56° (c 0.15, CHC13) [lit.79 [a]D26 -

ee as determined by chiral GC (at 0.5 uL) at 20.61 mins. 1H NMR (300 MH

2.06 - 2.17 (m, 1H, CH2), 2.29 - 2.42 (m, 1H, CH2), 2.47 - 2.73 (m, 2H,
1H, OCH3), 3.74 (s, 1H, OCH3), 3.75 - 3.81 (m, 1H, CH), 6.95 (dd, 7= 2.1, 4.2
=CH).

13

C NMR (75 MHz, CDC13) 8 28.8 (CH2), 32.7 (CH2), 49.3 (CH), 51.7 (CH3)

52.1 (OCH3), 134.7 (=C), 146.5 (=CH), 164.4 (C=0), 174.8 (C=0). LRMS: (ES +ve)

185 (M+l) (48 %), 153 (M - OCH3) (50 %), 125 (M - 2x(OCH3) + 2H + 1) (1
HRMS: (CI +ve) Calcd. for C9Hi304 (MH+) 185.0814, Found 185.0814.

Dimethyl (+)-(ll?)-cyclopent-2-ene-l,2-dicarboxylate[(+)-(lR)-112B]
Compound [(-)-(l/J)-109B] (40 mg, 0.14 mmol) was treated
"COOMe in the same manner as compound 96y in the synthesis of
MeOOC H compound 101. Purification on semi preparative TLC plates
[(+)-(1fiM12B]

(3Q % Et0Ac/Pet Sp) gave the tkle compound

[(+).(IR)-
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112B] as an oil (5 mg, 20 % ) and 4-benzyl-2-oxazolidinone (15 mg, 61 % ) . Data for

[(+)-(l/c)-112B]: [a]D23 + 55° (c 0.2, CHC13). The ee of [(+)-(l/c)-112B] wa

determined by chiral GC (at 0.5 uL) at 21.66 mins. Spectral data was i
compound [(+)-(lS)-109B].

Dimethyl cyclopent-3-ene-l,3-dicarboxylate [112A]
Compound 109A (60 mg, 0.18 mmol) was treated in the same
manner as compound 96y in the synthesis of compound 101.
Purification on semi preparative TLC plates (30 % EtOAc/Pet. Sp)

H

COOMe
.

gave 4-benzyl-2-oxazolidinone (26 mg, 81 %) and the title

compound [112A] as an oil (20mg, 61 %). Ratio of enantiomers was 55:4

determined by chiral GC (at 0.3 uL) at 25.52 mins and 26.05 mins resp

NMR (300 MHz, CDC13) 8 2.75 - 2.94 (m 4H, 2x CH2), 3.32 (m, 1H, CH), 3
OCH3), 3.74 (s, 3H, OCH3), 6.69 (t, 7 = 2.4 Hz, 1H, =CH).

13

C NMR (75 MHz, CD

8 35.1 (CH2), 36.7 (CH2), 41.5 (CH), 51.5 (OCH3), 52.0 (OCH3), 134.5 (=C), 141.
(=CH), 164.8 (OO), 175.3 (OO). LRMS: (CI +ve) 185 (M+l). HRMS: (CI +ve)
Calcd. for C9Hi304 (MH+) 185.0814, Found 185.0814.
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7.5 E X P E R I M E N T A L F O R C H A P T E R 5

Ethyl (5/?S, 7S/?)-l,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-8-ene-7carboxylate [113] and Ethyl (5RS, 7flS)-l,3-dibenzyl-2,4-dioxo-l,3diazaspiro[4.4]non-8-ene-7-carboxylate[114]

A solution of the cycloadduct 80 (261 mg, 0.65 mmol) in THF (10 mL) was bubbled

with argon for 10 min. It was then cooled to -78 °C and a solution of potassium
bistrimethylsilyl amide (1.3 mL of a 0.5 M solution in toluene, 0.65 mmol) was

Stirring was continued for 10 min before it was quenched with acetic acid (0.0

0.65 mmol). The mixture was allowed to warm to RT and was then diluted with die
ether (50 mL) and washed with water (2 x 50 mL). The organic extract was dried
(MgS04) and the solvent was removed in vacuo to give a light yellow oil, which
purified by column chromatography (30 % EtO Ac/Pet. Sp) to give 113 and 114 as

in a 1:1 ratio (as determined by integration of their olefinic proton resonanc
NMR of the isolated crude reaction mixture) (260 mg, 99 %).

Data for [113]: *H NMR (300 MHz, CDC13) 8 1.26 (t, 7 = 7.2 Hz, 3H, CH3), 2.37 (d

COOEt

= 6.0, 14.4 Hz, 1H, C ( 6 ) H A H B ) , 2.52

(dd, 7 =

9.0, 14.4 Hz, 1H, C(6)HAHB), 3.79 (ddt, 7 = 2.4,

6.0, 9.0 Hz, 1H, C(7)H), 4.16 (dq, 7 = 2.1, 7.2

"x^

Hz, 2H, OCH2), 4.44 (d, 7 = 15.6 Hz, 1H,
N(l)CHAHBBn), 4.62 (d, 7 = 15.6 Hz, 1H,

N(l)CHAHBBn), 4.71 (s, 2H, N(3)CH 2 Bn), 5.26 (dd, 7 = 2.4, 5.7 Hz, 1H, =CH), 6.10
(dd, 7 = 2.1, 5.7 Hz, 1H, =CH), 7.26 - 7.41 (m, 10H, ArCH). 13C NMR (75 MHz,
CDC13) 8 14.2 (CH3), 33.9 (C(6)H2), 42.8 (NCH2Bn), 43.5 (NCH2Bn), 49.7 (C(7)H),
61.3 (OCH2), 76.4 (Cspiro), 127.4 (ArCH), 127.8 (ArCH), 128.1 (ArCH), 128.4 (ArCH),
128.6 (ArCH), 130.3 (=CH), 135.9 (ArC), 136.9 (=CH), 137.4 (ArC), 155.4 (C(2)=0),

Chapter 7

212

172.3 ( O O ) , 174.3 (C(4)=0). L R M S : (CI +ve) m/z 405 (M+l). H R M S : (CI +ve)
Calcd. for C24H25N204 (MH+) 405.1814, Found 405.1805.

Data for [114]: *H NMR (300 MHz, CDC13) 8 1.24 (t, 7= 7.2 Hz, 3H, CH3), 1.
COOEt = 8-4'
114

14 7 Hz

-

> 1H,
^
r.

C(6)HAHB),

2.64 (dd, 7 =
6.3, 14.7 Hz, 1H, C(6)HAHB), 3.53

0

(ddt, 7 =

^\ 2.7, 6.3,N 8.4 Hz, 1H, C(7)H), 4.14 (q, 7 = 7.2

"xx?

Hz, 2H, OCH 2 ), 4.15 (d, 7 = 15.6 Hz, 1H,

N(l)CHAHBBn), 4.66 (d, 7 = 15.6 Hz, 1H,

N(l)CHAHBBn), 4.73 (s, 2H, N(3)CH2Bn), 5.38 (dd, 7 = 2.7, 5.7 Hz, 1H, =CH),
(dd, 7 = 2.4, 5.7 Hz, 1H, =CH), 7.22 - 7.47 (m, 10H, ArCH).

13

C NMR (75 MHz,

CDC13) 8 14.2 (CH3), 34.5 (C(6)H2), 42.9 (NCH2Bn), 43.9 (NCH2Bn), 50.2 (C(7)H)

61.3 (OCH2), 76.2 (Cspir0), 127.6 (ArCH), 127.8 (ArCH), 127.8 (ArCH), 128.0 (ArCH

128.3 (ArCH), 128.5 (ArCH), 129.0 (=CH), 136.0 (ArC), 137.3 (ArC), 138.2 (=CH),
155.5 (C(2)=0), 171.2 (OO), 173.7 (C(4)=0). LRMS: (CI +ve) m/z 405 (M+l).
HRMS: (CI +ve) Calcd. for C24H25N204 (MH+) 405.1814, Found 405.1805.

l,3-Dibenzyl-l,3-diazaspiro[4.4]non-8-ene-2,4,7-trione [115] and Ethyl 1
dibenzyl-7-hydroxy-2,4-dioxo-l,3-diazaspiro[4.4]non-8-ene-7-carboxylate

To a solution of 80 (130 mg, 0.321 mmol) in THF (5 mL) under a N2 atmosp

°C was added a solution of potassium bistrimethylsilylamide (0.642 mL of

solution in toluene, 0.321 mmol). The reaction turned yellow and was allo

1 hr before it was then quenched with acetic acid (0.018 mL. 0.321 mmol)

warmed to RT. The colourless mixture was then diluted with diethyl ether

washed with water (2 x 20 mL). The organic extract was dried (MgS04), the
removed in vacuo and purified by column chromatography (30 % EtOAc/Pet.

Chapter 7

213

% EtOAc/Pet. Sp) to give compounds 115 (47 mg, 42 % ) and 116 (50 mg, 37 % )

as

colourless oils.
Data for [115]: *H N M R (300 M H z , CDC1 3 ) 8 2.35 (d, 7 = 19.6 Hz, 1H, C H A H B ) , 2.66
(d, 7 = 19.6 Hz, 1H, CHAHB), 4.47 (ABq, 7 =

V7 \ 15-3 Hz, Av = 24.0 Hz, 2H, N(l)CH2Bn), 4.74 (s,
N' y° yy^X, 2H'N(3)CH2Bn), 6.33 (d, 7 = 5.4 Hz, 1H, =CH),
V ~™^y^Xy^
115

69

°^

J

= 5A

Hz

> 1H, =CH), 7.17 - 7.44 (m,

10H, ArCH). 13C NMR (75 MHz, CDC13) 841.0

(C(6)H2), 43.4 (NCH2Bn), 44.2 (NCH2Bn), 70.4 (Cspiro), 128.1 (ArCH), 128.1 (ArCH),
128.3 (ArCH), 128.6 (ArCH), 128.7 (ArCH), 128.9 (ArCH), 135.5 (ArC), 136.4 (ArC),
138.1 (=CH), 155.2 (C(2)=0), 156.7 (=CH), 171.4 (C(4)=0), 202.6 (C(7)=0). LRMS:
(CI +ve) m/z 347 (M+l). HRMS: (CI +ve) Calcd. for C2IH,9N203 (MH+) 347.1396,
Found 347.1396.

Data for [116]: *H NMR (300 MHz, CDC13) 8 1.31 (t, 7 = 7.2 Hz, 3H, CH3), 2.35 (d,
H0
V
f

COOEt

= 15.6 Hz, 1H, C H A H B ) , 2.95

(d, 7 = 15.6

Hz,

/\ 1H, CHAHB), 4.28 (dq, 7 = 2.7, 7.2 Hz, 2H,

N-

*C^O yfiX^ 0CH2)' 4.20 (d, 7 = 15.6 Hz, 1H, BnCHAHB),
4.64 (d, 7 = 15.6 Hz, 1H, BnCHAHs), 4.72 (s,

116 2H, BnCH2), 5.56 (d, 7 = 5.4 Hz, 1H, =CH), 6.10
(d, 7 = 5.4 Hz, 1H, =CH), 7.24 - 7.43 (m, 10H, ArCH).

13

C NMR (75 MHz,

14.2 (CH3), 39.5 (C(6)H2), 43.0 (NCH2Bn), 43.6 (NCH2Bn), 62.5 (OCH2), 75.2

95.1 (C(7)OH), 127.5 (ArCH), 127.9 (ArCH), 128.4 (ArCH), 128.4 (ArCH), 1

(ArCH), 128.6 (ArCH), 135.4 (=CH), 135.8 (ArC), 136.4 (=CH), 137.5 (ArC),

(C(2)=0), 170.4 (OO), 172.8 (C(4)=0). LRMS: (CI +ve) m/z 421 (M+l). HR
+ve) Calcd. for C24H25N205 (MH+) 421.1763, Found 421.1747.
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(5R, 7S)-l,3-Dibenzyl-7-[(lS, 5R, 7/?)-10,10-dimethyl-3,3-dioxo-3-thio-4-aza-

tricyclo[5.2.1.01'5]decane-4-carbonyl]-l,3-diaza-spiro[4.4]non-8-ene-2,4
The same procedure used for the synthesis of
113 and 114 was applied using the following
starting materials; (55)-95x (249 mg, 0.43
mmol), THF (6 mL), KN(TMS)2 (0.86 mL,
0.43 mmol) and acetic acid (0.025 mL, 0.43
mmol). After purification by column
chromatography (30 % EtOAc/Pet. Sp), the

title compound 119 was obtained as a white foam (224 mg, 90 %). *H NMR (

CDC13) 8 0.94 (s, 3H, CH3), 1.30 (s, 3H, CH3), 1.23 - 1.49 (m, 4H, C(CS)H), 1
(m, 3H, C(cs)H), 2.11 (dd, 7 = 5.4, 7.5 Hz, 1H,
C(6)HAHB),

C(6)HAHB),

2.59 (t, 7 = 5.4

3.11 (ABq, 2H, S02CH2), 3.41 (dd, 7= 7.8, 8.1 Hz, 1H, NCH), 4.38

(m, 1H, C(7)H), 4.46 (d, 7= 15.6 Hz, 1H, N(l)CHAHBBn), 4.70 (ABq, 7= 14.4 Hz,
N(3)CH2Bn), 4.81 (d, 7 = 15.6 Hz, 1H, N(l)CHAHBBn), 5.17 (dd, 7 = 2.4, 5.4
=CH), 5.98 (dd, 7= 2.4, 5.4 Hz, 1H, =CH), 7.23 - 7.41 (m, 10H, ArCH).

13

C NMR (7

MHz, CDC13) 8 19.8 (CH3), 20.8 (CH3), 26.4 (C(CS)H2), 32.7 (C(Cs)H2), 33.1 (C(6)H2
38.3 (C(CS)H2), 42.7 (NCH2Bn), 43.1 (NCH2Bn), 44.6 (C(CS)H), 47.7 (C(CS)), 48.5
(Qcs)), 50.9 (C(7)H), 52.9 (S02CH2), 65.2 (NC(Cs)H), 76.6 (Cspir0), 127.2 (ArCH),
(ArCH), 127.9 (ArCH), 128.1 (ArCH), 128.2 (ArCH), 128.3 (ArCH), 131.0 (=CH),

135.9 (ArC), 136.3 (=CH), 137.8 (ArC), 155.3 (C(2)=0), 171.0 (OO), 174.1 (C(4)
LRMS: (ES +ve) m/z 574 (M+l). HRMS: (CI +ve) Calcd. for C32H36N305S (MH+)
574.2376, Found 574.2375.
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(5S, 7fl)-l,3-Dibenzyl-7-[(lS, 5R, 7/?)-10,10-dimethyl-3,3-dioxo-3-thio-4-aza-

tricyclo[5.2.1.01,5]decane-4-carbonyl]-l,3-diaza-spiro[4.4]non-8-ene-2,4-dione[1

and (5S, 7S)-l,3-Dibenzyl-7-[(lS, 5R, 7/f)-10,10-dimethyl-3,3-dioxo-3-thio-4-az

tricyclo[5.2.1.0ls]decane-4-carbonyl]-l,3-diaza-spiro[4.4]non-8-ene-2,4-dione[12
The same procedure used for the synthesis of 113 and 114 was applied using the

following starting materials; (5R)-95x (200 mg, 0.35 mmol), THF (6 mL), KN(TMS)2

(0.70 mL, 0.35 mmol) and acetic acid (0.02 mL, 0.35 mmol). After purification by

column chromatography (30 % EtOAc/Pet. Sp), the title compounds 120 and 121 were

obtained as colourless oils in a ratio of 2:3 respectively (as determined by in

their olefinic proton resonances in the *H NMR spectrum of the isolated crude r
mixture) (188 mg, 94%).
Data for [120]: *H NMR (300 MHz, CDC13) 8 0.96 (s, 3H, CH3), 1.13 (s, 3H, CH3),
1.28-1.41 (m, 4H, C(CS)H), 1.79 - 1.95 (m,
3H, QcsjH), 2.07 (dd, 7 = 5.4, 14.7 Hz, 1H,
C(6)HAHB), 2.76 (dd, 7 = 9.3, 14.7 Hz, 1H,
C(6)HAHB), 3.44 (ABq, 7 = 13.8 Hz, 2H,

S02CH2), 3.84 (dd, 7 = 5.7, 6.6 Hz, 1H,
NCH), 4.35 - 4.41 (m, 1H, C(7)H), 4.47 (d, 7
= 15.6 Hz, 1H, N(l)CHAHBBn), 4.60 (d, 7 =
15.6 Hz, 1H, N(l)CHAMBBn), 4.69 (s, 2H, N(3)CH2Bn), 5.34 (dd, 7 = 2.1, 5.4 Hz, 1H,
=CH), 6.14 (dd, 7 = 2.1, 5.4 Hz, 1H, =CH), 7.21 - 7.41 (m, 10H, ArCH). 13C NMR (75
MHz, CDC13) 8 19.8 (CH3), 20.6 (CH3), 26.8 (C(Cs)H2), 32.3 (C(CS)H2), 35.5 (C(6)H2),
38.2 (C(CS)H2), 43.1 (NCH2Bn), 43.8 (NCH2Bn), 44.5 (C(CS)H), 47.7 (C(CS)), 48.5
(Qcs)), 49.5 (C(7)H), 53.1 (S02CH2), 65.2 (NC(CS)H), 75.6 (Cspir0), 127.6 (ArCH), 127.7
(ArCH), 128.3 (ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.6 (ArCH), 131.4 (=CH),
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135.3 (ArC), 137.6 (ArC), 137.9 (=CH), 155.6 (C(2)=0), 172.4 ( O O ) , 174.0 (C(4)=0).
LRMS: (ES +ve) m/z 574 (M+l). HRMS: (CI +ve) Calcd. for C32H36N305S (MH+)
574.2376, Found 574.2357.

Data for [121]: *H NMR (300 MHz, CDC13) 8 0.94 (s, 3H, CH3), 1.11 (s, 3H,
1.12 - 1.39 (m, 4H, C(CS)H), 1.73 - 1.93
(m, 3H, C(cS)H), 1.82 (dd, 7= 7.5, 14.7 Hz,
1H, C(6)HAHB), 2.86 (dd, 7 = 6.6, 14.7 Hz,
1H, C(6)HAHB), 3.45 (ABq, 7 = 13.8 Hz,

2H, S02CH2), 3.81 (t, J = 6.3 Hz, 1H,
NCH), 4.14 (d, 7 = 15.6 Hz, 1H,

N(l)CHAHBBn), 4.16 - 4.22 (m, 1H, C(7)H), 4.59 (d, / = 15.6 Hz, 1H, N(l)CHAH

4.69 (s, 2H, N(3)CH2Bn), 5.34 (dd, 7= 2.7, 5.4 Hz, 1H, =CH), 6.16 (dd, 7= 2.
1H, =CH), 7.18 - 7.40 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 19.9 (CH3), 20.

(CH3), 26.4 (C(CS)H2), 32.7 (C(Cs)H2), 33.7 (C(6)H2), 38.2 (C(Cs)H2), 42.8 (NCH2Bn)

43.8 (NCH2Bn), 44.5 (C(CS)H), 47.8 (C(CS)), 48.5 (C(CS)), 51.5 (C(7)H), 53.0 (S02CH
65.4 (NC(cs)H), 76.1 (Cspiro), 127.6 (ArCH), 127.7 (ArCH), 128.3 (ArCH), 128.4

(ArCH), 128.5 (ArCH), 128.6 (ArCH), 129.4 (=CH), 136.0 (ArC), 137.8 (ArC), 138
(=CH), 155.3 (C(2)=0), 169.2 (OO), 173.5 (C(4)=0). LRMS: (ES +ve) m/z 514

(M+l). HRMS: (CI +ve) Calcd. for C32H36N305S (MH+) 574.2376, Found 574.2375

Ethyl (5SR, IRS, 8S#)-l,3-dibenzyI-7,8-dihydroxy-2,4-dioxo-l,3-diazaspir

nonane-7-carboxylate [122] and Ethyl (5SR, ISR, 8/?S)-l,3-dibenzyl-7,8-d
2,4-dioxo-l,3-diazaspiro[4.4] nonane-7-carboxyIate [123]

Compound 80 (150 mg, 0.37 mmol) was dihydroxylated in the same manner as
the synthesis of 126. After stirring for 15 h at R T and purification by column
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chromatography (50 % EtOAc/Pet. Sp) the title compounds 122 and its diastereoisomer,

compound 123, were separated as colourless oils (70 mg each, total yi

Data for [122]: XH NMR (300 MHz, CDC13) 8 1.30 (t, 7 = 7.2 Hz, 3H, CH3),

HO

OH
•COOEt

= 8.1, 14.7 Hz, 1H, C ( 9 ) H A H B ) , 2.18 (d, 7=

15.6

Hz, 1H, C(6)HAHB), 2.22 (dd, 7 = 6.9, 14.7 Hz,
C(6)HAHB), 2.61 (d, 7 = 15.6 Hz, 1H,
C(6)HAHB), 3.57 (d, 7= 11.1 Hz, 1H, OH), 4.24

(q, 7 = 7.2 Hz, 2H, OCH2), 4.35 (s, 1H, OH),

4.56 (d, 7 = 15.9 Hz, 1H, N(l)CHAHBBn), 4.71 (s, 2H, N(3)CH2Bn), 4.72 (d
Hz, N(l)CHAHBBn), 7.26 - 7.41 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 14

(CH3), 40.0 (C(9)H2), 42.9 (N(3)CH2Bn), 43.1 (C(6)H2), 43.5 (N(l)CH2Bn), 62.

(OCH2), 68.1 (Cspiro), 76.8 (C(7)OH), 81.1 (C(8)HOH), 127.5 (ArCH), 127.9 (Ar
128.1 (ArCH), 128.4 (ArCH), 128.7 (ArCH), 128.8 (ArCH), 135.4 (ArC), 137.0

155.2 (C(2)=0), 172.7 (OO), 177.6 (C(4)=0). LRMS: (CI +ve) m/z 439 (M+l).
HRMS: (CI +ve) Calcd. for C24H26N206 (M+) 438.1790, Found 438.1794.

Data for [123]: *H NMR (300 MHz, CDC13) 8 1.28 (t, 7 = 7.2 Hz, 3H, CH3)

HO

OH
!.-> COOEt

= 11.1, 13.2 Hz, 1H, C ( 9 ) H A H B ) , 2.07 (d, 7 =
15.6 Hz, 1H, C(6)HAHB), 2.11 (dd, 7= 7.2, 13.2

f

0

Hz, 1H, C(9)HAHB), 2.61 (d, 7 = 9.3 Hz, 1H,

f^l
OH), 2.66 (d, 7 = 15.6 Hz, 1H, C(6)HAHB), 3.88

123

(d, 7 = 1.2 Hz, 1H, OH), 4.23 (q, 7 = 7.

OCH 2 ), 4.53 - 4.62 (m, 1H, C(8)H), 4.64 (ABq, 7 = 15.6 Hz, Av = 21.9 Hz, 2H,
N(l)CH2Bn), 4.68 (s, 2H, N(3)CH2Bn), 7.20 - 7.41 (m, 10H, ArCH).

13

C NMR (75

MHz, CDC13) 8 13.9 (CH3), 38.5 (C(9)H2), 42.0 (NCH2Bn), 42.3 (NCH2Bn), 42.9

(C(6)H2), 62.1 (OCH2), 66.1 (Cspiro), 74.9 (C(8)HOH), 80.2 (C(7)OH), 127.0 (Ar
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127.3 (ArCH), 127.5 (ArCH), 127.9 (ArCH), 128.2 (ArCH), 128.3 (ArCH), 135.6

(ArC), 137.6 (ArC), 155.4 (C(2)=0), 172.7 (OO), 176.4 (C(4)=0). LRMS: (CI +v
m/z 439 (M+l). HRMS: (CI +ve) Calcd. for C24H26N206 (M+) 438.1790, Found
438.1794.

Ethyl (SSR, IRS, 8S/c)-l,3-dibenzyl-7,8-isopropylidenedioxy-2,4-dioxo-l,3diazaspiro[4.4] nonane-7-carboxylate [124]
Compound 122 (125 mg, 0.285 mmol) was

O

treated in the same manner as compound 126 in

O
COOEt

the synthesis of 129. After purification b
K\" ''<y® yX^\
^

column chromatography (20 % EtO Ac/Pet. Sp to

"N 30 % EtOAc/Pet. Sp) the title compound 124

124

was obtained as a clear oil (109 mg, 80 % ) . *H

N M R (300 M H z , CDC13) 8 1.31 (t, 7 = 7.2 Hz, 3H, OCHaCHj), 1.33 (s, 3H, CCH 3 ),
1.68 (s, CCH3), 2.21 (dd, 7 = 6.3, 15.3 Hz, 1H,
1H,

C(9)HAMB),

C(9)HAHB),

2.35 (dd, 7 = 3.3

2.58 (ABq, 7 = 15.9 Hz, 2H, C(6)H2), 4.27 (m, 2H, OCH2), 4.52

15.9 Hz, 1H, N(l)CHAHBBn), 4.70 (s, 2H, N(3)CH2Bn), 4.81 (d, 7 = 15.9 Hz,
N(l)CHAHBBn), 4.83 (dd, 7 = 3.3, 6.3 Hz, C(8)H), 7.23 - 7.42 (m, 10H, ArCH).

1

NMR (75 MHz, CDC13) 8 14.2 (OCH2CH3), 25.7 (CH3), 27.2 (CH3), 40.4 (C(9)H2),
42.7 (N(3)CH2), 42.8 (N(1)CH2), 45.6 (C(6)H2), 62.1 (OCH2), 72.0 (Cspir0), 84.9

(C(8)HO), 90.6 (C(7)0), 114.0 (OCO), 127.1 (ArCH), 127.5 (ArCH), 127.7 (ArCH)
128.3 (ArCH), 128.5 (ArCH), 128.6 (ArCH), 135.9 (ArC), 137.5 (ArC), 155.5
(C(2)=0), 173.0 (OO), 174.7 (C(4)=0). LRMS: (CI +ve) m/z 479 (M+l). HRMS: (CI
+ve) Calcd. for C27H3oN206 (M+) 478.2104, Found 478.2091.
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Ethyl (5SR, 7SR, 8/?5)-l,3-dibenzyl-7,8-isopropylidenedioxy-2,4-dioxo-l,3diazaspiro[4.4] nonane-7-carboxylate [125]
Compound 123 (45 mg, 0.103 mmol) was treated
in the same manner as compound 126 in the

Q

o

synthesis of 129.
After purification by column
!.»COOEt
chromatography (20 % EtOAc/Pet. Sp to 30 %

rXyO

w

^

'Y

EtOAc/Pet. Sp) the title compound 125 was
^

obtained as a clear oil (42 mg, 86 %). *H NMR

125
(300 MHz, CDC13) 8 1.29 (t, 7 = 7.2 Hz, 3H,
O C H 2 C H 0 , 1.36 (s, 3H, CH 3 ), 1.49 (s, 3H, CH 3 ), 2.18 (dd, 7 = 3.3, 15.3 Hz, 1H,
C(9)HAHB), 2.28 (d, 7 = 15.0 Hz, 1H, C(6)HAHB), 2.43 (dd, 7 = 6.6, 15.3 Hz, 1H,
C(9)HAHB),

2.67 (d, 7 = 15.0 Hz, 1H,

C(6)HAHB),

4.26 (dq, 7 = 3.0, 7.2 Hz, 2H

4.65 (s, 2H, N(3)CH2Bn), 4.67 (ABq, 7 = 15.6 Hz, Av = 15.6 Hz, 2H, N(l)CH2Bn
(dd, 7 = 3.3, 6.6 Hz, 1H, C(8)H), 7.23 - 7.39 (m, 10H, ArCH).

13

C NMR (75 MHz,

CDC13) 8 14.1 (OCH2CH3), 25.5 (CH3), 27.8 (CH3), 38.9 (C(9)H2), 42.6 (N(3)CH2B
43.0 (N(l)CH2Bn), 43.7 (C(6)H2), 61.9 (OCH2), 71.6 (Cspiro), 83.1 (C(8)H), 89.9

(C(7)0), 114.1 (OCO), 127.4 (ArCH), 127.5 (ArCH), 127.8 (ArCH), 128.3 (ArCH),

128.6 (ArCH), 128.6 (ArCH), 135.8 (ArC), 136.9 (ArC), 155.4 (C(2)=0), 170.2 (
174.5 (C(4)=0). LRMS: (CI +ve) m/z 479 (M+l). HRMS: (CI +ve) Calcd. for
C27H30N2O6 (M+) 478.2104, Found 478.2091.
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Ethyl (5RS, 7SR, SSR, 9#S)-l,3-dibenzyl-8,9-dihydroxy-2,4-dioxo-l,3diazaspiro[4.4]nonane-7-carboxylate[126]
.COOEt

To a solut

ion of 113 (760 mg, 1.88 mmol) in

acetone/H20 (4:1, 7 mL) was added /Y-methyl
''''f® X^X morPholine
y^XX

and

oxide

(NMO) (440 mg, 3.76 mmol)

potassium osmate dihydrate (K20s04.2H20)

O
126

^

69 mg

' °-

188

n™01)- The reaction was stirred

for 5 d before it was filtered through celite and the filtrate concentrated i

resulting residue was purified by column chromatography (50 % EtO Ac/Pet. Sp)

the title compound 126 as an oil (610 mg, 74 %). *H NMR (300 MHz, CDC13) 8 1.
7 = 7.2 Hz, 3H, CH3), 2.14 (dd, 7 = 8.1, 14.1, 1H, C(6)HAHB), 2.40 (dd, 7 = 12.3, 14.1
Hz, 1H, C(6)HAHB), 2.71 (dd, 7= 9.6 Hz, 1H, OH), 2.98 (ddd, 7= 3.6, 8.1, 12.3 Hz, 1H,

C(7)H), 3.52 (d, 7= 2.1 Hz, 1H, OH), 4.15 (q, 7= 7.2 Hz, 2H, OCH2), 4.23 (dd, 7= 3.9,
9.6 Hz, 1H, C(9)H), 4.44 (dt, 2.4, 3.9 Hz, 1H, C(8)H), 4.65 (d, 7 = 16.2 Hz, 1H,
N(l)CHAHBBn), 4.69 (s, 2H, N(3)CH2Bn), 4.88 (d, 7 = 16.2 Hz, 1H, N(l)CHAHBBn),
7.22 - 7.39 (m, 10H, ArCH). 13C NMR (75 MHz, CDC13) 8 14.2 (CH3), 32.3 (C(6)H2),
42.7 (N(3)CH2Bn), 44.0 (C(7)H), 44.9 (N(l)CH2Bn), 61.4 (OCH2), 70.8 (Cspir0), 72.6
(C(9)HOH), 78.6 (C(8)HOH), 127.3 (ArCH), 127.4 (ArCH), 127.8 (ArCH), 128.0
(ArCH), 128.5 (ArCH), 128.6 (ArCH), 135.8 (ArC), 138.0 (ArC), 156.7 (C(2)=0),
171.9 (OO), 176.5 (C(4)=0). LRMS: (CI +ve) m/z 439 (M+l). HRMS: (CI +ve)
Calcd. for C24H26N206 (M+) 438.1790, Found 438.1783.
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Ethyl (SRS, 7RS, SRS, 9Sfl)-l,3-dibenzyl-8,9-dihydroxy-2,4-dioxo-l,3diazaspiro[4.4]nonane-7-carboxylate [127]

COOEt

Compound

114 (lOOmg, 0.25 mmol) was

dihydroxylated in the same manner as 113 in the
synthesis of 126. After stirring for 3 d at RT and
purification by column chromatography (50 %
EtOAc/Pet. Sp127
to 60 % EtOAc/Pet. Sp), the title

compound 127 was isolated as a white solid (66 mg, 60 %), mp 174 - 177

(300 MHz, CDC13) 8 1.26 (t, 7 = 7.2 Hz, 3H, CH3), 1.87 (dd, 7 = 9.6, 1
C(6)HAHB), 2.69 (d, 7 = 9.0 Hz, 1H, OH), 2.76 (dd, 7 = 10.8, 15.0 Hz, C(6)HAHB), 2.93

(Apparent dt, 7 = 3.9, 10.2 Hz, 1H, C(7)H), 4.15 (d, 7 = 3.9 Hz, 1H, OH)
7.2 Hz, OCH2), 4.22 (dd, 7 = 3.9, 11.4 Hz, 1H, C(8)H), 4.55 (d, 7 = 16.2 Hz,
N(l)CHAHBBn), 4.61 (d, 7 = 11.4 Hz, 1H, C(9)H), 4.69 (d, 7 = 16.2 Hz,
Bn), 4.74 (s, 2H, N(3)CH2Bn), 7.27 - 7.40 (m, 10H, ArCH).

13

N(

C NMR (75 MHz,

CDC13) 814.1 (CH3), 30.2 (CH2), 43.0 (BnCH2), 43.5 (BnCH2), 46.1 (CH), 61.3

(OCH2), 74.0 (CHOH), 74.3 (Cspir0), 75.3 (CHOH), 127.2 (ArCH), 128.0 (ArCH), 12
(ArCH), 128.2 (ArCH), 128.7 (ArCH), 129.1 (ArCH), 135.3 (ArC), 136.5 (ArC),

(C(2)=0), 170.0 (COOEt), 176.1 (C(4)=0). LRMS: (CI +ve) m/z 439 (M+l). HRM
(CI +ve) Calcd. for C24H26N206 (M+) 438.1790, Found 438.1783.
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(5R, IS, SS, 9fl)-l,3-Dibenzyl-8,9-dihydroxy-7-[(lS, SR, 7/?)-10,10-dimethyl-3,3dioxo-3-thio-4-aza-tricyclo[5.2.1.01'5]decane-4-carbonyl]-l,3-diaza-spiro[4.4]non-8ene-2,4-dione [128]
Compound 119 (125 mg, 0.22 mmol) was
dihydroxylated in the same manner as 113 in
the synthesis of 126. After stirring for 3 d at
RT

and

purification

by

column

chromatography (50 % EtOAc/Pet. Sp to 60
% EtOAc/Pet. Sp), the starting material (58
mg 46 %) was recovered and the title
compound 128 was isolated as an oil (50 mg, 37 % ) . [a]D26 -8.7° (c 1.3, CHC13). *H
N M R (300 M H z , CDC13) 8 0.95 (s, 3H, CH 3 ), 1.14 (s, 3H, CH 3 ), 1.33-1.41 (m, 2H,
C A ( CS)HAHB and

C B (CS)HAH B ), 1.80

-

1.98

(m, 4H,

C A( CS)HAHB, C B ( CS)HAHB

and

CC(cs)H2), 2.02 - 2.08 (m, 1H, C(CS)H), 2.10 (dd, 7 = 7.8, 14.1 Hz, 1H, C ( 6 ) H A H B ) , 2.73
(dd, 7 =

10.5, 14.1 Hz, 1H, C(6)HAMB), 3.10 (br d, 7 = 8.4 Hz, 1H, OH), 3.28 (br s, 1H,

OH), 3.46 (ABq, 7 = 13.8 Hz, Av = 25.5 Hz, 2H, S0 2 CH 2 ), 3.65 (ddd, 7 = 5.1, 7.8, 10.5
Hz, 1H, C(7)H), 3.86 (dd, 5.1, 7.5 Hz, 1H, NCH), 4.22 (dd, 7 = 3.9, 7.8 Hz, 1H,
C(9)HOH), 4.64 - 4.66 (hidden, 1H, C(8)HOH), 4.66 (s, 2H, N(3)CH2Bn), 4.77 (ABq, 7
= 16.2 Hz, A v = 39.3 Hz, 2H, N(l)CH2Bn), 7.23 - 7.42 (m, 10H, ArCH).13 C N M R (75
M H z , CDC13) 8 19.9 (CH3), 20.7 (CH3), 26.5 (C(CS)H2), 31.6 (C(CS)H2), 32.7 (C(6)H2),
38.3 ((C(CS)H2), 42.6 (N(3)CH2Bn), 44.6 (C(CS)H), 44.7 (C(7)H), 45.2 (N(l)CH2Bn),
47.8 (Qcs)), 48.5 (C(CS)), 53.0 (S02CH2), 65.3 (NC(CS)H), 71.0 (Cspir0), 73.3 (CHOH),
78.4 (CHOH), 127.2 (ArCH), 127.4 (ArCH), 127.7 (ArCH), 128.1 (ArCH), 128.4
(ArCH), 128.6 (ArCH), 135.8 (ArC), 138.0 (ArC), 156.7 (C(2)=0), 170.1 ( O O ) , 175.8
(C(4)=0). L R M S : (CI +ve) m/z 608 (M+l).
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Ethyl (SRS, 7SR, 8SR, 9/?S)-l,3-dibenzyl-8,9-isopropylidenedioxy-2,4-dioxo-l,3diazaspiro[4.4]nonane-7-carboxylate[129]

COOEt

To a stirred solution of the diol 126 (400 mg,

0.91 mmol) in CH2C12 (10 mL) and 2,2dimethoxypropane (10 mL) was added p-toluene
sulphonic acid.monohydrate (/?TsOH.H20) (18
mg, 0.091 mmol).
129 After 8 h at RT, all volatiles
were removed in vacuo and the remaining residue was purified by column

chromatography (20 % EtOAc/Pet. Sp to 30 % EtOAc/Pet. Sp) to give the t

compound 129 as a colourless oil (410 mg, 94 %). *H NMR (300 MHz, CDC13

(t, 7 = 7.2 Hz, 1.25 (s, 3H, CH3), 1.49 (s, 3H, CH3), 1.60 (dd, 7 = 6.9,
C(6)CHAHB), 2.62 (t, 7 = 13.2 Hz, 1H, C(6)HAHB), 3.60 (ddd, 7 = 6.6, 6.9, 13.2 Hz, 1H,

C(7)H), 4.12 (dq, 7 = 2.7, 7.2 Hz, 2H, OCH2), 4.44 (d, 7=5.1 Hz, 1H, C(9)H), 4.

2H, N(3)CH2Bn), 4.66 (d, 7 = 15.6 Hz, 1H, N(l)CHAHBBn), 4.96 (d, 7 = 15.6 H

N(l)CHAHBBn), 4.97 (dd, 7 = 5.1, 6.0 Hz, 1H, C(8)H), 7.22 - 7.39 (m, 10H, Ar
13

C NMR (75 MHz, CDC13) 8 14.2 (OCH2CH3), 24.1 (CCH3), 25.8 (CCH3), 30.1 (CH-

2), 42.5 (N(3)CH2Bn) 44.5 (CH), 45.3 (N(l)CH2Bn), 60.7 (OCH2), 69.5 (Cspiro), 80

(CspiroCHO), 82.6 (CHO), 112.0 (OCO), 127.2 (ArCH), 127.4 (ArCH), 127.8 (ArCH),
128.3 (ArCH), 128.4 (ArCH), 128.6 (ArCH), 135.7 (ArC), 137.9 (ArC), 155.8

(C(4)=0), 169.8 (OO), 174.0 (C(2)=0). LRMS: (CI +ve) m/z 479 (M+l). HRMS: (
+ve) Calcd. for C27H3oN206 (M+) 478.2104, Found 478.2091.
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Methyl (SRS, 7SR, SSR, 9/?S)-l,3-dibenzyl-8,9-isopropylidenedioxy-2,4-dioxo-l,3diazaspiro[4.4]nonane-7-carboxylate[130]
Compound 128 (50 mg, 0.082 mmol) was

.COOMe
treated in the same manner as compound 126 in
the synthesis of 129. After purification by
column chromatography (30 % EtOAc/Pet. Sp)
the title compound 130 was obtained as a
colourless oil (28 mg, 53 %). [a]D23 + 35 ° (c

0.4, CHC13). *H NMR (300 MHz, CDC13) 8 1.26 (s, 3H, CH3), 1.50 (s, 3H, CH3),
(dd, 7 = 7.2, 13.2 Hz, 1H, C(6)HAHB), 2.62 (t, 7 = 13.2 Hz, 1H, C(6)HAMB), 3.63 (ddd, 7

= 6.0, 7.2, 13.2 Hz, 1H, C(7)H), 3.68 (s, 3H, OCH3), 4.45 (d, 7 = 5.1 Hz, 1H, C
4.67 (s, 2H, N(3)CH2Bn), 4.68 (d, 7 = 15.9 Hz, 1H, N(l)CHAHBBn), 4.96 (d, 7

Hz, 1H, N(l)CHAHBBn), 4.98 (dd, 7 = 5.1, 6.0 Hz, 1H, C(8)HO), 7.22 - 7.39 (
ArCH).

13

C NMR (75 MHz, CDC13) 8 24.4 (CH3), 26.1 (CH3), 30.4 (C(6)H2), 42.9

(N(3)CH2Bn), 44.8 (C(7)H), 45.7 (N(l)CH2Bn), 52.3 (OCH3), 69.8 (Cspir0), 80.4
(C(8)HOH), 83.0 (C(9)HOH), 112.4 (OCO), 127.6 (ArCH), 127.7 (ArCH), 128.2

(ArCH), 128.6 (ArCH), 128.8 (ArCH), 129.0 (ArCH), 136.0 (ArC), 138.1 (ArC), 15

(C(2)=0), 170.7 (OO), 174.3 (C(4)=0). LRMS: (CI +ve) m/z 465 (M+l). HRMS: (C
+ve) Calcd. for C26H28N206 (M+) 464.1947, Found 464.1924.

(5RS, 6SR, 7RS, 8Sfl)-l,3-Dibenzyl-6,7-dihydroxy-8-(hydroxymethyl)-l,3-

diazaspiro[4.4]nonane-2,4-dione [131] and (5RS, 6RS, 7SR, 8Sfl)-l,3-Dibe
dihydroxy-8-(hydroxymethyl)-l,3-diazaspiro[4.4]nonane-2,4-dione[132]

Compound 156 (245 mg, 0.677 mmol) was dihydroxylated in the same manner
in the synthesis of 126. After stirring for 5 d at RT and purification
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chromatography (70 % EtOAc/Pet. Sp to 90 % EtOAc/Pet. Sp), the starting material 156

was recovered (40 mg, 16 %) and compound 131 (55 mg, 21 %) and its diepi
compound 132 (74 mg, 28 %) were isolated as oils.
Data for [131]: *H NMR (300 MHz, CDC13) 8 1.79 (dd, 7 = 9.9, 15.0 Hz, 1H,

,—OH

HO,

C ( 9 ) H A H B ) , 1.94
C(9)HAHB),

HO"-.0

N

' "''f^ (f^l

(dd, 7 = 10.8, 15.0 Hz,

1H,

2.22 (m, 1H, C(8)H), 2.51 (br s, 1H

0H) 2Al

'

(br s' 1H » O H ) ' 3-60 (dd> J = 4-8, H.l

Hz, 1H, C H A H B O H ) , 3.76 (dd, 7 = 8.4, 11.1 Hz,

131 1H, CHAHBOH), 4.03 (m, 1H, CHOH), 4.15 (br s,
1H, OH), 4.53 (d, 7 = 16.2 Hz, 1H, N(l)CHAHBBn), 4.67 (d, 7 = 16.2 Hz, 1H,
N(l)CHAHBBn), 4.68 (hidden, 1H, CHOH), 4.71 (s, 2H, N(3)CH2Bn), 7.23 -7.38
10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 31.2 (CH2), 42.3 (CH), 43.0 (NCH2Bn),

43.6 (NCH2Bn), 61.5 (CH2OH), 73.8 (CHOH), 74.6 (Cspiro), 75.5 (CHOH), 127.1

(ArCH), 127.8 (ArCH), 127.9 (ArCH), 128.0 (ArCH), 128.6 (ArCH), 128.9 (ArCH),

135.3 (ArC), 136.6 (ArCH), 155.6 (C(2)=0), 176.6 (C(4)=0). LRMS: (CI +ve) m/
(M+l). HRMS: (CI +ve) Calcd. for C22H25N205 (MH+) 397.1763, Found 397.1765.

Data for [132]: *H NMR (300 MHz, CDC13) 8 1.61 (dd, 7 = 7.2, 14.7 Hz, 1H,

•OH

C(9)HAH B ), 1.97
C(9)HAHB),

N-

% ^ ° r ^ ^

(dd, 7 = 9.6,

14.7 Hz,

1H,

2.17 (m, 1H, C(8)H), 2.45 (br s,

1H, OH), 3.14 (br s, 1H, OH), 3.43 - 3.57 (m,

t\Xyy 2H, QLOH), 3.78 (br s, 1H, OH), 4.07 - 4.18
132 (m, 1H, CHOH), 4.54 - 4.60 (m, 1H, CHOH),
4.64 (s, N(3)CH2Bn), 4.71 (d, 7 = 16.5 Hz, 1H, N(l)CHAHBBn), 4.98 (d,
1H, N(l)CHAHBBn), 7.18 - 7.38 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13)

(C(9)H2), 42.7 (NCH2Bn), 45.2 (NCH2Bn), 45.3 (C(8)H), 63.7 (CH2OH), 71.9
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74.4 ( C H O H ) , 78.3 ( C H O H ) , 127.1 (ArCH), 127.2 (ArCH), 127.8 (ArCH), 127.9
(ArCH), 128.5 (ArCH), 128.6 (ArCH), 135.7 (ArC), 138.1 (ArC), 156.5 (C(2)=0),
176.3 (C(4)=0). LRMS: (CI +ve) m/z 397 (M+l). HRMS: (CI +ve) Calcd. for
C22H25N205 (MH+) 397.1763, Found 397.1765.

(SRS, 6SR, 7RS, 8flS)-l,3-Dibenzyl-6,7-dihydroxy-8-(hydroxymethyl)-l,3-

diazaspiro[4.4]nonane-2,4-dione [133] and its diepimer (5RS, 6RS, 7SR, SRS)-l,3
Dibenzyl-6,7-dihydroxy-8-(hydroxymethyl)-l,3-diazaspiro[4.4]nonane-2,4-dione
[134]
Compound 142 (670 mg, 1.85 mmol) was
dihydroxylated in the same manner as 113 in the
synthesis of 126. After stirring for 3 d at RT, the
reaction produced a mixture of cis diols as foams,
133 and 134 which could not be readily separated by column
chromatography (460 mg, 63 %) and therefore could not be analysed by NMR. LRMS:
(CI +ve) m/z 397 (M+l). HRMS: (CI +ve) Calcd. for C22H25N205 (MH+) 397.1763,
Found 397.1765.

(SRS, 6SR, 7RS, 8/?S)-8-(Hydroxymethyl)-6,7-isopropylidenedioxy-l,3-dimethyll,3-diazaspiro[4.4]nonane-2,4-dione [135] and (5RS, 6RS, 7SR, 8/?S)-8-

(Hydroxymethyl)-6,7-isopropylidenedioxy-l,3-dimethyl-l,3-diazaspiro[4.4]nonane2,4-dione [136]

The triol mixture of 133 and 134 (460 mg, 1.16 mmol) was treated in the same man

as compound 126 in the synthesis of 127. After purification by column chromatog
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(30 % EtOAc/Pet. Sp to 50 % EtOAc/Pet. Sp) compound 135 (155 mg, 31 % ) and its
diepimer, compound 136 (233 mg, 46 %), were isolated as clear oils.

Data for [135]: *H NMR (300 MHz, CDC13) 8 1.19 (s, 3H, CH3), 1.38 (s, 3H, CH
1.86 (dd, 7 = 8.1, 13.5 Hz, 1H, CHAHB), 1.89 (t,
7 = 13.5 Hz, 1H, CHAHB), 3.01 (m, 1H, CH),
Nr

"xx?
135 =

f

^ \

3

- 5 3 (dd> J = 5-4, 10.8 Hz, 1H, C H A H B O H ) , 3.69

(dd, 7 = 4.8, 10.8 Hz, 1H, C H A H B O H ) , 4.43 (d, 7

O

16 5 Hz

-

"f

>

1H

> N(l)BnCHAHB), 4.51 (dd, 7 =

5.4, 8.1 Hz, 1H, C(7)HO), 4.63 (d, 7 = 8.1 Hz, 1H, C(6)HO), 4.67 (d, 7 = 14.7

N(3)BnCHAHB), 4.73 (d, 7 = 16.5 Hz, 1H, N(l)BnCHAHB), 4.76 (d, 7 = 14.7 Hz,
N(3)BnCHAHB), 7.22 - 7.42 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 24.7

(CH3), 25.4 (CH3), 34.2 (CH2), 42.3 (BnCH2), 42.9 (BnCH2), 44.6 (CH), 62.8 (CH2OH
72.3 (Cspiro), 80.3 (C(7)HO), 82.2 (C(6)HO), 115.5 (OCO), 127.0 (ArCH), 127.6
(ArCH), 127.6 (ArCH), 128.1 (ArCH), 128.4 (ArCH), 128.8 (ArCH), 136.1 (ArC),
137.2 (ArC), 156.1 (C(2)=0), 172.2 (C(4)=0). LRMS: (CI +ve) m/z 431 (M+l).
HRMS: (CI +ve) m/z Calc. C25H29N205 437.2076, found 437.2074.

Data for [136]: *H NMR (300 MHz, CDC13) 1.29 (s, 3H, CH3), 1.51 (dd, 7 = 6
Hz, 1H, CH2), 1.55 (s, 3H, CH3), 2.15 (t, 7 =
12.9 Hz, 1H, CH2), 2.82 (m, 1H, CH), 3.61
HSXyO

y^ (dd, 7 = 6.6, 11.7 Hz, 1H,

CHAHBOH),

3.77

N. JL II (dd, 7 = 4.2, 11.7 Hz, 1H, CHAHBOH), 4.48 (d,

n

v

7 = 5.4 Hz, 1H, C(6)HO), 4.66 (d, 7 = 16.2 Hz,
136
1H, N(l)BnCHAHB), 4.67 (s, 2H, N(3)BnCH2), 4.84 (t, 7 = 5.4 Hz, 1H, C(7)HO), 4.98
(d, 7= 16.2 Hz, 1H, N(l)BnCHAHB), 7.22 - 7.42 (m, 10H, ArCH).

13

C NMR (75 MHz

CDC13) 8 23.4 (CH3), 25.7 (CH3), 30.7 (CH2), 39.6 (CH), 42.4 (N(3)BnCH2), 45.3
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(N(l)BnCH2), 61.5 (CH 2 OH), 69.7 (Cspiro), 81.7 (C(7)H0), 83.4 (C(6)H0), 111.5
(OCO), 127.1 (ArCH), 127.2 (ArCH), 127.9 (ArCH), 128.4 (ArCH), 128.5 (ArCH),

128.7 (ArCH), 135.9 (ArC), 138.0 (ArC), 156.1 (C(2)=0), 174.5 (C(4)=0). LRMS
+ve) m/z 437 (M+l). HRMS: (CI +ve) m/z Calc. C25H29N205 437.2076, found
437.2074.

[(SRS, 7RS, SRS, 9S/c)-l,3-Dibenzyl-8,9-isopropylidenedioxy-2,4-dioxo-l,3diazaspiro[4.4]non-7-yl]methyl acetate [137]
OAc Compound 135 (70 mg 0.161 mmol) was treated
)-. / \ in the same manner as compound 136 in the
N '''fz-O (X^X preparation of 138. After purification by column
^
chromatography
(20 % EtOAc/Pet. Sp to 30 %

EtOAc/Pet. Sp) the title compound 137 was
isolated as a clear oil (73 mg, 95 % ) . *H N M R (300 M H z , CDC13) 8 1.19 (s, 3H, CH3),
1.38 (s, 3H, CH3), 1.78 (t, 7 = 13.2 Hz, 1H, CHAHB), 1.88 (dd, 7 = 7.2, 13.2 Hz, 1H,
CHAHB),

2.02 (s, 3H, CH3), 3.16 (m, 1H, CH), 4.05 (apparent d, 7 = 5.1 Hz,

2OAc),

4.40 (dd, 7 = 5.7, 8.1 Hz, 1H, C(7)HO), 4.43 (d, 7 = 16.2 Hz, 1H,

N(l)BnCHAHB), 4.63 (d, 7 = 8.1 Hz, 1H, C(6)HO), 4.72 (ABq, 7 = 14.7 Hz, 2H,

N(3)BnCH2), 4.78 (d, 7 = 16.2 Hz, 1H, N(l)BnCHAHB), 7.21 - 7.42 (m, 10H, ArC
13

C NMR (75 MHz, CDC13) 8 20.9 (OOCH3), 24.7 (CH3), 25.3 (CH3), 34.7 (CH2),

41.8 (CH), 42.3 (N(3)BnCH2), 42.9 (N(l)BnCH2), 64.3 (CH20), 71.9 (Cspiro), 80.3

(C(7)HO), 81.7 (C(6)HO), 115.7 (OCO), 127.0 (ArCH), 127.5 (ArCH), 127.8 (ArCH
128.1 (ArCH), 128.4 (ArCH), 128.8 (ArCH), 136.0 (ArC), 137.1, (ArC), 156.0

(C(2)=0), 170.7 (OOCH3), 172.0 (C(4)=0). LRMS: (CI +ve) m/z 479 (M+l). HRMS:
(CI +ve) m/z Calc. C27H3iN206 479.2169, found 479.2170.
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[(5RS, 7RS, SSR, 9/?S)-l,3-Dibenzyl-8,9-isopropylidenedioxy-2,4-dioxo-l,3diazaspiro[4.4]non-7-yl]methyl acetate [138]
OAc A solution of compound 136 (70 mg, 0.161
mmol) in CH3CN (1 mL), pyridine (0.5 mL) and
N

\ '''f' y^\

acetic anh dride

y

(1 mL) was stirred for 10 hrs.
All volatiles were removed in vacuo, and the

138
resulting residue purified by column

chromatography (20 % EtOAc/Pet. Sp to 30 % EtOAc/Pet. Sp) to give the title

compound 138 as a clear oil (76 mg, 99 %). *H NMR (300 MHz, CDC13) 8 1.29 (
CH3), 1.54 (s, 3H, CH3), 1.56 (dd, 7= 6.3, 12.9Hz, 1H,
1H,

CHAHB),

CHAHB),

1.87 (t, 7 = 12.

1.99 (s, 3H, OOCH3), 2.97 (m, 1H, CH), 4.01 (dd, 7 = 6.3, 11.1 Hz,

CHAHBOAC), 4.09 (dd, 7 = 8.1, 11.1 Hz, 1H, CHAHBOAC), 4.49 (d, 7 = 5.4 Hz, 1H,

C(6)HO), 4.66 (d, 7= 16.2 Hz, 1H, N(l)BnCHAHB), 4.68 (s, 2H, N(3)BnCH2), 4.75 (t

= 5.4 Hz, 1H, C(7)HO), 5.03 (d, 7= 16.2 Hz, 1H, N(l)BnCHAiiB), 7.18-7.39 (m,
ArCH). 13C NMR (75 MHz, CDC13) 8 20.8 (OOCH3), 23.5 (CH3), 25.7 (CH3), 31.9
(CH2), 37.3 (CH), 42.4 (N(3)BnCH2), 45.2 (N(l)BnCH2), 63.0 (CH20), 69.5 (Cspiro),
79.8 (C(7)HO), 83.3(C (6)HO), 111.5 (OCO), 127.1 (ArCH), 127.3 (ArCH), 127.9

(ArCH), 128.4 (ArCH), 128.5 (ArCH), 128.7 (ArCH), 135.9 (ArC), 138.1 (ArC), 156.1
(C(2)=0), 170.8 (OOCH3), 174.3 (C(4)=0). LRMS: (CI +ve) m/z 479 (M+l). HRMS:
(CI +ve) m/z Calc. C27H3iN206 479.2169, found 479.2170.
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(5RS, 6RS, 7SR, 8/?S)-6-(Acetyloxy)-8-[(acetyloxy)methyl]-l,3-dibenzyI-2,4-dioxol,3-diazaspiro[4.4]non-7-yl acetate [139] and (SRS, 6SR, 7RS, 8/fS)-6-(Acetyloxy)8-[(acetyloxy)methyl]-l,3-dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-7-yl acetate
[140]

A solution of a mixture of triols 133 and 134 (300 mg, 0.757 mmol) in CH3CN (5 mL),

pyridine (3 mL) and acetic anhydride (5 mL) was stirred at RT for 10 h. After this ti
all volatiles were removed in vacuo. The resulting residue was purified by column
chromatography (30 % EtOAc/Pet. Sp) to give compound 139 and its diepimer 140 as

clear oils in a ratio of 2:1, respectively (determined by !H NMR integration of their
respective acetate resonances) (359 mg, total yield 91 %).
Data for [139]: *H NMR (300 MHz, CDC13) 8 1.54 (dd, 7 = 12.0, 13.8 Hz, 1H,
AcO

OAc

CHAHB),

1.85

(dd,

7 =

7.8,

13.8

Hz,

1H,

CHAHB), 1.94 (s, 3H, CH3), 1.99 (s, 3H, CH3),

2.25 (s, 3H, CH3), 2.63 (m, 1H, CH), 3.86 (dd, 7
= 6.0, 11.1 Hz, 1H, CHAHBOAC), 4.08 (dd, 7 =
8.7, 11.1 Hz, 1H, CHAHBOAC), 4.31 (d, 7= 16.2

Hz, 1H, N(l)BnCHAHB), 4.69 (ABq, 7 = 7.5 Hz, 2H, N(3)BnCH2), 4.99 (d,
1H, N(l)BnCHAHB), 5.26 (d, 7 = 4.2 Hz, 1H, C(6)HO), 5.64 (t, 7 = 4.2
C(7)HO), 7.23 - 7.41 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 20.0 (CH3

(CH3), 21.0 (CH3), 33.8 (CH2), 37.6 (CH), 42.8 (BnCH2), 44.6 (BnCH2), 61.3

(CH2OAc), 68.6 (Cspiro), 72.4 (CHO), 76.8 (CHO), 126.9 (ArCH), 127.3 (ArCH

(ArCH), 128.6 (ArCH), 128.8 (ArCH), 128.8 (ArCH), 135.7 (ArC), 137.8 (A
(C(2)=0), 169.1 (OOCH3), 169.2 (OOCH3), 170.5(OOCH3), 175.9 (C(4)=0).

LRMS: (CI +ve) m/z 523 (M+l). HRMS: (CI +ve) Calcd. for C28H3iN208 (M
523.2080, Found 523.2076.
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Data for [140]: *H N M R (300 M H z , CDC13) 8 1.68 (s, 3H, CH 3 ), 1.96 (m, 2H, CH 2 ),
-OAc 2.00 (s, 3H, CH3), 2.03 (s, 3H, CH3), 3.07 (m,
1H, CH), 4.03 (apparent d, 7 = 4.8 Hz, 2H,
'"f0 t^^i CH2°Ac)' 4.35 (d, 7 = 16.2 Hz, 1H,
N(l)BnCHAHB), 4.71 (ABq, 7 = 9.3 Hz, 2H,
140 N(3)BnCH2), 4.87 (d, 7 = 16.2 Hz, 1H,

N(l)BnCHAHB), 5.01 (dd, 7 = 7.2, 8.1 Hz, 1H, C(7)HO), 5.28 (d, 7 = 7.2 Hz, 1
C(6)HO), 7.23 - 7.41 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 20.0 (CH3), 20.4

(CH3), 20.6 (CH3), 30.1 (CH2), 40.8 (CH), 42.4 (BnCH2), 43.0 (BnCH2), 63.3

(CH2OAc), 70.0 (CHO), 71.2 (Cspir0), 71.3 (CHO), 127.0 (ArCH), 127.6 (ArCH), 127.
(ArCH), 127.8 (ArCH), 128.0 (ArCH), 128.4 (ArCH), 136.0 (ArC), 136.8 (ArCH),
155.9 (C(2)=0), 169.1 (OOCH3), 170.2 (OOCH3), 170.5 (OOCH3), 171.6 (C(4)=0).
LRMS: (CI +ve) m/z 523 (M+l). HRMS: (CI +ve) Calcd. for C28H3,N208 (MH+)
523.2080, Found 523.2076.

l,3-Dibenzyl-7-(hydroxymethyl)-l,3-diazaspiro[4.4]non-7-ene-2,4-dione[14

(I) Compound (5S)-95x (300 mg, 0.52 mmol) was reduced in the same manner
compound 119 for the synthesis of 142 using the conditions of procedure

purification by column chromatography (50 % EtOAc/Pet. Sp to 60 % EtOAc/
the title compound 141 was obtained as a colourless oil (29 mg, 15 %).

(II) Compound (5S)-95x (100 mg, 0.17 mmol) was reduced in the same manne
compound 113 for the synthesis of 142 using the conditions of procedure

purification by column chromatography (50 % EtOAc/Pet. Sp to 60 % EtOAc/
the title compound 141 was obtained as a colourless oil (19 mg, 32 %).
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(III) Compound 80 (100 mg, 0.248 mmol) was reduced in the same manner as
compound 113 for the synthesis of 142 using the conditions of procedure C. After
purification by column chromatography (50 % EtOAc/Pet. Sp to 60 % EtOAc/Pet. Sp),
the title compound 141 was obtained as a colourless oil (15 mg, 17 % ) .
Data for [141]: *H N M R (300 M H z , CDC1 3 ) 8 2.21 (d, 7 = 16.8 Hz, 1H,

C(6)HAHB),

2.44 (dd, 7 = 1.5, 17.4 Hz, 1H, C ( 9 ) H A H B ) , 2.82
(d, 7 = 16.8 Hz, 1H, C ( 6 ) H A H B ) , (dd, 7 = 2.1,
17.4 Hz, 1H, C ( 9 ) H A H B ) , 3.96 (ABq, 7 =

13.8

Hz, A v = 24.6 Hz, Q f c O H ) , 4.21 (d, 7 = 15.6 Hz,
141

1H, N(l)CHAH B Bn), 4.64 (d, 7 = 15.6 Hz, 1H,

N(l)CHAHBBn), 4.73 (s, 2H, N(3)CH 2 ), 5.46 (m, 1H, =CH), 7.23 - 7.42 (m, 10H,
ArCH).

13

C NMR

(75 M H z , CDC1 3 ) 841.9 (CH 2 ), 42.5 (N(3)CH2Bn), 42.8

(N(l)CH2Bn), 43.8 (CH 2 ), 61.1 (CH 2 OH), 69.9 (Cspiro), 121.7 (=CH), 127.7 (ArCH),
127.8 (ArCH), 128.0 (ArCH), 128.3 (ArCH), 128.4 (ArCH), 128.6 (ArCH), 136.1
(ArC), 137.7 (ArC), 141.7 (=C), 155.4 (C(2)=0), 175.9 (C(4)=0). L R M S : (CI +ve) m/z
363 (M+l). H R M S : (CI +ve) m/z Calc. C 2 2 H 2 3 N 2 0 3 363.1708, found 363.1704.

(5«S,8S/?)-l,3-Dibenzyl-8-(hydroxymethyl)-l,3-diazaspiro[4.4]non-6-ene-2,4-dione
[142]
Procedure A - Reduction by UBH4.

To a solution of compound 119 (250 mg, 0.44

mmol) in diethyl ether (10 m L ) was added a 10 % MeOH/diethyl ether solution (0.18
m L ) followed by solid LiBH 4 (10 mg, 0.45 mmol). After 1 h the reaction was slowly
diluted with 1 0 % aqueous N H 4 C 1 (5 m L ) with stirring for 10 min. The reaction was then
extracted into ethyl acetate (30 mL). The organic

extract was washed with brine, dried

(MgS0 4 ), and then concentrated in vacuo to give a yellow residue. Purification of the
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residue by column chromatography (50 % EtOAc/Pet. Sp to 60 % EtOAc/Pet. Sp) gave
the title compound 142 as a colourless oil (41 mg, 26 %).

Procedure B - Reduction by NaBH4: (I) To a solution of compound 119 (18 mg, 0.031
mmol) in THF (1.5 mL) at 0 °C was slowly added a solution of NaBH4 (5 mg, 0.131
mmol) in H20 (0.5 mL). After 10 min the reaction was allowed to warm to RT and
stirring was continued for 2 h. It was then cooled to 0 °C and 1M HCI (1 mL) was

carefully added. The reaction was warmed to RT, extracted into ethyl acetate (2 x

mL), dried (MgS04) and concentrated in vacuo to give a yellow residue. Purificatio
column chromatography (50 % EtOAc/Pet. Sp to 60 % EtOAc/Pet. Sp) gave the title
compound 142 as a colourless oil (2.7 mg, 24 %).
(II) Compound 113 (40 mg, 0.1 mmol) was treated in the same manner as compound
119 (above) using reduction procedure B. The title compound 142 was obtained as a
colourless oil (2 mg, 5 %).
Procedure C - Reduction by DIBAL: To a solution of compound 113 (130 mg, 0.32
mmol) in THF (5 mL) at -78 °C was slowly added DIBAL (427 uL of a 1.5 M solution

in toluene, 0.64 mmol). Stirring was continued for 1 h before the reaction mixture

warmed to RT and stirred for another 3 h. After this time the reaction mixture was

diluted with water (40 mL) and extracted into ethyl acetate (2 x 40 mL). The comb

organic extracts were washed with brine, dried (MgS04) and the solvent was removed
in vacuo to give a light yellow oil, which was purified by column chromatography
% EtOAc/Pet. Sp to 60 % EtOAc/Pet. Sp) to yield the title compound 142 as a
colourless oil (12 mg, 10 %).
Procedure D - Reduction by Borane Methyl Sulphide. To a solution of 154 (900 mg,
2.39 mmol) in THF (20 mL) at 0 °C was added dropwise a 2 M solution of borane

methyl sulphide in THF (1.32 mL, 2.64 mmol). Stirring was continued for 6 h before
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water (10 m L ) was added. After 10 mins, the T H F was removed in vacuo and the

remaining residue was extracted into ethyl acetate (2 x 50 mL). The combined o

extracts were dried (MgS04), and concentrated in vacuo to give an oily residue.

Purification of this oily residue by column chromatography (50 % EtOAc/Pet. Sp

% EtO Ac/Pet. Sp) gave the title compound 142 as a colourless oil (822 mg, 95 %
Data for [142]: *H NMR (300 MHz, CD3CN) 8 1.76 (dd, 7 = 6.3, 14.1 Hz, 1H,
C(9)HAHB), 2.30 (dd, 7 = 8.4, 14.1 Hz, 1H,
C(9)HAHB), 2.98 (m, 1H, CH), 3.44 (dd, 7 =

2.1, 5.4 Hz, 2H, OCH2), 4.43
0 (d, 7 = 16.2 Hz,

y^
x
'Y
1H N(l)BnCHACH ), 4.52 (d, 7 =16.2 Hz,
"xy?

B

N
1H, N(l)BnCHAHB),
O 4.64 (s, 2H, N(3)BnCH2),
142
5.36 (dd, 7 = 2.4, 5.4 Hz, 1H, =CH 2 ), 6.08 (dd, 7 = 2.4, 5.4 Hz, 1H, =CH 2 ), 7.21 - 7.39
(m, 10H, ArCH). 13C NMR (75 MHz, CDC13) 8 34.0 (CH2), 42.4 (BnCH2), 43.2
(BnCH2), 47.4 (CH), 64.8 (CH2OH), 76.7 (Cspir0), 127.4 (ArCH) 127.7 (ArCH), 127.8
(ArCH), 128.2 (ArCH),128.4 (ArCH), 128.5 (ArCH), 129.2 (=CH), 136.0 (ArC), 137.5
(ArC), 140.8 (=CH), 155.7 (C(2)=0), 174.9 (C(4)=0). LRMS: (CI +ve) m/z 363 (M+l).
HRMS: (CI +ve) m/z Calc. C22H23N203 363.1708, found 363.1705.

(4RS, SRS, 7#S)-l,3-Dibenzyl-4-hydroxy-8-hydroxymethyl-l,3-diaza-

spiro[4.4]non-6-en-2-one [148A] and its epimer (4SR, SRS, 7flS)-l,3-Dibenzylhydroxy-8-hydroxymethyl-l,3-diaza-spiro[4.4]non-6-en-2-one[148B]
^OH Compound 114 (150 mg, 0.37 mmol), was
reduced in the same manner as compound 119
" Y * 0 H sX? X

for tne

synthesis of 142 using the conditions of

procedure A. A mixture of the title compounds
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148A and 148B were isolated as a white foam (75 mg, 56 % ) . Ratio of 148A to 148B

was 1:1 as determined by the chemical shifts of the olefinic protons, 5.

ppm for one diastereoisomer and 5.55 ppm and 5.82 ppm for the other dia
13

C NMR (on the mixture, 75 MHz, CDC13) 8 29.1, 36.7 (CH2), 43.6, 43.7, 44.3

(NCH2Bn), 64.7, 64.9 (CH2OH), 76.6, 76.9 (Cspiro), 83.8, 86.8 (C(4)HOH), 126.9,

127.2, 127.6, 128.0, 128.0, 128.3, 128.4 (ArCH), 131.2, 133.4 (=CH), 136.6,
(ArC), 137.3, 138.2 (ArC), 139.3, 139.4 (=CH), 158.6, 158.9 (C(2)=0). LRMS:

+ve) m/z 365 (M+l) (28 %), 347 [(M+l) - H20] (100 %). HRMS: (CI +ve) Cal
C22H25N203 (MH+) 365.1865, Found 365.1857.

(4RS, 5SR, 6RS, 7SR, 8/?S)-l,3-Dibenzyl-4-hydroxy-8-(hydroxymethyl)-6,7

isopropylidenedioxy-l,3-diazaspiro[4.4]nonan-2-one [149] and Ethyl (4RS

7S/^8S#,9/?S)-l,3-Dibenzyl-4-hydroxy-8,9-isopropylidenedioxy-2-oxo-l,3diazaspiro[4.4]nonane-7-carboxylate [150]

Compound 129 (355 mg, 0.74 mmol) was reduced in the same manner as comp

119 for the synthesis of 142 using the conditions of procedure A. After

chromatography (50 % EtOAc/Pet. Sp to 70 % EtOAc/Pet. Sp) compound 149 (
17 %) and compound 150 (253 mg, 71 %) were isolated as an oil and cubic
respectively.
Data for [149]: XH NMR (300 MHz, CDC13) 8 0.91 (dd, 7 = 5.1, 11.7 Hz, 1H,
1.26 (s, 3H, CH3), 1.84 (t, 7 = 11.7 Hz, 1H,

OH
CHAHB), 1.91 (m, 1H, CH), 3.52 (dd), 6.0,
OH y^ 11.1 Hz, 1H, CHAHBOH), 3.56 (dd, 7 = 4.5,
11.1 Hz, 1H, CHAHBOH), 4.51 (t, 7 = 5.4 Hz,

1H, C(7)HO), 4.15 (d, 7 = 15.3 Hz, 1H,
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N(3)BnCHAHB), 4.51 (t, 7 = 5.4 Hz, 1H, C(7)H0), 4.56 (d, 7 = 16.2 Hz,

N(l)BnCHAHB), 4.73 (d, 7 = 15.3 Hz, 1H, N(3)BnCHAHB), 4.85 (d, 7 = 16.2 Hz,
N(l)BnCHAHB), 4.92 (d, 7 = 5.4 Hz, 1H, C(6)H0), 7.18 - 7.33 (m, 10H, ArCH).

1

NMR (75 MHz, CDC13) 8 23.6 (CH3), 25.8 (CH3), 32.7 (CH2), 40.1 (CH), 44.3
(N(3)CH2Bn), 44.9 (N(l)CH2Bn), 61.9 (CH2OH), 68.0 (Cspiro), 79.9 (C(7)H0), 81.5
(C(4)H0H), 85.3 (C(6)H0), 110.5 (OCO), 127.0 (ArCH), 127.2 (ArCH), 127.6

(ArCH), 128.2 (ArCH), 128.4 (ArCH), 128.7 (ArCH), 136.9 (ArC), 140.0 (ArC), 15
(C(2)=0). LRMS: (CI +ve) m/z 439 (M+l) (74 %), 421 [(M+l) - H20] (100 %).
HRMS: (CI +ve) Calcd. for C25H31N205 (MH+) 439.2232, Found 439.2218.

Data for [150]: mp 149 -150 °C. XH NMR (300 MHz, CDC13) 8 1.01 (dd, 7 = 6.
Hz, 1H, CHAHB), 1.19 (t, 7 = 7.2 Hz, 3H,

COOEt
OCHzCHj), 1.21 (s, 3H, CH 3 ), 1.43 (s, 3H,
. CH3), 2.39 (t, 7 = 12.9 Hz, 1H, CHAHB), 2.67

I) (dt, 7 = 12.9, 6.6 Hz, 1H, CH), 4.08 (dq, 7 =
° 3.3, 7.2 Hz, 2H, OCH2), 4.12 (d, 7 = 14.7 Hz,
150
1H, N(3)CHAHBBn), 4.51 (d, 7 = 7.8 Hz, 1H, C(4)HOH), 4.56 (d, 7 = 16.2 Hz, 1H,

N(l)CHAHBBn), 4.67 (dd, 7 = 5.1, 6.6 Hz, 1H, CHO), 4.69 (d, 7 = 14.7 Hz, 1H

N(3)CHAHBBn), 4.82 (d, 7 = 16.2 Hz, 1H, N(l)CHAHBBn), 4.90 (d, 7 = 5.1 Hz,
CHO), 7.18 - 7.38 (m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 14.2 OCH2CHj),

24.2 (CH3), 25.9 (CH3), 31.9 (CH2), 44.3 (N(3)CH2Bn), 44.9 (N(l)CH2Bn), 45.0 (CH
60.7 (OCH2), 67.8 (Cspiro), 79.3 (CHO), 80.9 (CHO), 84.8 (C(4)HOH), 110.9 (OCO),
126.7 (ArCH), 127.0 (ArCH), 127.5 (ArCH), 128.1 (ArCH), 128.2 (ArCH), 128.6
(ArCH), 136.7 (ArC), 139.7 (ArC), 158.7 (C(2)=0), 170.3 (OO). LRMS: (Cl+ve)
481 (M+l) (60 %), 463 [(M+l) - H20] (100 %). HRMS: (CI +ve) Calcd. for
C27H33N206 (MH+) 481.2338, Found 481.2326.
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(5SR,7RS,8RS)-l,3-Dibenzyl-7,8-isopropylidenedioxy-4-hydroxy-7(hydroxymethyl)-l,3-diazaspiro[4.4]nonan-2-one[151]
Compound 125 (500 mg, 1.05 mmol) was
reduced in the same manner as compound 119

Q

O

for the synthesis of 142 using the conditions of
procedure A. After purification by column
chromatography (50 % EtOAc/Pet. Sp to 70 %
EtOAc/Pet. Sp), the title compound 151 was

151
0/-. ll

obtained as a white solid (365 mg, 80 % ) , mp 150 - 152 °C. 'H N M R (300 MHz,

CDC13) 8 1.23 (s, 3H, CH3), 1.41 (s, 3H, CH3), 1.57 (d, 7 = 10.2 Hz, 1H,
1.65 (ddd, 7 = 2.7, 6.9, 12.9 Hz, 1H, C(6)HAHB), 1.75 (dd, 7 = 1.5, 10.2 Hz, 1H,
C(9)HAHB), 1.88 (dd, 7 = 3.6, 12.9 Hz, 1H, C(6)HAHB), 3.46 (d, 7 = 10.8 Hz, 1H,
CHAHBOH),

3.98 (d, 7 = 10.8 Hz, 1H,

CHAHBOH),

4.03 (m, 1H, C(7)H), 4.12 (d, 7

15.3 Hz, 1H, CHAHBBn), 4.21 (s, 1H, C(4)HOH), 4.44 (ABq, 7 = 15.6 Hz, Av = 2

Hz, 2H, NCH2Bn), 4.89 (d, 7 = 15.3 Hz, 1H, CHAHeBn), 7.24 - 7.38 (m, 10H, ArC
13

C NMR (75 MHz, CDC13) 826.6(CH3), 28.1 (CH3), 34.0 (CH2), 38.4 (CH2), 43.9

(NCH2Bn), 44.8 (NCH2Bn), 67.1 (CH2OH), 69.7 (Cspiro), 82.6 (CHO), 84.3 (CHOH),
89.7 (C(8)0), 112.6 (OCO), 127.3 (ArCH), 127.4 (ArCH), 128.1 (ArCH), 128.4

(ArCH), 128.5 (ArCH), 136.5 (ArC), 138.5 (ArC), 157.4 (C(2)=0). LRMS: (CI +v

m/z 439 (M+l) (2 %), 421 [(M+l) - H20] (100 %). HRMS: (CI +ve) Calcd. fo
C25H28N204 (M- H20) 420.2049, Found 420.2047.
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(5SJR,7S«,8Sl?)-l,3-Dibenzyl-7,8-isopropylidenedioxy-7-(hydroxymethyl)-l,3-

diazaspiro[4.4]nonane-2,4-dione [152], (4SR 5SR, 7SR, 85i?)-l,3-Dibenzyl-7

isopropylidenedioxy-4-hydroxy-7-(hydroxymethyl)-l,3-diazaspiro[4.4]nonan
dione [153A] and its epimer (4RS, 5SR, 7SR, 85/?)-l,3-Dibenzyl-7,8-

isopropylidenedioxy-4-hydroxy-7-(hydroxymethyI)-l,3-diazaspiro[4.4]nonan
dione [153B]

Compound 124 (150 mg, 0.313 mmol) was reduced in the same manner as com

119 for the synthesis of 142 using the conditions of procedure A. After

column chromatography (50 % EtOAc/Pet. Sp to 60 % EtOAc/Pet. Sp), compou

(46 mg, 34 %) and diastereoisomers of compound 153 (A + B) (77 mg, 56 %
obtained as colourless oils.

Data for [152]: XH NMR (300 MHz, CDC13) 8 1.33 (s, 3H, CH3), 1.67 (s, 3H, C
2.12 (dd, 7 = 5.7, 15.6 Hz, 1H, C ( 9 ) H A H B ) , 2.18
(d, 7 = 16.2 Hz, 1H, C(6)HAHB), 2.45 (br s, 1H,

O

O

OH), 2.36 (dd, 7 = 2.4, 15.6 Hz, C(9)HAHB),

« ' V° yX^X

2M (d

'

J = 16 2 HZ

'

'

1H

'

C(6)HAHB)

' 3'59

(br S

'

^N
JLJJ 2H, CHSOH), 4.51 (dd, 7 = 2.4, 5.7 Hz, 1H,
^
O
152

C(8)H), 4.58

(ABq, 7 =

16.2 Hz, 2H,

N(l)CH2Bn), 4.70 (s, 1H, N(3)CH2Bn), 7.22 - 7.42 (m 10H, ArCH).

13

C NMR (75

MHz, CDC13) 827.3 (CH3), 27.7 (CH3), 39.5 (CH2), 42.7 (NCH2Bn), 43.0 (NCH2Bn),

43.4 (CH*), 65.5 (CH2OH), 71.3 (Cspiro), 82.7 (CHO), 91.8 (CO), 111.9 (OCO), 127.

(ArCH), 127.6 (ArCH), 127.7 (ArCH), 128.3 (ArCH), 128.5 (ArCH), 128.7 (ArCH),

136.0 (ArC), 137.4 (ArC), 155.7 (C(2)=0), 175.5 (C(4)=0). LRMS: (CI +ve) m/z

(M+l). HRMS: (CI +ve) Calcd. for C25H29N205 (MH+) 437.2076, Found 437.2074.
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Data for 153A and 153B. "
C N M R (on mixture, 75 M H z , CDC13) 8 25.8, 26.1 (CH3),

26.3, 26.7 (CH3), 34.4, 36.6 (CH2), 37.3, 41.1
(CH2), 42.8, 42.9 (NCH2Bn), 44.4, 44.5

O

O

(NCH2Bn), 66.0, 66.2 (CH 2 OH), 69.5, 70.5
(CSpiro), 80.5, 80.7 (CHO), 83.6, 83.7 (CHOH),
89.1, 89.9 (CO), 109.8, 109.8 (OCO), 129.9,
127.0, 127.0, 127.1, 127.3, 128.0, 128.3,
128.4, 128.5 (ArCH), 137.1, 137.5 (ArC),

139.1 (ArC), 158.4, 158.6 (C(2)=0). L R M S : (CI +ve) m/z 439 (M+l) (3 % ) , 421
[(M+l) - H 2 0] (100 %). H R M S : (CI +ve) Calcd. for C 2 5 H 2 8 N 2 0 4 (M- H 2 0 ) 420.2049,
Found 420.2045

(5/?S,7Sic)-l,3-Dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-8-ene-7-carboxylicacid
[154]

COOH

Compound

113 (1.14 g, 2.82 mmol) was

hydrolysed in the same manner as compound
114 for the preparation of 155 using procedure
A. The title compound 154 was obtained as a
white solid (1.05 g, 99 % ) , mp 140 - 144 °C. >H
N M R (300 M H z , CDC13) 8 2.39 (dd, 7 = 6.3, 14.4 Hz, 1H, CH 2 ), 2.53 (dd, 7 = 9.0, 14.4
Hz, 1H, CH 2 ), 3.86 (ddt, 7 = 2.4, 6.4, 9.0 Hz, 1H, CH), 4.43 (d, 7 = 15.9 Hz, 1H,
N(l)BnCHACHB), 4.60 (d, 7 = 15.9 Hz, 1H, N W B U C H A H B ) , 4.71 (s, 2H, N(3)BnCH2)
5.32 (dd, 7 = 2.4, 5.4 Hz, 1H, = C H A H B ) , 6.13 (dd, 7= 2.4, 5.4 Hz, 1H, = C H A H B ) , 7.27 -

7.43 (m, 10H, ArCH). 13 C N M R (75 M H z , CDC13) 8 33.7 (CH2), 42.8 (BnCH2), 43.6
(BnCH2), 49.3(CH), 76.3 (Cspiro), 127.7 (ArCH), 127.9 (ArCH), 128.2 (ArCH), 128.5
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(ArCH), 128.5 (ArCH), 128.7 (ArCH), 131.0 (=CH), 135.9 (ArC), 136.4 (=CH), 137.3
(ArC), 155.6 (C(2)=0), 174.3 (C(4)=0), 177.7 (COOH). LRMS: (CI +ve) m/z 377
(M+l). HRMS: (CI +ve) Calcd. for C22H20N2O4 (M+) 376.1423, Found 376.1406.

(5RS, 7/?1S)-l,3-Dibenzyl-2,4-dioxo-l,3-diazaspiro[4.4]non-8-ene-7-carboxylicac
[155]

Procedure A - Acid hydrolysis: To a solution of 114 (500 mg, 1.23 mmol) in CH3C

(10 mL) was added 10 % HCI (10 mL). The mixture was heated to 90 °C for 15 h be

it was cooled to RT and then extracted into ethyl acetate (2 x 50 mL). The comb

organic extract was dried (MgS04) and concentrated in vacuo to give compound 155
a white foam (464 mg, >99 %).

Procedure B - Base hydrolysis: To a solution of 114 (65 mg, 0.16 mmol) in THF/H

(3:1, 4 mL), was added LiOH.H20 (7 mg, 0.17 mmol). The reaction was allowed to st

at RT for 24 h before it was diluted with H20 (5 mL). The THF was removed in vac

and the remaining aqueous extract was then washed with diethyl ether (2 x 10 mL

acidified with 1M HCI and then extracted into ethyl acetate. The organic extrac

dried (MgS04) and the solvent was removed in vacuo to give an oily residue (60 m
%), which hardened at low temperatures. lH NMR analysis of this residue showed

compound 155 (20 %), its diastereoisomer 154 (48 %) and the conjugated acid (32

(as determined by the chemical shifts of the olefinic protons, 5.39 ppm and 6.21
155, 5.32 ppm and 6.13 ppm for 154 and 6.67 ppm for the conjugated acid).
Data for [155]: lU NMR (300 MHz, CDCI3) 8 2.00 (dd, 7 = 9.0, 14.7 Hz, 1H,

CHAHB),

2.57 (dd, 7 = 5.7, 14.7 Hz, 1H, CHAHB), 3.58 (ddt, 7 = 2.4, 5.7, 9.0 Hz, 1H, CH), 4.16

(d,7= 15.6 Hz, lH,N(l)BnCHAHB),4.66(d,7= 15.6 Hz, lH,N(l)BnCHAHB),4.71 (s,
2H, N(3)BnCH2) 5.39 (dd, 7 = 2.4, 5.1 Hz, 1H,

=CCHAHB),

6.21 (dd, 7 = 2.4, 5.1 Hz,

Chapter 7

241

COOH

1H, = C H A H B ) , 7.19 - 7.40 (m, 10H, ArCH). 13C

NMR (75 MHz, CDC13) 8 34.1 (CH2), 43.0

K 'T y^\ (N(3)CH2Bn)> 44.0 (N(l)CH2Bn), 50.3 (CH),
^

76.4 (Cspiro), 127.7 (ArCH), 127.9 (ArCH), 128.3

155 128.5 (ArCH), 128.6 (ArCH), 128.6
(ArCH),
(ArCH), 129.7 (=CH), 135.7 (ArC), 137.0 (ArC), 137.6 (=CH), 155.4 (C(2)=0), 174.3

(C(4)=0), 175.4 (COOH). LRMS: (CI +ve) m/z 311 (M+l). HRMS: (CI +ve) Calcd.
for C22H20N2O4 (M+) 376.1423, Found 376.1406.

(5RS, 8flS)-l,3-Dibenzyl-8-(hydroxymethyl)-l,3-diazaspiro[4.4]non-6-ene-2,4-dione

[156]
Compound 155 (260 mg, 0.69 mmol) was

"OH

reduced in the same manner as compound 154

7^° y^y

for the s ntnesis of 142 using rocedure D After

y

p

-

' purification by column chromatography (40 %
EtOAc/Pet. Sp to 60 % EtOAc/Pet. Sp), the title
156
compound 156 was obtained as a viscous oil (230 mg, 92 %). *H NMR (300
CDC13) 8 1.96 (br s, 1H,

C(9)HAHB),

1-99 (d, J= 1.8 Hz, 1H,

C(8)H), 3.64 (dd, 7 = 5.1, 10.8 Hz, 1H,
CHAHBOH),

CHAHBOH),

C(9)HAHB),

3.03 (

3.67 (dd, 7 = 5.4, 10.8 H

4.25 (d, 7 = 15.6 Hz, 1H, N(l)CHAHBBn), 4.60 (d, 7 = 15.6 Hz, 1H

NtDCHAHBBn), 4.70 (s, 2H, N(3)CH2Bn), 5.30 (dd, 7 = 1.8, 5.1 Hz, 1H, =CH),
(dd, 7 = 1.8, 5.1 Hz, 1H, =CH), 7.22 - 7.39 (m, 10H, ArCH).

13

C NMR (75 MHz,

CDC13) 8 35.0 (CH2), 42.9 (BnCH2), 43.8 (BnCH2), 47.9 (CH), 65.1 (CH2OH), 76.8

(Cspiro), 127.6 (ArCH) 127.8 (ArCH), 127.9 (=CH), 128.4 (ArCH), 128.5 (ArCH), 1
(ArCH), 128.6 (ArCH), 135.9 (ArC), 137.4 (ArC), 141.4 (=CH), 155.4 (C(2)=0),
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(C(4)=0). L R M S : (CI +ve) m/z 363 (M+l). H R M S : (CI +ve) m/z Calc. C 22 H 23 N 2 0 3
(MH+) 363.1708, found 363.1705.

(5SR,7RS, 8S/J)-l,3-Dibenzyl-7-bromomethyl-7,8-dihydroxy-l,3diazaspiro[4.4]nonane-2,4-dione[158]

HO

OH

A solution of 152 (32 mg, 0.074 mmol) in HBr

(45 % in acetic acid) was heated to reflux

before it was cooled and concentrated in v
The residue was taken up and concentrated

158

vacuo to give 158 as a yellow oil (34 mg,

>99%). J H N M R (300 M H z , CDC13) 8 1.93 (d, 7 = 14.4 Hz, 1H,

C(6)JIAHB), 2.50 (d,

7

= 14.4 Hz, 1H, C(6)HAHB), 2.51 (m, 1H, C(9)HAHB), 3.23 (dd, 7 = 6.3, 17.1 Hz, 1H,

C(9)

HAHB),

3.66 (s, 2H, CH2Br), 4.39 (d, 7 = 6.3 Hz, 1H, C(8)H), 4.65 (d,

1H, CHAHBBn), 4.74 (s, 2H, CH2Bn), 4.97 (d, 7= 16.5 Hz, 1H, CHAHBBn), 7.28 - 7
(m, 10H, ArCH).

13

C NMR (75 MHz, CDC13) 8 38.6 (C(7)H2Br), 40.6 (C(9)H2), 43.

(CH2Ph), 43.5 (C(6)H2), 44.0 (CH2Ph), 56.1 (C(8)H), 70.3 (Cspiro), 81.8 (C(7)OH)
127.1 (ArCH), 127.7 (ArCH), 128.2 (ArCH), 128.5 (ArCH), 128.7 (ArCH), 128.8
(ArCH), 135.1 (ArC), 137.0 (ArC), 155.0 (C(2)=0), 178.7 (C(4)=0).

(5SR, 6RS, 7SR, 8flS)-l,3-Dibenzyl-6,7-isopropylidenedioxy-4-hydroxy-8-

(hydroxymethyl)-l,3-diazaspiro[4.4]nonan-2-one [149] and (5SR, 6RS, 7SR
l-Benzyl-6,7-isopropylidenedioxy-4-hydroxy-8-(hydroxymethyl)-l,3diazaspiro[4.4]nonan-2-one [159]

Using a cold finger trap, NH3 (10 mL) was condensed, under a N2 atmosphe

necked flask at -78 °C containing Na (7 mg, 0.304 mmol). The solution tu
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then a solution of compound 138 (75 mg, 0.157
mmol) in THF (3 mL) was added via syringe.
After 30 mins a saturated solution of NHoCl (1
mL) was added and the reaction warmed to RT
to evaporate NH3. The resulting residue was

149

diluted with ethyl acetate (20 mL) and washed with water (2 x 20 mL). T

extract was dried (MgS04), concentrated in vacuo and then purified by co

chromatography (100 % EtO Ac to 10 % MeOH/EtOAc) to give compound 149 (

28 %) and compound 159 (18 mg, 33 %) as a viscous oil. Spectral data fo

identical to the compound synthesised from 129 using LiBH4 as the reduci

Data for [159]: *H NMR (300 MHz, CDC13) 8 1.20 (dd, 7 = 5.7, 12.6 Hz, 1H,
1.23 (s, 3H, CH3), 1.46 (s, 3H, CH3), 1.84 (t, 7 = 12.6
Hz, CHAHB), 1-97 (br s, 1H, OH), 2.04 (br s, 1H, OH),

%,/OH 2.07 (m, 1H, CH), 3.60 (ABq, 7 = 6.3Hz, 2H, CH2OH),
N
4.54 (d, / = 16.2 Hz, BnCHACH B ), 4.56 (t, 7 = 5.7 Hz,
H
o 4.72 (d, 7 = 16.2 Hz, BnCHACHB), 4.94
1H, C(7)HO),

^X^
159

(s, 1H, C(4)HOH), 4.95 (d, 7 = 5.7 Hz, 1H, C(6)HO), 6.47 (br s, 1H, NH), 7.
(m, 5H, ArCH).

13

C NMR (75 MHz, CDC13) 8 23.6 (CH3), 25.8 (CH3), 32.6 (CH2), 40.

(CH), 44.6 (BnCH2), 61.7 (CH2OH), 69.8 (Cspiro), 79.8 (C(7)HO), 81.0 (C(4)HOH),
82.8 (C(6)HO), 110.4 (OCO), 126.7 (ArCH), 126.8 (ArCH), 128.2 (ArCH), 139.8

(ArC), 160.7 (C(2)=0). LRMS: (CI +ve) m/z 349 (M+l) (4 %), 331 [(M+l) - H

(100 %). HRMS: (CI +ve) Calcd. for CI8H25N205 (MH+) 349.1763, Found 349.17
HRMS: (CI +ve) Calcd. for C18H22N204 (M - H20) 331.1657, Found 331.1656.

244

Chapter 7

(5RS, 6SR, 7RS, 8#S)-l-(Cyclohexa-l,4-dien-l-ylmethyl)-4-hydroxy-8-

(hydroxymethyl)-6,7-isopropylidenedioxy-l,3-diazaspiro[4.4]nonan-2-one[1
Q ^^ Using a cold finger trap, NH3 (10 mL) was condensed,

' X.

x

OH

under a N2 atmosphere, into a 2 necked flask at -78 °C
'OH containing Li (1 mg, 0.14 mmol). The solution turned
blue and then a solution of compound 136 (25 mg,

O

"

160

0.057 mmol) in THF (1 mL) and tert-butmol (0.1 mL)

was added. After 30 min MeOH (5 mL) was added and the reaction warmed to

evaporate NH3. The resulting residue was concentrated in vacuo and was p

column chromatography (100 % EtOAc to 10 % MeOH/EtOAc) to give the title

compound 160 as an oil (6 mg, 30 %). XH NMR (300 MHz, CDC13) 8 1.28 (s, 3
CH3), 1.42 (s, 3H, CH3), 1.61 (dd, 7 = 7.2, 13.5 Hz, 1H, CHAHB), 2.17 (m, 1H, CH),
2.46 (dd, 7 = 8.1, 13.5 Hz, 1H, CHAHB), 2.53 (m, 1H, =CHCHAHBC=), 2.67 (m, 1H,
=CHCHAHBO),

2.70 (br m, 2H, =CHCH2CH=), 3.53 (d, 7 = 15.0 Hz, 1H,

NCHAHB),

3.57 (dd, 7 = 4.5, 10.8 Hz, 1H, CHAHBOH), 3.68 (dd, 7= 5.1, 10.8 Hz, 1H, CHAHBOH),

4.00 (d, 7 = 15.0 Hz, 1H,

NCHASB),

4.26 (d, 7 = 6.6 Hz, 1H, C(6)HO), 4.60 (

3.3, 6.6 Hz, 1H, C(7)HO), 5.18 (s, 1H, C(4)HOH), 5.70 (br m, 3H, 3 x =CH).

13

C

(75 MHz, CDC13) 824.6 (CH3), 26.5 (CH3), 27.5 (=CCH2C=), 27.7 (=CCH2C=), 34.8
(CH2), 46.2 (NCH2), 46.8 (CH), 64.4 (CH2OH), 68.6 (Cspir0), 81.8 (C(4)HOH), 84.2
(C(7)HO), 89.1 (C(6)HO), 113.5 (OCO), 122.9 (=CH), 124.7 (=CH), 125.1 (=CH),

132.0 (=CCH2N), 161.5 (C(2)=0). LRMS: (CI +ve) m/z 351 (M + 1) (78 %), 333 (

H20 + 1) (100 %). HRMS: (EI +ve) Calcd. for C18H25N205 (M - 1 )+ 349.1763, F
349.1752.
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(5RS, 6RS, 7SR, 8#S)-6,7-Di(acetyloxy)-8-[(acetyloxy)methyl]-3-benzyl-l,3diazaspiro[4.4]nonane-2,4-dione [161], (5RS, 6SR, 7RS, 8flS)-6,7-Di(acetyloxy)-8[(acetyloxy)methyl]-3-benzyl-l,3-diazaspiro[4.4]nonane-2,4-dione [162], (5RS, 6RS,

7S«,81?S)-6,7-Di(acetyloxy)-8-[(acetyloxy)methyl]-l,3-diazaspiro[4.4]nonane-2,4-

dione [163] and (SRS, 6SR, 7RS, 8#S)-6,7-Di(acetyloxy)-8-[(acetyloxy)methyl]-l,3
diazaspiro[4.4]nonane-2,4-dione [164]
To a sealed tube, under a N2 atmosphere, was added a mixture of compound 139 and

140 (500 mg, 0.96 mmol), freshly redistilled chlorobenzene (20 mL), recrystallized
bromosuccinamide (511 mg, 2.87 mmol) and azobisisobutyronitrile (47 mg, 0.287

mmol). The reaction tube was sealed and heated to 125 °C with stirring for 14 h w
was then cooled on ice before it was filtered. The filtrate was concentrated in

give a brown residue, which was redissolved in ethyl acetate (20 mL) and then wa

with water (2 x 20 mL). The organic extract was dried and solvent removed in vac

give an oily residue that was purified by column chromatography (50 % EtOAc/Pet.
to 90 % EtO Ac/Pet. Sp) to give 161 (103 mg, 25 %) and its 6,7-diepimer 162 (45

11% as oils and compound 163 (101 mg, 31 %) and its 6,7-diepimer 164 (50 mg, 15
were isolated as white solids.
Data for [161]: XH NMR (300 MHz, CDC13) 8 1.84 (dd, 7 = 9.9, 13.5 Hz, 1H, CHAHB),
1.91 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.14 (s, 3H,

OAc
CH 3 ), 2.55

(dd, 7 = 9.0 Hz,

13.5

Hz,

1H

CHAHB),

2.63 (m, 1H, CH), 4.01 (dd, 7 = 6.3, 11.1 Hz, 1H,

HN' ""V"0 <X^X
\

I

I

C H A H B O A C ) , 4.15

(dd, 7 = 8.1, 11.1 Hz, 1H,

CH-

/r H\yyy
O

AHBOAC),

4.63 (s,2H,N(3)BnCH 2 ), 5.15 (d, 7 = 3 . 6

161
Hz, 1H, C(6)HOAc), 5.62 (t, 7 = 3.6 Hz, 1H, C(7)HOAc), 6.20 (br s, 1H, N H ) , 7.23 7.38 (m, 5H, ArCH). 13C NMR (75 MHz, CDC13) 8 20.0 (CH3), 20.6 (CH3), 20.7 (CH3),
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36.9 (CH2), 37.1 (CH), 42.4 (BnCH2), 61.8 (CH2OAc), 65.8 (Cspiro), 73.6 (C(7)H0Ac),
75.6 (C(6)H0Ac), 127.9 (ArCH), 128.3 (ArCH), 128.6 (ArCH), 135.7 (ArC), 156.6
(C(2)=0), 169.3 (O0CH3), 169.4 (O0CH3), 170.7 (OOCH3), 174.9 (C(4)=0).
LRMS: (CI +ve) m/z 433 (M+l). HRMS: (CI +ve) Calcd. for C21H25N208 (MH+)
433.1603, Found 433.1603.

Data for [162]: XH NMR (300 MHz, CDC13) 8 1.70 (dd, 7 = 9.0, 14.1 Hz, 1H, CHAHB),
AcO,,

OAc

1.91 (s, 3H, CH 3 ), 2.06 (s, 3H, CH 3 ), 2.07 (s, 3H,
CH3), 2.53 (dd, 7 = 9.3 Hz, 14.1 Hz, 1H, CHAHB),

AcO""

HN

;

X^O
^

2.96 (m, 1H, CH), 4.14 (dd, 7= 5.1, 11.4 Hz, 1H, CH-

-IN

AHBOAC), 4.18 (dd, 7 = 4.8, 11.4 Hz, 1H, CH-

O
AHBOAC),

162

4.63 (ABq, 7 = 14.7 Hz, 2H, N(3)BnCH2),

5.16 (dd, 7= 6.0, 8.1 Hz, 1H, C(7)HOAc), 5.28 (d, 7= 6.0 Hz, 1H, C(6)HOAc),

s, 1H, NH), 7.26 - 7.38 (m, 5H, ArCH). 13C NMR (75 MHz, CDC13) 8 20.2 (CH3), 20.6

(CH3), 20.8 (CH3), 33.8 (CH2), 40.5 (CH), 42.3 (BnCH2), 63.8 (CH2OAc), 66.9 (Cspiro),
71.9 (CHOAc), 76.8 (CHOAc), 127.9 (ArCH), 128.4 (ArCH), 128.6 (ArCH), 135.8
(ArC), 156.4 (C(2)=0), 169.8 (OOCH3), 170.4 (OOCH3), 170.9 (C=OCH3), 172.0
(C(4)=0). LRMS: (CI +ve) m/z 433 (M+l). HRMS: (CI +ve) Calcd. for C21H25N208
(MH+) 433.1603, Found 433.1603.

Data for [163]: White solid mp 163 - 165 °C. *H NMR (300 MHz, CDC13) 8 1.8
= 13.8, 17.7 Hz, 1H, C H A H B ) , 2.04 (s, 3H, CH 3 ), 2.06 (s, 3H,

OAc

CH3), 2.16 (s, 3H, CH3), 2.60 (dd, 7 = 9.0 Hz, 17.7 Hz, 1H
CHAHB), 2.62 (m, 1H, CH), 4.03 (dd, 7 = 5.7, 11.1 Hz, 1H,
CHAHBOAC), 4.17 (dd, 7 = 8.1, 11.1 Hz, 1H, CHAHBOAC),

5.14 (d, 7 = 3.6 Hz, 1H, C(6)HOAc), 5.64 (t, 7 = 3.6 Hz
163

C(7)HOAc), 5.87 (br s, 1H, NH), 7.89 (br s, 1H, NH). 13C
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N M R (75 M H z , CDC1 3 ) 8 20.2 (CH3), 20.6 (CH3), 20.7 (CH3), 37.0 (CH) 37.4 (CH2),
61.8 (CH2OAc), 66.9 (Cspiro), 73.5 (C(7)HOAc), 75.7 (C(6)HOAc), 156.7 (C(2)=0),
169.6 ( O O C H 3 ) , 169.7 ( O 0 C H 3 ) , 170.8 ( O O C H 3 ) , 176.4 (C(4)=0). L R M S : (CI
+ve) m/z 343 (M+l). H R M S : (CI +ve) Calcd. for C u Hi 9 N 2 0 8 (MH + ) 343.1141, Found
343.1131.
Data for [164]: *H NMR (300 MHz, CDC13) 8 1.76 (dd, 7 = 8.4, 14.4
^
AcO v

2.08 (s, 3H, CH 3 ), 2.09 (s, 3H, CH 3 ), 2.10 (s, 3H, CH 3 ), 2.63

A

A^OAc
(dd, 7 = 10.2, 14.4 Hz, 1H, C H A H B ) , 2.90 (m, 1H, CH), 4.14
(dd, 7 = 5.7, 11.4 Hz, 1H C H A H B O A C ) , 4.22 (dd, 7 = 5.4,
N

11.4 Hz, 1H, C H A H B O A C ) , 5.22 (dd, 7 = 5.4, 8.4 Hz, 1H,

H
C(7)HOAc), 5.32 (d, 7 = 5.4 Hz, C(6)HOAc), 7.24 (br s, 1H,

164

NH), 8.73 (br s, 1H, NH). 13 C N M R (75 M H z , CDC13) 8 20.58 (CH3), 20.6 (CH3), 20.8
(CH3), 33.9 (CH2), 40.0 (CH), 64.1 (CH 2 OAc), 67.6 (Cspiro), 72.5 (CHOAc), 77.3
(CHOAc), 156.4 (C(2)=0), 170.2 ( O O C H 3 ) , 170.5 (C=OCH 3 ), 171.2 (C=OCH 3 ),
173.1 (C(4)=0). L R M S : (CI +ve) m/z 343 (M+l). H R M S : (CI +ve) Calcd. for
C M H i 9 N 2 0 8 (MH + ) 343.1141, Found 343.1133.

(SRS, 6RS, 7SR, 8l?S)-6,7-dihydroxy-8-(hydroxymethyl)-l,3-diazaspiro[4.4]
2,4-dione [165]
H0

^

/—OH

To a

solution of compound 163 (35 mg, 0.102 mmol) in THF

(1 mL) was added 10 % HCI (1 mL). The reaction mixture was

WH^'Y0

heated at reflux for 4 h before a11 volatiles wer

// [j

reduced pressure to yield the title compound 165 as a white
solid (22 mg, >99 % ) . m p 203 - 204 °C. 2 H N M R (300 M H z ,

165
C D 3 O D ) 8 1.74 (dd, 7 = 9.6, 13.8 Hz, 1H, C H A H B ) , 2.14 (m, 1H, CH), 2.32 (dd, 7 = 9.6,
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13.8 Hz, 1H, C H A H B ) , 3.58 (dd, 7 = 6.0, 10.8 Hz, 1H, C H A H B O H ) , 3.76 (dd, 7 = 7.8,

10.8 Hz, 1H,
C(7)HO).

13

CHAHBOH),

4.04 (d, 7 = 3.3 Hz, 1H, C(6)HO), 4.14 (t, 7 = 3.3 H

C NMR (75 MHz, CD3OD) 8 37.0 (CH2), 42.3 (CH), 62.3 (CH2OH), 70.8

(CSpiro), 75.1 (CHOH), 79.2 (CHOH), 159.4 (C(2)=0), 180.9 (C(4)=0). LRMS: (CI

+ve) m/z 217 (M+l). HRMS: (CI +ve) Calcd. for C8H12N205 (MH+) 217.0824, Foun
217.0823.

(5RS, 6SR, 7RS, 8flS)-6,7-dihydroxy-8-(hydroxymethyl)-l,3-diazaspiro[4.
2,4-dione [3]
HO, /—OH Compound 164 (20 mg, 0.058 mmol) was treated in the same
/ \ manner as compound 163 for the synthesis of 165. The reaction

HO

X>

HN r"^ gave the title compound 3 as a yellow solid (12 mg, 95 %) (mp
// u 150 °C, lit.26'37 158-160 °C) with spectral data almost identical

O
3

to those reported in the literature (Table 5.8).26'37 *H N M R

(300 MHz, CD3OD) 8 1.62 (dd, 7 = 7.5, 13.2 Hz, 1H,

CHAHB),

2.29 (dd, 7 = 9.

Hz, 1H, CHAHB), 2.37 (m, 1H, CH), 3.55 (dd, 7 = 5.1, 10.8 Hz, 1H, CHAHBOH), 3.61

(dd, 7 = 5.4, 10.8 Hz, 1H,

CHAHBOH),

3.88 (dd, 7 = 3.3, 6.3 Hz, 1H, C(7)HO)

7 = 6.3 Hz, 1H, C(6)HO). [lit.26'37 *H NMR (270 MHz, CD3OD) 8 1.62 (dd, 7 =

12.9 Hz, 1H), 2.29 (dd, 7 = 9.2, 12.9 Hz, 1H), 2.34-2.44 (m, 1H), 3.58
10.8 Hz, 2H) 3.87 (dd, 7 = 3.2, 6.0 Hz, 1H), 3.96 (d, 7 = 6.0 Hz, 1H)].
MHz, CD3OD) 8 34.0 (CH2), 48.1 (CH), 64.3 (CH2OH), 73.6 (Cspir0), 74.7 (CHOH),
78.2 (CHOH), 159.0 (C(2)=0), 180.1 (C(4)=0). LRMS: (CI +ve) m/z 217 (M+l).
HRMS: (CI +ve) Calcd. for C8H12N205 (MH+) 217.0824, Found 217.0823.
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W e e d name: Lambsquarters, Chenopodium

album (CHEAL). It

commonly grows on rich soils and thus is often a problem in many
gardens and farm fields.
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